Citrus Sinensis ID: 021046
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 318 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZT07 | 833 | G-type lectin S-receptor- | yes | no | 0.959 | 0.366 | 0.506 | 2e-86 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.965 | 0.363 | 0.492 | 8e-82 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.968 | 0.362 | 0.510 | 8e-81 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.981 | 0.368 | 0.493 | 4e-80 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.959 | 0.358 | 0.491 | 4e-79 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.974 | 0.364 | 0.495 | 3e-78 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.823 | 0.334 | 0.484 | 8e-78 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.943 | 0.366 | 0.469 | 2e-77 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.943 | 0.356 | 0.484 | 1e-76 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.908 | 0.354 | 0.503 | 2e-76 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 318 bits (816), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 167/330 (50%), Positives = 222/330 (67%), Gaps = 25/330 (7%)
Query: 1 MNLNQCQAKCLKNCSCRAYANS--KLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58
+ L +C+ +CLKNCSC AYA++ + G GCL W G ++D R ++ +GQ YIRV
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVD 421
Query: 59 APE---------QGNKKLLWIIVVLVLPVVLLPS-FYIFRRRRRKHKEKENMEANWDLLA 108
E G +++L I++ L+ V+LL + R RRK + AN+ +
Sbjct: 422 KEELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVP 481
Query: 109 FDINMSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVY 168
FD + S DK+++ LPLF L ++ AAT NFS+Q KLG GGFGPVY
Sbjct: 482 FDFDESFRFE-----------QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVY 530
Query: 169 KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228
KG L N E+AVKRLS SGQG+ EFKNE+ LI+KLQHR+LVR+ GCC+E E +L+YEY
Sbjct: 531 KGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEY 590
Query: 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 288
+PNKSLD F+F+ +++ L W R+ I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLDS
Sbjct: 591 LPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDS 650
Query: 289 DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+M PKISDFGMARIFGG++++G T R+VGT
Sbjct: 651 EMIPKISDFGMARIFGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 303 bits (777), Expect = 8e-82, Method: Compositional matrix adjust.
Identities = 164/333 (49%), Positives = 229/333 (68%), Gaps = 26/333 (7%)
Query: 1 MNLNQCQAKCLKNCSCRAYANS--KLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58
+ L +C+ +CLKNCSC AYA++ + G GCL W G+++D R +S +GQ Y+RV
Sbjct: 367 ITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVD 424
Query: 59 APE---------QGNKKLLWIIVVLVLPVVLL-PSFYIFRRRRRKHKEKENME---ANWD 105
E G K+L+ I++ L+ V+LL SF+ + R+RR+ + + +++
Sbjct: 425 KSELARWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFA 484
Query: 106 LLAFDINMSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFG 165
+FD+ S E DKS+ LPLF L++++ AT NF+ Q KLG GGFG
Sbjct: 485 PSSFDLEDSFILE---------ELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFG 535
Query: 166 PVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225
PVYKG L NG E+AVKRLS SGQG+ EFKNE+ LI+KLQHR+LVR+ GCC+E E +L+
Sbjct: 536 PVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLV 595
Query: 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285
YEY+PNKSLD F+F+ +++ L W R+ II GI +G+LYLHQ SRLRIIHRDLKASN+L
Sbjct: 596 YEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVL 655
Query: 286 LDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LD++M PKI+DFG+ARIFGG++++G+T R+VGT
Sbjct: 656 LDNEMIPKIADFGLARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 164/321 (51%), Positives = 221/321 (68%), Gaps = 13/321 (4%)
Query: 5 QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQG- 63
C+ +CL+NCSC AY+ GG GC++W DL+DL++ + G S++IR+ E G
Sbjct: 380 DCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFEAG--GSSLHIRLADSEVGE 433
Query: 64 NKKLLWIIVVLVLPVVLLPSFY---IFRRRRRKHKEKENMEANWD--LLAFDINMSITTR 118
N+K ++V VL V+L + ++R +R+K N D ++ D+ S T
Sbjct: 434 NRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETT 493
Query: 119 TNELCEADGEGNDKSKD-SWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQE 177
+ D K+ + S LP+FSL +++ AT +F + +LG GGFGPVYKG L +G+E
Sbjct: 494 SAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE 553
Query: 178 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVF 237
+AVKRLS +SGQG+ EFKNE++LIAKLQHR+LVRL GCC E E +L+YEYMPNKSLD F
Sbjct: 554 IAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFF 613
Query: 238 LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297
LF K+ L+ W+ R IIEGIA+GLLYLH+ SRLRIIHRDLK SN+LLD++MNPKISDF
Sbjct: 614 LFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDF 673
Query: 298 GMARIFGGDELQGNTKRIVGT 318
GMARIFGG++ + NT R+VGT
Sbjct: 674 GMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 298 bits (763), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 160/324 (49%), Positives = 212/324 (65%), Gaps = 12/324 (3%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
+ L +C+ +CLK C+C A+AN+ + GGSGC++W G L D+R GQ +Y+RV A
Sbjct: 371 IGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG--GQDLYVRVAAG 428
Query: 61 EQGNKKLLWIIVV---LVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSITT 117
+ +K++ ++ + + ++LL SF IF +RK K ++ D+ S +
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTP----IVDLVRSQDS 484
Query: 118 RTNELCEADGEGNDKSKDS---WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 174
NEL +A K + LPL +++ AT NFST KLG+GGFG VYKG LL+
Sbjct: 485 LMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLD 544
Query: 175 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234
G+E+AVKRLS S QG EF NE+ LIAKLQH +LVRL GCC+++GE +LIYEY+ N SL
Sbjct: 545 GKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSL 604
Query: 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294
D LF + L WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKI
Sbjct: 605 DSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKI 664
Query: 295 SDFGMARIFGGDELQGNTKRIVGT 318
SDFGMARIFG +E + NT+R+VGT
Sbjct: 665 SDFGMARIFGREETEANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 165/336 (49%), Positives = 222/336 (66%), Gaps = 31/336 (9%)
Query: 5 QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGN 64
C KCL+NCSC AYA++ G G+GC +W D + + ++ +++YIR+ +G+
Sbjct: 366 DCYVKCLQNCSCVAYASTN--GDGTGCEIWNTDPTN--ENSASHHPRTIYIRI----KGS 417
Query: 65 K-KLLWIIVV----LVLPVVLLPSFYIFRRRRRKH----KEKENMEANWDLLAFDINMSI 115
K W++VV L++PV L + + R+ + K E M ++ + +S
Sbjct: 418 KLAATWLVVVASLFLIIPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQSCSLTNKRLS- 476
Query: 116 TTRTNELCEAD-------------GEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEG 162
T R + + G+ + ++ ++ L +FS SV+ AT+ FS KLGEG
Sbjct: 477 TLRVGSTIDQEMLLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEG 536
Query: 163 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222
GFGPVYKGRL++G+EVA+KRLS SGQGL EFKNE MLIAKLQH +LV+L GCC+E+ E
Sbjct: 537 GFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEK 596
Query: 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKAS 282
+LIYEYMPNKSLD FLF P +K +L W+ R RI+EGI QGLLYLH+YSRL++IHRD+KA
Sbjct: 597 MLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAG 656
Query: 283 NILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
NILLD DMNPKISDFGMARIFG E + NTKR+ GT
Sbjct: 657 NILLDEDMNPKISDFGMARIFGAQESKANTKRVAGT 692
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 162/327 (49%), Positives = 212/327 (64%), Gaps = 17/327 (5%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
+ + +C+ KCL++C+C A+AN+ + G GSGC+ W G+L D+R GQ +Y+R+ A
Sbjct: 373 IGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG--GQDLYVRLAAT 430
Query: 61 E---QGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEK---ENMEANWDLLAFDINMS 114
+ + N+ I + + V+LL SF IF +RK K E + L + D+ M+
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490
Query: 115 ---ITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGR 171
I++R + E + + D LPL V+ AT NFS KLG+GGFG VYKG+
Sbjct: 491 EVVISSRRHISRE------NNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGK 544
Query: 172 LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231
LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH +LVRL CC++ GE +LIYEY+ N
Sbjct: 545 LLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLEN 604
Query: 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291
SLD LF + L WQ R II GIA+GLLYLHQ SR RIIHRDLKASNILLD M
Sbjct: 605 LSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMT 664
Query: 292 PKISDFGMARIFGGDELQGNTKRIVGT 318
PKISDFGMARIFG DE + NT+++VGT
Sbjct: 665 PKISDFGMARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 8e-78, Method: Compositional matrix adjust.
Identities = 154/318 (48%), Positives = 200/318 (62%), Gaps = 56/318 (17%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
M+LN+C+ CL+NC+C AY+ + GG GC++WFGDLID+R+ N GQ +Y+R+ +
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNENGQDLYVRLASS 426
Query: 61 EQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSITTRTN 120
E + + S + R+ +E+E++E
Sbjct: 427 E--------------IETLQRESSRVSSRK----QEEEDLE------------------- 449
Query: 121 ELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAV 180
LP L +VS AT FS KLG+GGFGPVYKG L GQEVAV
Sbjct: 450 -----------------LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAV 492
Query: 181 KRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY 240
KRLS S QG+ EFKNE+ LIAKLQHR+LV++ G C+++ E +LIYEY PNKSLD F+F
Sbjct: 493 KRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFD 552
Query: 241 PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+++R L W RV II+GIA+G+LYLH+ SRLRIIHRDLKASN+LLDSDMN KISDFG+A
Sbjct: 553 KERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLA 612
Query: 301 RIFGGDELQGNTKRIVGT 318
R GGDE + NT R+VGT
Sbjct: 613 RTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 163/347 (46%), Positives = 212/347 (61%), Gaps = 47/347 (13%)
Query: 5 QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIR-------- 56
C A CL+N SC AYA+++ G+GC +W + K ++ + +++YIR
Sbjct: 329 DCSAICLQNSSCLAYASTE--PDGTGCEIW--NTYPTNKGSASHSPRTIYIRGNENKKVA 384
Query: 57 ----VPAPEQGNKKLLWIIVVLVLP---------------------VVLLPSFYIFRRRR 91
V A ++W I+ LVL V LL RRR
Sbjct: 385 AWHIVVATLFLMTPIIWFIIYLVLRKFNVKGRNCIRITHKTVLVSMVFLLTMIGFIRRRI 444
Query: 92 RKHKEKENMEANWDLLAFDINMSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATE 151
+ ++ L I+ S + NE + ++ L +FS SV +AT+
Sbjct: 445 LSLRFGSTIDQEMLLRELGIDRSCIHKRNE----------RKSNNELQIFSFESVVSATD 494
Query: 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+FS + KLGEGGFGPVYKG+LLNG+EVA+KRLS SGQGL EFKNE +LIAKLQH +LV+
Sbjct: 495 DFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQ 554
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
+ GCCIE+ E +LIYEYM NKSLD FLF P +K +L W R RI+EGI QGLLYLH+YSR
Sbjct: 555 VLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSR 614
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
L++IHRD+KASNILLD DMNPKISDFG+ARIFG +E + NTKR+ GT
Sbjct: 615 LKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVAGT 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 152/314 (48%), Positives = 209/314 (66%), Gaps = 14/314 (4%)
Query: 6 CQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPE-QGN 64
C CL NCSC AYA + G GC++W GDL+D++ + +G ++IRV E + +
Sbjct: 389 CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG--SGIDLFIRVAHSELKTH 442
Query: 65 KKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSITTRTNELCE 124
L +I V+ V+L+ + + R+ K + L F M T NE
Sbjct: 443 SNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFK-RMEALTSDNE--- 498
Query: 125 ADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 184
+++ K LPLF ++ +T++FS + KLG+GGFGPVYKG+L GQE+AVKRLS
Sbjct: 499 ---SASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLS 555
Query: 185 NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKK 244
+SGQGL E NE+++I+KLQHR+LV+L GCCIE E +L+YEYMP KSLD +LF P K+
Sbjct: 556 RKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQ 615
Query: 245 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
++L W+ R I+EGI +GLLYLH+ SRL+IIHRDLKASNILLD ++NPKISDFG+ARIF
Sbjct: 616 KILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFR 675
Query: 305 GDELQGNTKRIVGT 318
+E + NT+R+VGT
Sbjct: 676 ANEDEANTRRVVGT 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 162/322 (50%), Positives = 211/322 (65%), Gaps = 33/322 (10%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
M L C+ KC NCSC AYAN+ + GG GCL+WFGDL+D+R+ S+F GQ VYIR+
Sbjct: 373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMRE-YSSF-GQDVYIRMGFA 430
Query: 61 EQGNK----KLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSIT 116
+ K + + V+ + VVL+ F FR++ K EN + D+++ I
Sbjct: 431 KIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKG--IEEEDLDLPIF 488
Query: 117 TRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQ 176
R ++S AT++FS LG GGFGPVYKG+L +GQ
Sbjct: 489 DR-------------------------KTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQ 523
Query: 177 EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDV 236
E+AVKRLS SGQG+ EFKNE+ LIAKLQHR+LVRL GCCI+ E +LIYEYMPNKSLD
Sbjct: 524 EIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDF 583
Query: 237 FLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 296
F+F ++ L W+ R+ II G+A+G+LYLHQ SRLRIIHRDLKA N+LLD+DMNPKISD
Sbjct: 584 FIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISD 643
Query: 297 FGMARIFGGDELQGNTKRIVGT 318
FG+A+ FGGD+ + +T R+VGT
Sbjct: 644 FGLAKSFGGDQSESSTNRVVGT 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 318 | ||||||
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.977 | 0.449 | 0.588 | 3e-96 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.977 | 0.156 | 0.588 | 1e-95 | |
| 224111422 | 304 | predicted protein [Populus trichocarpa] | 0.930 | 0.973 | 0.546 | 3e-90 | |
| 356514913 | 829 | PREDICTED: G-type lectin S-receptor-like | 0.930 | 0.357 | 0.544 | 4e-89 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.946 | 0.362 | 0.546 | 9e-89 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.943 | 0.346 | 0.562 | 3e-88 | |
| 224138268 | 818 | predicted protein [Populus trichocarpa] | 0.930 | 0.361 | 0.557 | 4e-88 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.943 | 0.470 | 0.563 | 9e-88 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.902 | 0.352 | 0.521 | 1e-87 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 0.902 | 0.226 | 0.521 | 3e-87 |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 190/323 (58%), Positives = 237/323 (73%), Gaps = 12/323 (3%)
Query: 2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRK-PISNFTGQSVYIRVPAP 60
++ C+ CL CSC AYA++ CLMW L++L++ + G+++Y+++ A
Sbjct: 224 SIETCKMTCLNKCSCNAYAHN------GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAAS 277
Query: 61 EQGN----KKLLWII-VVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSI 115
E N K W+I +V+V +VLL + YI R+ ++ +++E M + D+L ++ M
Sbjct: 278 ELQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKRVQDREEMTTSQDILLYEFGMGS 337
Query: 116 TTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 175
NEL E + G DK+KD+WLPLFS ASVSAATE+FST+ KLG+GGFGPVYKG L NG
Sbjct: 338 KATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNG 397
Query: 176 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235
QE+AVKRLS SGQGL E KNE +L+A+LQHR+LVRL GCCIEQGE ILIYEYMPNKSLD
Sbjct: 398 QEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLD 457
Query: 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295
FLF P K+ L W RV IIEGIAQGLLYLH+YSRLRIIHRDLKASNILLD+DMNPKIS
Sbjct: 458 SFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKIS 517
Query: 296 DFGMARIFGGDELQGNTKRIVGT 318
DFGMAR+FGG+E NT RIVGT
Sbjct: 518 DFGMARMFGGNESYANTNRIVGT 540
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 355 bits (912), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 190/323 (58%), Positives = 237/323 (73%), Gaps = 12/323 (3%)
Query: 2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRK-PISNFTGQSVYIRVPAP 60
++ C+ CL CSC AYA++ CLMW L++L++ + G+++Y+++ A
Sbjct: 641 SIETCKMTCLNKCSCNAYAHN------GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAAS 694
Query: 61 EQGN----KKLLWII-VVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSI 115
E N K W+I +V+V +VLL + YI R+ ++ +++E M + D+L ++ M
Sbjct: 695 ELQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKRVQDREEMTTSQDILLYEFGMGS 754
Query: 116 TTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 175
NEL E + G DK+KD+WLPLFS ASVSAATE+FST+ KLG+GGFGPVYKG L NG
Sbjct: 755 KATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNG 814
Query: 176 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235
QE+AVKRLS SGQGL E KNE +L+A+LQHR+LVRL GCCIEQGE ILIYEYMPNKSLD
Sbjct: 815 QEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLD 874
Query: 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295
FLF P K+ L W RV IIEGIAQGLLYLH+YSRLRIIHRDLKASNILLD+DMNPKIS
Sbjct: 875 SFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKIS 934
Query: 296 DFGMARIFGGDELQGNTKRIVGT 318
DFGMAR+FGG+E NT RIVGT
Sbjct: 935 DFGMARMFGGNESYANTNRIVGT 957
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111422|ref|XP_002332932.1| predicted protein [Populus trichocarpa] gi|222837503|gb|EEE75882.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 337 bits (865), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 178/326 (54%), Positives = 219/326 (67%), Gaps = 30/326 (9%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPA- 59
M+L +C+ CL NCSC AY+ +T G +GCL+WF DL+D+R+ TGQ YIR+ A
Sbjct: 1 MDLEECRRVCLMNCSCTAYSTLNITDG-TGCLLWFEDLLDIREYTE--TGQDFYIRLSAS 57
Query: 60 ---PEQGNKKL--LWIIVV--LVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDIN 112
P + K+ +WII + LV + +L +F RRRK
Sbjct: 58 DLEPTRSPKRTTRVWIIAICLLVAGITILGFCLLFLMRRRK------------------- 98
Query: 113 MSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRL 172
M R + E D N KD LP+F A+++ AT NFS KLGEGGFGPVYKG+L
Sbjct: 99 MKTAARMVSMQERDYSINSTGKDLELPVFDFATIAIATSNFSGANKLGEGGFGPVYKGKL 158
Query: 173 LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232
+GQE+AVKRLS S QGL EFKNE++ IAKLQHR+LV+L GCCIE E +L+YEYMPNK
Sbjct: 159 EDGQEIAVKRLSKTSTQGLDEFKNEVICIAKLQHRNLVKLLGCCIESEETMLVYEYMPNK 218
Query: 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 292
SLD F+F K+ +LL W R II G+A+GLLYLHQ SRLRIIHRDLKASNIL+D DMNP
Sbjct: 219 SLDAFIFDQKQSKLLDWSMRYNIINGVARGLLYLHQDSRLRIIHRDLKASNILVDYDMNP 278
Query: 293 KISDFGMARIFGGDELQGNTKRIVGT 318
KISDFGMAR FGG+E+QGNTKR+VGT
Sbjct: 279 KISDFGMARSFGGNEIQGNTKRVVGT 304
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514913|ref|XP_003526146.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 334 bits (856), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 176/323 (54%), Positives = 224/323 (69%), Gaps = 27/323 (8%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP-- 58
M L +C+ KC +NCSC AYAN + G GSGC +WFGDLIDL+ + + +GQ +YIR+
Sbjct: 377 MTLEECKVKCWENCSCTAYANLDIRGAGSGCSIWFGDLIDLK--VVSQSGQYLYIRMADS 434
Query: 59 ---APEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSI 115
A + KK L +I +V P+VL+ IF +RK K +E N+S+
Sbjct: 435 QTDAKDAHKKKELLLIGTIVPPIVLVILLAIFYSYKRKRKYEEE------------NVSV 482
Query: 116 TTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 175
+ EA G+ + LPLF LA++ AT NFST KLG+GGFGPVYKG L G
Sbjct: 483 VKKD----EAGGQEHSME----LPLFDLATLVNATNNFSTDNKLGQGGFGPVYKGVLAGG 534
Query: 176 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235
QE+AVKRLS SGQGLTEFKNE++L AKLQHR+LV++ GCCIE+ E +L+YEYMPNKSLD
Sbjct: 535 QEIAVKRLSRSSGQGLTEFKNEVILCAKLQHRNLVKVLGCCIEEEEKMLLYEYMPNKSLD 594
Query: 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295
FLF K ++L W R I+ A+GLLYLHQ SRLRIIHRDLKASNILLD+++NPKIS
Sbjct: 595 SFLFDSTKSKILDWSKRFHILCATARGLLYLHQDSRLRIIHRDLKASNILLDNNLNPKIS 654
Query: 296 DFGMARIFGGDELQGNTKRIVGT 318
DFG+AR+ GGD+++GNT R+VGT
Sbjct: 655 DFGLARMCGGDQIEGNTNRVVGT 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 333 bits (853), Expect = 9e-89, Method: Compositional matrix adjust.
Identities = 178/326 (54%), Positives = 222/326 (68%), Gaps = 25/326 (7%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRV--- 57
+NL +C+ CLKNCSC AYAN + GGSGC++WFGDLID+R+ N GQ +YIR+
Sbjct: 371 INLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAAS 428
Query: 58 ----PAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKE-NMEANWDLLAFDIN 112
P +G K++ I++ + L L + +F R RK+K+++ E N
Sbjct: 429 VIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGN--------- 479
Query: 113 MSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRL 172
TN E D +++D LPLF LA+++ AT FS KLG+GGFGPVYKG L
Sbjct: 480 ----VVTNP--EQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGIL 533
Query: 173 LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232
+GQE+AVKRLS +S QG+ EF+NE++ IAKLQHR+LV+L GCCIE E +LIYEYMPNK
Sbjct: 534 QDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNK 593
Query: 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 292
SLD F+F ++ LL W R II GIA+GLLYLHQ SRLRIIHRDLKASNILLD +MNP
Sbjct: 594 SLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNP 653
Query: 293 KISDFGMARIFGGDELQGNTKRIVGT 318
KISDFGMAR FGGDE NT RIVGT
Sbjct: 654 KISDFGMARSFGGDETSANTSRIVGT 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 331 bits (848), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 180/320 (56%), Positives = 220/320 (68%), Gaps = 20/320 (6%)
Query: 5 QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRK-PISNFTGQSVYIRVPAPE-- 61
QC++ CL NCSC AY+ C +W GDL++L++ N GQ Y+++ A E
Sbjct: 408 QCESDCLNNCSCSAYSYYM-----EKCTVWGGDLLNLQQLSDDNSNGQDFYLKLAASELS 462
Query: 62 ---QGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSITTR 118
+K +W+IV L + V +F I+ RRR ++ EN LL FD++ S
Sbjct: 463 GKVSSSKWKVWLIVTLAISVT--SAFVIWGIRRRLRRKGEN------LLLFDLSNSSVDT 514
Query: 119 TNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEV 178
EL E + + K+ LP+FS ASVSAAT NFS + KLGEGGFGPVYKG+ G EV
Sbjct: 515 NYELSETSKLWSGEKKEVDLPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEV 574
Query: 179 AVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL 238
AVKRLS +SGQG E KNE+MLIAKLQH++LV+LFG CIE+ E ILIYEYMPNKSLD FL
Sbjct: 575 AVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFL 634
Query: 239 FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
F P K +L W+ RV II+G+AQGLLYLHQYSRLRIIHRDLKASNILLD DMNP+ISDFG
Sbjct: 635 FDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFG 694
Query: 299 MARIFGGDELQGNTKRIVGT 318
MARIFGG+E + T IVGT
Sbjct: 695 MARIFGGNESKA-TNHIVGT 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 330 bits (847), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 180/323 (55%), Positives = 224/323 (69%), Gaps = 27/323 (8%)
Query: 2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPE 61
N +C+ CL +CSC +A + SGC +W GDL++L++ G +YI++
Sbjct: 365 NATRCELDCLGSCSCTVFAYNN-----SGCFVWEGDLVNLQQQAGE--GYFLYIQI---- 413
Query: 62 QGNKKLLWIIVVLVLPVVLLPSFYIF------RRRRRKHKEKENMEANWDLLAFDINMSI 115
GNK+ I+ +V+PV L+ +F +F R+ + HK +E+ N LL FD +
Sbjct: 414 -GNKRRTRAILAVVIPVTLI-TFGLFIYCCYLRKSKLHHKGEEDTSEN--LLFFDFDTCP 469
Query: 116 TTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 175
+ N D ++ K+ LPLFS SVSA TE FS KLGEGGFGPVYKG+L NG
Sbjct: 470 NSTNNVPSSVD----NRRKNVELPLFSYESVSAVTEQFSH--KLGEGGFGPVYKGKLSNG 523
Query: 176 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235
EVAVKRLS +SGQGL EF+NE M+IA+LQHR+LVRL GCCIE+ E ILIYEYMPNKSLD
Sbjct: 524 VEVAVKRLSKRSGQGLEEFRNETMVIARLQHRNLVRLLGCCIERDEKILIYEYMPNKSLD 583
Query: 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295
FLF K+++L W +RVRIIEGIAQGLLYLH+YSRLRIIHRDLK SNILLDS+MNPKIS
Sbjct: 584 FFLFDANKRQILDWGSRVRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKIS 643
Query: 296 DFGMARIFGGDELQGNTKRIVGT 318
DFGMARIFG E + NTK+I GT
Sbjct: 644 DFGMARIFGDSETEANTKKIAGT 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 329 bits (844), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 182/323 (56%), Positives = 222/323 (68%), Gaps = 23/323 (7%)
Query: 5 QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRK-PISNFTGQSVYIRVPAPE-- 61
QC++ CL NCSC AY+ C +W GDL++L++ N GQ Y+++ A E
Sbjct: 177 QCESDCLNNCSCSAYSYYM-----EKCTVWGGDLLNLQQLSDDNSNGQDFYLKLAASELS 231
Query: 62 -QGNKKL-----LWIIVVLVLPVVLLPSFYIFRRRRRKHKEKENMEANWDLLAFDINMSI 115
+GNK +W+IV L + V +F I+ RRR ++ EN LL FD++ S
Sbjct: 232 GKGNKISSSKWKVWLIVTLAISVT--SAFVIWGIRRRLRRKGEN------LLLFDLSNSS 283
Query: 116 TTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 175
EL E + + K+ LP+FS ASVSAAT NFS + KLGEGGFGPVYKG+ G
Sbjct: 284 VDTNYELSETSKLWSGEKKEVDLPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKG 343
Query: 176 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235
EVAVKRLS +SGQG E KNE+MLIAKLQH++LV+LFG CIE+ E ILIYEYMPNKSLD
Sbjct: 344 YEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLD 403
Query: 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295
FLF P K +L W+ RV II+G+AQGLLYLHQYSRLRIIHRDLKASNILLD DMNP+IS
Sbjct: 404 FFLFDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQIS 463
Query: 296 DFGMARIFGGDELQGNTKRIVGT 318
DFGMARIFGG+E + T IVGT
Sbjct: 464 DFGMARIFGGNESKA-TNHIVGT 485
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 328 bits (842), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 171/328 (52%), Positives = 222/328 (67%), Gaps = 41/328 (12%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
M+LN+C+ KCL+NCSC A+AN+ + G GSGC +WFG+L+D++ + GQ +Y+R+ A
Sbjct: 366 MSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIK--VVRRGGQDLYVRMLAS 423
Query: 61 EQGNKKLLWIIVVLVLPVVLLPS-------FYIFRRRRRKHKEKENMEANWDLLAFDINM 113
E KK + V +++ L FY+ R +RRK
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRK-------------------- 463
Query: 114 SITTRTNELCEADGEGND---KSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKG 170
EA G G D + D LPLF+LA++S AT+NFS KLGEGGFG V++G
Sbjct: 464 ---------LEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRG 514
Query: 171 RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230
RL +G+E+AVKRLS+ S QG EFKNE++LIAKLQHR+LV+L GCCI+ E +LIYEYMP
Sbjct: 515 RLTDGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMP 574
Query: 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290
NKSLD F+F +K+LL W R II G+A+G+LYLHQ SRLRIIHRDLKASN+LLD D+
Sbjct: 575 NKSLDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDL 634
Query: 291 NPKISDFGMARIFGGDELQGNTKRIVGT 318
NPKISDFGMAR FGGD+ +GNT+R+VGT
Sbjct: 635 NPKISDFGMARTFGGDQTEGNTRRVVGT 662
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 328 bits (840), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 171/328 (52%), Positives = 222/328 (67%), Gaps = 41/328 (12%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
M+LN+C+ KCL+NCSC A+AN+ + G GSGC +WFG+L+D++ + GQ +Y+R+ A
Sbjct: 366 MSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIK--VVRRGGQDLYVRMLAS 423
Query: 61 EQGNKKLLWIIVVLVLPVVLLPS-------FYIFRRRRRKHKEKENMEANWDLLAFDINM 113
E KK + V +++ L FY+ R +RRK
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRK-------------------- 463
Query: 114 SITTRTNELCEADGEGND---KSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKG 170
EA G G D + D LPLF+LA++S AT+NFS KLGEGGFG V++G
Sbjct: 464 ---------LEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRG 514
Query: 171 RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230
RL +G+E+AVKRLS+ S QG EFKNE++LIAKLQHR+LV+L GCCI+ E +LIYEYMP
Sbjct: 515 RLTDGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMP 574
Query: 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290
NKSLD F+F +K+LL W R II G+A+G+LYLHQ SRLRIIHRDLKASN+LLD D+
Sbjct: 575 NKSLDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDL 634
Query: 291 NPKISDFGMARIFGGDELQGNTKRIVGT 318
NPKISDFGMAR FGGD+ +GNT+R+VGT
Sbjct: 635 NPKISDFGMARTFGGDQTEGNTRRVVGT 662
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 318 | ||||||
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.588 | 0.229 | 0.636 | 8.4e-79 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.694 | 0.282 | 0.576 | 2e-77 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.603 | 0.225 | 0.671 | 1.6e-75 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.977 | 0.368 | 0.476 | 1.8e-74 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.981 | 0.368 | 0.490 | 3.1e-74 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.959 | 0.359 | 0.496 | 5.9e-73 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.984 | 0.368 | 0.481 | 4.1e-72 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.962 | 0.360 | 0.488 | 8.6e-72 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.606 | 0.240 | 0.610 | 1.8e-68 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.597 | 0.236 | 0.6 | 4.2e-67 |
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 8.4e-79, Sum P(2) = 8.4e-79
Identities = 119/187 (63%), Positives = 150/187 (80%)
Query: 132 KSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 191
+ +D LP+F ++S AT++FS LG GGFGPVYKG+L +GQE+AVKRLS SGQG+
Sbjct: 479 EEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGV 538
Query: 192 TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 251
EFKNE+ LIAKLQHR+LVRL GCCI+ E +LIYEYMPNKSLD F+F ++ L W+
Sbjct: 539 EEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKK 598
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 311
R+ II G+A+G+LYLHQ SRLRIIHRDLKA N+LLD+DMNPKISDFG+A+ FGGD+ + +
Sbjct: 599 RMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESS 658
Query: 312 TKRIVGT 318
T R+VGT
Sbjct: 659 TNRVVGT 665
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 2.0e-77, Sum P(2) = 2.0e-77
Identities = 128/222 (57%), Positives = 156/222 (70%)
Query: 97 KENMEANWDLLAFDINMSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQ 156
+E E DL + I T E ++ +D LP L +VS AT FS
Sbjct: 410 REYNENGQDLYVRLASSEIETLQRESSRVSSRKQEE-EDLELPFLDLDTVSEATSGFSAG 468
Query: 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
KLG+GGFGPVYKG L GQEVAVKRLS S QG+ EFKNE+ LIAKLQHR+LV++ G C
Sbjct: 469 NKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYC 528
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+++ E +LIYEY PNKSLD F+F +++R L W RV II+GIA+G+LYLH+ SRLRIIH
Sbjct: 529 VDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIH 588
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
RDLKASN+LLDSDMN KISDFG+AR GGDE + NT R+VGT
Sbjct: 589 RDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGT 630
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
Identities = 129/192 (67%), Positives = 157/192 (81%)
Query: 127 GEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ 186
G+ + ++ ++ L +FS SV+ AT+ FS KLGEGGFGPVYKGRL++G+EVA+KRLS
Sbjct: 501 GKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLA 560
Query: 187 SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 246
SGQGL EFKNE MLIAKLQH +LV+L GCC+E+ E +LIYEYMPNKSLD FLF P +K +
Sbjct: 561 SGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIV 620
Query: 247 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
L W+ R RI+EGI QGLLYLH+YSRL++IHRD+KA NILLD DMNPKISDFGMARIFG
Sbjct: 621 LDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQ 680
Query: 307 ELQGNTKRIVGT 318
E + NTKR+ GT
Sbjct: 681 ESKANTKRVAGT 692
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 1.8e-74, Sum P(2) = 1.8e-74
Identities = 155/325 (47%), Positives = 204/325 (62%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
+ L C+ +CL++C+C A+AN+ + GGSGC++W +++D+R GQ +Y+R+ A
Sbjct: 367 IGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAA 424
Query: 61 EQGNKKXXXXXXXXXXXXXXXX---SFYIFXXXXXKHKEKENMEA-NWDLLAFD---INM 113
E +K+ SF IF K K ++ N D + IN
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLIND 484
Query: 114 SITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL 173
+ +R + KS+ LPL L +++ AT NFS KLG+GGFG VYKGRLL
Sbjct: 485 VVVSRRGYTSK-----EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLL 539
Query: 174 NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS 233
+G+E+AVKRLS S QG EF NE+ LIAKLQH +LVRL GCC+++GE +LIYEY+ N S
Sbjct: 540 DGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLS 599
Query: 234 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293
LD LF + L WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PK
Sbjct: 600 LDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPK 659
Query: 294 ISDFGMARIFGGDELQGNTKRIVGT 318
ISDFGMARIFG +E + NT+R+VGT
Sbjct: 660 ISDFGMARIFGREETEANTRRVVGT 684
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 3.1e-74, P = 3.1e-74
Identities = 159/324 (49%), Positives = 207/324 (63%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
+ L +C+ +CLK C+C A+AN+ + GGSGC++W G L D+R GQ +Y+RV A
Sbjct: 371 IGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG--GQDLYVRVAAG 428
Query: 61 EQGNKKXXXXXXXXXXXXXXXX---SFYIFXXXXXKHKEKENMEANWDLLAFDINMSITT 117
+ +K+ SF IF K K+K ++ ++ D+ S +
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFW--KRKQKRSITIQTPIV--DLVRSQDS 484
Query: 118 RTNELCEADGEGNDK-SKDSWL--PLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 174
NEL +A K +K +L PL +++ AT NFST KLG+GGFG VYKG LL+
Sbjct: 485 LMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLD 544
Query: 175 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234
G+E+AVKRLS S QG EF NE+ LIAKLQH +LVRL GCC+++GE +LIYEY+ N SL
Sbjct: 545 GKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSL 604
Query: 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294
D LF + L WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKI
Sbjct: 605 DSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKI 664
Query: 295 SDFGMARIFGGDELQGNTKRIVGT 318
SDFGMARIFG +E + NT+R+VGT
Sbjct: 665 SDFGMARIFGREETEANTRRVVGT 688
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
Identities = 160/322 (49%), Positives = 214/322 (66%)
Query: 6 CQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQG-N 64
C+ +CL+NCSC AY+ L GG GC++W DL+DL++ + G S++IR+ E G N
Sbjct: 381 CRERCLRNCSCNAYS---LVGG-IGCMIWNQDLVDLQQFEAG--GSSLHIRLADSEVGEN 434
Query: 65 KKXXXXXXXXXXXXXXXXSFYIFXXXXXKHKEKENMEANWDLLAFDINMSIT--TRTNEL 122
+K IF + K K+++ + D ++ + T++ E
Sbjct: 435 RKTKIAVIVAVLVGVILIG--IFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKET 492
Query: 123 CEADGEGND---KSK---DSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQ 176
A D + K S LP+FSL +++ AT +F + +LG GGFGPVYKG L +G+
Sbjct: 493 TSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGR 552
Query: 177 EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDV 236
E+AVKRLS +SGQG+ EFKNE++LIAKLQHR+LVRL GCC E E +L+YEYMPNKSLD
Sbjct: 553 EIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDF 612
Query: 237 FLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 296
FLF K+ L+ W+ R IIEGIA+GLLYLH+ SRLRIIHRDLK SN+LLD++MNPKISD
Sbjct: 613 FLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISD 672
Query: 297 FGMARIFGGDELQGNTKRIVGT 318
FGMARIFGG++ + NT R+VGT
Sbjct: 673 FGMARIFGGNQNEANTVRVVGT 694
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 4.1e-72, P = 4.1e-72
Identities = 156/324 (48%), Positives = 201/324 (62%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
+ + +C+ KCL++C+C A+AN+ + G GSGC+ W G+L D+R GQ +Y+R+ A
Sbjct: 373 IGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG--GQDLYVRLAAT 430
Query: 61 E---QGNKKXXXXXXXXXXXXXXXXSFYIFXXXXXKHKEKENMEA---NWDLLAFDINMS 114
+ + N+ SF IF K K +E + L + D+ M+
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490
Query: 115 ITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 174
++ E N + D LPL V+ AT NFS KLG+GGFG VYKG+LL+
Sbjct: 491 EVVISSRR-HISRENN--TDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLD 547
Query: 175 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234
GQE+AVKRLS S QG EFKNE+ LIA+LQH +LVRL CC++ GE +LIYEY+ N SL
Sbjct: 548 GQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSL 607
Query: 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294
D LF + L WQ R II GIA+GLLYLHQ SR RIIHRDLKASNILLD M PKI
Sbjct: 608 DSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKI 667
Query: 295 SDFGMARIFGGDELQGNTKRIVGT 318
SDFGMARIFG DE + NT+++VGT
Sbjct: 668 SDFGMARIFGRDETEANTRKVVGT 691
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
Identities = 155/317 (48%), Positives = 199/317 (62%)
Query: 6 CQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPE-QGN 64
C+ CL NCSC AY + TG CL W +LID+ + + ++ +++PA E +G+
Sbjct: 386 CRTVCLNNCSCGAYVYTATTG----CLAWGNELIDMHELQTG--AYTLNLKLPASELRGH 439
Query: 65 KKXXXXXXXXXXXXXXXXSFYIFXXXXXKHKEKENMEANWDLLAFDINMSITTRTNELCE 124
+ + K+ + +W + ++ +
Sbjct: 440 HPIWKIATIISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRSRHSSTQSQQNSAMLDISQ 499
Query: 125 A---DGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK 181
+ D + D K L ++SL + AT NFS KLGEGGFGPVY G L G+EVAVK
Sbjct: 500 SIRFDDDVED-GKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVK 558
Query: 182 RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP 241
RL SGQGL EFKNE++LIAKLQHR+LVRL GCCI + E IL+YEYMPNKSLD FLF P
Sbjct: 559 RLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNP 618
Query: 242 KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+K+RLL W+ R IIEGIA+GLLYLH+ SRLR++HRDLKASNILLD+DM PKISDFGMAR
Sbjct: 619 EKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMAR 678
Query: 302 IFGGDELQGNTKRIVGT 318
+FGGD+ Q NT R+VGT
Sbjct: 679 MFGGDQNQFNTNRVVGT 695
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 1.8e-68, Sum P(2) = 1.8e-68
Identities = 119/195 (61%), Positives = 148/195 (75%)
Query: 126 DGEGND-KSKD-SWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRL 183
D ND K +D L F + ++ AT NFS KLG+GGFG VYKG+L +G+E+AVKRL
Sbjct: 462 DAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRL 521
Query: 184 SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK 243
S+ SGQG EF NE++LI+KLQHR+LVR+ GCCIE+ E +LIYE+M NKSLD FLF +K
Sbjct: 522 SSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRK 581
Query: 244 KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+ + W R II+GIA+GLLYLH SRLR+IHRDLK SNILLD MNPKISDFG+AR++
Sbjct: 582 RLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMY 641
Query: 304 GGDELQGNTKRIVGT 318
G E Q NT+R+VGT
Sbjct: 642 QGTEYQDNTRRVVGT 656
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 4.2e-67, Sum P(2) = 4.2e-67
Identities = 114/190 (60%), Positives = 145/190 (76%)
Query: 129 GNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 188
G ++ S + F + ++ AT NFS KLG+GGFGPVYKG+L++G+E+ VKRL++ SG
Sbjct: 464 GFERQDVSGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSG 523
Query: 189 QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG 248
QG EF NE+ LI+KLQHR+LVRL G CI+ E +LIYE+M NKSLD+F+F P K L
Sbjct: 524 QGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELD 583
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
W R II+GIA+GLLYLH+ SRLR+IHRDLK SNILLD MNPKISDFG+AR+F G +
Sbjct: 584 WPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQY 643
Query: 309 QGNTKRIVGT 318
Q NT+R+VGT
Sbjct: 644 QDNTRRVVGT 653
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 318 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 5e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 58/150 (38%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
KLGEG FG VYKG+L EVAVK L + S Q + EF E ++ KL H ++V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L G C E+ ++ EYM L +L K + L + IA+G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IHRDL A N L+ ++ KISDFG++R
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 59/150 (39%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 158 KLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
KLGEG FG VYKG L EVAVK L + S Q + EF E ++ KL H ++V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L G C E+ +++ EYMP L +L + K L + IA+G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---S 121
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IHRDL A N L+ ++ KISDFG++R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-42
Identities = 56/150 (37%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVR 211
KLGEG FG VYKG L +VAVK L + + EF E ++ KL H ++VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L G C + ++ EYMP L FL K L + +++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+HRDL A N L+ ++ KISDFG++R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-41
Identities = 59/155 (38%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 158 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRL 212
KLGEG FG VYKG+L EVAVK L S + +F E ++ KL H ++VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYL 266
G C E+ L+ EYM L +L F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +HRDL A N L+ D+ KISDFG++R
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-40
Identities = 62/163 (38%), Positives = 88/163 (53%), Gaps = 10/163 (6%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
LGEGGFG VY R G++VA+K + S L E E+ ++ KL H ++V+L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
++ L+ EY SL + + L +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSL--KDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 277 RDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNTKRIVGT 318
RDLK NILLDSD K++DFG++++ D+ T IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 55/164 (33%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 158 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
KLG G FG VYK + G+ VAVK L ++ + + E+ ++ +L H ++VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
++ L+ EY L +L + L +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 275 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IHRDLK NILLD + KI+DFG+A+ + VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-36
Identities = 59/168 (35%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 153 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLV 210
+ KLGEG FG VY R G+ VA+K + + + E E+ ++ KL+H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
RL+ ++ + L+ EY L L K+ RL +AR + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS-- 115
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRDLK NILLD D + K++DFG+AR E VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 13/153 (8%)
Query: 158 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LGEG FG V R G++VAVK L+ + Q ++F+ E+ ++ L H ++V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 212 LFGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
G C + G LI EY+P+ SL +L + + + + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
R IHRDL A NIL++S+ KISDFG+A++
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 60/168 (35%), Positives = 88/168 (52%), Gaps = 13/168 (7%)
Query: 157 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG G FG VY G+ +AVK LS S + L + E+ +++ LQH ++VR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 214 GCCIEQGEN-ILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRI-IEGIAQGLLYLHQYS 270
G ++ +N + I+ EY+ SL L KK L + +R I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLP-EPVIRKYTRQILEGLAYLH--- 118
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRD+K +NIL+DSD K++DFG A+ G E T + GT
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 152 NFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLTEFKNEMMLIAKLQHRH 208
N+ +G G FG VYKG L G VA+K++S + L E+ L+ L+H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 209 LVRLFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+V+ G IE +++ I EY N SL + KK + + QGL YLH
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ +IHRD+KA+NIL D K++DFG+A + +VGT
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E F+ + KLG G FG V++G N VA+K L + +F+ E+ + +L+H+HL+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------LGWQARVRIIEGIAQGL 263
LF C +I E M SL FL P+ + L + Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
YL + IHRDL A NIL+ D+ K++DFG+AR+
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 53/170 (31%), Positives = 90/170 (52%), Gaps = 15/170 (8%)
Query: 153 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
F K+G+GGFG VYK R G+EVA+K + +S + + NE+ ++ K +H ++V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 212 LFGCCIEQGENILIYEYMPNKSL-DVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQ 268
+G +++ E ++ E+ SL D+ + + + + + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-----VCKELLKGLEYLHS 116
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IIHRD+KA+NILL SD K+ DFG++ +VGT
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-25
Identities = 58/151 (38%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
KLG G FG V+ G +VAVK L F E ++ KL+H LV+L+ C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC- 70
Query: 218 EQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ E I I EYM SL FL + K+L V + IA+G+ YL IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDE 307
RDL A NIL+ ++ KI+DFG+AR+ DE
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 158 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H ++V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82
Query: 215 CCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+ E ++ EYM SL D+ + + + + QGL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCREVLQGLEYLHS---QN 136
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+IHRD+K+ NILL D + K++DFG A + + +VGT
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 53/171 (30%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 153 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEF----KNEMMLIAKLQHR 207
+ ++GEG +G VYK R G+ VA+K++ ++ + F E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58
Query: 208 HLVRLFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
++VRL +G+ +++EYM + L L P+ K Q + ++ + +GL Y
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQY 115
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
LH I+HRD+K SNIL+++D K++DFG+AR + T R++
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRH 208
+ LG+G G VYK R G+ A+K++ + + + E+ + + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V+ +G ++GE ++ EYM SL L KK + I I +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
+ IIHRD+K SN+L++S KI+DFG++++
Sbjct: 118 --KRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 12/155 (7%)
Query: 159 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 212
LG G FG VYKG + VA+K L ++ + E +E ++A + H H+VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G C+ + LI + MP L ++ K +G Q + IA+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R++HRDL A N+L+ + + KI+DFG+A++ DE
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 9e-24
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVR 211
LGEG FG V+ G + + VAVK L + + F+ E L+ QH ++V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKKKRLLGWQARVRIIEGIA 260
+G C E I+++EYM + L+ FL L ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
G++YL + +HRDL N L+ D+ KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 58/169 (34%), Positives = 81/169 (47%), Gaps = 24/169 (14%)
Query: 159 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LGEG FG VYKG L N + VA+K L N + EF+ E L++ LQH ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLF-------------YPKKKRLLGWQARVRIIEG 258
L G C ++ +++EY+ + L FL K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
IA G+ YL S +HRDL A N L+ + KISDFG++R I+ D
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 58/160 (36%), Positives = 87/160 (54%), Gaps = 10/160 (6%)
Query: 159 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
+G G FG V +GRL L G++ VA+K L + S + +F E ++ + H +++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
G + ++I EYM N SLD FL K V ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK 313
+HRDL A NIL++S++ K+SDFG++R E TK
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.1 bits (240), Expect = 7e-23
Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH-R 207
++ KLGEG FG VY R + + VA+K L+ + + + F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++V+L+ ++G L+ EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 268 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGGD----ELQGNTKRIVGT 318
IIHRD+K NILLD D K+ DFG+A++ + VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 63/151 (41%), Positives = 82/151 (54%), Gaps = 15/151 (9%)
Query: 159 LGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRL 212
LGEG FG V Y N G+ VAVK L + GQ T +K E+ ++ L H ++V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 213 FGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
GCC EQG LI EY+P SL +L PK K L + + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IHRDL A N+LLD+D KI DFG+A+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 6/155 (3%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
++G G FG V+ G L ++VA+K + + +F E ++ KL H LV+L+G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
E+ L++E+M + L +L ++ + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 278 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
DL A N L+ + K+SDFGM R D+ +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
E F KLGEG +G VYK GQ VA+K + + L E E+ ++ + ++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 210 VRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
V+ +G + + ++ EY S D + K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHS 117
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ IHRD+KA NILL+ + K++DFG++ + NT ++GT
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 4e-22
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 25/158 (15%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLTEFKN---EMMLIAKLQHRHLVRL 212
KLGEG +G VYK R G+ VA+K++ + +G+ E+ L+ +L+H ++V+L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYL 266
+ + L++EY + L +L P + + +Q + +GL Y
Sbjct: 64 LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAYC 114
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
H + RI+HRDLK NIL++ D K++DFG+AR FG
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-22
Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 15/173 (8%)
Query: 152 NFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRH 208
+F K+G+G FG V+K R + + A+K+ LS + + E +E ++AKL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL---LGWQARVRIIEGIAQGLLY 265
++R + +++G+ ++ EY N L L + + L W R I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LH +I+HRD+K+ N+ LD+ N KI D G+A++ + NT IVGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 59/159 (37%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 159 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 212
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H HLVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G C+ L+ + MP+ L + + K +G Q + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 311
R++HRDL A N+L+ S + KI+DFG+AR+ GDE + N
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 2e-21
Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
++G+G FG VY R +G+ +K LSN S + + NE+ ++ KL H ++++ +
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 215 CCIEQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGW--QARVRIIEGIAQGLLY 265
E+G+ ++ EY L + ++++L W Q + L Y
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------LCLALKY 118
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LH SR +I+HRD+K NI L S+ K+ DFG++++ T +VGT
Sbjct: 119 LH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 59/158 (37%), Positives = 79/158 (50%), Gaps = 20/158 (12%)
Query: 159 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG G FG V KG + +G+E VAVK L G EF E ++A+L H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 214 GCCIEQGEN-ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE---GIAQGLLYLHQY 269
G C +GE +L+ E P L +L KK+R + + E +A G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYL---KKRREI---PVSDLKELAHQVAMGMAYLES- 113
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+HRDL A N+LL + KISDFGM+R G
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 159 LGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LGEG FG V +G+L + +VAVK +L + + EF +E + H ++++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 213 FGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRL---LGWQARVRIIEGIAQGL 263
G C E ++I +M + L FL Y + L L Q ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
YL S IHRDL A N +L DM ++DFG+++ I+ GD
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 56/150 (37%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
KLG G FG V+ G +VA+K L Q F E L+ +LQH LVRL+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
++ I I EYM N SL FL P+ +L + + IA+G+ ++ R IHR
Sbjct: 72 QEPIYI-ITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 278 DLKASNILLDSDMNPKISDFGMARIFGGDE 307
DL+A+NIL+ + KI+DFG+AR+ +E
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 60/168 (35%), Positives = 84/168 (50%), Gaps = 22/168 (13%)
Query: 158 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LGEG FG V+ LL Q+ VAVK L S +F+ E L+ LQH+H+VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----------LGWQARVRIIEGI 259
+G C E ++++EYM + L+ FL P K L L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
A G++YL + L +HRDL N L+ + KI DFGM+R I+ D
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 22/159 (13%)
Query: 157 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN-----EMMLIAKLQHRHLV 210
KLGEG + VYK R G+ VA+K++ + + N E+ L+ +L+H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 211 RL---FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLY 265
L FG NI L++E+M L+ + K K ++ A ++ + +GL Y
Sbjct: 66 GLLDVFG----HKSNINLVFEFMET-DLEKVI---KDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
LH I+HRDLK +N+L+ SD K++DFG+AR FG
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-20
Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 218
+G+G FG V G GQ+VAVK L + S F E ++ L+H +LV+L G ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD 278
++ EYM SL +L + + ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 279 LKASNILLDSDMNPKISDFGMAR 301
L A N+L+ D+ K+SDFG+A+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 218
LG G FG V+ G+ +VA+K + + +F E ++ KL H +LV+L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD 278
Q ++ EYM N L +L ++K LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 279 LKASNILLDSDMNPKISDFGMARIFGGDE 307
L A N L+ D K+SDFG+AR D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-20
Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
KLG G FG V++G N VAVK L + +F E ++ KL+H L++L+ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 218 EQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
E I I E M SL +L R L + + +A G+ YL + IH
Sbjct: 72 -LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDE 307
RDL A N+L+ + K++DFG+AR+ D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 159 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 211
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H ++V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL-------------------FYPKKKRLLGWQAR 252
L G C L++EYM L+ FL L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGN 311
+ I + +A G+ YL S + +HRDL N L+ +M KI+DFG++R I+ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 47/154 (30%), Positives = 87/154 (56%), Gaps = 13/154 (8%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLF 213
K+GEG +G VYK R L G+ VA+K++ + K E+ L+ +L H ++++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIK-LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLHQYSRL 272
+G+ L++E+M D++ ++R L ++ ++ + + QGL + H +
Sbjct: 65 DVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH--- 117
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
I+HRDLK N+L++++ K++DFG+AR FG
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 32/162 (19%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
K+GEG +G VYK R L G+ VA+K++ + G T + E+ L+ +L H ++VRL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 214 GCCIEQGENILIYEYM-----------PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
+ + L++E++ P LD L K L +Q +++GIA
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYL--YQ----LLQGIA-- 113
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
Y H + R++HRDLK N+L+D + K++DFG+AR FG
Sbjct: 114 --YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-19
Identities = 55/154 (35%), Positives = 88/154 (57%), Gaps = 15/154 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
K+GEG +G VYKGR GQ VA+K++ S + G T + E+ L+ +LQH ++V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQ 65
Query: 214 GCCIEQGENILIYEYMP---NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+++ LI+E++ K LD PK + + + + + I QG+L+ H
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQ-ILQGILFCH--- 118
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
R++HRDLK N+L+D+ K++DFG+AR FG
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-19
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 26/175 (14%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLT--EFKNEMMLIAKLQHRHLVR 211
LG G F Y+ R + G +AVK+++ S Q + E+ L+A+L H H++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ G E L E+M S+ L + K+ ++ + E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 270 SRLRIIHRDLKASNILLDSD-MNPKISDFGMA-----RIFGGDELQGNTKRIVGT 318
+IIHRD+K +N+L+DS +I+DFG A + G E QG +++GT
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGT 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-19
Identities = 53/145 (36%), Positives = 77/145 (53%), Gaps = 6/145 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 216
K+G+G FG VYKG L EVAVK + L F E ++ + H ++V+L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+++ ++ E +P SL FL KKK L + +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 277 RDLKASNILLDSDMNPKISDFGMAR 301
RDL A N L+ + KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 24/162 (14%)
Query: 159 LGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG+G FG V R G+ VAVK+L + + + L +F+ E+ ++ LQH ++V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 214 GCCIEQGEN--ILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLY 265
G C G L+ EY+P SL +L +K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
L R +HRDL NIL++S+ KI DFG+ ++ D+
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 52/158 (32%), Positives = 90/158 (56%), Gaps = 18/158 (11%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ---HRHLVR 211
+GEG +G VYK R L G+ VA+K++ ++ G L+ + E+ L+ +L+ H ++VR
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65
Query: 212 LFGCC-IEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
L C + + L++E++ ++ L +L K L + ++ + +G+ +L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFL 123
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
H + RI+HRDLK NIL+ SD KI+DFG+ARI+
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 27/177 (15%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLF 213
KLGEG FG VYK R + G+ VA+K++ + G +T + E+ ++ KL+H ++V L
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLI 73
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKR----LLGWQARVR--------IIEGIAQ 261
+E+ + K V++ P LL V+ + + +
Sbjct: 74 DMAVERPDKSK------RKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
G+ YLH+ I+HRD+KA+NIL+D+ KI+DFG+AR + G GT
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 158 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH---LVRLF 213
+LG G G V K G+ +AVK + + K + + L + +V +
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKK---KRLLGWQARVRIIEGIAQGLLYLHQYS 270
G G+ + EYM SLD L + +R+LG +I + +GL YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +IIHRD+K SNIL++S K+ DFG++
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 159 LGEGGFGPVYKGRLL-NGQEVAVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+GEG F V + +E A+K L + E K + + H ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLN--GHPGII 65
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L+ ++ + EY PN L L Y +K L + I L YLH
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGEL---LQYIRKYGSLDEKCTRFYAAEILLALEYLHS-- 120
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK 313
IIHRDLK NILLD DM+ KI+DFG A++ + + K
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQ 205
N + +LGEG FG V+ N Q+ VAVK L + S +F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR----------VRI 255
H H+V+ +G C+E I+++EYM + L+ FL +L + + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 54/150 (36%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
KLG G FG V+ G N +VAVK L + + F E L+ LQH LVRL+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
++ +I EYM SL FL + ++L + IA+G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 278 DLKASNILLDSDMNPKISDFGMARIFGGDE 307
DL+A+N+L+ + KI+DFG+AR+ +E
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-18
Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
+LG G FG V+ G+ +VA+K + N+ +F E ++ KL H LV+L+G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
+Q ++ E+M N L +L +++ L + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 278 DLKASNILLDSDMNPKISDFGMARIFGGDE 307
DL A N L+ S K+SDFGM R DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 158 KLGEGGFGPVYKGRLL-NGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
++GEG G V+K + G+ VA+K+ L G + E+ + QH ++V+L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
+L+ EYMP+ +V + L Q + + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERP--LPEAQVK-SYMRMLLKGVAYMHA---NGI 120
Query: 275 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
+HRDLK +N+L+ +D KI+DFG+AR+F +E + + ++
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-17
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 5/58 (8%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58
++L +C+ CL NCSC AYA + G GCL+W G L +LR + G ++Y+R+
Sbjct: 32 ISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 52/152 (34%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 158 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRL 212
KLG+G FG V +G VAVK L + + +F E ++ L H +L+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG---WQARVRIIEGIAQGLLYLHQY 269
+G + +++ E P SL L L V+I A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
R IHRDL A NILL SD KI DFG+ R
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 158 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LGEG FG V+ N VAVK L + + +F+ E L+ LQH H+V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLF------------YPKK-KRLLGWQARVRIIEG 258
+G C + I+++EYM + L+ FL P++ K LG + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IA G++YL + +HRDL N L+ +++ KI DFGM+R
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 51/155 (32%), Positives = 82/155 (52%), Gaps = 24/155 (15%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 213 FGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-----IAQGLLYL 266
+GC + E + I+ EYMP S+ K +L + A + I +G+ YL
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSV--------KDQLKAYGALTETVTRKYTRQILEGVEYL 120
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
H I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 55/165 (33%), Positives = 88/165 (53%), Gaps = 28/165 (16%)
Query: 159 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 212
LG G FG V+KG + + VA+K + ++SG Q E + M+ + L H ++VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 213 FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKR-------LLGWQARVRIIEGIAQGLL 264
G C G ++ L+ + P SL L + ++ R LL W + IA+G+
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSL---LDHVRQHRDSLDPQRLLNWCVQ------IAKGMY 123
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
YL ++ R++HR+L A NILL SD +I+DFG+A + D+ +
Sbjct: 124 YLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 29/163 (17%)
Query: 159 LGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LG+G FG VY+G VA+K ++ N S + EF NE ++ + H+VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 212 LFGCCIEQGENILIYEYM-------------PNKSLDVFLFYPKKKRLLGWQARVRIIEG 258
L G +++ E M P + L P ++ + A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IA G+ YL + +HRDL A N ++ D+ KI DFGM R
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 54/157 (34%), Positives = 87/157 (55%), Gaps = 18/157 (11%)
Query: 159 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIAKLQHRHL 209
+G G FG V++G L + G++ VA+K L G TE F +E ++ + H ++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLK----PGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+RL G + ++I EYM N +LD +L +Q V ++ GIA G+ YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQL-VGMLRGIAAGMKYL--- 123
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
S + +HRDL A NIL++S++ K+SDFG++R+ D
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 53/152 (34%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 159 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
+G G FG V +GRL L G+ VA+K L S + + +F +E ++ + H +++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ----ARVRIIEGIAQGLLYLHQY 269
G + ++I E+M N +LD FL R Q V ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
S + +HRDL A NIL++S++ K+SDFG++R
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 45/159 (28%), Positives = 83/159 (52%), Gaps = 16/159 (10%)
Query: 158 KLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLTEFK-NEMMLIAKLQHRHLVR 211
+G G +G VYK + N G+E A+K+ + G+++ E+ L+ +L+H ++V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 212 LFGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLHQ 268
L +E + L+++Y + + F+ + KR+ + V+ ++ I G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 269 YSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIF 303
++HRDLK +NIL+ + KI D G+AR+F
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 54/160 (33%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 159 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLV 210
LG G FG VY+G + VAVK L + Q EF E L++ H ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR----LLGWQARVRIIEGIAQGLLYL 266
+L G C+ +I E M L +L + +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 267 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMAR 301
Q + IHRDL A N L+ D+D KI DFG+AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LTEFKNEMMLIAK 203
N LG G FG V+ + +E V VK L + +EF+ E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL------LGWQARVRIIE 257
L H+++VRL G C E + +I EY L FL K K L + +V +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IA G+ +L S R +HRDL A N L+ S K+S +++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG+G FG V R + G+ A+K L + + + E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRL 272
+ E + L+ EY P L + K+ + R R I L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL---FSHLSKEGRFS-EERARFYAAEIVLALEYLH---SL 112
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
II+RDLK NILLD+D + K++DFG+A+ + + NT GT
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 18/163 (11%)
Query: 159 LGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LG G FG VY+G R +G +VAVK L + S Q ++F E ++++K H+++VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYLH 267
L G E+ ++ E M L FL P++ L + + +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 268 QYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR-IFGGD 306
+ IHRD+ A N LL KI+DFGMAR I+
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 52/163 (31%), Positives = 89/163 (54%), Gaps = 18/163 (11%)
Query: 159 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LGEG FG V +G+L +VAVK +++ + + +F +E + + + H +++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 214 GCCIEQGEN------ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLL 264
G C++ E+ ++I +M + L FL Y + + L Q V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGD 306
YL S IHRDL A N +L+ +MN ++DFG++ +I+ GD
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 58/165 (35%), Positives = 85/165 (51%), Gaps = 18/165 (10%)
Query: 159 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIAKLQHRHL 209
+G G FG V GRL L G+ VA+K L G TE F +E ++ + H ++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ L G + +++ EYM N SLD FL K V ++ GIA G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL--- 122
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
S + +HRDL A NIL++S++ K+SDFG++R+ D T R
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-17
Identities = 52/146 (35%), Positives = 81/146 (55%), Gaps = 10/146 (6%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
+GEG FG V +G GQ+VAVK + + + Q F E ++ KL H++LVRL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ G I++ E M +L FL + + L+ ++ +A+G+ YL +++H
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 277 RDLKASNILLDSDMNPKISDFGMARI 302
RDL A NIL+ D K+SDFG+AR+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
++G G FG VY R + + VA+K++S QS + + E+ + +L+H + +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
GC + + L+ EY + D+ + K + + A I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHER-- 136
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARI 302
IHRD+KA NILL K++DFG A +
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 56/159 (35%), Positives = 87/159 (54%), Gaps = 17/159 (10%)
Query: 159 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRL 212
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H ++V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 213 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL--HQ 268
G C E G N LI E++P+ SL +L P+ K + + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
Y +HRDL A N+L++S+ KI DFG+ + D+
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 6e-17
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 153 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQ-HRH 208
+ +LG+G FG VY R G+ VA+K++ + S + + E+ + KL H +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPN 59
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLH 267
+V+L E E ++EYM +++ +K ++ +R II I QGL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ HRDLK N+L+ KI+DFG+AR
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-17
Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 18/152 (11%)
Query: 159 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LTEFKNEMMLIAKLQHRHLVRL 212
LG G FG VY+G L +G AVK +S Q+GQ + + + E+ L++KLQH ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 213 FGCCIEQGENILIY-EYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
G E +N+ I+ E +P SL L + + ++ R I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
R +HRD+K +NIL+D++ K++DFGMA+
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 23/161 (14%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN----EMMLIAKLQ 205
+ +GEG +G V K R G+ VA+K+ + + + K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK-----KKRLLGWQARVRIIEGIA 260
H ++V L +G L++EY+ L++ P R WQ +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
Q + Y H IIHRD+K NIL+ K+ DFG AR
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
+LG G FG V G+ +VA+K + S EF E ++ KL H LV+L+G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL--HQYSRLRII 275
+Q ++ EYM N L +L K+ + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQF-----I 122
Query: 276 HRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
HRDL A N L+D K+SDFG++R DE
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 156 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
+G G VY L N ++VA+KR+ + + E + E+ +++ H ++V+ +
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+ E L+ Y+ SL + + L +++ + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 274 IIHRDLKASNILLDSDMNPKISDFGM-ARIF-GGDELQGNTKRIVGT 318
IHRD+KA NILL D + KI+DFG+ A + GGD + K VGT
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 54/158 (34%), Positives = 88/158 (55%), Gaps = 23/158 (14%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGL--TEFKNEMMLIAKLQHRHLVRLF 213
K+GEG +G VYK R + + +A+K++ Q +G+ T + E+ L+ ++QH ++VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQ 67
Query: 214 GCCIEQGENILIYEYMP---NKSLDVFLFYPKKKRLLG---WQARVRIIEGIAQGLLYLH 267
+ L++EY+ K +D + K RL+ +Q I+ GIA Y H
Sbjct: 68 DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCH 119
Query: 268 QYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFG 304
+ R++HRDLK N+L+D N K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 208
E +LGEG G V K RL N + A+K ++ L + E+ + + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 209 LVRLFGCCI-EQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARV------RIIEGIA 260
+V+ +G + E +I I EY SLD K++ R+ +I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----KKVKKRGGRIGEKVLGKIAESVL 115
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
+GL YLH +IIHRD+K SNILL K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 22/163 (13%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH 208
NF KLGEG + VYKGR G+ VA+K L + G T + E+ L+ +L+H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 209 LVRLFGCCIEQGENILIYEYMPN---KSLDVF----LFYPKKKRLLGWQARVRIIEGIAQ 261
+VRL + + +L++EYM K +D P + +Q + +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
G+ + H+ R++HRDLK N+L++ K++DFG+AR FG
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 26/178 (14%)
Query: 158 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLV 210
+LGE FG VYKG L Q VA+K L +++ L EFK+E M+ ++LQH ++V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIE 257
L G ++ +I+ Y + L FL K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQGNT 312
IA G+ +L S ++H+DL N+L+ +N KISD G+ R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 50/157 (31%), Positives = 89/157 (56%), Gaps = 10/157 (6%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQS-GQGLTEFKNEMMLIAKLQHR 207
NF K+GEG +G VYK R L G+ VA+K RL ++ G T + E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++V+L + + L++E++ ++ L F+ + + + + + QGL + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCH 117
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
+ R++HRDLK N+L++++ K++DFG+AR FG
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 51/144 (35%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT-EFKNEMMLIAKLQHRHLVRLFGCCI 217
LG+G FG V+KG L + VAVK Q L +F +E ++ + H ++V+L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
++ ++ E +P D F KKK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 278 DLKASNILLDSDMNPKISDFGMAR 301
DL A N L+ + KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 50/170 (29%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLTEFKNEMM 199
KLGEG FG V+ Q+ VAVK L + S +F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY--------PKKKRLLGWQA 251
++++L ++ RL G C +I EYM N L+ FL + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ + IA G+ YL L +HRDL N L+ + KI+DFGM+R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-16
Identities = 21/41 (51%), Positives = 31/41 (75%), Gaps = 1/41 (2%)
Query: 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDL 41
+ L +C+ +CL NCSC AYA + + GGSGCL+W G+L+D+
Sbjct: 27 IGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTGELVDM 66
|
Length = 66 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 16/169 (9%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL 204
+ + L EG FG ++ G L++ +EV VK + + + + +T E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 205 QHRHLVRLFGCCIEQGEN-ILIYEYMPNKSLDVFLFYPK-----KKRLLGWQARVRIIEG 258
H++++ + CIE GE ++Y YM +L +FL + + L Q V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
IA G+ YLH + +IH+D+ A N ++D ++ KI+D ++R +F D
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-16
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 158 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
KLG G +G VY+G VAVK L + + EF E ++ +++H +LV+L G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ +I E+M +L +L ++ + + + I+ + YL + + IH
Sbjct: 72 TREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGD 306
RDL A N L+ + K++DFG++R+ GD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 48/155 (30%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 152 NFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRH 208
+F KLG+G +G VYK RL + Q A+K L + S + + NE+ ++A + H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK-KRLLGWQARVRIIEGIAQGLLYLH 267
++ ++ + ++ EY P L + KK ++L+ Q RI + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
+ +I+HRDLK++NILL ++ KI D G++++
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 153 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLV 210
F+ +G+G FG VYK Q VA+K + ++ + + + E+ +++ + ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 211 RLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ +G ++ + +I EY S LD+ L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLEYLHEE 117
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
IHRD+KA+NILL + + K++DFG++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 55/162 (33%), Positives = 83/162 (51%), Gaps = 26/162 (16%)
Query: 159 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG G FG VYKG + E VA+K L S + E +E ++A + + H+ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-------LLGWQARVRIIEGIAQGLLY 265
G C+ LI + MP L L Y ++ + LL W + IA+G+ Y
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQ------IAKGMNY 124
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
L + R++HRDL A N+L+ + + KI+DFG+A++ G DE
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 54/158 (34%), Positives = 84/158 (53%), Gaps = 8/158 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHL 209
E+ + KLG+G FG V+ G VA+K L + G E F E ++ KL+H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
V+L+ E+ I + EYM SL FL + + L V + IA G+ Y+
Sbjct: 64 VQLYAVVSEEPIYI-VTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE-- 119
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R+ +HRDL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 35/164 (21%)
Query: 159 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
LG+G +G VY R L+ Q +A+K + + + + E+ L + L+HR++V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 218 EQGENILIYEYMPNKSLDVFL---------------FYPKKKRLLGWQARVRIIEGIAQG 262
E G + E +P SL L FY K+ I +G
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ---------------ILEG 120
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGG 305
L YLH +I+HRD+K N+L+++ KISDFG ++ G
Sbjct: 121 LKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 159 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG VY GR L ++V S ++ + ++ + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 213 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+GC ++ E L EYMP S+ L K L + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 40/190 (21%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLTEFKNEMM 199
KLGEG FG V+ ++N Q+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY--------------PKKKR 245
++++L+ +++RL G C+++ +I EYM N L+ FL P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 246 LL--GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-I 302
L + + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 303 FGGD--ELQG 310
+ GD +QG
Sbjct: 189 YAGDYYRIQG 198
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 47/144 (32%), Positives = 80/144 (55%), Gaps = 6/144 (4%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
+LG+G FG VYK + G A K + +S + L ++ E+ ++A H ++V+L G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
G+ ++ E+ P ++D + + L Q +V I + + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 277 RDLKASNILLDSDMNPKISDFGMA 300
RDLKA N+LL D + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 24/172 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAK 203
+ + LGEG FG V K + VAVK L + + + L++ +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 204 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---- 258
+ +H++++ L G C ++G ++ EY + +L FL + R E
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 259 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 55/151 (36%), Positives = 80/151 (52%), Gaps = 8/151 (5%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 216
KLG G FG V+ G +VAVK L + G E F E ++ KL+H LV+L+
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
E+ I + EYM SL FL + R L V + +A G+ Y+ R+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDE 307
RDL+++NIL+ + KI+DFG+AR+ +E
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
E++ ++G G +G VYK R + G+ VA+K + + G + E+ ++ + +H ++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 210 VRLFGCCIEQGENILIYEYMPNKSL-DVF--LFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
V FG + + + ++ EY SL D++ P + + + R + +GL YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYL 117
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
H+ IHRD+K +NILL D + K++DFG++
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 26/158 (16%)
Query: 159 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LTEFKNEMMLIAKLQHRH 208
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 209 LVRLFGCCIEQGENILIYEYMPNKS----LDVFLFYPKKKRLLGWQARVR-IIEGIAQGL 263
+V+ G ++ + EY+P S L+ + + + VR + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--------ETLVRNFVRQILKGL 119
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
YLH +R IIHRD+K +NIL+D+ KISDFG+++
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 153 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRH 208
FS ++G G FG VY R + N + VA+K++S QS + + E+ + KL+H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
++ GC + + L+ EY + D+ + K + + A + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 133
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
++ +IHRD+KA NILL K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 8/158 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHL 209
E+ KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
V L+ E+ I + E+M SL FL K L Q V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R+ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 153 FSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLTEFKNEMMLIAKLQHRH 208
F+ ++G G FG VY R + EV A+K++S QS + + E+ + +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+ GC + + L+ EY + D+ + K + + A I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS 143
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
++ +IHRD+KA NILL K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 26/178 (14%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H ++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR--------------VRIIE 257
L G ++ +++EY+ L FL +G + + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQGNT 312
IA G+ YL + +H+DL A NIL+ ++ KISD G++R I+ D +Q +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 43/143 (30%), Positives = 79/143 (55%), Gaps = 6/143 (4%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
LG+G FG VYK + G A K + +S + L +F E+ ++++ +H ++V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
+ + ++ E+ +LD + ++ L Q R + + + L +LH + ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127
Query: 278 DLKASNILLDSDMNPKISDFGMA 300
DLKA NILL D + K++DFG++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLTEFKNEMMLI 201
NF + K+G+G F VYK LL+G+ VA+K++ + L E L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK-KRLLGWQARVRIIEGIA 260
+L H ++++ IE E ++ E L + + KK KRL+ + + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
L ++H RI+HRD+K +N+ + + K+ D G+ R F ++ VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 38/177 (21%)
Query: 159 LGEGGFGPVYKG-RLLNGQEVAVKRLS---------NQSGQGLTE-FKNEMMLIAKLQHR 207
+G+G +G VY + G+ +AVK++ + + + + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 208 HLVRLFGCCIEQGENIL-IY-EYMPNKSLDVFL-----FYPKKKRLLGWQARVRIIEGIA 260
++V+ G E E L I+ EY+P S+ L F + R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----IFGGDE---LQG 310
+GL YLH I+HRDLKA N+L+D+D KISDFG+++ I+ D+ +QG
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 47/179 (26%)
Query: 159 LGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LGEG FG V K L G+ VAVK L N S L + +E L+ ++ H H+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL----------------------FYPKKKRL--- 246
L+G C + G +LI EY SL FL P ++ L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 247 ----LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
WQ I++G+ YL + ++++HRDL A N+L+ KISDFG++R
Sbjct: 128 DLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 51/158 (32%), Positives = 85/158 (53%), Gaps = 18/158 (11%)
Query: 158 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR----HLV 210
+LG G FG V KG ++ Q +VA+K L N++ + + + EMM A++ H+ ++V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
R+ G C + E + L+ E L+ FL KK + V ++ ++ G+ YL
Sbjct: 59 RMIGVC--EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ +HRDL A N+LL + KISDFG+++ G D+
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 51/151 (33%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 159 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG G FG VY GR L ++V S ++ + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 213 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+GC + E L EYMP S+ L K L R I QG+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSN- 125
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 31/181 (17%)
Query: 158 KLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLTEFKNEMMLI 201
KLGEG FG V+ E VAVK L ++ + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL---------GWQAR 252
++L++ +++RL G C+ +I EYM N L+ FL + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQ 309
+ + IA G+ YL + L +HRDL N L+ + KI+DFGM+R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 310 G 310
G
Sbjct: 189 G 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 54/158 (34%), Positives = 84/158 (53%), Gaps = 14/158 (8%)
Query: 159 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG G FG VYKG + E VA+K L N S + E +E ++A + ++ RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-LLGWQARVRIIEGIAQGLLYLHQYSR 271
G C+ L+ + MP L L Y ++ + +G Q + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL---LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
+R++HRDL A N+L+ S + KI+DFG+AR+ DE +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 39/169 (23%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMMLIAKLQHRH 208
+G G +G V G++VA+K++SN F + E+ L+ L+H +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP----------KKKRLLGWQARVRIIEG 258
++ L +IL + + DV++ K + L +
Sbjct: 61 IIGLL--------DILRPPSPEDFN-DVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ 111
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
I +GL YLH +IHRDLK SNIL++S+ + KI DFG+AR DE
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 16/162 (9%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E+ + KLG G FG V+ +VAVK + S + F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-----LLGWQARVRIIEGIAQGLLY 265
+L ++ I I E+M SL FL + + L+ + A+ IA+G+ +
Sbjct: 65 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ Q + IHRDL+A+NIL+ + + KI+DFG+AR+ +E
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-14
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 213 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+GC + E L E+MP S+ L K L + I +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 19/158 (12%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGL--TEFKNEMMLIAKLQHRHLVRLF 213
K+G+G FG V+K R Q VA+K+ L +G T + E+ ++ L+H ++V L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 77
Query: 214 GCC--IEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
C N L++E+ + L L K L ++++ + GL Y
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNGLYY 134
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+H R +I+HRD+KA+NIL+ D K++DFG+AR F
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 19/155 (12%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRHLVRLFG 214
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+++VRL+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 215 CCIEQGENILIYEYMPN---KSLDVFLFYPKKK--RLLGWQARVRIIEGIAQGLLYLHQY 269
+ L++EY K D + + +Q + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
++HRDLK N+L++ + K++DFG+AR FG
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 158 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LTEFKNEMMLIAKLQHRHLVRLFG 214
K+G G FG VY L+ E+ AVK + Q + E +EM ++ L+H +LV+ +G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
+ + + + EY +L+ L + R+L + +GL YLH + I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 275 IHRDLKASNILLDSDMNPKISDFGMARI 302
+HRD+K +NI LD + K+ DFG A
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 49/172 (28%), Positives = 90/172 (52%), Gaps = 31/172 (18%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLTEFKNEMML--IAK 203
+ + ++GEG +G V+K R L G+ VA+KR+ Q+ G L+ + +L +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 204 LQHRHLVRLFGCCI-----EQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGWQA 251
+H ++VRLF C + + L++E++ ++ L +L + + + +Q
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 118
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+ +GL +LH + R++HRDLK NIL+ S K++DFG+ARI+
Sbjct: 119 -------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ +G+G FG V G G +VAVK + N + F E ++ +L+H +LV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 211 RLFGCCIEQ-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L G +E+ G ++ EYM SL +L + + +LG ++ + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +HRDL A N+L+ D K+SDFG+ +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 16/172 (9%)
Query: 158 KLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H ++VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 212 LFGCCI-EQGENILIY-EYMPNKSLDVFL-FYPKKKRLLGWQARVRIIEGIAQGLLYLH- 267
+ I + + I EY L + K+++ + + RI+ + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 268 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
++HRDLK +NI LD++ N K+ DFG+A+I G D K VGT
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 27/164 (16%)
Query: 159 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LTEFKNEMMLIAKL-QHRHLVRLF 213
+GEG FG V K R+ + A+KR+ + + +F E+ ++ KL H +++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVRIIE 257
G C +G L EY P+ +L FL +K R+L Q +
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ YL Q + IHRDL A NIL+ + KI+DFG++R
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 158 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRL 212
+GEG FG VY+G ++ VAVK N + + E F E ++ + H H+V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G E I + E P L +L K L + + ++ L YL
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMAR 301
R +HRD+ A N+L+ S K+ DFG++R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCC 216
+GEG +G VYK R GQ VA+K + E K E ++ K H ++ +G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 217 IEQGENI------LIYEYMPNKSL-DVFLFYPKKKRLLGWQARVR------IIEGIAQGL 263
I++ L+ E S+ D+ K L R++ I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
YLH+ ++IHRD+K NILL + K+ DFG++
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 22/160 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
E + KLGEG + VYKGR L GQ VA+K RL ++ G T + E L+ L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHA 63
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQ 261
++V L + L++EY+ + L ++ RL +Q + +
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLR 114
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
GL Y HQ R++HRDLK N+L+ K++DFG+AR
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 47/153 (30%), Positives = 82/153 (53%), Gaps = 19/153 (12%)
Query: 159 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLF 213
+G+G FG VY G L+ +GQ++ AVK L+ + + + +F E +++ H +++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 214 GCCI-EQGENILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQ 268
G C+ +G +++ YM + L F+ K L+G+ +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +HRDL A N +LD K++DFG+AR
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 66 KLLWIIV---VLVLPVVLLPSF-YIFRRRRR--KHKEKENMEANWDLLAFDINMSITTRT 119
W + + V+ L +F ++F R R + K EN + W+L FD +S +
Sbjct: 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI 685
Query: 120 NELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEV 178
N++ + E N + G G YKG+ + NG +
Sbjct: 686 NDILSSLKEEN---------------------------VISRGKKGASYKGKSIKNGMQF 718
Query: 179 AVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL 238
VK +++ + +E + + KLQH ++V+L G C + LI+EY+ K+L L
Sbjct: 719 VVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 239 FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294
R L W+ R +I GIA+ L +LH ++ +L I++D P +
Sbjct: 775 ------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 52/178 (29%), Positives = 91/178 (51%), Gaps = 21/178 (11%)
Query: 153 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ-SGQGLTEFKNEMMLIAKLQHRH 208
F ++GEG +G VYK R G+ VA+K RL N+ G +T + E+ ++ +L HR+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 209 LVRLFGCCI----------EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 258
+V L ++G L++EYM + D+ ++
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
+ +GL Y H+ + L HRD+K SNILL++ K++DFG+AR++ +E + T +++
Sbjct: 125 LLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 159 LGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG V + +L + Q+VAVK L S + EF E + + H ++++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 213 FGCCIEQGEN------ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGL 263
G + ++I +M + L FL + + L Q VR + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
YL S IHRDL A N +L+ +M ++DFG+++ I+ GD
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-13
Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 18/158 (11%)
Query: 158 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLTEFKNEMMLIAK----LQHRHLV 210
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + ++V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 211 RLFGCCIEQGEN-ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
R+ G C + E+ +L+ E L+ FL +K + + + ++ ++ G+ YL +
Sbjct: 60 RMIGIC--EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ +HRDL A N+LL + KISDFG+++ G DE
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 11/179 (6%)
Query: 123 CEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR 182
++ E +D D +P A A+ ++ L G G V+ GQ V
Sbjct: 38 DDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVL 96
Query: 183 LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK 242
Q G L E ML+ + H ++R+ + ++ +P+ S D++ + K
Sbjct: 97 KIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTK 149
Query: 243 KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ R L + I + I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 51/171 (29%), Positives = 92/171 (53%), Gaps = 13/171 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRH 208
E F+ ++G+G FG VYKG +EV A+K + + + + + + E+ ++++ +
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 209 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+ R +G ++ + +I EY+ S LD+ P ++ + I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
R IHRD+KA+N+LL + K++DFG+A +++ NT VGT
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 32/182 (17%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLTEFKNEMM 199
KLGEG FG V+ ++ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--------FYPKKKRLLGWQA 251
++++L+ +++RL CI +I EYM N L+ FL + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--EL 308
+ + IA G+ YL S L +HRDL N L+ + KI+DFGM+R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 309 QG 310
QG
Sbjct: 189 QG 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
++G G FG VY + E VAVK++S Q+ + + E+ + +L+H + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
GC +++ L+ EY + D+ + K + + A I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHN--- 141
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARI 302
+IHRD+KA NILL K++DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 158 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLF 213
++G G FG V G R ++ V VK L + F E+ +L H ++++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLYLHQYSR 271
G CIE +L+ E+ P L +L + Q V R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMA 300
IH DL N L +D++ KI D+G+A
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 55/166 (33%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 159 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKL-QHRH 208
LGEG FG V K R VAVK L N + + L + +EM L+ + +H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRI 255
++ L G C ++G +I EY +L FL + + L ++ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ YL SR R IHRDL A N+L+ D KI+DFG+AR
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 37/173 (21%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQH 206
+ + ++ EG +G VY+ R G+ VA+K+L + G +T + E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 207 RHLVRL----FGCCIEQGENILIY---EYMPN--KSL-----DVFLFYPKKKRLLGWQAR 252
++V + G +++ IY EY+ + KSL FL + K L+
Sbjct: 64 PNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFL-QSEVKCLM----- 112
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305
++++ G+A +LH I+HRDLK SN+LL++ KI DFG+AR +G
Sbjct: 113 LQLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT------EFKNEMMLIAKLQHRHLVRL 212
LG+G +G VY G GQ +AVK++ + L + + E+ L+ L+H ++V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
G C++ + E++P S+ L F P + + + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNC 122
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
++HRD+K +N++L + K+ DFG AR
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 43/153 (28%), Positives = 84/153 (54%), Gaps = 11/153 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
E+F ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 210 VRLFGCCIEQGENILIYEYMPNKSL-DVF-LFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
V FG + + + + E+ SL D++ + P + + + +R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+ +HRD+K +NILL + + K++DFG++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 157 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMM-LIAKLQHRH---LVR 211
+LG G +G V K R + G +AVKR+ E K +M L ++ V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVT 64
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQ 268
+G +G+ + E M + SLD F Y K K + +I I + L YLH
Sbjct: 65 FYGALFREGDVWICMEVM-DTSLDKF--YKKVYDKGLTIPEDILGKIAVSIVKALEYLH- 120
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
S+L +IHRD+K SN+L++ + K+ DFG++
Sbjct: 121 -SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 158 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
++G G FG V G + +V VK L + S Q +F E LQH +L++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLYLHQYSR 271
G C E +L+ E+ P L +L +K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMA 300
IH DL N LL +D+ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 24/178 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL----SNQSGQGLTEFKNEMMLIAKL- 204
+ KLG+G +G V+K + VA+K++ N + T F+ E+M + +L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT-FR-EIMFLQELG 64
Query: 205 QHRHLVRLFGCCIEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 260
H ++V+L + + EN L++EYM + L + +L + I+ +
Sbjct: 65 DHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLL 117
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ L Y+H S +IHRDLK SNILL+SD K++DFG+AR EL+ N + V T
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLT 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 156 QCKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQ 205
Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++KL
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLSKLD 60
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLL 264
H +V+ +E+ +I EY + LD L + L + ++ E Q LL
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL---SENQVCEWFIQLLL 117
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305
+H + RI+HRDLKA NI L +++ KI DFG++R+ G
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 143 LASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--EMM 199
+V T + +G G FG V R L GQ VA+K++ + + E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 259
L+ L+H +++ L I E+I + L L R L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
+GL Y+H ++HRDLK SNIL++ + + KI DFG+ARI
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 50/153 (32%), Positives = 81/153 (52%), Gaps = 22/153 (14%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
KLGEG + VYKG+ +NG+ VA+K RL + G T + E L+ L+H ++V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 215 CCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+ L++EY+ + L ++ +P+ +L +Q + +GL Y+HQ
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRGLSYIHQ 121
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I+HRDLK N+L+ K++DFG+AR
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 22/153 (14%)
Query: 158 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRLFG 214
KLGEG + VYKG +NGQ VA+K +S ++ +G+ T + E L+ L+H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 215 CCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+ ++EYM + L ++ +P RL +Q + +GL Y+H
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ--------LLRGLAYIH- 120
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I+HRDLK N+L+ K++DFG+AR
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 44/146 (30%), Positives = 79/146 (54%), Gaps = 11/146 (7%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
++G G +G VYK R L G+ AVK + + G + + E+ ++ + +H ++V FG
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 217 IEQGENILIYEYMPNKSL-DVF-LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
+ + + + EY SL D++ + P + + + R + QGL YLH ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 275 IHRDLKASNILLDSDMNPKISDFGMA 300
HRD+K +NILL + + K++DFG+A
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 32/176 (18%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLTEFKN-------------EMMLIAK 203
LGEG +G V K L G+ VA+K++ +T+ + E+ ++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPN---KSLD--VFLFYPKKKRLLGWQARVRIIEG 258
++H +++ L +E L+ + M + K +D + L + K +L Q
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ-------- 127
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
I GL LH++ +HRDL +NI ++S KI+DFG+AR +G +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
|
Length = 335 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 28/173 (16%)
Query: 162 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLFGCCI 217
G +G V+ + G A+K + + + E ++++ Q ++V+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 218 EQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGW----QARVRIIEGIAQGLLYLHQYSRL 272
+ +N+ L+ EY+P L L +G AR+ I E I L YLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLL------ENVGSLDEDVARIYIAE-IVLALEYLHSNG-- 113
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN-------TKRIVGT 318
IIHRDLK NIL+DS+ + K++DFG+++ G Q N KRIVGT
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 22/153 (14%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
KLGEG + VYKGR L VA+K RL ++ G T + E+ L+ L+H ++V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 215 CCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+ L++EY+ +K L +L +L +Q + +GL Y H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ--------LLRGLNYCH- 121
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
R +++HRDLK N+L++ K++DFG+AR
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 138 LPLFSLASVSAATENFSTQC--------------KLGEGGFGPVYKGRLL-NGQEVAVKR 182
LP S +S S+++ + S ++G G G VYK G+ A+K
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106
Query: 183 L-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP 241
+ N + E+ ++ + H ++V+ GE ++ E+M SL+ +
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HI 164
Query: 242 KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
++ L AR +I+ GIA YLH R I+HRD+K SN+L++S N KI+DFG++R
Sbjct: 165 ADEQFLADVAR-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
Query: 302 I 302
I
Sbjct: 217 I 217
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 44/144 (30%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
+LG+G FG VYK + G A K + +S + L ++ E+ ++A H ++V+L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ ++ E+ ++D + ++ L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 277 RDLKASNILLDSDMNPKISDFGMA 300
RDLKA NIL D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 153 FSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFK---NEMMLIAKLQHRH 208
F ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 209 LVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
LV+L + E + L EY+P L L AR + E + LH
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
L IHRDLK N L+D+ + K++DFG++
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLFGC 215
+G G FG V+ R Q++ + + E +NE ++ L H +++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
+E +++ EY P +L ++ +KR I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 276 HRDLKASNILLDS-DMNPKISDFGMARIFG 304
HRDLK NILLD M KI DFG+++I
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 7/146 (4%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVRLFGC 215
++G G FG V+ GRL + VAVK L +F E ++ + H ++VRL G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
C ++ ++ E + + D F + L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 276 HRDLKASNILLDSDMNPKISDFGMAR 301
HRDL A N L+ KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 23/160 (14%)
Query: 159 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLTEFKNEMMLIAKLQHRH 208
LG+G F +YKG L GQEV+V + + F L+++L H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
LV+L+G C+ ENI++ EY+ LDVFL K L W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 269 YSRLRIIHRDLKASNILL---DSDMNP----KISDFGMAR 301
+++H ++ NIL+ + K+SD G+
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 18/158 (11%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQ---HRHLV 210
++G G +G VYK R +G VA+K + +N+ G L+ + E+ L+ +L+ H ++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 211 RLFGCCI-----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
RL C + + L++E++ ++ L +L L + ++ +GL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDF 123
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
LH I+HRDLK NIL+ S K++DFG+ARI+
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 45/176 (25%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHR 207
NF + K+G G F VY+ LL+ + VA+K++ + + E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLD-VFLFYPKKKRLLG----WQARVRIIEGIAQG 262
++++ IE E ++ E L + ++ K+KRL+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H +SR R++HRD+K +N+ + + K+ D G+ R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
K+GEG +G VYK R G+ VA+K+ ++ G T + +L + ++VRL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 214 GCCIEQGEN-------ILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLL 264
+E E L++EY+ + L F+ R L + + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIF 303
+ H++ ++HRDLK N+L+D KI+D G+ R F
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
KLGEG + V+KGR L VA+K RL ++ G T + E+ L+ L+H ++V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
+ L++EY+ + D+ + L+ + + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124
Query: 275 IHRDLKASNILLDSDMNPKISDFGMAR 301
+HRDLK N+L++ K++DFG+AR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK---NEMMLIAKLQH 206
E + K+GEG +G V+K R GQ VA+K+ +S K E+ ++ +L+H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV-ESEDDPVIKKIALREIRMLKQLKH 59
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
+LV L + + L++EY + L+ P+ + +II Q + +
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFC 116
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305
H+++ IHRD+K NIL+ K+ DFG ARI G
Sbjct: 117 HKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 197 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVR 254
E+ ++ + + ++V +G + + + E+M SLD P +LG +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----K 107
Query: 255 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
I + +GL YL Y+ RI+HRD+K SNIL++S K+ DFG++
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 17/158 (10%)
Query: 158 KLGEGGFGPVYKG---RLLNGQ---EVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+LG+G FG VY+G ++ G+ VAVK ++ + S + EF NE ++ H+V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 263
RL G + +++ E M + L +L P+ + G Q +++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 28/166 (16%)
Query: 152 NFSTQCKLGEGGFGPVY--KGRLLNGQ----EVAVKRLSNQSGQGLTEFKNEMMLIAKLQ 205
+ K+GEG FG +Y K + + E+ + ++ + + K E++L+AK++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA---SKKEVILLAKMK 57
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSL-------DVFLFYPKKKRLLGWQARVRIIEG 258
H ++V F E G ++ EY L LF + ++L W +
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ 109
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIF 303
I+ GL ++H +I+HRD+K+ NI L + M K+ DFG+AR
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 55/165 (33%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ----SGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG G FG V R + A+K LS Q + NE ++ ++H LV L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
G + L+ EY+P L F K R AR + + L YLH L
Sbjct: 68 GSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHS---LD 121
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I++RDLK N+LLDSD KI+DFG A+ ++G T + GT
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
KLGEG + V+KGR L VA+K RL ++ G T + E+ L+ L+H ++V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
L++EY+ D+ + ++ + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 275 IHRDLKASNILLDSDMNPKISDFGMAR 301
+HRDLK N+L++ K++DFG+AR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 27/172 (15%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKL-Q 205
E+ + +GEG FG V + + A+K L + + +F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GW 249
H +++ L G C +G + EY P +L FL +K R+L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118
Query: 250 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
Q ++ +A G+ YL S + IHRDL A N+L+ ++ KI+DFG++R
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 45/168 (26%), Positives = 89/168 (52%), Gaps = 20/168 (11%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQH---RHLVRLF 213
+G G +G VY+G+ + G+ VA+K ++ + +++ + E+ L+++L+ ++ + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 214 GCCIEQGENILIYEYMPNKSLDVFL-FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G ++ +I EY S+ + P ++ + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI--VGT 318
+IHRD+KA+NIL+ + N K+ DFG+A + Q ++KR VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 19/174 (10%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQH 206
++ +G G FG V+ R ++ A+K ++ L + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 207 RHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
++RLF E + L + EY+P L F + R E I L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALE 115
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
YLH I++RDLK NILLD + + K++DFG A+ +L+ T + GT
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE--FKNEMMLIAKLQHR 207
E + +GEG +G V K + GQ VA+K+ + + E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+LV L + L++E++ + LD YP L + + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
++ IIHRD+K NIL+ K+ DFG AR
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 6e-11
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI 217
+G G +G VYKGR + ++A ++ + +G E K E+ ++ K HR++ +G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 218 EQG------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
++ + L+ E+ S+ L K L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
++IHRD+K N+LL + K+ DFG++ D G +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGC 215
+G G FG V K G +AVKR+ S + ++ ++ + ++V+ +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 216 CIEQGENILIYEYMPNKSLDVF--LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+G+ + E M + SLD F Y K ++ + +I + L YL + L+
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELK 128
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMA 300
IIHRD+K SNILLD + N K+ DFG++
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 37/171 (21%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGL--TEFKNEMMLIAKLQHR 207
F ++GEG +G VY+ R +G+ VA+K++ + G+ + + E+ L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 208 HLVRLFGCCI-EQGENI-LIYEY-----------MPNKSLDVFLFYPKKKRLLGWQARVR 254
++V L + + ++I L+ EY MP F +++V+
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP------FS---------ESQVK 111
Query: 255 -IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
++ + +GL YLH+ IIHRDLK SN+LL KI+DFG+AR +G
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 159 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 208
LGEG FG V + + VAVK L S+ + + L++ +EM ++ + +H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKK--KRLLGWQARVRI 255
++ L G C + G +I EY +L +L + P + + L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 155 TQCK-LGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMMLIAKLQH 206
T + LG+G FG VY KG + + E VA+K ++ S + EF NE ++ +
Sbjct: 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 68
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR-----LLGWQARVRIIEGI 259
H+VRL G + ++I E M L +L P+ + + +++ I
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
A G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 35/161 (21%)
Query: 159 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFG 214
+G G +G V G++VA+K+LS + Q K E+ L+ + H +++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 215 CCIEQGENILIYEYMPNKSL----DVFLFYP----------KKKRLLGWQARVRIIEGIA 260
+ P SL DV+L K ++L + ++ I
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQIL 128
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+GL Y+H IIHRDLK SNI ++ D KI DFG+AR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHR 207
NF + K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFL-FYPKKKRLLG----WQARVRIIEGIAQG 262
++++ + IE E ++ E L + + K+KRL+ W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H +SR R++HRD+K +N+ + + K+ D G+ R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 47/171 (27%), Positives = 92/171 (53%), Gaps = 13/171 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRH 208
E F+ ++G+G FG V+KG Q+V A+K + + + + + + E+ ++++ +
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 209 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+ + +G ++ + +I EY+ S LD+ P + + +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLH 118
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 159 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG G FG + +G +L + +E VA+ L + S + F E + + + H ++VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
G +++ EYM N +LD FL K + L + ++ G+A G+ YL S +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 274 IIHRDLKASNILLDSDMNPKISDFG 298
+H+ L A +L++SD+ KIS F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 157 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--EMMLIAKLQ-HRHLVRL 212
K+GEG F V K + G+ A+K + + + L + N E+ + +L H +++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 213 FGCCIEQ--GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLHQY 269
++ G L++E M ++++ +KR L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH-- 117
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
R I HRD+K NIL+ D K++DFG R
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHR 207
+F +G+G FG V + + +++ A+K ++ Q + NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 208 HLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
LV L+ + EN+ L+ + + L L +K + Q + I E I L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
H IIHRD+K NILLD + I+DF +A D L
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 31/167 (18%)
Query: 151 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
+ +GEG +G V G +VA+K++S F+++ L+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS--------PFEHQTFCQRTLREIKI 56
Query: 210 VRLFGCCIEQGENIL-IYEYMPNKSLDVF-------------LFYPKKKRLLGWQARVRI 255
+R F ENI+ I + + S + F L+ K + L
Sbjct: 57 LRRFKH-----ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYF 111
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
+ I +GL Y+H + ++HRDLK SN+LL+++ + KI DFG+ARI
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 48/171 (28%), Positives = 89/171 (52%), Gaps = 13/171 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRH 208
E F+ K+G+G FG V+KG Q+V A+K + + + + + + E+ ++++ +
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 209 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+ + +G ++ + +I EY+ S LD+ P + + I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 118
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ IHRD+KA+N+LL K++DFG+A +++ N VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 159 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRH 208
LGEG FG V K + VAVK L + + + L++ +EM ++ + +H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 255
++ L G C + G ++ EY +L +L + + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 159 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G F ++KG L+ EV +K L F ++++L H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+G C+ E+I++ EY+ SLD +L K K L+ ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 271 RLRIIHRDLKASNILL-----DSDMNP---KISDFGMA 300
+ H ++ A N+LL NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG+GGFG V ++ G+ A K+L + +G NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRLR 273
+ + L+ M L + Y + +AR I GL +LHQ R
Sbjct: 61 AFETKDDLCLVMTLMNGGDLK-YHIYNVGEPGFP-EARAIFYAAQIICGLEHLHQ---RR 115
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I++RDLK N+LLD N +ISD G+A G K GT
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 159 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG +Y+ L+ +EV + RLS + + NE+++++ LQH +++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYLHQ 268
+ ++ ++ EY +L + K + ++ W + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK 119
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRD+K NI L K+ DFG+++I G + T +VGT
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 32/169 (18%)
Query: 159 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKL-QHRH 208
LGEG FG V K + VAVK L + + + L++ +EM ++ + +H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG----------------WQAR 252
++ L G C + G +I EY +L +L + +R G ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 159 LGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 210
LG G FG V + L +VAVK L + E +E+ +++ L H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
L G C G ++I EY L FL K++ L + + +A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IHRDL A N+LL KI DFG+AR
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
K+GEG G V + G++VAVK++ + Q NE++++ QH ++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 210 VRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
V ++ + E ++ E++ +L D+ R+ Q + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHA 133
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFG 298
+IHRD+K+ +ILL SD K+SDFG
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
K+GEG G V R +G++VAVK + + Q NE++++ QH+++V ++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ E ++ E++ +L + + RL Q + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQI-ATVCESVLQALCYLHSQG---VIH 140
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
RD+K+ +ILL D K+SDFG D + K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 27/164 (16%)
Query: 159 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LTEFKNEMMLIAKL-QHRHLVRLF 213
+GEG FG V K R+ + A+KR+ + + +F E+ ++ KL H +++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVRIIE 257
G C +G L EY P+ +L FL +K R+L Q +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 12/145 (8%)
Query: 159 LGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
LG G G VYK LL + +AVK + + + + + +E+ ++ K +++ +G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ + E+M SLDV+ P+ +LG RI + +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEH--VLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 277 RDLKASNILLDSDMNPKISDFGMAR 301
RD+K SN+L+++ K+ DFG++
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 55/173 (31%), Positives = 78/173 (45%), Gaps = 29/173 (16%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQ---GLTEFKNEMMLIAKLQHRH-- 208
LG+G FG V L E+ AVK L Q +TE + + L +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR-----VLALAGKHPF 57
Query: 209 LVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
L +L C + + + + EY+ D+ + R +AR E I GL +LH
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYV--NGGDLMFHIQRSGRFDEPRARFYAAE-IVLGLQFLH 113
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGDELQGNTKRIVGT 318
+ II+RDLK N+LLDS+ + KI+DFGM + I GG T GT
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 20/119 (16%)
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++V +G GE + E+M SLD L KK + +I + +GL YL
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLR 116
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGG-------DELQGN 311
+ + +I+HRD+K SNIL++S K+ DFG MA F G + LQG
Sbjct: 117 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 28/62 (45%), Positives = 38/62 (61%), Gaps = 9/62 (14%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGDELQGNTKRIV 316
IA GL +LH II+RDLK N++LD++ + KI+DFGM + IFGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 317 GT 318
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 44/166 (26%)
Query: 158 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL--VRLFG 214
+G G +G V +G++VA+K++ + ++ +AK R L +R F
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLRELKILRHF- 61
Query: 215 CCIEQGENIL-IYE-YMPNKSL--DVFLFYPKKKRLLGWQARVRIIEG------------ 258
+ +NI+ I + P + DV++ + L II
Sbjct: 62 ----KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLH-----HIIHSDQPLTEEHIRYF 112
Query: 259 ---IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +GL Y+H + +IHRDLK SN+L++ D +I DFGMAR
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 140 LFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFK-NE 197
L ++ SV + ++ K+G+G G VY + GQEVA+K++ N Q E NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 198 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 256
++++ + +H ++V + E ++ EY+ SL DV + + R
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 122
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
Q L +LH ++IHRD+K+ NILL D + K++DFG
Sbjct: 123 -ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 17/156 (10%)
Query: 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG+G FG V RL +G+ AVK L Q + +L H L +L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 214 GCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSR 271
CC + + + + E++ L +F+ +K R +AR R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGG 305
II+RDLK N+LLD + + K++DFGM + IF G
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 159 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----NQSGQGLTEFKNEMMLIAK-LQ 205
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
H ++VR + +E ++ + + L + F +KK+ + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
YLH+ R I+HRDL +NI+L D I+DFG+A+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 140 LFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEM 198
L S+ SV + ++ K+G+G G VY + GQEVA+K+++ Q NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 199 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 257
+++ + ++ ++V + E ++ EY+ SL DV + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 122
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
Q L +LH ++IHRD+K+ NILL D + K++DFG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 214
LG GGFG V ++ + A+K + + G E +E ++ + H +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG-WQARVRIIEGIAQGLLYLHQYSRLR 273
++ ++ EY L L + + L + AR I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARF-YIACVVLAFEYLH---NRG 113
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
II+RDLK N+LLDS+ K+ DFG A+ + T GT
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 159 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+GGFG V G+L +++ KRL + +G E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII--EGIAQGLLYLHQYS 270
+ ++ + + N + Y + G+ I GL +LHQ
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMA 300
RII+RDLK N+LLD+D N +ISD G+A
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 15/168 (8%)
Query: 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI 217
+G G +G VYKGR + ++A ++ + + E K E+ ++ K HR++ +G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 218 EQG------ENILIYEYMPNKSLDVFLFYPKKKRLL-GWQARVRIIEGIAQGLLYLHQYS 270
++ + L+ E+ S+ + K L W A I I +GL +LH +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH- 140
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
++IHRD+K N+LL + K+ DFG++ D G +GT
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRH 208
++F +LG G G V K + + ++L + + + E+ ++ + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V +G GE + E+M SLD L K+ + + + ++ + +GL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 318
+ +I+HRD+K SNIL++S K+ DFG MA F G + +R+ GT
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 38/143 (26%), Positives = 72/143 (50%), Gaps = 23/143 (16%)
Query: 175 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI----------- 223
+ VAVK++ Q + E+ +I +L H ++V+++ G ++
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 224 ---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280
++ EYM L L ++ L AR+ + + + +GL Y+H + ++HRDLK
Sbjct: 90 SVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLK 141
Query: 281 ASNILLDS-DMNPKISDFGMARI 302
+N+ +++ D+ KI DFG+ARI
Sbjct: 142 PANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 159 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 213
+G+G FG V R +G AVK L ++ E + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+ + +Y+ L F +++ L +AR E +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LN 116
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
II+RDLK NILLDS + ++DFG+ + G E + T GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 213
+G+G FG V + +G+ AVK L ++ E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+ + +Y+ L F +++ +AR E IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---LN 116
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
II+RDLK NILLDS + ++DFG+ + G E T GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 48/157 (30%), Positives = 68/157 (43%), Gaps = 32/157 (20%)
Query: 159 LGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHRH 208
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQG 262
LV LF C + + EY L DVF + R + + A V + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVVL------G 113
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
L YLH+ +I++RDLK N+LLD++ KI+DFG+
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 140 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 198
L S+ SV + ++ K+G+G G VY + GQEVA+++++ Q NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 199 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 257
+++ + ++ ++V + E ++ EY+ SL DV + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
Q L +LH ++IHRD+K+ NILL D + K++DFG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGC 215
CK+G G +G VYK + +G++ L G G++ E+ L+ +L+H +++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 216 CIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQ 268
+ + L+++Y + + F+ K + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 269 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIF 303
++HRDLK +NIL+ + P KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 140 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 198
L ++ S+ + ++ K+G+G G V+ + GQEVA+K+++ Q NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 199 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 257
+++ +L++ ++V + E ++ EY+ SL DV + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCR 122
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
Q L +LH ++IHRD+K+ N+LL D + K++DFG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-08
Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 13/146 (8%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCC 216
L G VY ++ +K ++ E + ++ + + V ++
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
G + L+ E++ ++LD K+ I E +A+ L LHQ L + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVLCH 112
Query: 277 RDLKASNILLDSDMNPKISDFGMARI 302
DL NIL+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS-------GQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG V L EV A+K L +TE K + L AK H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE-KRILALAAK--HPFLT 59
Query: 211 RLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQ 268
L CC + + + + EY+ L +F ++ R + R R + L++LH+
Sbjct: 60 ALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHR 114
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +I+RDLK NILLD++ + K++DFGM +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 22/162 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 207
E +++ ++G G +G V G++VA+K+LS QS E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 208 HLVRLFGCCIEQ--GENIL-IYEYMPNKSLDV-----FLFYPKKKRLLGWQARVRIIEGI 259
+++ L G+ Y MP D+ K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 31/147 (21%)
Query: 175 GQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231
GQ VA+K+LS + Q +T K E++L+ + H++++ L + P
Sbjct: 41 GQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQ 87
Query: 232 KSL----DVFLFYPKK--------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL 279
KSL DV+L + L + ++ + G+ +LH IIHRDL
Sbjct: 88 KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144
Query: 280 KASNILLDSDMNPKISDFGMARIFGGD 306
K SNI++ SD KI DFG+AR G
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 25/58 (43%), Positives = 37/58 (63%), Gaps = 3/58 (5%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
I +GL YLH I+HRD+K N+L++S+ KI DFG+AR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 12/149 (8%)
Query: 159 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG V+ R + GQ A+K L + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
+G+ LI +++ + D+F K+ + + E +A L +LH L
Sbjct: 64 HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLH---SL 117
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMAR 301
II+RDLK NILLD + + K++DFG+++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGC 215
CK+G G +G VYK + +G++ L G G++ E+ L+ +L+H +++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 216 CIEQGEN--ILIYEYMPNKSLDVFLFY----PKKKRLLGWQARVR-IIEGIAQGLLYLHQ 268
+ + L+++Y + + F+ KK + ++ V+ ++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 269 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIF 303
++HRDLK +NIL+ + P KI+D G AR+F
Sbjct: 127 N---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 158 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
K+GEG G V G++VAVK++ + Q NE++++ H ++V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ E ++ E++ +L + + + + + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 277 RDLKASNILLDSDMNPKISDFG 298
RD+K+ +ILL SD K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 10/128 (7%)
Query: 174 NGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231
VAVK+ L + S + L + E++ +LQH +++ I E ++ M
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 232 KSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 289
S + L +P+ L A I++ + L Y+H IHR +KAS+ILL D
Sbjct: 84 GSCEDLLKTHFPEG---LPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGD 137
Query: 290 MNPKISDF 297
+S
Sbjct: 138 GKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 20/159 (12%)
Query: 159 LGEGGFGPVYKGRLLNGQE----VAVKRLS------NQSGQGLTEFKNEMMLIAKLQHRH 208
LG+GG+G V++ R + G + A+K L NQ T K E ++ ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT--KAERNILEAVKHPF 61
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V L G+ LI EY+ L F+ ++ + A + E I+ L +LHQ
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ 118
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGG 305
II+RDLK NILLD+ + K++DFG+ + I G
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 23/60 (38%), Positives = 40/60 (66%), Gaps = 2/60 (3%)
Query: 250 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
++ VR+ IA+ +L L +L II+RD+K NILLDS+ + ++DFG+++ F +E +
Sbjct: 104 ESEVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 32/157 (20%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+G G FG V+ R + +V A+K L NQ E +++ A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE--RDILADAD--SPWIV 64
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG------IAQGL 263
+L+ + E++ L+ EYMP L + R + IA+ +
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELV 111
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
L L +L IHRD+K NIL+D+D + K++DFG+
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 20/150 (13%)
Query: 159 LGEGGFGPVYKGRL----LNGQEVAVKRLSN----QSGQGLTEFKNEMMLIAKLQHRHLV 210
+G G FG V RL G A+K+L + Q + + E ++A+ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L+ + + LI EY+P + L KK + R I E I L +
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----LAIDSI 117
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGM 299
+L IHRD+K N+LLD+ + K+SDFG+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 16/149 (10%)
Query: 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH----LVRLF 213
+G G G VYK R G +AVK++ + E K +M + + H +V+ +
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 214 GCCIEQGENILIYEYMPN--KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
G I + + E M L + P + +LG ++ I + L YL + +
Sbjct: 81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--K 133
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMA 300
+IHRD+K SNILLD+ N K+ DFG++
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 159 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
+ L+ M L +++ + +A E I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMA 300
RI++RDLK NILLD + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
+LG+G +G VYK G +A+K RL + + E+ ++ K ++V +G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLYLHQYSRL 272
+G + EYM SLD Y G V RI + +GL +L +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKL--YAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMA 300
IIHRD+K +N+L++ + K+ DFG++
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
++G G FG V + VA VK L +N S + EF + LQH ++++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKR----LLGWQARVRIIEGIAQGLLYLHQY 269
G C+E +L++EY L +L + R LL Q R+ IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-- 116
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGM 299
+ +H DL N L SD+ K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 37/152 (24%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 158 KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H ++V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
E G ++ +Y D++ ++ +L + +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVL-FPED-QILDWFVQICLALKHVHD 119
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+I+HRD+K+ NI L D K+ DFG+AR+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 23/164 (14%)
Query: 159 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYP-----KKKRLLGWQARVRIIEGIAQGLLYLH 267
+ L+ M L ++ +++R L + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGDELQG 310
+ + ++RDLK NILLD + +ISD G+A +I G+ ++G
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 37/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
K+GEG G V + +G+ VAVK++ + Q NE++++ QH ++V ++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ E ++ E++ +L + + + + + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 277 RDLKASNILLDSDMNPKISDFG 298
RD+K+ +ILL D K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 26/87 (29%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 259
L++++ H HL + G C+ ENI++ E++ + LDV L K + + W ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILL 286
A L YL + ++H ++ A NILL
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 20/43 (46%), Positives = 32/43 (74%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +GL Y+H + ++HRDLK SN+LL+++ + KI DFG+AR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQS---GQGLTEFKNEMMLIAKLQ 205
E+F+ LG G FG V N VA+KR + + +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H V L+G ++ L+ E++ + F F + KR + V AQ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKR---FPNDVGCFYA-AQIVLI 143
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
L I++RDLK N+LLD D K++DFG A++
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 7e-07
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 151 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 207
E + +G G +G V G VAVK+LS QS E+ L+ ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 208 HLVRLF-----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
+++ L +E+ ++ + ++ L+ + K ++L + I + I +G
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQ-ILRG 132
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 310
L Y+H IIHRDLK SN+ ++ D KI DFG+AR DE+ G
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 197 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 256
E+ ++ + ++V +G GE + E+M SLD L KK + Q ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 109
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDEL 308
+ +GL YL + + +I+HRD+K SNIL++S K+ DFG MA F G
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167
Query: 309 QGNTKRIVGT 318
+ +R+ GT
Sbjct: 168 YMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 15/139 (10%)
Query: 175 GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLF--GCCIEQGENILIYEYM 229
G EVA+K L + + + F+ E L A+L H ++V L G G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--- 286
P ++L L L R++ + L H I+HRDLK NI++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 287 DSDMNPKISDFGMARIFGG 305
+ K+ DFG+ + G
Sbjct: 116 GVRPHAKVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 159 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
+G G +G V Y RL Q+VAVK+LS QS E+ L+ ++H +++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 214 -----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
IE + + + L+ + K ++L + I + + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQFLIYQ-LLRGLKYIHS 136
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 310
IIHRDLK SN+ ++ D +I DFG+AR DE+ G
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 159 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 213
+G+G FG V R L+G+ AVK L + E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+ + +++ L F +++ +AR E IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMAR 301
I++RDLK NILLDS + ++DFG+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 175 GQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LI 225
G VAVK+LS + Q T K E++L+ + H++++ L +E+ +++ L+
Sbjct: 46 GINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285
E M V +R+ ++ + G+ +LH IIHRDLK SNI+
Sbjct: 105 MELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155
Query: 286 LDSDMNPKISDFGMAR 301
+ SD KI DFG+AR
Sbjct: 156 VKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-06
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 7/59 (11%)
Query: 1 MNLNQCQAKCLK-NCSCRAYANSKLTGGGSGCLMW-FGDLIDLRKPISNFTGQSVYIRV 57
+L +C +KCL NCSCR++ + G GCL+W L D R G +Y ++
Sbjct: 25 ASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARL--FPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 213
+G+G FG V R ++ AVK L ++ E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+ + +Y+ L F +++ L +AR E IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I++RDLK NILLDS + ++DFG+ + E G T GT
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 159 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFKN----EMMLIAKLQHRHLVRLF 213
+GEG +G V K R +E VA+K+ + E K E+ ++ L+ ++V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+G+ L++EY+ L++ P +VR I Q + +H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----PEKVR--SYIYQLIKAIHWCHKND 120
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMAR 301
I+HRD+K N+L+ + K+ DFG AR
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 35/161 (21%)
Query: 159 LGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
+G G +G V G +VA+K+L F++E L AK +R L RL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYR-------PFQSE--LFAKRAYREL-RLLKHM- 71
Query: 218 EQGENI--LIYEYMPNKSLDVF----LFYP----------KKKRLLGWQARVR-IIEGIA 260
+ EN+ L+ + P+ SLD F L P K ++L + R++ ++ +
Sbjct: 72 -KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL--SEDRIQFLVYQML 128
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 22/153 (14%)
Query: 159 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKK-----RLLGWQARVRIIEGIAQGLLYLH 267
+ L+ M L ++ ++ R++ + A+ I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+ I++RD+K N+LLD N ++SD G+A
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 18/160 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTE-FKNEMMLIAKLQH 206
E F + G FG VY GR N + AVK + ++ + + + E +A +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 207 RHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGW---QARVRIIEGIAQG 262
+V L+ ++ N+ L+ EY+ + L + G+ + V+ I +A
Sbjct: 64 PFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYISEVALA 116
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
L YLH++ IIHRDLK N+L+ ++ + K++DFG++++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 199 MLIAKLQHRHLVRLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 257
+L +H L LF C + E++ + EY+ D+ R +AR E
Sbjct: 48 VLALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGG--DLMFHIQSSGRFDEARARFYAAE 104
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I GL +LH+ II+RDLK N+LLD D + KI+DFGM +
Sbjct: 105 -IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 27/172 (15%)
Query: 159 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYP-----KKKRLLGWQARVRIIEGIAQGLLYLH 267
+ L+ M L ++ ++R + + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGDELQGNTKRIVGT 318
R RI++RDLK NILLD + +ISD G+A I G+ ++G VGT
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 12/107 (11%)
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 259
++ ++ H+H+V L+G C+ ENI++ E++ LD LF +K +L + ++ + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILL-----DSDMNP--KISDFGM 299
A L YL ++H ++ NILL D + P K+SD G+
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 24/192 (12%)
Query: 140 LFSLASVSAATENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEM 198
+ L S+ T+ + +G+G +G VYK +G AVK L S E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 199 MLIAKL-QHRHLVRLFGCCIEQ-----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 252
++ L H ++V+ +G + G+ L+ E S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 253 VR------IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
+ I+ G GL +LH RIIHRD+K +NILL ++ K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 307 ELQGNTKRIVGT 318
L+ NT VGT
Sbjct: 182 RLRRNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 15/167 (8%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIAK 203
NF LG G +G V+ R ++G + A+K L Q + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 204 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
+ Q LV L + LI +Y+ L F +++R + ++ E I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
L +LH +L II+RD+K NILLDS+ + ++DFG+++ F DE++
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 36/147 (24%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 159 LGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
+GEG FG + + + Q+ A+K + +S + + + E +L+AK++H ++V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
G ++ EY L + ++ +L ++ + G+ ++H+ R++H
Sbjct: 68 EADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLH 123
Query: 277 RDLKASNILLDSDMNPKISDFGMARIF 303
RD+K+ NI L + K+ DFG AR+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAK------LQHRHLVR 211
LG+G FG V+ L Q A+K L L + E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 212 LFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
L+ C + EN+ + EY+ L +F+ + I GL +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I++RDLK NILLD+D + KI+DFGM +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H LV L C + + EY+ D+ ++++L AR E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNY 111
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
LH+ II+RDLK N+LLDS+ + K++D+GM +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 46/172 (26%)
Query: 159 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---- 212
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H +++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 213 FGCCIEQGE-NI---LIYEYMP-------------NKSLDVFLFYPKKKRLLGWQARVRI 255
+ C ++ E NI ++ E++P N +L +FL +L +Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMAR-IFGG 305
+ + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ + G
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
|
Length = 440 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRIIEGIAQGLL 264
H LV L C + + E++ L +F+ +++R L + AR E I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+LH+ II+RDLK N+LLD++ + K++D+GM +
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 40/172 (23%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK 203
E+F T +G+G FG V RL+ G+ A+K L L K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSL------------DVFLFYPKKKRLLGWQA 251
+V L+ + LI E++P L DV FY
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY----------- 106
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+A+ +L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 159 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
+ L+ M L F Y Q + + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLK-FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGDELQGNTKRIVGT 318
RI++RDLK NILLD + +ISD G+A +I G+ ++G VGT
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 21/45 (46%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
I GL Y+H + ++HRDLK N+L+++D KI DFG+AR F
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 22/43 (51%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I+ GL +LH R II+RDLK N++LDS+ + KI+DFGM +
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 17/137 (12%)
Query: 176 QEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYE 227
+ VA+K+LS Q+ E++L+ + H++++ L +E+ +++ L+ E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 287
M V +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 288 SDMNPKISDFGMARIFG 304
SD KI DFG+AR G
Sbjct: 154 SDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAK 203
E+F + +G G FG V RL+ G A+K L + + + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
+V++F ++ LI E++P + L KK L + + I A+ +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETV 111
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
L + +L IHRD+K N+LLDS + K+SDFG+
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 23/133 (17%)
Query: 181 KRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE---YMPNKSLDVF 237
KR+ S + + +NE++ + +L H +++++ E IL E YM + D
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 238 LF-------YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290
L+ + K R L Q R I++ + + Y+H ++IHRD+K NI L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 291 NPKISDFGMARIF 303
+ DFG A F
Sbjct: 305 KIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 18/37 (48%), Positives = 25/37 (67%), Gaps = 3/37 (8%)
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
YLH II+RDLK N+LLD+ + K++DFG A+
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 162 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN----EMMLIAKLQHRHLVRLFGCC 216
G FG VY + G A+K L + N +++ + + ++ +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-YS 65
Query: 217 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
+ + + L+ EY+ + K L + I + G+ LHQ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 276 HRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
HRD+K N+L+D + K++DFG++R G E K+ VGT
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IA GL +LH II+RDLK N++LDS+ + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIAK 203
NF LG G +G V+ R + G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 204 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQ 261
+ Q LV L + + LI +Y+ + L+ +R + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
L +LH +L I++RD+K NILLDS+ + ++DFG+++ F +E
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 45/138 (32%), Positives = 63/138 (45%), Gaps = 19/138 (13%)
Query: 176 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL- 234
+ VA+K+LS F+N+ AK +R LV L C + L+ + P KSL
Sbjct: 50 RNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 235 ---DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILL 286
DV++ L ++ + LLY + IIHRDLK SNI++
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 287 DSDMNPKISDFGMARIFG 304
SD KI DFG+AR G
Sbjct: 160 KSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRIIEGIAQGLLYLH 267
LV L C L+ EY+ L +F+ +++R L + AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ II+RDLK N+LLD+D + K++D+GM +
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
+ L Y+H + + HRDLK NIL ++D KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 159 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
+G+G +G V + R Q V K L N S + + E L+++L+H ++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 216 CIEQGENILIYEYMP-NKSLDVF-LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
+GE+ L+Y M + D++ +K +LL V IA L YLH+
Sbjct: 68 W--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIF 303
I+HRDLK N+ L K+ D G+AR+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 25/113 (22%)
Query: 197 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEY---------MPNKSLDVFLFYPKKKRLL 247
E+ ++ + HR ++ L I+ Y MP D+F Y + L
Sbjct: 136 EIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDLFT-YVDRSGPL 182
Query: 248 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+ + I + + L YLH IIHRD+K NI LD N + DFG A
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAK 203
++F + +G G FG V RL+ G A+K L + + + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
+V++F ++ LI E++P + L KK L + I E +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETV---- 111
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
L + +L IHRD+K N+LLD+ + K+SDFG+
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 159 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 216
+G+G +G V+K NG + AVK L E + E ++ L H ++V+ +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 217 ----IEQGENI-LIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
++ G+ + L+ E S+ D+ + K+ + I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ IHRD+K +NILL ++ K+ DFG++ L+ NT VGT
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I L YLH +++RDLK N++LD D + KI+DFG+ +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 43/160 (26%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKNEMM-------------LIAKL 204
+G G FG V R + ++V A+K LS K EM+ ++A
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWEERDIMAHA 100
Query: 205 QHRHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEG 258
+V+L Q + L + EYMP L V L P+K W AR E
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEK-----W-ARFYTAE- 150
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
+ L +H IHRD+K N+LLD + K++DFG
Sbjct: 151 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 5/48 (10%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFG 304
I GL +LH II+RDLK N++LD D + KI+DFGM + +FG
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 26/153 (16%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+G G FG V R ++ + A+K L NQ+ K E ++A+ + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----VKAERDILAEADNEWVV 64
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYL 266
+L+ ++ + +Y+P + L + + AR I E + + +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED------LARFYIAE-LTCAIESV 117
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
H ++ IHRD+K NIL+D D + K++DFG+
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 18/43 (41%), Positives = 29/43 (67%)
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
Q LL +H +IHRD+K++NILL S+ K+ DFG ++++
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG+G FG V R +G+ A+K L + + + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRLR 273
+ + EY+ L F+ ++R+ + R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMAR 301
I++RDLK N++LD D + KI+DFG+ +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 19/40 (47%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
L YLH Y I+HRDLK N+L+ S + K++DFG+++I
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 6/78 (7%)
Query: 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 283
L+ +YM L F K+ R +A+ I E + L +LH+Y I++RDLK N
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD---IVYRDLKPEN 126
Query: 284 ILLDSDMNPKISDFGMAR 301
ILLD+ + + DFG+++
Sbjct: 127 ILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 26/100 (26%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
+ + ++L+ ++LI +Y+ + L L KK+ L +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALND 124
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFG 304
LH++ IIH D+K N+L D + + D+G+ +I G
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 27/104 (25%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 197 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 256
E ++ + H +++L G LI +P D++ + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+ + + YLH+ RIIHRD+KA NI ++ + + DFG A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG G FG V ++ + A+K L + + + K E ++A+ + +V+L+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 215 CCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
++ + +Y+P + L +P+ AR I A+ L +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV------LARFYI----AELTLAIESVH 118
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
++ IHRD+K NIL+D D + K++DFG+ F
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+AQG+ +L + IHRD+ A N+LL KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 2/43 (4%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I L YLH S +++RDLK N++LD D + KI+DFG+ +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 37/166 (22%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
++F +G G FG EVAV ++ + TE M ++ K + L
Sbjct: 1 DDFEIIKVIGRGAFG-----------EVAVVKMKH------TERIYAMKILNKWEM--LK 41
Query: 211 RLFGCCIEQGENILI-----------YEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIE 257
R C + N+L+ Y + L + + Y LL ++ R+ E
Sbjct: 42 RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE 101
Query: 258 G-----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
IA+ +L +H +L +HRD+K N+LLD + + +++DFG
Sbjct: 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG G FG V R ++ + + A+K L + + K E ++A+ + +VRL+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 215 CCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
++ + +Y+P + L +P+ AR I E +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED------LARFYIAELTCA----VESVH 118
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
++ IHRD+K NIL+D D + K++DFG+ F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I L YLH +++RD+K N++LD D + KI+DFG+ +
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 45/145 (31%), Positives = 63/145 (43%), Gaps = 10/145 (6%)
Query: 158 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLF 213
LG+G G V+ RL G+ A+K L + + K E ++A L H L L+
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 214 GCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
+ + L+ +Y P L L K L AR E + L YLH L
Sbjct: 68 -ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHL---L 122
Query: 273 RIIHRDLKASNILLDSDMNPKISDF 297
I++RDLK NILL + +SDF
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 6/58 (10%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGNTK 313
+A+G+ +L + IHRDL A NILL KI DFG+AR D ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 41/175 (23%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-------NEMMLIAKLQHRHL 209
+G+GG G VY + + VA+K++ + L+E E + A L H +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIR----EDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG--WQ---------------AR 252
V ++ C G+ +Y MP ++ K LL WQ A
Sbjct: 65 VPVYSIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ I I + Y+H S+ ++HRDLK NILL I D+G A +E
Sbjct: 116 LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 14/40 (35%), Positives = 27/40 (67%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
+A+ +L + +L +HRD+K N+LLD + + +++DFG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSN-----QSGQGLTEFKNEMMLIAKL 204
E++ +G G FG V R + Q+V A+K LS +S F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 205 QHRHLVRLFGCCIEQGENIL--IYEYMPNKSL-DVFLFY--PKKKRLLGWQARVRIIEGI 259
+V+LF C Q + L + EYMP L ++ Y P+K W
Sbjct: 101 NSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFY-----T 148
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
A+ +L L + +IHRD+K N+LLD + K++DFG
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 19/54 (35%), Positives = 30/54 (55%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
A+ L L + +I+RDLK NILLD + + DFG+ ++ D+ + NT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 7/61 (11%)
Query: 241 PKKKRLLGWQARVRIIEGIA-QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
P+ KR + +I+G+ Q L L + R+ I+HRD+K N+L+ D KI DFG
Sbjct: 302 PQDKR------DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGA 355
Query: 300 A 300
A
Sbjct: 356 A 356
|
Length = 507 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 35/160 (21%)
Query: 159 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFG 214
+G GGFG VY R + G+ A+K L + QG T NE ++++ LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 215 C----CIEQGENI-----LIYEYMPNKSLDVFL-----FYPKKKRLLGWQARVRIIEGIA 260
C C+ + I + M L L F K+ R II G+
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA----TEIILGLE 111
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
H ++R +++RDLK +NILLD + +ISD G+A
Sbjct: 112 ------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 139 PLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLTE 193
PL L S ++F KLGEG FG VYK L+N + +K+ + G E
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE---YGAVE 176
Query: 194 -FKNEMML------IAKLQHRHLVRLFGCCIEQGENILIYEY---------MPNK----S 233
+ NE + A + L + ++ E L++ Y M +K +
Sbjct: 177 IWMNERVRRACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYN 234
Query: 234 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDSDMNP 292
++ +L + G + +II+ I + +L+ L I+HRD+K NI+
Sbjct: 235 VEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS 294
Query: 293 -KISDFGMA 300
KI D G A
Sbjct: 295 FKIIDLGAA 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 318 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.98 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.98 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.94 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.93 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.93 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.92 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.92 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.91 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.91 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.91 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.91 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.91 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.9 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.9 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.9 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.9 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.9 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.89 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.89 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.89 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.89 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.89 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.89 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.89 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.89 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.89 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.88 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.87 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.83 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.79 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.78 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.69 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.47 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.38 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.36 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.3 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.3 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.25 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.24 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.07 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.73 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.68 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.5 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.1 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.97 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.78 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.52 | |
| PLN02236 | 344 | choline kinase | 97.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.28 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.02 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.76 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.71 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.48 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.42 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.29 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.19 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.14 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.95 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.31 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.21 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.24 Aligned_cols=168 Identities=51% Similarity=0.826 Sum_probs=154.4
Q ss_pred CCCcccHHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEE
Q 021046 137 WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216 (318)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 216 (318)
....|++.++..+|++|...+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999999999999988865443156699999999999999999999999
Q ss_pred EecC-eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 217 IEQG-ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 217 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 88999999999999999999999988899999999999999999999999
Q ss_pred ecccceeecC
Q 021046 296 DFGMARIFGG 305 (318)
Q Consensus 296 DfGla~~~~~ 305 (318)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.15 Aligned_cols=161 Identities=30% Similarity=0.529 Sum_probs=140.4
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
...+|...+.||+|+|+.||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||+|++++..++..|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3468888899999999999999874 5789999998765 445566789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC------CCceEeeccc
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD------MNPKISDFGM 299 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~------~~~ki~DfGl 299 (318)
||||++|+|..|++. ...+++.+...++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999953 457999999999999999999999988 9999999999999775 3589999999
Q ss_pred ceeecCCccccccceeecC
Q 021046 300 ARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 300 a~~~~~~~~~~~~~~~~Gt 318 (318)
||.+..... ..+.+||
T Consensus 162 AR~L~~~~~---a~tlcGS 177 (429)
T KOG0595|consen 162 ARFLQPGSM---AETLCGS 177 (429)
T ss_pred hhhCCchhH---HHHhhCC
Confidence 999985543 3344554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=255.45 Aligned_cols=161 Identities=28% Similarity=0.441 Sum_probs=137.8
Q ss_pred HhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCCCc-------CHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
..+.|.+.+.||+|+||.|-+|. -++|+.||||++++.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567888999999999999995 467999999999764211 2234579999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CCceEeec
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDF 297 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~ki~Df 297 (318)
..||||||++||+|-+++. .+..+.+.....+++|++.|+.|||+++ |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999988874 3456777888899999999999999998 9999999999999776 77999999
Q ss_pred ccceeecCCccccccceeecC
Q 021046 298 GMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 298 Gla~~~~~~~~~~~~~~~~Gt 318 (318)
|||++.+... .+++++||
T Consensus 324 GlAK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGT 341 (475)
T ss_pred chhhccccce---ehhhhcCC
Confidence 9999987544 35567887
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=255.92 Aligned_cols=153 Identities=39% Similarity=0.619 Sum_probs=134.7
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCc--CHHHHHHHHHHHhccCCCccceEEEEEEecC-eeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-ENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 227 (318)
.++...+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 344555679999999999999976556999999864322 2568999999999999999999999999987 7999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~~~~ 306 (318)
|+++|+|..+++.. ....+++..++.++.|||+||.|||++.. ||||||||+|+|++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999764 46789999999999999999999999763 99999999999999998 9999999999987653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.74 Aligned_cols=160 Identities=31% Similarity=0.478 Sum_probs=145.3
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.+|...+.||+|+|+.+|+++. .+|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 78999999999763 3445677899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+|++|+|..++. ....+++.++.++..||+.||.|||+++ |||||||..|++++++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998883 5678999999999999999999999987 999999999999999999999999999999877
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
+.+ ..+++||
T Consensus 172 ~Er--k~TlCGT 181 (592)
T KOG0575|consen 172 GER--KKTLCGT 181 (592)
T ss_pred ccc--cceecCC
Confidence 544 3457887
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=257.93 Aligned_cols=157 Identities=38% Similarity=0.613 Sum_probs=140.9
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
...+.+...+.||+|.||.||.|.+.....||+|.++.. ....++|.+|+.+|++|+|+|||+++|+|..+++++||||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 344556677899999999999999988789999999864 3455789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
||+.|+|.+||.. .....++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||...+++
T Consensus 282 ~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999965 34677888999999999999999999988 9999999999999999999999999999776665
Q ss_pred cc
Q 021046 308 LQ 309 (318)
Q Consensus 308 ~~ 309 (318)
..
T Consensus 358 Y~ 359 (468)
T KOG0197|consen 358 YT 359 (468)
T ss_pred ee
Confidence 53
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=251.32 Aligned_cols=162 Identities=30% Similarity=0.467 Sum_probs=138.8
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (318)
..+.|+.+++||+|+||.||+|+. .+|+.||+|+++-.. +....-..+||.+|++|+||||++|.+..++. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 456788899999999999999964 679999999887543 34445568999999999999999999999887 6899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+|||++ ||.-++. .....+++.++..+++|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999987 5555552 33567899999999999999999999998 999999999999999999999999999999
Q ss_pred cCCccccccceee
Q 021046 304 GGDELQGNTKRIV 316 (318)
Q Consensus 304 ~~~~~~~~~~~~~ 316 (318)
..+.....|.+++
T Consensus 269 ~~~~~~~~T~rVv 281 (560)
T KOG0600|consen 269 TPSGSAPYTSRVV 281 (560)
T ss_pred cCCCCcccccceE
Confidence 8877655565554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=244.28 Aligned_cols=159 Identities=31% Similarity=0.426 Sum_probs=137.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe-eEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-NILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e 227 (318)
.+++....||+|..|.||++.++ +++.+|+|.+... .+...+++.+|++++.+.+||+||.++|.|..++. ..++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45667789999999999999874 6788999998543 34456788999999999999999999999999994 999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
||++|||+.++. ....+++...-.|+.++++||.|||+. .+||||||||+|+|+++.|++||+|||.++.+.+.
T Consensus 159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999983 336689999999999999999999963 24999999999999999999999999999988765
Q ss_pred cccccceeecC
Q 021046 308 LQGNTKRIVGT 318 (318)
Q Consensus 308 ~~~~~~~~~Gt 318 (318)
....++||
T Consensus 233 ---~a~tfvGT 240 (364)
T KOG0581|consen 233 ---IANTFVGT 240 (364)
T ss_pred ---hccccccc
Confidence 33455666
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.70 Aligned_cols=162 Identities=28% Similarity=0.402 Sum_probs=142.1
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|++.+.||+|+||+||.++. .+++.+|+|.+++.. ....+....|..+|.+++||+||+++-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 457899999999999999999975 458899999998652 2345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+||++||.|...| ++...+++..+..++..|+.||.|||+.+ ||||||||+|||+|.+|+++|+||||++.--
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999998888 34567888888888999999999999998 9999999999999999999999999999655
Q ss_pred CCccccccceeecC
Q 021046 305 GDELQGNTKRIVGT 318 (318)
Q Consensus 305 ~~~~~~~~~~~~Gt 318 (318)
.++. .+.+++||
T Consensus 177 ~~~~--~t~tfcGT 188 (357)
T KOG0598|consen 177 KDGD--ATRTFCGT 188 (357)
T ss_pred cCCC--ccccccCC
Confidence 4432 35568888
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.35 Aligned_cols=153 Identities=34% Similarity=0.541 Sum_probs=134.8
Q ss_pred HHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
....+....+.||+|+||+||+|+.. +...||||.++..... ...+|++|+++++.++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34566777889999999999999753 3457999999976555 6789999999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKK-----------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 289 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~ 289 (318)
+++||+|||..|||.+||..... ...|+..+.+.||.|||.||+||-++. +|||||.++|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999964321 223888999999999999999999877 9999999999999999
Q ss_pred CCceEeecccceee
Q 021046 290 MNPKISDFGMARIF 303 (318)
Q Consensus 290 ~~~ki~DfGla~~~ 303 (318)
..|||+||||+|-.
T Consensus 640 l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 640 LVVKISDFGLSRDI 653 (774)
T ss_pred eEEEecccccchhh
Confidence 99999999999643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=242.12 Aligned_cols=161 Identities=34% Similarity=0.526 Sum_probs=139.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHh--ccCCCccceEEEEEEecC----eeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIA--KLQHRHLVRLFGCCIEQG----ENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~ 223 (318)
.......+.+|+|.||.||+|.+. ++.||||++.. +..+.|.+|-.+.+ .++|+||++++++-...+ +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345566789999999999999985 48999999975 34456777777665 468999999999987766 889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------SRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
||+||.++|+|.+|| ....++|....+|+..|++||+|||+. .+++|+|||||++||||.+++++.|+||
T Consensus 285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999 456799999999999999999999963 4568999999999999999999999999
Q ss_pred ccceeecCCccccccceeecC
Q 021046 298 GMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 298 Gla~~~~~~~~~~~~~~~~Gt 318 (318)
|||.++..+..++.+...+||
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred ceeEEecCCCCCcchhhhhhh
Confidence 999999988777777778887
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=243.83 Aligned_cols=152 Identities=32% Similarity=0.451 Sum_probs=136.3
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (318)
...+|..++.||+|+|++|++|+. .+++++|||++.+. .....+-...|-..|.+| .||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 457899999999999999999975 56889999998764 233445567788888898 8999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|+||+++|+|.+++ .+...|++.....++.+|+.||+|||+.+ ||||||||+|||+|.++++||+|||-|+++
T Consensus 151 FvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999 34578999999999999999999999988 999999999999999999999999999999
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
++.
T Consensus 225 ~~~ 227 (604)
T KOG0592|consen 225 SPS 227 (604)
T ss_pred Chh
Confidence 764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-34 Score=234.71 Aligned_cols=167 Identities=28% Similarity=0.467 Sum_probs=141.2
Q ss_pred hcCCccccccccCCcccEEEEE-ecCCcEEEEEEccC--CCCcCHHHHHHHHHHHhccCCCccceEEE-EEEecCe-eEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFG-CCIEQGE-NIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~l 224 (318)
..+|++.++||+|.||.||++. ..+|..||.|.+.= .+....++...|+.+|++|+|||||++++ -+.++++ +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4578899999999999999996 57899999998762 24445667899999999999999999998 4555555 799
Q ss_pred EEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 225 IYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQYS-RLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
||||+.+|+|...+.. .+..+.++++++++++.|++.||..+|++- +..|+||||||.||+++.+|.+||+||||+|+
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999998864 345778999999999999999999999832 12499999999999999999999999999999
Q ss_pred ecCCccccccceeecC
Q 021046 303 FGGDELQGNTKRIVGT 318 (318)
Q Consensus 303 ~~~~~~~~~~~~~~Gt 318 (318)
+..+.. -+...+||
T Consensus 178 l~s~~t--fA~S~VGT 191 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGT 191 (375)
T ss_pred hcchhH--HHHhhcCC
Confidence 976643 34456776
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=221.63 Aligned_cols=150 Identities=34% Similarity=0.570 Sum_probs=132.0
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-cC-HHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QG-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|...+++|+|.||.||+|+. .+|+.||||+++.... .+ .....+|++.|+.++||||+.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999975 6799999999975422 12 3457899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+- +|...+. .+...++..+...++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.++..
T Consensus 82 fm~t-dLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9964 7877773 34667889999999999999999999987 999999999999999999999999999999753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=246.99 Aligned_cols=153 Identities=32% Similarity=0.511 Sum_probs=134.1
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcC-HHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.+.+.....++||+|.||.|.+++...+..||||+++...... ..+|.+|+++|.+++||||++|+|+|..++++++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3445566778999999999999999888999999999765544 479999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||++|+|.+|+..... ..+.-....+|+.|||.||+||.+.. +|||||.++|+|++.++++||+||||+|-+-
T Consensus 615 EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999965432 22445566789999999999999876 9999999999999999999999999998553
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=237.84 Aligned_cols=153 Identities=25% Similarity=0.523 Sum_probs=138.8
Q ss_pred hcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..+|++.+.||+|.||+|-+|. ...|+.||||.+++.. .+..-.+.+|+++|..|+||||++++.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4578899999999999999996 4789999999988653 34445678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||..+|.|.+|+ .....|++.+...++.||..|+.|+|.+. ++|||||.+|||+|.++.+||+||||+.++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45677999999999999999999999887 99999999999999999999999999999876
Q ss_pred Ccc
Q 021046 306 DEL 308 (318)
Q Consensus 306 ~~~ 308 (318)
+.+
T Consensus 206 ~kf 208 (668)
T KOG0611|consen 206 KKF 208 (668)
T ss_pred ccH
Confidence 653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=229.01 Aligned_cols=149 Identities=26% Similarity=0.396 Sum_probs=131.6
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+.|+...++|+|+||.||+++.+ +|+.||||++..... .-.+-.++|+++|++++|||+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999875 599999999975432 223456899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|++..-|++.-. ....++......+..|++.|+.|+|++. +|||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999988877653 3456788999999999999999999987 99999999999999999999999999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=222.60 Aligned_cols=158 Identities=32% Similarity=0.453 Sum_probs=140.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|+..+.||.|+||.|.+.+.+ +|..+|+|++++.. ..+.+...+|..+|+.+.||++++|++.|.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 468899999999999999999874 57889999998643 23445577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||++||.|..+++ +...+++..+..++.||+.||+|||+.+ |++|||||+|||+|++|.+||+|||+|+...+
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999993 4567899999999999999999999988 99999999999999999999999999998854
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
. |-+++||
T Consensus 197 r-----T~TlCGT 204 (355)
T KOG0616|consen 197 R-----TWTLCGT 204 (355)
T ss_pred c-----EEEecCC
Confidence 3 4567776
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=238.95 Aligned_cols=153 Identities=35% Similarity=0.510 Sum_probs=133.3
Q ss_pred HHHhcCCccccccccCCcccEEEEEecC--C---cEEEEEEccC---CCCcCHHHHHHHHHHHhccCCCccceEEEEEEe
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLN--G---QEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 218 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~---~~vavK~l~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 218 (318)
+...++....++||+|+||.||+|++.. + ..||||..+. .......+|.+|+++|..++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3445666677899999999999997643 2 2389998875 234567789999999999999999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
+.++++|||+|+||+|+++|... ...++..++..++.+.|+||+|||++. +|||||.++|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999533 236899999999999999999999988 9999999999999999999999999
Q ss_pred cceeec
Q 021046 299 MARIFG 304 (318)
Q Consensus 299 la~~~~ 304 (318)
|++.-.
T Consensus 308 Ls~~~~ 313 (474)
T KOG0194|consen 308 LSRAGS 313 (474)
T ss_pred cccCCc
Confidence 987543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=224.69 Aligned_cols=151 Identities=30% Similarity=0.486 Sum_probs=131.7
Q ss_pred hcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC--eeEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--ENILIY 226 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 226 (318)
..++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... ..++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778899999999999998754 8899999887653333677899999999999999999999855444 689999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++.... . .+++..+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 96 Ey~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999984322 2 6999999999999999999999988 999999999999999 79999999999998874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=232.10 Aligned_cols=162 Identities=28% Similarity=0.444 Sum_probs=138.5
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC----CC-cCHHHHHHHHHHHhccC-CCccceEEEEEEecC
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ----SG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 220 (318)
...++|...+.||+|+||+|+.|.. .++..||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++...+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999965 56899999977653 11 23445678999999999 999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeeccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM 299 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~DfGl 299 (318)
..++||||+.+|+|.+++.. ...+.+..+..++.|++.|++|+|+++ |+||||||+|+|++.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999843 466888999999999999999999988 9999999999999999 9999999999
Q ss_pred ceeec-CCccccccceeecC
Q 021046 300 ARIFG-GDELQGNTKRIVGT 318 (318)
Q Consensus 300 a~~~~-~~~~~~~~~~~~Gt 318 (318)
+.... .+. ...+.+||
T Consensus 168 s~~~~~~~~---~l~t~cGs 184 (370)
T KOG0583|consen 168 SAISPGEDG---LLKTFCGS 184 (370)
T ss_pred ccccCCCCC---cccCCCCC
Confidence 99884 332 23445565
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=230.75 Aligned_cols=152 Identities=26% Similarity=0.383 Sum_probs=136.5
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
....++|+.+..||+|+||.||+++- .+|..+|+|++++.. ..+....+.|-.+|...++|.||+|+-.|.+.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34578999999999999999999975 569999999998753 34456788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
||||||+|||++..+| .....|++..+..++.+++.|++-+|+.+ +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999988 34567899988999999999999999988 99999999999999999999999999975
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
+.
T Consensus 291 l~ 292 (550)
T KOG0605|consen 291 LD 292 (550)
T ss_pred hh
Confidence 54
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=246.47 Aligned_cols=151 Identities=34% Similarity=0.539 Sum_probs=135.8
Q ss_pred CCccccccccCCcccEEEEEecC----CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
...+.+.||.|.||.|++|+++- ...||||.|+... +....+|+.|+.+|.+.+||||++|.|+.+...+..+|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 44577899999999999998743 3469999999764 455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|||+||+|+.||+... ..+.+.+...+.++||.||+||-+.+ +|||||.++||||+++..+|++||||+|.+.+|
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999996543 45889999999999999999999877 999999999999999999999999999999776
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 785 ~ 785 (996)
T KOG0196|consen 785 P 785 (996)
T ss_pred C
Confidence 5
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=226.03 Aligned_cols=150 Identities=31% Similarity=0.485 Sum_probs=129.1
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--------------CcCHHHHHHHHHHHhccCCCccceE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--------------GQGLTEFKNEMMLIAKLQHRHLVRL 212 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~l 212 (318)
...++|++.+.||+|.||.|-+|.. .+++.||||++.+.. ....+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4567899999999999999999975 468899999987531 1123578999999999999999999
Q ss_pred EEEEEec--CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 213 FGCCIEQ--GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 213 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
+.+.-+. +..|||+|||..|.+... ......+++.+++.++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9998754 678999999999987432 222333899999999999999999999998 99999999999999999
Q ss_pred CceEeecccceee
Q 021046 291 NPKISDFGMARIF 303 (318)
Q Consensus 291 ~~ki~DfGla~~~ 303 (318)
++||+|||.+-..
T Consensus 248 ~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 248 TVKISDFGVSNEF 260 (576)
T ss_pred cEEeeccceeeec
Confidence 9999999999877
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=226.85 Aligned_cols=165 Identities=28% Similarity=0.442 Sum_probs=139.4
Q ss_pred CCCCCCCCCcccHHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhc--cCCCc
Q 021046 131 DKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK--LQHRH 208 (318)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~n 208 (318)
.+.+.+++|.+...++. .+..+.+.||+|.||.||+|.+. |+.||||++...++ +.+.+|.++... |+|+|
T Consensus 194 tSGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHEN 266 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHEN 266 (513)
T ss_pred cCCCCCCchhHhHHhhh---heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccch
Confidence 44556778877665544 56778899999999999999994 78999999976443 456677777664 69999
Q ss_pred cceEEEEEEecC----eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCC
Q 021046 209 LVRLFGCCIEQG----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-----QYSRLRIIHRDL 279 (318)
Q Consensus 209 iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivH~Dl 279 (318)
|+.+++.-..++ .+|||++|.++|||.+|| ....++-...++++..+|.||++|| .++++.|.||||
T Consensus 267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999998765543 679999999999999999 3467889999999999999999999 468899999999
Q ss_pred CCCCEEEcCCCCceEeecccceeecCC
Q 021046 280 KASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 280 k~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+.||||.+++++.|+|+|||-....+
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEeccc
Confidence 999999999999999999999887765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=233.50 Aligned_cols=159 Identities=30% Similarity=0.469 Sum_probs=140.8
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+. .....+.+.+|++++++++||||+.++++|....+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999754 5789999998764 33456678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
|+.+ +|..++ .....++++.+..++.++..||.|||+.. |+|||+||+|||++.++.+|++|||+||.++.+.
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 999998 34567999999999999999999999987 9999999999999999999999999999887654
Q ss_pred cccccceeecC
Q 021046 308 LQGNTKRIVGT 318 (318)
Q Consensus 308 ~~~~~~~~~Gt 318 (318)
+ +.++|.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 3 45677776
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=231.57 Aligned_cols=151 Identities=29% Similarity=0.448 Sum_probs=132.5
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHH--HHHHHHHHhccC-CCccceEEEEEEecC-eeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTE--FKNEMMLIAKLQ-HRHLVRLFGCCIEQG-ENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 223 (318)
..++|...++||.|+||.||+|+. .++..||||++++.-.. +++ -++|+..|++|+ ||||++|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457899999999999999999975 56889999999875322 343 368999999998 999999999999988 899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|||||+. +|.+++.. +++.+++.++..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||-.
T Consensus 87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 67777743 3788999999999999999999999988 999999999999999999999999999977
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 161 ~Sk 163 (538)
T KOG0661|consen 161 RSK 163 (538)
T ss_pred ccC
Confidence 543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=216.83 Aligned_cols=151 Identities=31% Similarity=0.490 Sum_probs=128.8
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-c-CHHHHHHHHHHHhccCCCc-cceEEEEEEecC-----
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-Q-GLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQG----- 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~-~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 220 (318)
...|...++||+|+||.||+|+. .+|+.||+|+++-... + .-....+|+.++++++|+| |++|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677788999999999999975 5688999999875433 2 2235688999999999999 999999999887
Q ss_pred -eeEEEEEeccCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 221 -ENILIYEYMPNKSLDVFLFYPKKK-RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
..++|+||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+|+||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999964 788888543221 45777889999999999999999988 9999999999999999999999999
Q ss_pred cceeec
Q 021046 299 MARIFG 304 (318)
Q Consensus 299 la~~~~ 304 (318)
+|+.++
T Consensus 166 lAra~~ 171 (323)
T KOG0594|consen 166 LARAFS 171 (323)
T ss_pred hHHHhc
Confidence 999765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=216.90 Aligned_cols=153 Identities=28% Similarity=0.429 Sum_probs=130.3
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-cC-HHHHHHHHHHHhccCCCccceEEEEEEec--Cee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QG-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 222 (318)
...++|+.++.|++|+||.||+|+. ++++.||+|+++.... .+ --..++|+.+|.+.+|||||.+-.+.... +..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3457899999999999999999986 4678999999985422 11 12357899999999999999998887643 679
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
|+|||||+. +|...+... ...+...+...+..|+++|++|||... |+||||||+|+|++..|.+||+||||||.
T Consensus 153 y~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 999999986 677777443 357888899999999999999999887 99999999999999999999999999999
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
++..
T Consensus 227 ygsp 230 (419)
T KOG0663|consen 227 YGSP 230 (419)
T ss_pred hcCC
Confidence 9765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=232.12 Aligned_cols=163 Identities=27% Similarity=0.420 Sum_probs=139.3
Q ss_pred HHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCe
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 221 (318)
....++|...++||+|+||+|+++..+ +++.+|||.+++.. ....+..+.|-+++.-. +||.++.|+.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345678999999999999999999875 47789999998763 34556677888877766 59999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
++.||||+.||++..+. ....+++..+..++..++.||.|||+++ ||+||||.+|||+|.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954433 3467899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCccccccceeecC
Q 021046 302 IFGGDELQGNTKRIVGT 318 (318)
Q Consensus 302 ~~~~~~~~~~~~~~~Gt 318 (318)
---..+ ..|.+++||
T Consensus 517 e~m~~g--~~TsTfCGT 531 (694)
T KOG0694|consen 517 EGMGQG--DRTSTFCGT 531 (694)
T ss_pred ccCCCC--CccccccCC
Confidence 544322 357789998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=209.88 Aligned_cols=162 Identities=31% Similarity=0.433 Sum_probs=138.1
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|++++.||+|.||.||.|+. +++-.||+|++.+. ..+....+.+|+++-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 457899999999999999999976 45678999988753 22334578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++||.++|+|...|... ....+++.....+..|+|.||.|+|... +|||||||+|+|++..+.+||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999888532 3456788888899999999999999877 9999999999999999999999999987543
Q ss_pred CCccccccceeecC
Q 021046 305 GDELQGNTKRIVGT 318 (318)
Q Consensus 305 ~~~~~~~~~~~~Gt 318 (318)
. ...++++||
T Consensus 176 ~----~kR~tlcgt 185 (281)
T KOG0580|consen 176 S----NKRKTLCGT 185 (281)
T ss_pred C----CCceeeecc
Confidence 2 223456666
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=227.92 Aligned_cols=161 Identities=31% Similarity=0.486 Sum_probs=142.6
Q ss_pred HhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
....|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34577777899999999999996 46688999999987555555668899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
||++|+|.+.. ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999998887 3445899999999999999999999998 9999999999999999999999999999987766
Q ss_pred cccccceeecC
Q 021046 308 LQGNTKRIVGT 318 (318)
Q Consensus 308 ~~~~~~~~~Gt 318 (318)
. ....++||
T Consensus 424 ~--KR~TmVGT 432 (550)
T KOG0578|consen 424 S--KRSTMVGT 432 (550)
T ss_pred C--ccccccCC
Confidence 5 34567887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=226.31 Aligned_cols=155 Identities=28% Similarity=0.412 Sum_probs=130.4
Q ss_pred HHhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
.+.++|.+.++||+|+||.||+|.. .++..||||+++.... .....+.+|+.++..+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3457899999999999999999974 2346799999875432 2345789999999999 899999999998765
Q ss_pred C-eeEEEEEeccCCChhhhhhcCCC-------------------------------------------------------
Q 021046 220 G-ENILIYEYMPNKSLDVFLFYPKK------------------------------------------------------- 243 (318)
Q Consensus 220 ~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 243 (318)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999988854211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 244 ----KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 244 ----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134788899999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=220.34 Aligned_cols=153 Identities=31% Similarity=0.520 Sum_probs=131.0
Q ss_pred hcCCccccccccCCcccEEEEEecC-----------------CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVR 211 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 211 (318)
.++|...++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 3369999887543 233457999999999999999999
Q ss_pred EEEEEEecCeeEEEEEeccCCChhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021046 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK----------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275 (318)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 275 (318)
+++++.+.+..++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998875321 1235788899999999999999999987 99
Q ss_pred ecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 276 HRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 276 H~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||||||+|||++.++.+||+|||+++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceeccc
Confidence 999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=244.47 Aligned_cols=151 Identities=36% Similarity=0.606 Sum_probs=133.9
Q ss_pred hcCCccccccccCCcccEEEEEecC--Cc----EEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
..+....+.||+|.||.||+|...+ +. .||||.+++. +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456677899999999999998643 32 4999999875 345677999999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
++++|||++|+|..||...+. ...+...+.+.++.|||+|+.||++++ +|||||.++|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999975432 467889999999999999999999987 9999999999999999999999999
Q ss_pred cceee
Q 021046 299 MARIF 303 (318)
Q Consensus 299 la~~~ 303 (318)
|||.+
T Consensus 848 lArDi 852 (1025)
T KOG1095|consen 848 LARDI 852 (1025)
T ss_pred hhHhh
Confidence 99933
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=227.95 Aligned_cols=155 Identities=35% Similarity=0.583 Sum_probs=137.3
Q ss_pred cHHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 142 SLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
+.+.+++..+.+.+.+.||+|.||+||+|.|-+ .||||.++... .+..+.|++|+..+++-+|.||+-+.|+|..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 345566677788889999999999999998853 69999998653 34678999999999999999999999999998
Q ss_pred CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
.. .+|+.+|+|-+|..+++..+ ..|+..+...|+.|||+||.|||.++ |||||||..||++.+++.|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 77 99999999999999997653 56888899999999999999999998 99999999999999999999999999
Q ss_pred ceeec
Q 021046 300 ARIFG 304 (318)
Q Consensus 300 a~~~~ 304 (318)
|..-.
T Consensus 535 atvk~ 539 (678)
T KOG0193|consen 535 ATVKT 539 (678)
T ss_pred eeeee
Confidence 96543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=220.98 Aligned_cols=151 Identities=26% Similarity=0.387 Sum_probs=132.9
Q ss_pred HhcCCccccccccCCcccEEEEEecC--CcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..++|...+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999997643 368999988643 2234567889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 108 lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999884 3346889999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 182 ~~ 183 (340)
T PTZ00426 182 DT 183 (340)
T ss_pred CC
Confidence 53
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=224.24 Aligned_cols=148 Identities=26% Similarity=0.387 Sum_probs=131.7
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|+..+.||+|+||.||++... +++.||+|++.... ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999764 58899999987532 233456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999998843 456899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=224.59 Aligned_cols=147 Identities=28% Similarity=0.382 Sum_probs=130.4
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...+.||+|+||.||++.. .+++.||||.+... .....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999976 46889999988643 1233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+++|+|..++. ....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999884 3456888899999999999999999987 999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=223.55 Aligned_cols=151 Identities=25% Similarity=0.297 Sum_probs=132.8
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
...++|+..+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 5789999988642 2223456789999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|..++. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+
T Consensus 120 lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999883 235788899999999999999999987 999999999999999999999999999887
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 193 ~~ 194 (370)
T cd05621 193 DE 194 (370)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=220.43 Aligned_cols=149 Identities=24% Similarity=0.397 Sum_probs=132.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+..|+.++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 58899999987532 233457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999984 3446889999999999999999999987 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=223.72 Aligned_cols=148 Identities=25% Similarity=0.396 Sum_probs=132.1
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999874 58899999987531 233456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998843 346899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=224.43 Aligned_cols=146 Identities=24% Similarity=0.366 Sum_probs=129.9
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+|...+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.++..++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999976 457899999987532 2334578899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999998843 346888889999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=219.09 Aligned_cols=150 Identities=24% Similarity=0.350 Sum_probs=133.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467899999999999999999874 5889999998653 223456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999988843 346788899999999999999999987 99999999999999999999999999987754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=217.52 Aligned_cols=141 Identities=27% Similarity=0.331 Sum_probs=125.2
Q ss_pred cccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 157 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
+.||+|+||.||++.. .+++.||+|.++... ......+..|+.++.+++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 468899999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|..++. ....+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9988884 3456899999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=212.31 Aligned_cols=155 Identities=26% Similarity=0.367 Sum_probs=137.4
Q ss_pred HhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|++.+.||.|..+.||+|. .+.+..||||++.-.. ....+.+.+|+..|..++||||++++-.|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45789999999999999999996 4678999999997543 334688999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
.||.+||+.+.+...- ...+++..+..|.+++++||.|||+++ .||||||+.||||+++|.+||+|||.+.-+...
T Consensus 104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999885432 345899999999999999999999998 999999999999999999999999988666544
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 180 G 180 (516)
T KOG0582|consen 180 G 180 (516)
T ss_pred C
Confidence 3
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=221.80 Aligned_cols=163 Identities=26% Similarity=0.422 Sum_probs=141.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe-eEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-NILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 225 (318)
.++|..++++|+|+||.++..+++ ++..+++|.+.-. +....+...+|+.++++++|||||.+.+.|..++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999998764 4678999987643 34445578999999999999999999999999988 8999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+|++||+|.+.+...+ ...++++....++.|++.|+.|||+.. |+|||||+.||+++.++.+||+|||+||.++.
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999986544 678999999999999999999999776 99999999999999999999999999999987
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
+.. .....+||
T Consensus 159 ~~~--~a~tvvGT 169 (426)
T KOG0589|consen 159 EDS--LASTVVGT 169 (426)
T ss_pred chh--hhheecCC
Confidence 652 34456776
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.77 Aligned_cols=149 Identities=27% Similarity=0.361 Sum_probs=132.0
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999874 68899999986432 233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++. ....+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999884 3346888999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=221.46 Aligned_cols=147 Identities=24% Similarity=0.369 Sum_probs=130.1
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||+++. .+++.||||.+.... ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999986 458899999986432 233466889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999998843 346788888999999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=222.78 Aligned_cols=146 Identities=25% Similarity=0.392 Sum_probs=129.4
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+|...++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999976 457899999987532 2334578899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+++|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999988843 346788889999999999999999987 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=213.12 Aligned_cols=150 Identities=30% Similarity=0.458 Sum_probs=122.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----eeEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENILI 225 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 225 (318)
.|...+++|.|+||.||+|... +++.||||+.-.... --.+|+.+|+.++|||||+|.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667789999999999999874 468999998865332 2246899999999999999998887543 23589
Q ss_pred EEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~DfGla~~~ 303 (318)
|||||. +|...+.. ...+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 57666642 223456677777788999999999999977 9999999999999987 89999999999999
Q ss_pred cCCccc
Q 021046 304 GGDELQ 309 (318)
Q Consensus 304 ~~~~~~ 309 (318)
..++..
T Consensus 177 ~~~epn 182 (364)
T KOG0658|consen 177 VKGEPN 182 (364)
T ss_pred ccCCCc
Confidence 877654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=226.16 Aligned_cols=152 Identities=19% Similarity=0.219 Sum_probs=132.2
Q ss_pred CCccccccccCCcccEEEEEec-C-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.|...+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999753 3 5778888775544444556788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 230 PNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 230 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++|+|.+++... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999887532 23456889999999999999999999987 999999999999999999999999999987644
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=210.97 Aligned_cols=149 Identities=28% Similarity=0.352 Sum_probs=130.3
Q ss_pred CccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++..++|+|++++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999976 568999999886432 22334678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999998777432 2346889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=221.10 Aligned_cols=154 Identities=31% Similarity=0.416 Sum_probs=132.1
Q ss_pred HhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 220 (318)
..++|+..+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+.++..+ +||||++++++|..++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 356789999999999999999964 235689999987532 23445788999999999 8999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCC----------------------------------------------------------
Q 021046 221 ENILIYEYMPNKSLDVFLFYPK---------------------------------------------------------- 242 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 242 (318)
..++||||+++|+|..++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999998885321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 243 --------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 243 --------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0125788999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=215.91 Aligned_cols=141 Identities=28% Similarity=0.338 Sum_probs=125.4
Q ss_pred cccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 157 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999976 46889999998753 2234567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 9988874 3356889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=220.66 Aligned_cols=151 Identities=25% Similarity=0.299 Sum_probs=132.3
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|+..+.||+|+||.||++... +++.||+|.+... .......+..|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999864 5889999998642 22334457889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|..++.. ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998832 34788888899999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
.+
T Consensus 194 ~~ 195 (370)
T cd05596 194 AN 195 (370)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=219.94 Aligned_cols=153 Identities=24% Similarity=0.289 Sum_probs=133.5
Q ss_pred HHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
....++|...+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 345689999999999999999999875 5788999988642 122344578899999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999883 234788888999999999999999987 99999999999999999999999999987
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 192 ~~~~ 195 (371)
T cd05622 192 MNKE 195 (371)
T ss_pred cCcC
Confidence 7543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=225.53 Aligned_cols=160 Identities=32% Similarity=0.478 Sum_probs=138.5
Q ss_pred CccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecC------eeEE
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ENIL 224 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 224 (318)
|...+.||+|+||.||+|+. .+|+.||||.++... ....+..-+|+++|++++|||||++.+.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567899999999999985 579999999998643 345667889999999999999999999866544 5689
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE--cCCCC--ceEeecccc
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMN--PKISDFGMA 300 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~~--~ki~DfGla 300 (318)
|||||++|||...|..++....|++.+.+.+..+++.||.|||+++ |+||||||.||++ ..+|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988888889999999999999999999999887 9999999999998 33343 799999999
Q ss_pred eeecCCccccccceeecC
Q 021046 301 RIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 301 ~~~~~~~~~~~~~~~~Gt 318 (318)
|-+.++. ....++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9997766 46678887
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=215.77 Aligned_cols=141 Identities=26% Similarity=0.334 Sum_probs=125.0
Q ss_pred cccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 157 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
+.||+|+||.||++.. .+|..||+|.+... .......+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999986 46889999998753 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9988773 3346889999999999999999999987 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=213.92 Aligned_cols=140 Identities=24% Similarity=0.296 Sum_probs=124.7
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||+|+||.||++... +++.||+|.+... .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999874 5789999998643 233456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 988843 346889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=223.03 Aligned_cols=152 Identities=29% Similarity=0.451 Sum_probs=136.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..-|.+++.||.|+.|.|-.|++ .+|+.+|||.+.+.. ......+.+|+.+|+-+.|||+++++++|.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 34578889999999999999975 679999999998652 23345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
.||+++|.|.+++. ....+++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+.+||+|||||.+-.+
T Consensus 91 lEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999984 4567888999999999999999999887 99999999999999999999999999998766
Q ss_pred Cc
Q 021046 306 DE 307 (318)
Q Consensus 306 ~~ 307 (318)
+.
T Consensus 165 gk 166 (786)
T KOG0588|consen 165 GK 166 (786)
T ss_pred Cc
Confidence 53
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=214.56 Aligned_cols=150 Identities=22% Similarity=0.305 Sum_probs=132.1
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||++... +++.||+|.+.+. .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999864 5889999998642 2233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999998843 2346888999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=215.83 Aligned_cols=151 Identities=22% Similarity=0.321 Sum_probs=133.3
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...+.||+|+||.||++... +++.||+|.++... ......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999764 68899999987532 234456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988432 346899999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=212.97 Aligned_cols=142 Identities=26% Similarity=0.313 Sum_probs=124.7
Q ss_pred cccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 157 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
+.||+|+||.||++.. .+++.||+|.+... .......+..|+.++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 46889999998753 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|..++. ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9988873 34568999999999999999999997 55 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=214.24 Aligned_cols=151 Identities=21% Similarity=0.285 Sum_probs=132.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|.+.+.||+|+||.||+++.. +++.||+|.+.+. .......+..|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999874 5788999988642 1223445788999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998532 346888999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=218.41 Aligned_cols=155 Identities=28% Similarity=0.397 Sum_probs=132.1
Q ss_pred HHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccC-CCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 219 (318)
...++|.+.+.||+|+||.||+|+.. .+..||||++..... ...+.+.+|+.++.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34678899999999999999999752 134699999975432 33467899999999996 99999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCC---------------------------------------------------------
Q 021046 220 GENILIYEYMPNKSLDVFLFYPK--------------------------------------------------------- 242 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 242 (318)
+..++||||+++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998875321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 021046 243 ------------------------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 286 (318)
Q Consensus 243 ------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 286 (318)
....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 0134788889999999999999999987 9999999999999
Q ss_pred cCCCCceEeecccceeecC
Q 021046 287 DSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 287 ~~~~~~ki~DfGla~~~~~ 305 (318)
+.++.+||+|||+++.+..
T Consensus 271 ~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 271 AQGKIVKICDFGLARDIMH 289 (400)
T ss_pred eCCCEEEEEeCCcceeccc
Confidence 9999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=217.61 Aligned_cols=150 Identities=27% Similarity=0.437 Sum_probs=133.8
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|.+.+.||+|+||.||++... +++.||||++.... ......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999875 68899999987532 234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999998843 256889999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=213.91 Aligned_cols=148 Identities=26% Similarity=0.357 Sum_probs=129.2
Q ss_pred CCccccccccCCcccEEEEEe----cCCcEEEEEEccCC----CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQ----SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
+|++.+.||+|+||.||+++. .+++.||+|.+.+. .....+.+..|+.++..+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999975 35789999998642 123345678899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988843 356889999999999999999999987 99999999999999999999999999986
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=214.21 Aligned_cols=161 Identities=29% Similarity=0.427 Sum_probs=140.2
Q ss_pred HHhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCc---CHHHHHHHHHHHhccC-CCccceEEEEEEecCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 222 (318)
.....|++.+.||+|.||.||++..+. |+.+|+|.+.+.... ....+.+|+.+|.++. |||||++.+.+.+.+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999998755 999999999865443 3468999999999998 99999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC----CCceEeecc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFG 298 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~ki~DfG 298 (318)
++|||++.+|.|.+.+... .+++.++..++.|++.++.|||+.+ ++||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999888544 3899999999999999999999987 9999999999999654 479999999
Q ss_pred cceeecCCccccccceeecC
Q 021046 299 MARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 299 la~~~~~~~~~~~~~~~~Gt 318 (318)
+|+..... .....++||
T Consensus 185 la~~~~~~---~~~~~~~Gt 201 (382)
T KOG0032|consen 185 LAKFIKPG---ERLHTIVGT 201 (382)
T ss_pred CceEccCC---ceEeeecCC
Confidence 99998762 245567776
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=218.55 Aligned_cols=155 Identities=32% Similarity=0.461 Sum_probs=131.8
Q ss_pred HHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
...++|+..+.||+|+||.||++... ++..||+|+++.... .....+.+|+.+++.+ +||||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34568999999999999999998742 245799999975432 2345688999999999 899999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCC---------------------------------------------------------
Q 021046 220 GENILIYEYMPNKSLDVFLFYPK--------------------------------------------------------- 242 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 242 (318)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999998875321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 243 ----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 243 ----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1134788899999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=216.43 Aligned_cols=148 Identities=26% Similarity=0.412 Sum_probs=131.5
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|+..+.||+|+||.||++... +++.||+|.+... .......+..|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999864 5889999998643 2334567888999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999884 3456889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=212.50 Aligned_cols=141 Identities=30% Similarity=0.426 Sum_probs=123.8
Q ss_pred cccccCCcccEEEEEe----cCCcEEEEEEccCC----CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQ----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+.||+|+||.||+++. .+++.||+|.++.. .......+..|+.++..++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35788999998753 122345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++|+|.+++. ....+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999988884 3346788888899999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=222.78 Aligned_cols=159 Identities=28% Similarity=0.461 Sum_probs=140.1
Q ss_pred HHHHhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++....+....++||-|.||.||.|.|+. ...||||.++. +....++|+.|+.+|+.++|||+|+|+|+|+.....|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33444556667899999999999998854 56899999976 45677899999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+|||..|+|.+||.... ...++.-..++++.||+.||+||..+. +|||||.++|+|+.++..+||+||||++++.
T Consensus 341 iTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999996542 345667788999999999999999887 9999999999999999999999999999999
Q ss_pred CCccc
Q 021046 305 GDELQ 309 (318)
Q Consensus 305 ~~~~~ 309 (318)
+|...
T Consensus 417 gDTYT 421 (1157)
T KOG4278|consen 417 GDTYT 421 (1157)
T ss_pred CCcee
Confidence 88654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=208.45 Aligned_cols=149 Identities=29% Similarity=0.448 Sum_probs=129.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|...+.||+|+||.||+|... ++..||+|.++... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357888999999999999999764 67899999887532 2334567899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++ +|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 84 YLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 9985 88887742 2345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=205.76 Aligned_cols=149 Identities=28% Similarity=0.434 Sum_probs=130.8
Q ss_pred hcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+..+..++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999753 356899999876432 334578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999988532 346889999999999999999999887 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=211.41 Aligned_cols=144 Identities=30% Similarity=0.368 Sum_probs=126.3
Q ss_pred cccccCCcccEEEEEe----cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 157 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
+.||+|+||.||+++. .+++.+|+|++.... ......+..|+.++.+++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999998883 3456899999999999999999999987 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=214.75 Aligned_cols=146 Identities=28% Similarity=0.429 Sum_probs=127.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|+..++||+|+||.||++... +++.||||.+..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356777889999999999999864 688999999865322 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++|+|.... ..++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999985432 3456778889999999999999987 99999999999999999999999999987653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=226.49 Aligned_cols=152 Identities=29% Similarity=0.444 Sum_probs=132.7
Q ss_pred HHhcCCccccccccCCcccEEEEEecCC-cEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEE-e------
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCI-E------ 218 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-~------ 218 (318)
....++++.+.|.+|||+.||.|....+ ..+|+|++-..++...+...+|+.+|+.|+ |||||.+++... .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3455778889999999999999998665 999999988777788889999999999998 999999999432 1
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
.-+.+|+||||.+|.|-+++...... .|++.++++|+.++++|+++||.. ++||||||||-+||||+.++..||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 13578999999999999998644333 399999999999999999999997 5789999999999999999999999999
Q ss_pred cce
Q 021046 299 MAR 301 (318)
Q Consensus 299 la~ 301 (318)
-|.
T Consensus 192 Sat 194 (738)
T KOG1989|consen 192 SAT 194 (738)
T ss_pred ccc
Confidence 884
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=210.92 Aligned_cols=151 Identities=26% Similarity=0.342 Sum_probs=132.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++..++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999874 57889999887542 2334578999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999998843 346889999999999999999999853 499999999999999999999999999986643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=211.54 Aligned_cols=150 Identities=21% Similarity=0.280 Sum_probs=130.8
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...++||+|+||.||++... +++.+|+|.+.+. .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999875 4678999988642 2223445888999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999998532 346889999999999999999999987 99999999999999999999999999976643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=211.40 Aligned_cols=150 Identities=27% Similarity=0.355 Sum_probs=131.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|+..++||+|+||.||++... ++..+|+|.+.... ......+.+|+.++..++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999875 57889999876532 2334578999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++|+|.+++.. ...+++.....++.|++.||.|||+.+ +++||||||+|||+++++.+||+|||++..+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999998843 345888999999999999999999743 39999999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=215.38 Aligned_cols=142 Identities=23% Similarity=0.289 Sum_probs=125.7
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..+|.+.+.||+|+||.||++.. .+++.||+|.... ..+.+|+.++++++||||+++++++..++..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999976 4688999997542 3568899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+. ++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 85 67877773 2346889999999999999999999987 9999999999999999999999999997643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=210.36 Aligned_cols=151 Identities=34% Similarity=0.576 Sum_probs=129.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCc----EEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..+|+..+.||+|+||.||+|.+. ++. .||+|.++... ....+++..|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999763 333 48999987543 23456789999999999999999999999864 578
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999988532 345888999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
..+
T Consensus 160 ~~~ 162 (316)
T cd05108 160 GAD 162 (316)
T ss_pred cCC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=207.16 Aligned_cols=149 Identities=23% Similarity=0.389 Sum_probs=130.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999875 57889999987532 2335678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|++++++..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987765542 2346889999999999999999999887 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=210.77 Aligned_cols=141 Identities=27% Similarity=0.389 Sum_probs=123.3
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++... +++.+|+|.+++. .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 5789999998753 223345677888888776 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99988773 3356899999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=206.47 Aligned_cols=151 Identities=26% Similarity=0.335 Sum_probs=134.8
Q ss_pred HhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|+..+.||+|.-|+||++++.+ +..+|+|++.+.. .....+...|-++|+.++||.++.|+..+..++..++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34678888999999999999999865 5889999998753 3345567889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+||+|...++. +..+.+++..+..++..++.||+|||-.| ||.|||||+||||-++|++.|+||.|+...
T Consensus 155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999987754 35678999999999999999999999888 999999999999999999999999999765
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=205.28 Aligned_cols=152 Identities=34% Similarity=0.520 Sum_probs=131.2
Q ss_pred cCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|+..+.||+|+||.||+|.. .++..+++|.+..... ....++.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999974 2457899999875332 334678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 225 IYEYMPNKSLDVFLFYPKK--------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
||||+++++|.+++..... ...+++.....++.|++.||+|||+++ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 235788999999999999999999987 99999999999999999
Q ss_pred CceEeecccceeecC
Q 021046 291 NPKISDFGMARIFGG 305 (318)
Q Consensus 291 ~~ki~DfGla~~~~~ 305 (318)
.+||+|||+++....
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999986643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-29 Score=230.53 Aligned_cols=151 Identities=34% Similarity=0.541 Sum_probs=132.4
Q ss_pred CccccccccCCcccEEEEEe-cCCc----EEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
....++||+|+||+||+|.+ +.|+ +||||.+... ..+...+++.|+..|++|+|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34557899999999999965 4444 6899988754 3345678999999999999999999999999876 88999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+||+.|+|.+|++.. ...+..+..+.|..|||+||.|||.+. +|||||.++||||.+...+||+|||+|+++..|
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999653 456788999999999999999999887 999999999999999999999999999999887
Q ss_pred ccc
Q 021046 307 ELQ 309 (318)
Q Consensus 307 ~~~ 309 (318)
+.+
T Consensus 852 ~~e 854 (1177)
T KOG1025|consen 852 EKE 854 (1177)
T ss_pred ccc
Confidence 654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=207.73 Aligned_cols=149 Identities=30% Similarity=0.433 Sum_probs=129.2
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 688999999875432 233467889999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 577666632 2345788899999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=201.98 Aligned_cols=148 Identities=32% Similarity=0.485 Sum_probs=132.5
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
++|+..+.||+|+||.||++.+.++..+|+|.+... .....++..|+.++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999888889999988643 3345688999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999988532 235889999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=209.97 Aligned_cols=146 Identities=27% Similarity=0.363 Sum_probs=126.8
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCC-ccceEEEEEEecCeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHR-HLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 226 (318)
+|...+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999864 4778999998753 233456788899999999765 5888999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+++|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999988884 3346889999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=209.78 Aligned_cols=141 Identities=27% Similarity=0.391 Sum_probs=123.3
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 4789999998753 223445677888888765 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99988874 3356889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=210.66 Aligned_cols=140 Identities=24% Similarity=0.381 Sum_probs=123.8
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999864 5789999999753 223345678899999888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99988773 3356899999999999999999999987 99999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=210.49 Aligned_cols=144 Identities=28% Similarity=0.441 Sum_probs=124.1
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHH---hccCCCccceEEEEEEecCeeEEE
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLI---AKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
|.+.+.||+|+||.||++... +++.||||.++... ....+.+..|+.++ ..++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999764 58899999987532 23345566676554 567899999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|||+++|+|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999988773 346899999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=209.08 Aligned_cols=142 Identities=29% Similarity=0.356 Sum_probs=121.3
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhc-cCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 57889999987532 2334455667666664 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+|..++.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999888742 346888999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=201.68 Aligned_cols=152 Identities=31% Similarity=0.472 Sum_probs=135.9
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|...+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++|||++++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788889999999999999998778899999987533 3457799999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++.... ...+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999885432 356899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=204.38 Aligned_cols=150 Identities=29% Similarity=0.473 Sum_probs=130.1
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe-----cCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-----QGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 221 (318)
...|...+.||+|+||.|..+.. .+|+.||||++.+. .....++-.+|+.+|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45566678999999999999976 56899999999743 34456788999999999999999999999876 357
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.|+|+|+| ..+|...+ +.+..++..-...+..|+++||+|+|+.+ ++||||||+|+|++.+..+||+|||||+
T Consensus 101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 66888888 34455888889999999999999999988 9999999999999999999999999999
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 174 ~~~~~ 178 (359)
T KOG0660|consen 174 YLDKF 178 (359)
T ss_pred ecccc
Confidence 98653
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=201.06 Aligned_cols=150 Identities=31% Similarity=0.496 Sum_probs=133.3
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
++|...+.||+|+||.||+|...++..+|+|.+... ....+++.+|+.++.+++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888899999999999998877778999988753 3345779999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+|+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....+
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999988532 236899999999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=204.35 Aligned_cols=144 Identities=31% Similarity=0.401 Sum_probs=125.7
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||+|+||.||++... +++.+|+|.+.... ....+.+..|+.+++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999764 68899999986532 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 235 DVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 235 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
..++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 8877432 23457899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=208.91 Aligned_cols=147 Identities=28% Similarity=0.348 Sum_probs=126.4
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (318)
+|...+.||+|+||.||+|... +++.||+|.+.+.. ......+..|..++..+ +||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 57799999987532 22334567777777776 5899999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999988874 2346889999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=187.32 Aligned_cols=148 Identities=28% Similarity=0.465 Sum_probs=128.0
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|...++||+|.||+||+|+. .+++.||+|+++-. ++.......+|+.+++.++|.|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566778999999999999975 45788999988643 223345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+.. +|..|.. .-+..++.+....++.|+++||.|+|++. +.|||+||.|.||+.+|++|++|||+|+-++-
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 954 6766652 34567888999999999999999999987 99999999999999999999999999998753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=203.19 Aligned_cols=153 Identities=35% Similarity=0.561 Sum_probs=138.5
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
...+|...++||+|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44678889999999999999999888899999999876555667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999998543 3456899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=213.75 Aligned_cols=155 Identities=29% Similarity=0.431 Sum_probs=131.8
Q ss_pred HHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccC-CCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 219 (318)
...++|.+.+.||+|+||.||+|.+. .+..||+|+++.... ...+.+..|+.++.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34567888899999999999999853 345899999975432 22457889999999997 99999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCC---------------------------------------------------------
Q 021046 220 GENILIYEYMPNKSLDVFLFYPK--------------------------------------------------------- 242 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 242 (318)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999886421
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 021046 243 --------------------------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 284 (318)
Q Consensus 243 --------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 284 (318)
....+++.....++.|++.||+|||+.+ ++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124677888999999999999999876 99999999999
Q ss_pred EEcCCCCceEeecccceeecC
Q 021046 285 LLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 285 ll~~~~~~ki~DfGla~~~~~ 305 (318)
|+++++.+||+|||+++.+..
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred EEeCCCEEEEEecCcceeccc
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=204.05 Aligned_cols=150 Identities=31% Similarity=0.540 Sum_probs=131.3
Q ss_pred cCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI 223 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (318)
.+|+..+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++..++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 35789999998766555567899999999999999999999987643 4678
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988432 345899999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=210.05 Aligned_cols=146 Identities=26% Similarity=0.421 Sum_probs=125.5
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----eeE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI 223 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 223 (318)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 6889999998743 2233457889999999999999999999986543 479
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||++ ++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68887773 3446899999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=220.79 Aligned_cols=156 Identities=21% Similarity=0.281 Sum_probs=132.8
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC----
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG---- 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 220 (318)
...++|.+.+.||+|+||.||++.. .+++.||||.+... .......+.+|+..+..++|+|+++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999975 56899999998653 2334456889999999999999999988776433
Q ss_pred ----eeEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 221 ----ENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 357999999999999988542 23457899999999999999999999987 9999999999999999999999
Q ss_pred ecccceeecCC
Q 021046 296 DFGMARIFGGD 306 (318)
Q Consensus 296 DfGla~~~~~~ 306 (318)
|||+++.+...
T Consensus 186 DFGls~~~~~~ 196 (496)
T PTZ00283 186 DFGFSKMYAAT 196 (496)
T ss_pred ecccCeecccc
Confidence 99999887543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-27 Score=203.88 Aligned_cols=143 Identities=20% Similarity=0.358 Sum_probs=125.0
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcC---HHHHHHHHHHHhccCCCccceEEEEEEe----cCeeEEEEEec
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIYEYM 229 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 229 (318)
..||+|+++.||+|.+ +|+.||||.++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999997643333 4678899999999999999999999987 34679999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++|+|.+++.. ...+++.....++.|++.||.|||+.. +++||||||+||++++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999843 356889999999999999999999742 288999999999999999999999999987654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=208.57 Aligned_cols=141 Identities=29% Similarity=0.426 Sum_probs=123.4
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++... +++.||+|.+... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 5789999998753 233455677888888776 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99988874 3346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=200.96 Aligned_cols=152 Identities=34% Similarity=0.505 Sum_probs=135.6
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++||||+++++.+..++..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 34678999999999999999999888889999988653 23457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999988543 2456788999999999999999999887 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=208.38 Aligned_cols=141 Identities=28% Similarity=0.372 Sum_probs=121.0
Q ss_pred cccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHH-HHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++.. .+|+.+|+|++.... ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999976 468899999986531 223345555654 56779999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988773 3456889999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=204.04 Aligned_cols=150 Identities=29% Similarity=0.358 Sum_probs=130.7
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999986 468899999986532 1223457789999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999998877532 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=200.81 Aligned_cols=150 Identities=27% Similarity=0.463 Sum_probs=134.4
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++..++||||+++++.+..++..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 346799999999999999999986 5678999999876554555678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999988842 346889999999999999999999887 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=207.67 Aligned_cols=141 Identities=29% Similarity=0.375 Sum_probs=120.8
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHH-HHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|... +++.||+|.+.... ......+..|.. ++..++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999874 68899999986532 222344555544 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 99988884 3456888999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=208.26 Aligned_cols=147 Identities=27% Similarity=0.365 Sum_probs=126.9
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 226 (318)
+|+..+.||+|+||.||++... +++.||+|.+... .......+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677789999999999999864 5889999998753 2233456778888888886 577888999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999988873 3356899999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=207.43 Aligned_cols=155 Identities=30% Similarity=0.480 Sum_probs=131.6
Q ss_pred ccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 156 QCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
.+.||.|.||+||-|.+ ++|+.||||.+.+. .....+.+.+|+.+|.+++||.||.|.-.|.+.+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999975 67999999999764 345557899999999999999999999999999999999999955
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CCceEeecccceeecCCccc
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARIFGGDELQ 309 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~ki~DfGla~~~~~~~~~ 309 (318)
++.+.+... +...|++.....++.||+.||.|||.++ |+|+||||+|||+.+. -++||+|||.||++++..++
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 554544333 4556888888899999999999999988 9999999999999654 36999999999999876653
Q ss_pred cccceeecC
Q 021046 310 GNTKRIVGT 318 (318)
Q Consensus 310 ~~~~~~~Gt 318 (318)
+.++||
T Consensus 724 ---rsVVGT 729 (888)
T KOG4236|consen 724 ---RSVVGT 729 (888)
T ss_pred ---hhhcCC
Confidence 456776
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=202.24 Aligned_cols=146 Identities=43% Similarity=0.653 Sum_probs=126.0
Q ss_pred cccccccCCcccEEEEEec-----CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 155 TQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|+..+.+++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 256899999965332 3467899999999999999999999999988889999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++|+|.+++... ....+++..+..|+.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999654 2456899999999999999999999987 9999999999999999999999999998873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=199.53 Aligned_cols=149 Identities=32% Similarity=0.489 Sum_probs=132.3
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.+|+..+.||+|+||.||++.+.++..+|+|.+... .....++.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 457788999999999999998877778999988643 2344678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|.+++... ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999988532 236899999999999999999999987 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=207.72 Aligned_cols=141 Identities=28% Similarity=0.366 Sum_probs=120.1
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHH-HHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+++.. +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 57899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|...+. ....+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99988773 2346788888899999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=203.30 Aligned_cols=154 Identities=30% Similarity=0.495 Sum_probs=131.5
Q ss_pred HhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|+..+.||+|+||.||+|... .+..||+|++..... ....++.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 246799998864322 234578899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 222 NILIYEYMPNKSLDVFLFYPKK-------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854221 234678889999999999999999987 999999999999999999999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||+++.+..
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05062 161 GDFGMTRDIYE 171 (277)
T ss_pred CCCCCccccCC
Confidence 99999976543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=201.22 Aligned_cols=143 Identities=30% Similarity=0.457 Sum_probs=122.2
Q ss_pred ccccCCcccEEEEEecC---CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCC
Q 021046 158 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+..++.++||||+++++.+.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 34688888764332 234568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 234 LDVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 234 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|.+++..... ....++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999864332 234567888999999999999999987 999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=224.05 Aligned_cols=150 Identities=25% Similarity=0.329 Sum_probs=131.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.++||+|+||.||+|... +++.||+|++..... ...+++.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999864 588999999875322 22457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 227 EYMPNKSLDVFLFYPK--------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
||+++|+|.+++.... ....+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234567788999999999999999987 9999999999999999999999999
Q ss_pred cceee
Q 021046 299 MARIF 303 (318)
Q Consensus 299 la~~~ 303 (318)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99877
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=214.49 Aligned_cols=145 Identities=25% Similarity=0.329 Sum_probs=126.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|+.++++++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 347889999999999999999875 478899995432 3467899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+. ++|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 688777742 2346899999999999999999999987 999999999999999999999999999877543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=200.02 Aligned_cols=150 Identities=34% Similarity=0.544 Sum_probs=132.2
Q ss_pred hcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|...+.||+|+||.||+|.+.. ...||||.++.... ....+|.+|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998742 35799998875432 334578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998532 346899999999999999999999987 9999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=207.45 Aligned_cols=141 Identities=28% Similarity=0.380 Sum_probs=123.9
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++... +++.+|+|.++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 57899999997532 23345678899998888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99988773 2346899999999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=205.57 Aligned_cols=141 Identities=28% Similarity=0.392 Sum_probs=122.1
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhc-cCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|... +++.||||.++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 47899999987531 2334556677777775 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 99998884 2346889999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=200.68 Aligned_cols=150 Identities=34% Similarity=0.504 Sum_probs=126.7
Q ss_pred cCCccccccccCCcccEEEEEec-CCc----EEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|+..+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56888899999999999999863 344 477887764332 23467888888999999999999999875 456789
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998532 346899999999999999999999987 9999999999999999999999999998765
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
.+
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=202.40 Aligned_cols=152 Identities=34% Similarity=0.581 Sum_probs=132.8
Q ss_pred cCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999742 345689999876555556689999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 225 IYEYMPNKSLDVFLFYPK----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885321 2235899999999999999999999987 999999999999999999999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||+++....
T Consensus 162 ~dfg~~~~~~~ 172 (288)
T cd05093 162 GDFGMSRDVYS 172 (288)
T ss_pred ccCCccccccC
Confidence 99999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=223.58 Aligned_cols=151 Identities=27% Similarity=0.406 Sum_probs=133.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.++||+|+||.||+|... +++.||||+++.... .....+..|+.++..++||||+++++++...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999875 688999999875322 2235788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++++|..++.. ...+++...+.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999998843 345788999999999999999999987 99999999999999999999999999997654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 157 ~ 157 (669)
T cd05610 157 R 157 (669)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=203.68 Aligned_cols=152 Identities=30% Similarity=0.476 Sum_probs=129.9
Q ss_pred hcCCccccccccCCcccEEEEEecC---------------CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLF 213 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~ 213 (318)
.++|++.+.||+|+||.||++...+ ...||+|.+.... ......|.+|+.++.+++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987532 2358999987542 23345789999999999999999999
Q ss_pred EEEEecCeeEEEEEeccCCChhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 021046 214 GCCIEQGENILIYEYMPNKSLDVFLFYPK---------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 284 (318)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 284 (318)
+++..++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885321 1124788999999999999999999987 99999999999
Q ss_pred EEcCCCCceEeecccceeec
Q 021046 285 LLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 285 ll~~~~~~ki~DfGla~~~~ 304 (318)
++++++.+||+|||+++.+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=201.10 Aligned_cols=152 Identities=33% Similarity=0.567 Sum_probs=132.9
Q ss_pred hcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|.+.+.||+|+||.||+|...+ +..||||.++..... ....+.+|+.++.+++|||++++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999997633 478999998765443 456899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 223 ILIYEYMPNKSLDVFLFYPK-----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
++||||+++++|.+++.... ....+++.....++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999985421 2345788999999999999999999987 999999999999999999
Q ss_pred ceEeecccceeec
Q 021046 292 PKISDFGMARIFG 304 (318)
Q Consensus 292 ~ki~DfGla~~~~ 304 (318)
+||+|||+++.+.
T Consensus 161 ~kl~d~g~~~~~~ 173 (280)
T cd05049 161 VKIGDFGMSRDVY 173 (280)
T ss_pred EEECCcccceecc
Confidence 9999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=199.37 Aligned_cols=146 Identities=31% Similarity=0.417 Sum_probs=124.4
Q ss_pred cccccCCcccEEEEEecC---CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 157 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 45799998875432 23357889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 233 SLDVFLFYPK--KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 233 ~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccC
Confidence 9999986432 2235677888899999999999999987 99999999999999999999999999975543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=205.40 Aligned_cols=141 Identities=28% Similarity=0.375 Sum_probs=122.0
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhc-cCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+++.. ++..||+|.++... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 57899999987531 2334556778777765 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999888742 346888999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=205.95 Aligned_cols=141 Identities=28% Similarity=0.349 Sum_probs=119.1
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHH-HHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEM-MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++... +++.||+|.+.... ......+..|. .++..++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 56789999986532 12233444444 356788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++.. ...+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999988843 345778888889999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=203.64 Aligned_cols=148 Identities=28% Similarity=0.455 Sum_probs=128.5
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999864 577899999875432 2334678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++ +|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 77776633 2345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=202.71 Aligned_cols=154 Identities=30% Similarity=0.491 Sum_probs=130.6
Q ss_pred HHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
...++|++.+.||+|+||.||+|... .+..||+|.+..... ....++.+|+..++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999653 245799998864322 23346888999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCce
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKK-------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 293 (318)
..++||||+++|+|.+++..... ....++.....++.|++.||.|||+++ ++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999854211 234567788899999999999999887 99999999999999999999
Q ss_pred Eeecccceeec
Q 021046 294 ISDFGMARIFG 304 (318)
Q Consensus 294 i~DfGla~~~~ 304 (318)
|+|||+++.+.
T Consensus 160 L~Dfg~~~~~~ 170 (288)
T cd05061 160 IGDFGMTRDIY 170 (288)
T ss_pred ECcCCcccccc
Confidence 99999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=209.68 Aligned_cols=148 Identities=26% Similarity=0.403 Sum_probs=127.9
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----eeE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI 223 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 223 (318)
+|+..+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++..++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 468999999986532 233467889999999999999999999998776 789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|+||+. ++|...+. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 56776663 3456899999999999999999999987 999999999999999999999999999876
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
..+
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=209.84 Aligned_cols=154 Identities=29% Similarity=0.427 Sum_probs=134.9
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.....|.+...||+|.|++|.+|.+ .++..||||.+.+... .....+.+|+++|..|+|||||+++.+...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456788999999999999999976 5688999999986533 233458899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+.+|.+.+++... ....+.....++.|+.+|++|||++. |+|||||++|+|++.+..+||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999532 33444788889999999999999998 9999999999999999999999999999987
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
...
T Consensus 207 ~~~ 209 (596)
T KOG0586|consen 207 YGL 209 (596)
T ss_pred ccc
Confidence 544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=200.20 Aligned_cols=151 Identities=30% Similarity=0.509 Sum_probs=123.6
Q ss_pred cCCccccccccCCcccEEEEEec--CCcEEEEEEccCCC--CcCHHHHHHHHHHHhcc---CCCccceEEEEEEe-----
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIE----- 218 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 218 (318)
++|+..+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46789999886432 22234566777776665 69999999999863
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
....++||||++ ++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 5888887432 2345889999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCC
Q 021046 299 MARIFGGD 306 (318)
Q Consensus 299 la~~~~~~ 306 (318)
+|+.+...
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=201.52 Aligned_cols=152 Identities=34% Similarity=0.570 Sum_probs=132.5
Q ss_pred cCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|+..+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999742 345689999876555555679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 225 IYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 1235899999999999999999999987 999999999999999999
Q ss_pred ceEeecccceeecC
Q 021046 292 PKISDFGMARIFGG 305 (318)
Q Consensus 292 ~ki~DfGla~~~~~ 305 (318)
++|+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=207.54 Aligned_cols=153 Identities=29% Similarity=0.449 Sum_probs=128.7
Q ss_pred HhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEec-
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ- 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 219 (318)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999963 3467899999975432 2345688999999999 689999999988755
Q ss_pred CeeEEEEEeccCCChhhhhhcCCC--------------------------------------------------------
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKK-------------------------------------------------------- 243 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (318)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999988753210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 244 --------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 244 --------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 124678888999999999999999987 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=199.89 Aligned_cols=152 Identities=35% Similarity=0.563 Sum_probs=131.0
Q ss_pred hcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|+..+.||+|+||.||+|.... ...||+|.+.... .....+|.+|+..+..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578889999999999999997643 2579999887533 23345789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC
Q 021046 223 ILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 289 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~ 289 (318)
+++|||+++|+|.+++..... ...+++.....++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 999999999999998854321 145888999999999999999999987 9999999999999999
Q ss_pred CCceEeecccceeec
Q 021046 290 MNPKISDFGMARIFG 304 (318)
Q Consensus 290 ~~~ki~DfGla~~~~ 304 (318)
+.+||+|||+++...
T Consensus 161 ~~~~L~dfg~~~~~~ 175 (283)
T cd05048 161 LTVKISDFGLSRDIY 175 (283)
T ss_pred CcEEECCCcceeecc
Confidence 999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=206.27 Aligned_cols=145 Identities=24% Similarity=0.312 Sum_probs=125.8
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
....+|.+.+.||+|+||.||+|... ++..||+|..... ....|+.++.+++||||+++++++..++..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999875 4678999975432 2356999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 578777643 3456899999999999999999999987 9999999999999999999999999997543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=196.94 Aligned_cols=143 Identities=31% Similarity=0.488 Sum_probs=126.4
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999874 68899999876432 23346789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 998843 2346889999999999999999999887 9999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=198.57 Aligned_cols=149 Identities=32% Similarity=0.588 Sum_probs=125.0
Q ss_pred ccccccccCCcccEEEEEecCC-c--EEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEec------Cee
Q 021046 154 STQCKLGEGGFGPVYKGRLLNG-Q--EVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------GEN 222 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 222 (318)
.+.+.||+|+||.||+|...+. . .+|+|.++.. +....+.+..|+.++..++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999987543 2 5899988653 233456788999999999999999999988542 246
Q ss_pred EEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 223 ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
+++|||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 987653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=198.98 Aligned_cols=152 Identities=32% Similarity=0.536 Sum_probs=131.8
Q ss_pred hcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..+|.+.+.||+|+||.||+|... .+..+|+|.++... ......+..|+.++..++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888899999999999999763 23379999887532 2334678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|.+++... ...+++.+...++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999998532 346889999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 158 ~~ 159 (267)
T cd05066 158 DD 159 (267)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=201.65 Aligned_cols=153 Identities=30% Similarity=0.489 Sum_probs=131.0
Q ss_pred hcCCccccccccCCcccEEEEEec-----------------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVR 211 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 211 (318)
.++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 23468999987543 233567899999999999999999
Q ss_pred EEEEEEecCeeEEEEEeccCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 021046 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKK--------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 283 (318)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 283 (318)
+++++..++..+++|||+++|+|..++..... ...+++.+...++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998854321 235788899999999999999999987 9999999999
Q ss_pred EEEcCCCCceEeecccceeecC
Q 021046 284 ILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 284 ill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++.++.++|+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred EEEcCCCCEEeccCcccccccC
Confidence 9999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=200.95 Aligned_cols=153 Identities=31% Similarity=0.475 Sum_probs=132.2
Q ss_pred hcCCccccccccCCcccEEEEEecC-----------------CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVR 211 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 211 (318)
..+|++.+.||+|+||.||++.... +..||+|.+.... ....+.+.+|+.++.+++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678899999999999999997642 2458999987543 234567899999999999999999
Q ss_pred EEEEEEecCeeEEEEEeccCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 021046 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK--------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 283 (318)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 283 (318)
+++++..++..++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999885432 1236899999999999999999999887 9999999999
Q ss_pred EEEcCCCCceEeecccceeecC
Q 021046 284 ILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 284 ill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++.++.++|+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=215.05 Aligned_cols=156 Identities=31% Similarity=0.472 Sum_probs=130.7
Q ss_pred cccccccCCcccEEEEEe-cCCcEEEEEEcc--C--CCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe--eEEEEE
Q 021046 155 TQCKLGEGGFGPVYKGRL-LNGQEVAVKRLS--N--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE--NILIYE 227 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~--~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 227 (318)
....||+|+|-+||+|.+ .+|.+||--.++ . .++...++|..|+.+|+.|+||||++++..|.+..+ ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 446899999999999976 347777743222 1 244556899999999999999999999999998765 789999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~~ 306 (318)
.+..|+|..|+. +.+.++.+....|++||++||.|||++. +||||||||.+||+|+. -|.|||+|+|||.++...
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999984 4456788899999999999999999985 78999999999999975 589999999999998755
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
.. +.++||
T Consensus 200 ~a----ksvIGT 207 (632)
T KOG0584|consen 200 HA----KSVIGT 207 (632)
T ss_pred cc----ceeccC
Confidence 43 347787
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=200.39 Aligned_cols=150 Identities=34% Similarity=0.552 Sum_probs=128.6
Q ss_pred CCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
+|.+.+.||+|+||.||+|... ....+++|.+..... ....++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999752 235788988875432 234678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 021046 225 IYEYMPNKSLDVFLFYPK---------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 283 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 283 (318)
++||+++|+|.+++.... ....+++...+.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1245889999999999999999999887 9999999999
Q ss_pred EEEcCCCCceEeecccceeec
Q 021046 284 ILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 284 ill~~~~~~ki~DfGla~~~~ 304 (318)
|++++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=207.87 Aligned_cols=154 Identities=29% Similarity=0.457 Sum_probs=129.3
Q ss_pred HhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEec-
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ- 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 219 (318)
+.++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+..|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4568999999999999999999642 347899999875322 2345678899999999 899999999988754
Q ss_pred CeeEEEEEeccCCChhhhhhcCCC--------------------------------------------------------
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKK-------------------------------------------------------- 243 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (318)
...++++||+++|+|..++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999988753211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 244 --KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 244 --~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
...++|..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 136889999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=198.66 Aligned_cols=150 Identities=27% Similarity=0.473 Sum_probs=134.2
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.++..++||||+++++.+..++..++|+|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 345788889999999999999976 4588999999876554555678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++++|.+++. ....+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 87 FCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred ccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999999874 3346889999999999999999999987 9999999999999999999999999997664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=204.03 Aligned_cols=141 Identities=30% Similarity=0.402 Sum_probs=123.6
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++... +++.||+|.++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 4789999998753 233455677888888877 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99988773 3346899999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=202.09 Aligned_cols=154 Identities=30% Similarity=0.521 Sum_probs=132.5
Q ss_pred HhcCCccccccccCCcccEEEEEec--------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
..++|.+.+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567888899999999999999641 24479999887532 34456789999999999 89999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
.+..+++|||+++|+|..++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999864321 235788999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecC
Q 021046 286 LDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~ 305 (318)
++.++.+||+|||+|+.+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 170 VTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EcCCCcEEECCCccceeccc
Confidence 99999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=201.63 Aligned_cols=155 Identities=30% Similarity=0.507 Sum_probs=133.5
Q ss_pred HHhcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
...++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678889999999999999997632 3579999887532 23345688999999999 899999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 021046 220 GENILIYEYMPNKSLDVFLFYP-------------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 286 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 286 (318)
+..+++|||+++|+|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999988532 22456899999999999999999999887 9999999999999
Q ss_pred cCCCCceEeecccceeecC
Q 021046 287 DSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 287 ~~~~~~ki~DfGla~~~~~ 305 (318)
+.++.+||+|||+++.+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 166 TEDHVMKIADFGLARDIHH 184 (293)
T ss_pred cCCCeEEeCcccccccccc
Confidence 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=196.21 Aligned_cols=151 Identities=32% Similarity=0.518 Sum_probs=131.5
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|.+.++||+|+||.||+|...+...||+|+++.. ....+.+.+|+.++..++||||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 4568999999999999999998877778999999753 234567899999999999999999999874 45689999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999998532 2346789999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=202.08 Aligned_cols=149 Identities=27% Similarity=0.329 Sum_probs=130.1
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999764 57889999886532 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++++|.+++.. ...+++.....++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999843 356889999999999999999999742 39999999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=200.52 Aligned_cols=152 Identities=34% Similarity=0.512 Sum_probs=130.2
Q ss_pred cCCccccccccCCcccEEEEEecC------CcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.+|.+.+.||+|+||.||+|...+ ++.||+|+++..... ..+.+..|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457778899999999999997632 468999999754332 2356889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 224 LIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
+++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999874221 1245888999999999999999999987 99999999999999999
Q ss_pred CceEeecccceeecC
Q 021046 291 NPKISDFGMARIFGG 305 (318)
Q Consensus 291 ~~ki~DfGla~~~~~ 305 (318)
.+||+|||+++.+..
T Consensus 162 ~~kl~Dfg~~~~~~~ 176 (283)
T cd05091 162 NVKISDLGLFREVYA 176 (283)
T ss_pred ceEeccccccccccc
Confidence 999999999986643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=199.75 Aligned_cols=141 Identities=28% Similarity=0.404 Sum_probs=120.0
Q ss_pred ccccCCcccEEEEEecC-------------------------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceE
Q 021046 158 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l 212 (318)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998875444445678899999999999999999
Q ss_pred EEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC--
Q 021046 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-- 290 (318)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-- 290 (318)
++++..++..++||||+++|+|+.++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 2346889999999999999999999887 99999999999997654
Q ss_pred -----CceEeecccceee
Q 021046 291 -----NPKISDFGMARIF 303 (318)
Q Consensus 291 -----~~ki~DfGla~~~ 303 (318)
.+|++|||++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3799999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=200.55 Aligned_cols=151 Identities=28% Similarity=0.435 Sum_probs=135.2
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+.++|++.+.||+|+||.||++... ++..+|+|.+........+.+..|+.++++++|||++++++.+..++..++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3567999999999999999999874 578999999876555566789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++++|..++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 83 FCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred ccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998743 2346899999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=207.90 Aligned_cols=146 Identities=23% Similarity=0.348 Sum_probs=127.3
Q ss_pred HhcCCccccccccCCcccEEEEEec---CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
...+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|+.+++.++||||+++++++...+..++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999753 3568999988643 2356899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+. ++|..++ .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99986 5777777 23457899999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 238 ~ 238 (392)
T PHA03207 238 H 238 (392)
T ss_pred c
Confidence 4
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=199.56 Aligned_cols=154 Identities=29% Similarity=0.468 Sum_probs=133.2
Q ss_pred HhcCCccccccccCCcccEEEEEecC-----CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEe-cCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 221 (318)
..++|...+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++|||++++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788889999999999999998755 6789999887542 2335678899999999999999999999876 467
Q ss_pred eEEEEEeccCCChhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEee
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKK-----RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 296 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~D 296 (318)
.++++||+++|+|..++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543322 56899999999999999999999887 99999999999999999999999
Q ss_pred cccceeecC
Q 021046 297 FGMARIFGG 305 (318)
Q Consensus 297 fGla~~~~~ 305 (318)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=196.74 Aligned_cols=150 Identities=31% Similarity=0.543 Sum_probs=127.8
Q ss_pred CccccccccCCcccEEEEEecC----CcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe-----
Q 021046 153 FSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----- 221 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 221 (318)
|.+.+.||+|+||.||+|.... +..||+|+++... ......+.+|+..++.++|||++++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 3679999987532 2334678999999999999999999999876554
Q ss_pred -eEEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 222 -NILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
.++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999998885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecC
Q 021046 298 GMARIFGG 305 (318)
Q Consensus 298 Gla~~~~~ 305 (318)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=197.68 Aligned_cols=150 Identities=32% Similarity=0.536 Sum_probs=131.1
Q ss_pred cCCccccccccCCcccEEEEEecC-C---cEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.+|...+.||+|+||.||+|.... + ..||||.+... ......+|..|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788999999999999998643 3 36999998754 233456899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|..++... ...+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988532 346889999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=198.47 Aligned_cols=151 Identities=34% Similarity=0.558 Sum_probs=132.2
Q ss_pred cCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|...++||+|+||.||++... ++..+|+|.+..........+.+|+.++..++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999642 355799998876655566789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCc
Q 021046 225 IYEYMPNKSLDVFLFYPKK------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 292 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 292 (318)
+|||+++|+|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998854321 135889999999999999999999887 9999999999999999999
Q ss_pred eEeecccceeec
Q 021046 293 KISDFGMARIFG 304 (318)
Q Consensus 293 ki~DfGla~~~~ 304 (318)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=212.15 Aligned_cols=149 Identities=34% Similarity=0.500 Sum_probs=128.8
Q ss_pred CccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 153 FSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
...++-||.|+-|-||+|++. ++.||||+++... ..+++-|++|+||||+.+.|+|.....+++|||||+.|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 344568999999999999985 5899999887532 34788999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCcccccc
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~ 312 (318)
.|...| +....+.......+..+||.||.|||.+. |||||||+-||||+.+..+||+|||.++.+.+... .
T Consensus 198 qL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---k 268 (904)
T KOG4721|consen 198 QLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---K 268 (904)
T ss_pred cHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh---h
Confidence 999999 45567788888999999999999999886 99999999999999999999999999998865422 2
Q ss_pred ceeecC
Q 021046 313 KRIVGT 318 (318)
Q Consensus 313 ~~~~Gt 318 (318)
..+.||
T Consensus 269 MSFaGT 274 (904)
T KOG4721|consen 269 MSFAGT 274 (904)
T ss_pred hhhhhh
Confidence 235665
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=195.70 Aligned_cols=152 Identities=36% Similarity=0.540 Sum_probs=136.3
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|.+.+.||+|+||.||++...+++.+|||.+... .....++.+|+.++++++|||++++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45788999999999999999999888889999998753 34557899999999999999999999999998999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999988542 2346899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=196.20 Aligned_cols=151 Identities=30% Similarity=0.504 Sum_probs=133.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.+|...+.||+|+||.||+|... .++.||+|.+... .....++.+|+.++..++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778889999999999999864 4788999998753 344568999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999988432 2346899999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=195.57 Aligned_cols=151 Identities=36% Similarity=0.534 Sum_probs=133.3
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|+..++||+|+||.||+|...+++.||+|.+.... ....++.+|+.++++++|||++++++++ .++..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 356788899999999999999998889999999987533 3456899999999999999999999986 45678999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999987543 2456889999999999999999999887 99999999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=200.60 Aligned_cols=152 Identities=25% Similarity=0.396 Sum_probs=132.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|+.++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 6889999988653 223346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++++|..++........+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999988854333447899999999999999999999742 39999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-26 Score=197.13 Aligned_cols=149 Identities=34% Similarity=0.542 Sum_probs=130.5
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++.+++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999874 68899999886432 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++ ++|..++........+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688887754444467899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=198.49 Aligned_cols=154 Identities=29% Similarity=0.474 Sum_probs=132.3
Q ss_pred HhcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||+|.... +..||+|.+..... .....+.+|+.++..++|||++++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34678889999999999999997642 36899999865432 334578899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 222 NILIYEYMPNKSLDVFLFYPKK-------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
.++||||+++|+|..++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999998854321 234788999999999999999999887 999999999999999999999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||+++.+..
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05032 161 GDFGMTRDIYE 171 (277)
T ss_pred CCcccchhhcc
Confidence 99999986644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=200.38 Aligned_cols=151 Identities=26% Similarity=0.405 Sum_probs=135.3
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
...+|...+.||+|+||.||++.. .+++.||+|.+........+.+..|+.+++.++|||++++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 447899999999999999999986 5689999999876555556678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++++|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....+
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999883 245788999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=195.48 Aligned_cols=149 Identities=30% Similarity=0.529 Sum_probs=133.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|+..+.||+|+||.||++... ++.||+|.+..... ..+.+.+|+.++.+++|||++++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888899999999999999874 78999999976543 5678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++++|.+++... ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 999999988532 2236899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=197.94 Aligned_cols=148 Identities=28% Similarity=0.347 Sum_probs=129.1
Q ss_pred CccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
|...+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+.++..++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999976 468899999986532 12234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999998877432 2346899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=196.98 Aligned_cols=145 Identities=27% Similarity=0.410 Sum_probs=127.7
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999975 56889999988654 223345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999996543 3678888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=209.46 Aligned_cols=155 Identities=30% Similarity=0.508 Sum_probs=134.0
Q ss_pred HHHhcCCccccccccCCcccEEEEEecC---Cc--EEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
+...+.....++||.|.||.||+|...+ |+ .||||.-+.. .....+.|+.|..+|+.++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3444556677899999999999997532 33 5899988763 45567789999999999999999999999987 4
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
+.|+|||.++-|.|..||.. +...++..+...++.||+.||+|||+.. +|||||.++|||+.+..-+||+||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999954 3456888899999999999999999987 999999999999999999999999999
Q ss_pred eeecCCc
Q 021046 301 RIFGGDE 307 (318)
Q Consensus 301 ~~~~~~~ 307 (318)
|.+.++.
T Consensus 539 R~~ed~~ 545 (974)
T KOG4257|consen 539 RYLEDDA 545 (974)
T ss_pred hhccccc
Confidence 9987664
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=197.54 Aligned_cols=142 Identities=27% Similarity=0.432 Sum_probs=120.7
Q ss_pred ccccCCcccEEEEEecCC---cEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCC
Q 021046 158 KLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 346677665432 2345689999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 234 LDVFLFYPKK-KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 234 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
|..++..... ....++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9998864322 345677788899999999999999887 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=198.50 Aligned_cols=150 Identities=33% Similarity=0.552 Sum_probs=130.0
Q ss_pred cCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEec--Cee
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 222 (318)
..|...+.||+|+||.||++.. .++..||+|.++... ......+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567889999999999999974 357789999987543 33446789999999999999999999999875 567
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988432 345899999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=195.11 Aligned_cols=152 Identities=24% Similarity=0.456 Sum_probs=132.6
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788899999999999999986 468899999876422 233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875322 3456788999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=203.36 Aligned_cols=139 Identities=27% Similarity=0.366 Sum_probs=118.7
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhcc---CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
||+|+||.||+|+.. +++.||||++.... ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58899999986432 12233455566666655 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99988874 3456889999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=195.19 Aligned_cols=142 Identities=31% Similarity=0.501 Sum_probs=122.5
Q ss_pred cccccCCcccEEEEEecCCc-----------EEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 157 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875433 5788877654333 6789999999999999999999999988 788999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-------CceEeecc
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-------NPKISDFG 298 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-------~~ki~DfG 298 (318)
|||+++|+|..++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999988542 226889999999999999999999887 99999999999999888 79999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
++..+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=214.14 Aligned_cols=152 Identities=34% Similarity=0.493 Sum_probs=131.2
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccC---CCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
+...|..++.||.|+||-||.|+. .+.+.||||++.- .+...+.++..|+..|..++|||++.+-||+..+...||
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 345677888999999999999976 5678899999873 244557889999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||||- |+-.+++.- ..+++.+-.+..|..+.+.||+|||+.. .||||||+-|||+++.|.|||+|||-|.+..
T Consensus 104 VMEYCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 104 VMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999995 455665532 2456788888899999999999999987 9999999999999999999999999998876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
+-
T Consensus 178 PA 179 (948)
T KOG0577|consen 178 PA 179 (948)
T ss_pred ch
Confidence 53
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=198.25 Aligned_cols=150 Identities=31% Similarity=0.488 Sum_probs=133.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.+.|++.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.+++.++|||++++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467888999999999999999874 4789999999876555667889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999887643 2346899999999999999999999887 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=195.65 Aligned_cols=143 Identities=27% Similarity=0.389 Sum_probs=123.7
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||+|+||.||++... +|+.+|+|.+.... ......+..|+.++.+++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999764 58999999986422 12234556799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
..++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 8877432 2345889999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=194.04 Aligned_cols=150 Identities=33% Similarity=0.521 Sum_probs=132.0
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++.+++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 45788899999999999999998888899999987643 34567999999999999999999999875 45689999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999988542 2345889999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=196.58 Aligned_cols=150 Identities=30% Similarity=0.434 Sum_probs=131.6
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999875 58899999886432 2234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998887763 3346899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=200.43 Aligned_cols=150 Identities=34% Similarity=0.570 Sum_probs=128.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCc--EEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (318)
.++|++.+.||+|+||.||+|.+. ++. .+++|.++... ......+.+|+.++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999864 343 46888776432 23445788999999999 89999999999999999999
Q ss_pred EEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 225 IYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
||||+++|+|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999885432 1236889999999999999999999887 999999999999999999
Q ss_pred ceEeeccccee
Q 021046 292 PKISDFGMARI 302 (318)
Q Consensus 292 ~ki~DfGla~~ 302 (318)
+||+|||+++.
T Consensus 163 ~kl~dfg~~~~ 173 (303)
T cd05088 163 AKIADFGLSRG 173 (303)
T ss_pred EEeCccccCcc
Confidence 99999999964
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=210.01 Aligned_cols=149 Identities=22% Similarity=0.384 Sum_probs=122.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec--------
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-------- 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 219 (318)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456899999999999999999986 468899999886432 2345799999999999999999987542
Q ss_pred CeeEEEEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeec
Q 021046 220 GENILIYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDF 297 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~Df 297 (318)
...++||||+++ +|..++.. ......+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135789999985 56555532 234567899999999999999999999987 99999999999998665 7999999
Q ss_pred ccceeecC
Q 021046 298 GMARIFGG 305 (318)
Q Consensus 298 Gla~~~~~ 305 (318)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987654
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=200.63 Aligned_cols=152 Identities=31% Similarity=0.518 Sum_probs=131.3
Q ss_pred hcCCccccccccCCcccEEEEEec--------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
.++|.+.+.||+|+||.||++... +...+|+|.+.... .....++..|+.++..+ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 23469999987542 23445788899999999 799999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 286 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 286 (318)
+..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999864321 235889999999999999999999887 9999999999999
Q ss_pred cCCCCceEeecccceeec
Q 021046 287 DSDMNPKISDFGMARIFG 304 (318)
Q Consensus 287 ~~~~~~ki~DfGla~~~~ 304 (318)
+.++.+||+|||+|+.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=192.70 Aligned_cols=144 Identities=33% Similarity=0.481 Sum_probs=127.3
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChh
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (318)
++||+|+||.||+|...++..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998764332 2346889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
.++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccc
Confidence 987432 345789999999999999999999887 99999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=195.36 Aligned_cols=143 Identities=27% Similarity=0.423 Sum_probs=122.6
Q ss_pred cccccCCcccEEEEEecC-------------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 157 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
+.||+|+||.||+|...+ ...|++|.+..........|..|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2258899887654445567889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC-------ceEee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-------PKISD 296 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-------~ki~D 296 (318)
+||||+++|+|+.++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 2346899999999999999999999987 999999999999987664 89999
Q ss_pred cccceeec
Q 021046 297 FGMARIFG 304 (318)
Q Consensus 297 fGla~~~~ 304 (318)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-26 Score=198.16 Aligned_cols=150 Identities=32% Similarity=0.437 Sum_probs=132.9
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999864 58899999886532 234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998843 356889999999999999999999987 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-26 Score=197.06 Aligned_cols=148 Identities=28% Similarity=0.441 Sum_probs=131.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.|++.+.||+|+||.||++... ++..+++|.+..........+.+|+.++..++|||++++++++..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3577789999999999999875 477889998876555556788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999887743 2356899999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=200.01 Aligned_cols=153 Identities=31% Similarity=0.450 Sum_probs=132.0
Q ss_pred HhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 220 (318)
..++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467889999999999999999641 24579999887543 23345789999999999 7999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||+++|+|..++.... ...+++.+...++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999885322 234899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+.+..
T Consensus 189 ~~~~~ 193 (302)
T cd05055 189 RDIMN 193 (302)
T ss_pred ccccC
Confidence 86643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=193.70 Aligned_cols=150 Identities=33% Similarity=0.512 Sum_probs=130.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998777789999886532 34567899999999999999999999875 46689999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999988543 2345789999999999999999999887 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=193.51 Aligned_cols=143 Identities=33% Similarity=0.527 Sum_probs=123.1
Q ss_pred ccccCCcccEEEEEec---CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCC
Q 021046 158 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
.||+|+||.||+|.+. .+..||+|.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 355799999876433 23467899999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 234 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9998843 2346899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=196.23 Aligned_cols=150 Identities=32% Similarity=0.509 Sum_probs=128.6
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCc----EEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|+..+.||+|+||.||+|.+ .++. .||+|.++... .....++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46788889999999999999975 3444 48999887542 2335678899999999999999999999875 4578
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++||+++|+|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999888432 346899999999999999999999987 999999999999999999999999999877
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-27 Score=198.87 Aligned_cols=161 Identities=29% Similarity=0.492 Sum_probs=140.8
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+.+-|.++++||+|+||.||++.+ .+|+.+|||.+.- ....+++..|+.++.+.+.|++|+++|.+.....+|+|||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 345578889999999999999976 4699999999875 4567899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
||..|+..+.++. .+.+|.+.++..+....+.||+|||... -||||||+-|||++.+|.+||+|||.|-.+.+.-
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999999854 4578999999999999999999999865 8999999999999999999999999999887543
Q ss_pred cccccceeecC
Q 021046 308 LQGNTKRIVGT 318 (318)
Q Consensus 308 ~~~~~~~~~Gt 318 (318)
.+. .+++||
T Consensus 184 AKR--NTVIGT 192 (502)
T KOG0574|consen 184 AKR--NTVIGT 192 (502)
T ss_pred Hhh--CccccC
Confidence 332 345666
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=196.03 Aligned_cols=145 Identities=34% Similarity=0.543 Sum_probs=128.2
Q ss_pred CccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHH--HHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 153 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
|+..+.||+|+||.||++.... ++.+|+|.+......... ....|+.++.+++||||+++++++..++..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999998754 568999999865433222 3456999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
++++|..++. ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999985 3466899999999999999999999987 999999999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-27 Score=205.48 Aligned_cols=160 Identities=28% Similarity=0.426 Sum_probs=140.6
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..|...+.||+|.||.||+|.. .+++.||+|.+.-. .....++..+|+.++..+++|||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566778999999999999976 56889999999754 344567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCcc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 308 (318)
+.+|++.+.+ +....+++....-+..++..||.|||.++ .+|||||+.|||+..+|.+|++|||.|..+..+..
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999888 34455577888888999999999999988 99999999999999999999999999999987765
Q ss_pred ccccceeecC
Q 021046 309 QGNTKRIVGT 318 (318)
Q Consensus 309 ~~~~~~~~Gt 318 (318)
.. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 43 567887
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=198.19 Aligned_cols=150 Identities=25% Similarity=0.405 Sum_probs=134.2
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
...+|...+.||+|+||.||+|.. .+++.|++|.+........+.+..|+.++..++|||++++++.+..++..++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346888899999999999999975 4688999999876555556788999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999883 235788999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=195.92 Aligned_cols=150 Identities=31% Similarity=0.459 Sum_probs=131.4
Q ss_pred cCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
++|.....||+|+||.||+|+.. +.+.+++|.+...... ...++.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999863 2457999988764433 3567999999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 224 LIYEYMPNKSLDVFLFYPKKK------RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 26899999999999999999999987 999999999999999999999999
Q ss_pred ccceee
Q 021046 298 GMARIF 303 (318)
Q Consensus 298 Gla~~~ 303 (318)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-27 Score=191.96 Aligned_cols=162 Identities=31% Similarity=0.445 Sum_probs=137.4
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC----CCcCH----HHHHHHHHHHhcc-CCCccceEEEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ----SGQGL----TEFKNEMMLIAKL-QHRHLVRLFGCCI 217 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~ 217 (318)
..-..|...+.||+|..+.|-++.. .+|.+.|+|++... +.... ++-.+|+.+|+++ -||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456778888999999999998865 56889999988632 12222 3446789999998 5999999999999
Q ss_pred ecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
.+...++|+|.|+.|.|.++| .+...++++...+|++|+..|++|||... ||||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999999 45678999999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCccccccceeecC
Q 021046 298 GMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 298 Gla~~~~~~~~~~~~~~~~Gt 318 (318)
|+|..+.+.+. .+.++||
T Consensus 168 GFa~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGT 185 (411)
T ss_pred ceeeccCCchh---HHHhcCC
Confidence 99999877653 3345555
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=197.45 Aligned_cols=152 Identities=31% Similarity=0.518 Sum_probs=132.0
Q ss_pred hcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++++++|||++++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999763 46789999987542 23346789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 021046 223 ILIYEYMPNKSLDVFLFYPK-------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 283 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 283 (318)
+++|||+++|+|..++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1235788999999999999999999987 9999999999
Q ss_pred EEEcCCCCceEeecccceeec
Q 021046 284 ILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 284 ill~~~~~~ki~DfGla~~~~ 304 (318)
|+++.++.++|+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=196.27 Aligned_cols=149 Identities=30% Similarity=0.353 Sum_probs=129.1
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
|+..+.||+|+||.||++... +++.+|+|.+..... .....+..|+.++.+++|+|++.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999764 688999998865322 2234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999887432 2345889999999999999999999887 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=198.34 Aligned_cols=150 Identities=31% Similarity=0.540 Sum_probs=128.3
Q ss_pred cCCccccccccCCcccEEEEEecC-C--cEEEEEEccCC-CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLN-G--QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (318)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998743 3 24788888743 233456789999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCc
Q 021046 226 YEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 292 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 292 (318)
+||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999987 9999999999999999999
Q ss_pred eEeecccceee
Q 021046 293 KISDFGMARIF 303 (318)
Q Consensus 293 ki~DfGla~~~ 303 (318)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=193.22 Aligned_cols=149 Identities=32% Similarity=0.499 Sum_probs=131.0
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-----cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-----QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|...+.||+|+||.||++.. .+++.+|+|.+..... ...+.+.+|+.++.+++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999976 4688999998764321 224568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988742 345788999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=196.39 Aligned_cols=146 Identities=38% Similarity=0.563 Sum_probs=126.4
Q ss_pred CccccccccCCcccEEEEEe-----cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeEE
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENIL 224 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 224 (318)
|...+.||+|+||.||++.. .++..||+|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3577899999875432 3456788999999999999999999998764 35789
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998842 35899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=192.68 Aligned_cols=149 Identities=32% Similarity=0.469 Sum_probs=131.1
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-----CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
+|...+.||+|+||.||+|... ++..|++|.+.... .+..+.+.+|+.+++.++|||++++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999875 78899999886532 22446789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998842 345889999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 155 ~ 155 (258)
T cd06632 155 F 155 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=201.55 Aligned_cols=154 Identities=30% Similarity=0.511 Sum_probs=131.5
Q ss_pred HhcCCccccccccCCcccEEEEEecC--------CcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
...+|.+.+.||+|+||.||++.... +..||+|.+.... .....++.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34568889999999999999997421 2368999887532 33456889999999999 79999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
++..++++||+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 999999999999999999885421 2245888999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecC
Q 021046 286 LDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~ 305 (318)
++.++.+||+|||+++.+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred EcCCCcEEECCcccceeccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=192.58 Aligned_cols=152 Identities=26% Similarity=0.446 Sum_probs=134.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...+.||+|+||.||+|... +++.||+|.++.. .......+.+|+.++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999875 7899999988632 2233567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|..++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887542 23456899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=194.24 Aligned_cols=151 Identities=32% Similarity=0.565 Sum_probs=131.7
Q ss_pred hcCCccccccccCCcccEEEEEecC-C---cEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|+..+.||+|+||.||+|.... + ..+|+|.+.... ....+++..|+.++..++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3577888999999999999998742 3 379999887542 2335678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998843 2356899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=199.61 Aligned_cols=153 Identities=32% Similarity=0.525 Sum_probs=131.3
Q ss_pred HhcCCccccccccCCcccEEEEEec--------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
..++|.+.+.||+|+||.||+++.. ....+|+|.++... .....++..|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467888999999999999999742 24568999887532 23456788999999999 69999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
++..+++|||+++|+|..++.... ....+++.+...++.|++.||.|||+.+ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999985422 1245889999999999999999999887 999999999999
Q ss_pred EcCCCCceEeecccceeec
Q 021046 286 LDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~ 304 (318)
++.++.+||+|||+++.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 167 VTEDNVMKIADFGLARGVH 185 (314)
T ss_pred EcCCCcEEEcccccccccc
Confidence 9999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=191.33 Aligned_cols=151 Identities=24% Similarity=0.386 Sum_probs=133.1
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|+..+.||+|+||.||.++. .+++.+++|.+... ......++.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999999975 45889999987643 334556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999885432 456889999999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=191.63 Aligned_cols=147 Identities=39% Similarity=0.599 Sum_probs=130.4
Q ss_pred cccccCCcccEEEEEecC----CcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||++.... +..+++|.+...... ..+.+..|+..+..++|||++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998754 778999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 232 KSLDVFLFYPKK------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 232 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999854321 367899999999999999999999987 99999999999999999999999999988765
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=194.45 Aligned_cols=155 Identities=29% Similarity=0.443 Sum_probs=131.8
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34555666678999999999999864 57789999887665556678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~ 305 (318)
||+++++|..++.........++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||++..+..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999998854322112277888899999999999999887 999999999999976 67999999999986643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=194.41 Aligned_cols=152 Identities=30% Similarity=0.481 Sum_probs=131.5
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEec------C
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ------G 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~ 220 (318)
+.+.|+..+.||+|+||.||+|... +++.||+|.+... ......+..|+.++.++ +|||++++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5677888899999999999999864 5788999998653 34456788999999998 699999999998763 4
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 579999999999999988542 2356889999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+.+..
T Consensus 159 ~~~~~ 163 (272)
T cd06637 159 AQLDR 163 (272)
T ss_pred eeccc
Confidence 87643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=197.17 Aligned_cols=149 Identities=29% Similarity=0.444 Sum_probs=129.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357889999999999999999764 57899999886432 2334567889999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|++ ++|..++.. ....+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 85 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 85 YLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred ccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 997 588877743 2346789999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=194.79 Aligned_cols=153 Identities=32% Similarity=0.491 Sum_probs=131.2
Q ss_pred HhcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......|..|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999998753 5678999886543 2334578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceE
Q 021046 222 NILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKI 294 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki 294 (318)
.++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 236899999999999999999999987 99999999999998765 5999
Q ss_pred eecccceeec
Q 021046 295 SDFGMARIFG 304 (318)
Q Consensus 295 ~DfGla~~~~ 304 (318)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=192.05 Aligned_cols=142 Identities=32% Similarity=0.522 Sum_probs=123.2
Q ss_pred ccccCCcccEEEEEe---cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 158 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 3577899999875432 23567899999999999999999999875 45678999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.+..+
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99998843 346889999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=191.41 Aligned_cols=151 Identities=29% Similarity=0.452 Sum_probs=133.1
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|...+.||+|+||.||++... +++.|++|.+... ......++.+|+.+++.++|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999874 5889999988643 234456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|.+++... ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999988543 2456889999999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=194.67 Aligned_cols=150 Identities=33% Similarity=0.563 Sum_probs=129.8
Q ss_pred hcCCccccccccCCcccEEEEEecC-Cc----EEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..+|...+.||+|+||.||+|.... +. .+|+|.+..... ....++.+|+.++++++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578888999999999999998643 32 589998875433 334678899999999999999999999987 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++... ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999988532 345899999999999999999999977 999999999999999999999999999876
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 160 ~~ 161 (279)
T cd05057 160 DV 161 (279)
T ss_pred cC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=196.49 Aligned_cols=149 Identities=31% Similarity=0.454 Sum_probs=130.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc-----CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
+|...+.||+|+||.||+|... +++.||||.+...... ....+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999864 5889999998754322 234567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+ +|+|..++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999988432 236899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 155 ~ 155 (298)
T cd07841 155 P 155 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=197.36 Aligned_cols=150 Identities=25% Similarity=0.430 Sum_probs=134.7
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..+|+..+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+..++.++|||++++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35789999999999999999975 56889999998765555567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|..++. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..+
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999873 235899999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=192.31 Aligned_cols=148 Identities=32% Similarity=0.524 Sum_probs=129.5
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc---------CHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ---------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
+|.....||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|+.++..++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999976 45789999988654322 12468889999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.+++|||+++++|..++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999883 3356888999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 7753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=192.23 Aligned_cols=151 Identities=28% Similarity=0.499 Sum_probs=135.2
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999864 5778999998866555678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|..++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999987432 256889999999999999999999987 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=192.79 Aligned_cols=151 Identities=31% Similarity=0.466 Sum_probs=133.0
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|...++||+|+||.||++...++..+|+|.+... ....+.+.+|+.+++.++|+|++++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45678899999999999999999877788999988753 2345678999999999999999999999887 778999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999998543 2456788999999999999999999877 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=202.17 Aligned_cols=150 Identities=28% Similarity=0.395 Sum_probs=127.7
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec-----
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ----- 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 219 (318)
...++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++..++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999976 467899999987532 22345678899999999999999999988643
Q ss_pred -CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 220 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 220 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
...++++|++ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 778887762 346899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07878 164 LARQADD 170 (343)
T ss_pred cceecCC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=211.04 Aligned_cols=154 Identities=36% Similarity=0.522 Sum_probs=135.7
Q ss_pred HhcCCccccccccCCcccEEEEEec--CCc--EEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--NGQ--EVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..+.....++||+|.||.|++|.|. +|+ .||||.++..... ..++|++|+..|.+|+|||+++|||+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 3445666789999999999999874 344 6899999876544 67899999999999999999999999888 6889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+|.++.|+|.+.|+. .....|-......++.|||.||.||.+++ +|||||.++|+|+.....+||+||||.|-+
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999976 34566778888999999999999999987 999999999999999999999999999999
Q ss_pred cCCc
Q 021046 304 GGDE 307 (318)
Q Consensus 304 ~~~~ 307 (318)
+.++
T Consensus 263 g~ne 266 (1039)
T KOG0199|consen 263 GENE 266 (1039)
T ss_pred CCCC
Confidence 8654
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=191.99 Aligned_cols=144 Identities=35% Similarity=0.467 Sum_probs=127.0
Q ss_pred cccccCCcccEEEEEecC--C--cEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|.+.+ + ..||||.+..... ...+.+..|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987655 456789999999999999999999999988 889999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+|..++..... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999998854322 56899999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=201.23 Aligned_cols=147 Identities=29% Similarity=0.395 Sum_probs=125.0
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----- 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 220 (318)
..++|...+.||+|+||.||++.. .++..||+|.+... .......+.+|+.++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999976 45889999998643 2234567889999999999999999999987543
Q ss_pred -eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 221 -ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
..++||||++++ |...+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 469999999764 544442 24788888999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 021046 300 ARIFG 304 (318)
Q Consensus 300 a~~~~ 304 (318)
|+...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=194.55 Aligned_cols=152 Identities=25% Similarity=0.456 Sum_probs=133.0
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...+.||+|+||.||++.. .++..++||.+.... .....++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 578899999876432 223457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++++|.+++... .....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999987532 23456899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=197.27 Aligned_cols=144 Identities=28% Similarity=0.493 Sum_probs=118.9
Q ss_pred ccccccCCcccEEEEEec---CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCeeEEEEEecc
Q 021046 156 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENILIYEYMP 230 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 230 (318)
.++||+|+||.||+|... +++.+|+|.+.... ....+.+|+.++.+++||||+++++++.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986532 23467889999999999999999999865 456789999986
Q ss_pred CCChhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCCceEeecccc
Q 021046 231 NKSLDVFLFYPK------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMA 300 (318)
Q Consensus 231 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~ki~DfGla 300 (318)
+ +|..++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7766654221 2235889999999999999999999987 9999999999999 45678999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=199.05 Aligned_cols=141 Identities=22% Similarity=0.300 Sum_probs=114.2
Q ss_pred HhcCCccccccccCCcccEEEEEec--CCcEEEEEEccCCC-----CcCHHHHHHHHHHHhccCCCccce-EEEEEEecC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVR-LFGCCIEQG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~ 220 (318)
..++|...+.||+|+||+||+|.+. +++.+|||++.... ......|.+|+.+|.+++|+|+++ +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 4578999999999999999999764 57778999875321 122456899999999999999985 443 24
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEEcCCCCceEeeccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-k~~Nill~~~~~~ki~DfGl 299 (318)
..++||||+++++|.... .. . ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 679999999999996321 11 1 1357889999999999987 999999 99999999999999999999
Q ss_pred ceeecCC
Q 021046 300 ARIFGGD 306 (318)
Q Consensus 300 a~~~~~~ 306 (318)
|+.+...
T Consensus 159 A~~~~~~ 165 (365)
T PRK09188 159 ASVFRRR 165 (365)
T ss_pred ceecccC
Confidence 9987543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=192.70 Aligned_cols=146 Identities=28% Similarity=0.508 Sum_probs=129.3
Q ss_pred CCccccccccCCcccEEEEEecCCcEEEEEEccCCCC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
+|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+..++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999888889999998864321 1234588899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999843 345788999999999999999999887 999999999999999999999999999765
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=197.09 Aligned_cols=146 Identities=26% Similarity=0.400 Sum_probs=129.5
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|+..+.||+|+||.||++... +++.|++|.+.... ......+.+|+.++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999864 47899999887542 233457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
||+++++|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999843 346889999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=193.08 Aligned_cols=147 Identities=29% Similarity=0.427 Sum_probs=127.9
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--c--------CHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--Q--------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
+|...+.||+|+||.||+|.. .+++.+|+|.++.... . ..+.+..|+.++..++|||++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999975 4688999998753211 1 1246788999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998843 356889999999999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 021046 301 RIFG 304 (318)
Q Consensus 301 ~~~~ 304 (318)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=194.13 Aligned_cols=149 Identities=34% Similarity=0.531 Sum_probs=130.8
Q ss_pred cCCccccccccCCcccEEEEEec-----CCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEe--cCee
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGEN 222 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 222 (318)
++|...+.||+|+||.||++.+. ++..+|||.+...... ....|.+|+..++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777789999999999999853 3678999999764432 46789999999999999999999999987 5578
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998532 235899999999999999999999987 99999999999999999999999999987
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=190.43 Aligned_cols=149 Identities=30% Similarity=0.536 Sum_probs=132.2
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.+|+..+.||+|+||.||++.+.++..+|+|.+... .....++..|+.++..++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788999999999999998877889999988753 2345679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|.+++... ...+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999888432 345789999999999999999999887 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=193.79 Aligned_cols=154 Identities=29% Similarity=0.485 Sum_probs=128.3
Q ss_pred HhcCCccccccccCCcccEEEEEecC-----CcEEEEEEccCCCC-cCH-HHHHHHHHHHhccCCCccceEEEEEEe-cC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSG-QGL-TEFKNEMMLIAKLQHRHLVRLFGCCIE-QG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~-~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 220 (318)
....|+....||+|+||.||+|.-.+ ...+|||+++.... .+. ...-+|+.+++.++|||++.|..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 44578888999999999999995422 23689999975422 222 346789999999999999999999987 78
Q ss_pred eeEEEEEeccCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC----CCceE
Q 021046 221 ENILIYEYMPNKSLDVFLFYP--KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKI 294 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~ki 294 (318)
..+|++||.+. +|...++.. ...+.++......|..||+.|+.|||++- |+||||||.||||..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999987 676666543 23567889999999999999999999987 9999999999999877 89999
Q ss_pred eecccceeecCC
Q 021046 295 SDFGMARIFGGD 306 (318)
Q Consensus 295 ~DfGla~~~~~~ 306 (318)
+|||+||++.+.
T Consensus 178 aDlGlaR~~~~p 189 (438)
T KOG0666|consen 178 ADLGLARLFNNP 189 (438)
T ss_pred ecccHHHHhhcc
Confidence 999999998754
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=188.65 Aligned_cols=150 Identities=23% Similarity=0.407 Sum_probs=131.7
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+..|+.+++.++|||++++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999764 5889999988643 2334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++|+|..++... ....+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999998877432 3445788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=192.79 Aligned_cols=148 Identities=31% Similarity=0.468 Sum_probs=127.3
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-----CcCHHHHHHHHHHHhccCCCccceEEEEEEec--Cee
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 222 (318)
.+|...+.||+|+||.||.+.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999986 458899999875321 12245788899999999999999999998764 467
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
+++|||+++++|.+++.. ...+++.....++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998842 245788889999999999999999987 99999999999999999999999999986
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=195.97 Aligned_cols=149 Identities=28% Similarity=0.429 Sum_probs=130.9
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999875 588999998865322 234578899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++++|..+... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999877632 335899999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=189.09 Aligned_cols=143 Identities=35% Similarity=0.506 Sum_probs=127.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChh
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 235 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (318)
++||+|+||.||++...+++.||+|.+...... ....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998877899999988764333 4567899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 236 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++... ...+++.....++.+++.||.|||+++ ++||||+|+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 988432 335788999999999999999999887 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-27 Score=192.52 Aligned_cols=151 Identities=28% Similarity=0.430 Sum_probs=130.1
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccC--CCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..+.|++-+.||+|.|+.||+... ++|+.+|+|.+.- -+..+.+++.+|+.+-..|+||||++|.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999954 6789999887753 2445778899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEeeccccee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARI 302 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~DfGla~~ 302 (318)
+|+|.|++|..-+.. ...+++..+-..+.||+++|.|+|.++ |||||+||.|+|+.+.. -+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999655422 255677888899999999999999988 99999999999996543 489999999999
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+++
T Consensus 163 l~~ 165 (355)
T KOG0033|consen 163 VND 165 (355)
T ss_pred eCC
Confidence 984
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=194.26 Aligned_cols=158 Identities=25% Similarity=0.348 Sum_probs=133.1
Q ss_pred HHHHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEE----
Q 021046 144 ASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI---- 217 (318)
Q Consensus 144 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~---- 217 (318)
..+....++|+..+.||+|+||.||++.. .+++.+|+|.+... .....++.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 33445778999999999999999999976 45789999988653 22345688899999999 6999999999885
Q ss_pred -ecCeeEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 218 -EQGENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
.++..++||||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999877532 23456888999999999999999999887 9999999999999999999999
Q ss_pred ecccceeecC
Q 021046 296 DFGMARIFGG 305 (318)
Q Consensus 296 DfGla~~~~~ 305 (318)
|||+++.+..
T Consensus 167 dfg~~~~~~~ 176 (286)
T cd06638 167 DFGVSAQLTS 176 (286)
T ss_pred cCCceeeccc
Confidence 9999987653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=190.93 Aligned_cols=143 Identities=35% Similarity=0.592 Sum_probs=122.8
Q ss_pred cccccCCcccEEEEEecC-Cc--EEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|...+ +. .+++|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 47888887532 33456788999999999 799999999999999999999999999
Q ss_pred CChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 232 KSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 232 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885321 1235789999999999999999999887 9999999999999999999999999
Q ss_pred ccee
Q 021046 299 MARI 302 (318)
Q Consensus 299 la~~ 302 (318)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=192.48 Aligned_cols=151 Identities=28% Similarity=0.457 Sum_probs=129.3
Q ss_pred hcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|...+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567888999999999999997643 2468999887644 3445679999999999999999999998875 56789
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 345899999999999999999999887 9999999999999999999999999998765
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 159 ~~ 160 (270)
T cd05056 159 DE 160 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=195.51 Aligned_cols=150 Identities=37% Similarity=0.654 Sum_probs=126.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCc----EEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999763 343 478888875432 2234688999999999999999999998754 567
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998843 2346889999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 160 ~~ 161 (303)
T cd05110 160 EG 161 (303)
T ss_pred cC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=188.75 Aligned_cols=149 Identities=30% Similarity=0.517 Sum_probs=129.1
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe-cCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 228 (318)
.++|...+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+.++++++|||++++++++.. ++..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888899999999999999774 678999988653 335678999999999999999999998654 4578999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999988532 2345889999999999999999999987 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=194.73 Aligned_cols=150 Identities=27% Similarity=0.349 Sum_probs=132.6
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc---CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|...+.||+|+||.||++... +++.+|+|.+...... ....+..|+.++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999875 4889999998764322 4457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++++|.+++... ....+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999987532 3456899999999999999999999987 9999999999999999999999999997664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=193.56 Aligned_cols=148 Identities=30% Similarity=0.450 Sum_probs=128.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367888999999999999999875 678999999865322 223456789999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+++ +|..++... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 84 YLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 9985 888877432 346789999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-25 Score=191.74 Aligned_cols=149 Identities=30% Similarity=0.474 Sum_probs=132.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 68899999987543 33356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+ +++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+...
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999887533 356899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=190.09 Aligned_cols=148 Identities=31% Similarity=0.506 Sum_probs=132.4
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc--CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|...+.||+|+||.||++... +++.+++|.++..... ..+.+..|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 6889999998765443 567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999998843 345788999999999999999999987 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=200.76 Aligned_cols=149 Identities=28% Similarity=0.390 Sum_probs=125.7
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC----
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG---- 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 220 (318)
...++|...+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3467899999999999999999976 457899999987532 233457788999999999999999999986543
Q ss_pred --eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 221 --ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 221 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46999999976 5555552 24788889999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
+|+....
T Consensus 165 ~~~~~~~ 171 (355)
T cd07874 165 LARTAGT 171 (355)
T ss_pred ccccCCC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=193.74 Aligned_cols=148 Identities=29% Similarity=0.452 Sum_probs=130.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999764 57889999887432 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999998873 346889999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=189.07 Aligned_cols=149 Identities=30% Similarity=0.484 Sum_probs=134.2
Q ss_pred hcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|+..+.||+|+||.||++...+ ++.+++|.+..... .+++.+|+.++++++|||++++++++..+...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999998754 78999999875432 67899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999998843 2457899999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=187.88 Aligned_cols=149 Identities=38% Similarity=0.594 Sum_probs=130.3
Q ss_pred ccccccccCCcccEEEEEecC-----CcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.+.+.||+|+||.||++...+ +..||+|.+...... ....+..|+..+..++||||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998754 378999999765433 56789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999998853221 12899999999999999999999987 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=192.83 Aligned_cols=148 Identities=28% Similarity=0.352 Sum_probs=129.4
Q ss_pred CCccccccccCCcccEEEEEe----cCCcEEEEEEccCCC----CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
+|+..+.||+|+||.||++.. .+|..||+|.++... ....+.+.+|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999976 368899999987532 22345688899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 346788999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=196.32 Aligned_cols=148 Identities=26% Similarity=0.424 Sum_probs=129.9
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
+.|.....||+|+||.||++.. .++..||||.+........+.+.+|+..+..++|||++++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 4445556899999999999976 458899999987654455567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++++|..++. ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..+..
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999998873 235789999999999999999999987 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=189.91 Aligned_cols=148 Identities=26% Similarity=0.493 Sum_probs=131.0
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhccC---CCccceEEEEEEecCeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 226 (318)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999986 56889999988754 3344567889999999986 999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36889999999999999999999987 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-27 Score=210.47 Aligned_cols=163 Identities=26% Similarity=0.427 Sum_probs=139.5
Q ss_pred HhcCCccccccccCCcccEEEEEecCCc-EEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+.+.|.++..||.|+||+||+|..++.. ..|.|.+...+....++|..|+.+|+..+||+||+|++.|...+.+|++.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3455677778999999999999876533 456788887788889999999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
||.||-.+..+. .-...|.+.++..+++|++.||.|||++. |||||||+-|||++-+|.++|+|||.+.......
T Consensus 110 FC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 999999988774 34678999999999999999999999987 9999999999999999999999999987654332
Q ss_pred cccccceeecC
Q 021046 308 LQGNTKRIVGT 318 (318)
Q Consensus 308 ~~~~~~~~~Gt 318 (318)
.+ ...++||
T Consensus 185 qk--RDsFIGT 193 (1187)
T KOG0579|consen 185 QK--RDSFIGT 193 (1187)
T ss_pred hh--hccccCC
Confidence 22 2345665
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=191.93 Aligned_cols=151 Identities=27% Similarity=0.411 Sum_probs=125.9
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHH-HhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMML-IAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999874 58999999987542 2233455666665 566789999999999999999999999
Q ss_pred eccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|++ |+|..++... .....+++..+..++.|++.||.|||++. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 6787776432 23457899999999999999999999861 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=193.07 Aligned_cols=150 Identities=26% Similarity=0.376 Sum_probs=131.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888899999999999999764 58899999876532 3345688999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++++|..++.. ...+++.....++.+++.||.|||+.. +++||||+|+||++++++.++|+|||++..+.
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999988732 346899999999999999999999742 39999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=195.31 Aligned_cols=146 Identities=29% Similarity=0.443 Sum_probs=129.0
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+..+..++|||++++++++..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444558999999999999764 6889999998765445566788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99988762 245889999999999999999999987 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=193.34 Aligned_cols=144 Identities=29% Similarity=0.497 Sum_probs=118.5
Q ss_pred cccccCCcccEEEEEec---CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 231 (318)
.+||+|+||.||+|... ++..||+|.+.... ....+.+|+.++..++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 58999999999999864 35689999887532 23467889999999999999999999864 4577999999875
Q ss_pred CChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCCceEeecccce
Q 021046 232 KSLDVFLFYP------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR 301 (318)
Q Consensus 232 g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~ki~DfGla~ 301 (318)
+|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666655321 12335889999999999999999999987 9999999999999 567789999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 161 ~~~~~ 165 (317)
T cd07867 161 LFNSP 165 (317)
T ss_pred ccCCC
Confidence 77543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=191.62 Aligned_cols=149 Identities=28% Similarity=0.360 Sum_probs=132.6
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+..+++++||||+++++++..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999875 58899999887532 2346789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++++|..++.. ...+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999998843 257889999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=187.96 Aligned_cols=152 Identities=27% Similarity=0.434 Sum_probs=134.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+..++.++|||++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 57889999987532 23567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|..++........+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999854333356899999999999999999999887 99999999999999999999999999976654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=191.84 Aligned_cols=162 Identities=29% Similarity=0.324 Sum_probs=136.4
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCH---HHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGL---TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|..+++||+|.||+|.+++- .+++.+|+|++++...... ..-+.|-++|...+||.+..|--.|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457899999999999999999965 5688999999987543332 334678889999999999999989999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||..||.|.-+| ...+.+++.....+-..|..||.|||+++ ||.||||.+|.|+|.+|++||+||||++-=-
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999997666 34567788777788899999999999987 9999999999999999999999999998433
Q ss_pred CCccccccceeecC
Q 021046 305 GDELQGNTKRIVGT 318 (318)
Q Consensus 305 ~~~~~~~~~~~~Gt 318 (318)
.+. ..+++++||
T Consensus 320 ~~g--~t~kTFCGT 331 (516)
T KOG0690|consen 320 KYG--DTTKTFCGT 331 (516)
T ss_pred ccc--ceeccccCC
Confidence 222 345678887
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=188.97 Aligned_cols=150 Identities=31% Similarity=0.524 Sum_probs=125.5
Q ss_pred CccccccccCCcccEEEEEec----CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
|...+.||+|+||.||+|.+. +++.||||.+... .....+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999753 3678999988753 2234567889999999999999999999987543
Q ss_pred eeEEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 221 ENILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988875322 2235788999999999999999999887 999999999999999999999999
Q ss_pred ccceeecC
Q 021046 298 GMARIFGG 305 (318)
Q Consensus 298 Gla~~~~~ 305 (318)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=193.90 Aligned_cols=150 Identities=27% Similarity=0.473 Sum_probs=126.9
Q ss_pred CCccccccccCCcccEEEEEec---CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI 223 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (318)
+|...++||+|+||.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999874 47899999987632 33446778899999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC----CCCceEeec
Q 021046 224 LIYEYMPNKSLDVFLFYPK--KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDF 297 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~ki~Df 297 (318)
+||||+++ +|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 5555553222 2236889999999999999999999987 999999999999999 999999999
Q ss_pred ccceeecC
Q 021046 298 GMARIFGG 305 (318)
Q Consensus 298 Gla~~~~~ 305 (318)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=204.78 Aligned_cols=154 Identities=31% Similarity=0.498 Sum_probs=133.7
Q ss_pred ccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChhh
Q 021046 158 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDV 236 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 236 (318)
+||+|.||+||-|+..+ ...+|||-+.....+..+-+..|+.+-+.|+|.|||+++|.+.+++..-+.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998755 45799999988777777889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecCCccccccc
Q 021046 237 FLFYPKKKRLL--GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTK 313 (318)
Q Consensus 237 ~l~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~ 313 (318)
.|... =.++ ++.+.-.+.+||++||.|||++. |||||||-+||||+. .|.+||+|||.++.+.+-.. .|+
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence 98542 2334 67788889999999999999987 999999999999965 78899999999998876433 456
Q ss_pred eeecC
Q 021046 314 RIVGT 318 (318)
Q Consensus 314 ~~~Gt 318 (318)
++-||
T Consensus 735 TFTGT 739 (1226)
T KOG4279|consen 735 TFTGT 739 (1226)
T ss_pred ccccc
Confidence 66676
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=192.66 Aligned_cols=149 Identities=31% Similarity=0.427 Sum_probs=127.5
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++++|...+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.++..++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999976 4588999999875432 22346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||++ ++|..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 667666532 2345778888899999999999999987 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=189.87 Aligned_cols=148 Identities=27% Similarity=0.438 Sum_probs=131.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|||++++++++..++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999864 57899999887532 33456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|+|.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999883 245788899999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=187.62 Aligned_cols=143 Identities=38% Similarity=0.564 Sum_probs=123.4
Q ss_pred cccccCCcccEEEEEecC----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
++||+|+||.||+|.... +..+|+|.+..... ...+++..|+.+++.++|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999996522 26899999876443 24567899999999999999999999876 4568999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+|.+++.. ...+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 999999843 336899999999999999999999887 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=199.26 Aligned_cols=148 Identities=28% Similarity=0.396 Sum_probs=125.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEec------
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------ 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 219 (318)
..++|...+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999976 45788999998753 223446788999999999999999999987644
Q ss_pred CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356999999975 5665552 24788889999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=191.30 Aligned_cols=149 Identities=30% Similarity=0.506 Sum_probs=129.9
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ...+.+..|+..+++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999975 5688999998864321 124578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIF 303 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~ 303 (318)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998842 346889999999999999999999987 99999999999998776 5999999999877
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 155 ~~~ 157 (268)
T cd06630 155 AAK 157 (268)
T ss_pred ccc
Confidence 543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=190.55 Aligned_cols=149 Identities=31% Similarity=0.531 Sum_probs=130.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
+|+..+.||+|++|.||+|+.. ++..||||.++.... .....+.+|+.+++.++|||++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999875 588999998875432 23456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++ +|..++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 78777754333456899999999999999999999987 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=188.79 Aligned_cols=143 Identities=29% Similarity=0.514 Sum_probs=120.9
Q ss_pred cccccCCcccEEEEEec----CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEe-cCeeEEEEEecc
Q 021046 157 CKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENILIYEYMP 230 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 230 (318)
+.||+|+||.||+|... +...+|+|++.... ....+.+..|+.+++.++|||++++++++.. ++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 23579999886432 3345678899999999999999999998764 456799999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|+|.+++... ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998532 334677888899999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=189.34 Aligned_cols=148 Identities=32% Similarity=0.512 Sum_probs=127.5
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-----cCHHHHHHHHHHHhccCCCccceEEEEEEec--Cee
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-----QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 222 (318)
.+|...+.||+|+||.||++... ++..|++|.+..... .....+.+|+.+++.++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999764 588999998864321 2235688899999999999999999998763 567
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998842 345788999999999999999999877 99999999999999999999999999986
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=189.32 Aligned_cols=149 Identities=28% Similarity=0.411 Sum_probs=132.9
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788889999999999999864 58899999987543 34456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999998842 27899999999999999999999987 999999999999999999999999999887643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=187.96 Aligned_cols=150 Identities=29% Similarity=0.440 Sum_probs=134.7
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||+|++|.||++... +++.|++|++..... .....+.+|+..+.+++|||++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999875 489999999876543 3457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|.+++.. ...+++.....++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999843 3668999999999999999999998 77 999999999999999999999999999877544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=192.52 Aligned_cols=149 Identities=27% Similarity=0.417 Sum_probs=133.2
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|...+.||+|+||.||++.. .++..|++|.+........+.+..|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46888999999999999999975 46789999998755455567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|..++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999999883 235788999999999999999999987 99999999999999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=191.63 Aligned_cols=144 Identities=28% Similarity=0.433 Sum_probs=122.9
Q ss_pred cccccCCcccEEEEEecC--------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+.||+|+||.||+|.... ...+++|.+........+.+..|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 234888887654444556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC--------ceEeecccc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PKISDFGMA 300 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--------~ki~DfGla 300 (318)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998533 336889999999999999999999987 999999999999988765 599999998
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 75543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=189.12 Aligned_cols=147 Identities=28% Similarity=0.443 Sum_probs=129.8
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
-|...+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+..+.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778999999999999976 467899999876432 234467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++++|..++. ...+++.....++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999998883 345889999999999999999999987 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=218.05 Aligned_cols=169 Identities=25% Similarity=0.295 Sum_probs=143.1
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEe
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 218 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 218 (318)
...+....++|.+.+.||+|+||.|...+++ +++.+|.|++++. ......-|..|-.+|..-+.+=|++|+-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3344556789999999999999999999874 5788999999863 22334568889999998899999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
.+++|+|||||+||+|-.++. ....+++..+..++..|..||.-||+-| +|||||||+|||+|..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999988883 3336888888889999999999999887 9999999999999999999999999
Q ss_pred cceeecCCccccccceeecC
Q 021046 299 MARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 299 la~~~~~~~~~~~~~~~~Gt 318 (318)
-+-.+..|+.- .+..-+||
T Consensus 221 sClkm~~dG~V-~s~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTV-RSSVAVGT 239 (1317)
T ss_pred hHHhcCCCCcE-EeccccCC
Confidence 99888877643 33445776
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=187.38 Aligned_cols=146 Identities=34% Similarity=0.544 Sum_probs=127.7
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
++|.+.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++..++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688889999999999999975 6778999988653 2346789999999999999999999998764 5799999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999998543 2345789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=214.99 Aligned_cols=158 Identities=23% Similarity=0.351 Sum_probs=130.6
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEec--Cee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 222 (318)
...++|.+.+.||+|+||.||++... ++..+|+|.+... .......|..|+.++..++||||++++++|... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999864 4678899988643 223356789999999999999999999998654 568
Q ss_pred EEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCEEEcCC--------
Q 021046 223 ILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSR----LRIIHRDLKASNILLDSD-------- 289 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivH~Dlk~~Nill~~~-------- 289 (318)
++||||+++|+|..++.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+..
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999885422 23568999999999999999999998542 349999999999999642
Q ss_pred ---------CCceEeecccceeecC
Q 021046 290 ---------MNPKISDFGMARIFGG 305 (318)
Q Consensus 290 ---------~~~ki~DfGla~~~~~ 305 (318)
..+||+|||+++.+..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred ccccccCCCCceEEccCCccccccc
Confidence 3489999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=180.63 Aligned_cols=141 Identities=18% Similarity=0.182 Sum_probs=109.4
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCc--C-------HHHH-----------------HHHHHHHhccCCCcc
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LTEF-----------------KNEMMLIAKLQHRHL 209 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~~-----------------~~e~~~l~~l~h~ni 209 (318)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998754211 1 1122 349999999988877
Q ss_pred ceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCEEEcC
Q 021046 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDS 288 (318)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlk~~Nill~~ 288 (318)
.....+.. ...++||||++++++..... ....+++.....++.|++.+|.|+ |+.+ |+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 54433322 33489999999987754431 234688899999999999999999 6766 99999999999998
Q ss_pred CCCceEeecccceeecC
Q 021046 289 DMNPKISDFGMARIFGG 305 (318)
Q Consensus 289 ~~~~ki~DfGla~~~~~ 305 (318)
++.++|+|||+|...+.
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=194.63 Aligned_cols=145 Identities=21% Similarity=0.289 Sum_probs=124.3
Q ss_pred cccccccC--CcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 155 TQCKLGEG--GFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 155 ~~~~lg~G--~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
+.++||+| +|++||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7889999976 568999999987542 223346778999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+..+
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999988432 2335889999999999999999999987 999999999999999999999999875443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=191.53 Aligned_cols=158 Identities=28% Similarity=0.373 Sum_probs=133.8
Q ss_pred HHHHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecC-
Q 021046 144 ASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG- 220 (318)
Q Consensus 144 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~- 220 (318)
.++..+.++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.++.++ +|||++++++++...+
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 33445678899999999999999999987 468899999886532 2345678899999998 7999999999987643
Q ss_pred ----eeEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 221 ----ENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 579999999999999887532 23456899999999999999999999887 9999999999999999999999
Q ss_pred ecccceeecC
Q 021046 296 DFGMARIFGG 305 (318)
Q Consensus 296 DfGla~~~~~ 305 (318)
|||+++.+..
T Consensus 171 dfg~~~~~~~ 180 (291)
T cd06639 171 DFGVSAQLTS 180 (291)
T ss_pred ecccchhccc
Confidence 9999986543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=215.15 Aligned_cols=151 Identities=34% Similarity=0.504 Sum_probs=123.0
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEec-----
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ----- 219 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 219 (318)
.....+|+..+.||+||||.||+++. -+|+.+|||++... +........+|+.++++|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45677899999999999999999975 47999999999754 334456788999999999999999988744210
Q ss_pred --------------------------------------------------------------------------------
Q 021046 220 -------------------------------------------------------------------------------- 219 (318)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (318)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 021046 220 ----------------------------------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265 (318)
Q Consensus 220 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y 265 (318)
..+|+-||||+...|.+++....... .....++++.+|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 11356788888877777774322111 356778999999999999
Q ss_pred HHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 266 LH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
+|+++ ||||||||.||+++++..|||+|||+|..
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 99998 99999999999999999999999999987
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=190.46 Aligned_cols=150 Identities=28% Similarity=0.415 Sum_probs=131.3
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999875 5789999988753 23345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|++++.+..+.. ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999887776552 2345889999999999999999999987 999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=190.43 Aligned_cols=150 Identities=28% Similarity=0.425 Sum_probs=129.4
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILI 225 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 225 (318)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999875 578999998874322 2234567899999999999999999999887 889999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++ +|..++... ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 888877432 236899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=189.74 Aligned_cols=149 Identities=31% Similarity=0.500 Sum_probs=122.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhcc---CCCccceEEEEEEec-----C
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQ-----G 220 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 220 (318)
+|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999864 588999998875321 2223456677777665 799999999998653 4
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..+++|||+++ +|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 787777432 2345899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=187.58 Aligned_cols=148 Identities=33% Similarity=0.503 Sum_probs=127.8
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-----CCcCHHHHHHHHHHHhccCCCccceEEEEEEec--Cee
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 222 (318)
.+|.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788899999999999999986 45889999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988842 345788999999999999999999987 99999999999999999999999999986
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=196.52 Aligned_cols=152 Identities=25% Similarity=0.351 Sum_probs=132.7
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.-|.+.+.||+|.|..|-+|++ -+|..||||++.+..- -....+.+|++-|+-++|||||+||.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999965 5799999999986432 334467899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE-cCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill-~~~~~~ki~DfGla~~~~~~ 306 (318)
.=++|+|.+|+... ...+.+....+++.||+.|+.|+|+.+ +|||||||+||++ ..-|-+||+|||++..+.+.
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999543 456889999999999999999999877 9999999999886 55688999999999877765
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
+
T Consensus 173 ~ 173 (864)
T KOG4717|consen 173 K 173 (864)
T ss_pred c
Confidence 4
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=182.00 Aligned_cols=154 Identities=29% Similarity=0.342 Sum_probs=137.3
Q ss_pred HHhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----e
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----E 221 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 221 (318)
...++|.+.+.||+|||+-||.++ ..++..+|+|++...+.++.+..++|++..++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456789999999999999999997 5678899999998777777888999999999999999999999876543 4
Q ss_pred eEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 222 NILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
.|+++.|...|+|.+.+...+ ++..+++.+.+.|+.++++||++||+.. +++.||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886543 4568999999999999999999999975 57999999999999999999999999987
Q ss_pred ee
Q 021046 301 RI 302 (318)
Q Consensus 301 ~~ 302 (318)
..
T Consensus 177 ~~ 178 (302)
T KOG2345|consen 177 TQ 178 (302)
T ss_pred cc
Confidence 64
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=205.20 Aligned_cols=154 Identities=21% Similarity=0.357 Sum_probs=118.9
Q ss_pred HHhcCCccccccccCCcccEEEEEecC--CcEEEEE------------------EccCCCCcCHHHHHHHHHHHhccCCC
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLTEFKNEMMLIAKLQHR 207 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~e~~~l~~l~h~ 207 (318)
...++|.+.+.||+|+||+||++.... +...++| .+.. .......+.+|+.++.+++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999986532 2222222 1111 112345688999999999999
Q ss_pred ccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 208 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
||+++++++...+..++|+|++. ++|..++..... ...........++.|++.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 456665532211 122335567789999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
++.++.+||+|||+|+.+...
T Consensus 300 l~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred ECCCCCEEEEeCCCceecCcc
Confidence 999999999999999887543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=185.13 Aligned_cols=150 Identities=24% Similarity=0.397 Sum_probs=131.4
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|+..+.||+|+||.+|.+.. .+++.+|+|.+... ......++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999976 46889999988643 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++++|.+++... ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999998887432 2345789999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=199.98 Aligned_cols=148 Identities=29% Similarity=0.405 Sum_probs=128.1
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-C-----CccceEEEEEEecCeeEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-H-----RHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 224 (318)
+|++.+.||+|+||+|.+|.. .+++.||||++++. .....+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999975 56999999999874 344566788999999997 4 489999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC--CceEeeccccee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARI 302 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~--~~ki~DfGla~~ 302 (318)
|+|.++ .+|.+++... .-..++......++.||+.||.+||+.+ |||+||||+||||.+.+ .+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999985 5899988543 3456889999999999999999999887 99999999999997644 699999999986
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
...
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=219.60 Aligned_cols=143 Identities=27% Similarity=0.498 Sum_probs=123.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
...+...+.||+|+||.||+|.. .++..||||++...... ...|+..+++++|||||+++|+|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677778999999999999987 57889999998753322 23468889999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++|+|.+++. .++|..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+++. ||++...
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999983 37899999999999999999997656679999999999999999988876 6766543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-24 Score=181.88 Aligned_cols=150 Identities=34% Similarity=0.551 Sum_probs=134.7
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
+|...+.||+|+||.||++... ++..+++|++..........+.+|+..++.++|||++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999875 688999999987555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999988432 257899999999999999999999976 999999999999999999999999999877654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=189.02 Aligned_cols=148 Identities=30% Similarity=0.511 Sum_probs=129.1
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|+..+.||.|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 68899999886432 22345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++ ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6788877543 2456899999999999999999999887 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=183.10 Aligned_cols=149 Identities=33% Similarity=0.470 Sum_probs=133.0
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|+..+.||+|++|.||++... +++.+++|.+..... ...+.+.+|+.++.+++|||++++++++..++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999764 578999999876543 3456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999998843 356899999999999999999999887 999999999999999999999999999877643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=185.87 Aligned_cols=153 Identities=27% Similarity=0.455 Sum_probs=128.1
Q ss_pred CCccccccccCCcccEEEEEecC--CcEEEEEEccCC----------CCcCHHHHHHHHHHHhc-cCCCccceEEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIE 218 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 218 (318)
+|+..+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998754 678999987532 11233457788887765 799999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 219 QGENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887432 23456889999999999999999999632 3999999999999999999999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=175.90 Aligned_cols=142 Identities=21% Similarity=0.234 Sum_probs=112.6
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCc---------------------C-----HHHHHHHHHHHhccCCCcc
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---------------------G-----LTEFKNEMMLIAKLQHRHL 209 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni 209 (318)
...||+|+||.||+|...+|+.||||.++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998878999999998754211 0 1123578899999999988
Q ss_pred ceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcC
Q 021046 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS 288 (318)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~ 288 (318)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655544333 3489999999886543321 12356778889999999999999999 77 99999999999998
Q ss_pred CCCceEeecccceeecCC
Q 021046 289 DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 289 ~~~~ki~DfGla~~~~~~ 306 (318)
++.++|+|||+|+.+.++
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 899999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=193.79 Aligned_cols=155 Identities=30% Similarity=0.425 Sum_probs=129.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-C------CcCHHHHHHHHHHHhccCCCccceEEEEEEec-C
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-S------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-G 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~ 220 (318)
.++|-.+.+||+|+|+.||+|.. ...+.||||+-.-. . ....+...+|.++-+.|+||.||++++++.-+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35677788999999999999964 55778999965321 1 11223456789999999999999999999865 5
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCCceEeec
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDF 297 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~ki~Df 297 (318)
..+-|+||++|.+|+-|| +..+.++++++..|+.||+.||.||.+. ++||||-||||.|||+- ..|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 678999999999999998 4567789999999999999999999987 57899999999999994 4578999999
Q ss_pred ccceeecCCcc
Q 021046 298 GMARIFGGDEL 308 (318)
Q Consensus 298 Gla~~~~~~~~ 308 (318)
||++++.++..
T Consensus 618 GLSKIMdddSy 628 (775)
T KOG1151|consen 618 GLSKIMDDDSY 628 (775)
T ss_pred chhhhccCCcc
Confidence 99999987643
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=188.04 Aligned_cols=145 Identities=35% Similarity=0.525 Sum_probs=124.7
Q ss_pred cccccCCcccEEEEEecC-------CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997642 2578999886543 23456889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-----CceEeeccc
Q 021046 229 MPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-----NPKISDFGM 299 (318)
Q Consensus 229 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-----~~ki~DfGl 299 (318)
+++++|.+++.... ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2345789999999999999999999887 99999999999999887 899999999
Q ss_pred ceeec
Q 021046 300 ARIFG 304 (318)
Q Consensus 300 a~~~~ 304 (318)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 97654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=190.67 Aligned_cols=147 Identities=27% Similarity=0.490 Sum_probs=127.3
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|+..+.||+|+||.||+|... +|+.+|+|.++... ......+.+|+.++.+++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999874 68899999886432 22335678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++ ++|..++.. ....+++.....++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 477766632 2345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=190.34 Aligned_cols=150 Identities=31% Similarity=0.487 Sum_probs=128.7
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
....|...+.||+|+||.||+|... +++.||+|.+..... ....++.+|+.++..++|||++++.+++..++..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456888899999999999999864 588999998864322 233568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||++ |++.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 566665532 2346899999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=187.89 Aligned_cols=150 Identities=28% Similarity=0.417 Sum_probs=127.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccC-CCccceEEEEEEecCe-----
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGE----- 221 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 221 (318)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999864 68899999876532 223457888999999995 6999999999987766
Q ss_pred eEEEEEeccCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecc
Q 021046 222 NILIYEYMPNKSLDVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFG 298 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfG 298 (318)
.++||||+++ +|..++..... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78877754322 356899999999999999999999987 999999999999998 8999999999
Q ss_pred cceeec
Q 021046 299 MARIFG 304 (318)
Q Consensus 299 la~~~~ 304 (318)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=187.02 Aligned_cols=149 Identities=29% Similarity=0.386 Sum_probs=131.7
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..+.||+|+||.||++... +++.+++|.+.... .....++.+|+.++++++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 58899999887643 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++++|.+++.... ..+++.....++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||++..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999885432 578889999999999999999998 66 9999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=183.37 Aligned_cols=150 Identities=26% Similarity=0.373 Sum_probs=129.2
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEe-cCeeEEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENILIYE 227 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 227 (318)
+|++.+.||+|+||.||++... +++.+|+|++.... ....+.+..|+.++++++|||++++++.+.. ++..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999764 47889999986532 2345678899999999999999999998764 446789999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++++|.+++... ....+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999888532 2446899999999999999999999987 99999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=186.65 Aligned_cols=141 Identities=29% Similarity=0.421 Sum_probs=127.3
Q ss_pred cccccCCcccEEEEE-ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 157 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
+.||+|+|+.|--+. +.+|.++|||++.+.......+..+|++++...+ |+||++|+++|.+++..|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999885 6789999999999987788889999999999985 99999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEeecccceee
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIF 303 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~DfGla~~~ 303 (318)
...+. +...+++.++.++.++|+.||.|||.++ |.||||||+|||-.+.. -+||+||.|+.-+
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 88884 4567899999999999999999999998 99999999999986554 4899999998543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=187.57 Aligned_cols=151 Identities=30% Similarity=0.429 Sum_probs=129.5
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 226 (318)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|+.++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999874 578899998875432 3456789999999999999999999998754 4689999
Q ss_pred EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 227 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||+++++|.+++... .....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999998876432 23456888999999999999999999987 9999999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=186.51 Aligned_cols=151 Identities=30% Similarity=0.454 Sum_probs=134.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..+.|+..+.||+|+||.||++... ++..+++|.+..... ....+..|+..+..++|||++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999875 688999999876443 56678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999985422 37899999999999999999999977 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=186.65 Aligned_cols=142 Identities=30% Similarity=0.391 Sum_probs=124.1
Q ss_pred cccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||+|+||+||++.. .+++.+|+|.+.... ......+..|+.++..++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999975 458899999886432 22344677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
..++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..+.
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 98885432 246899999999999999999999987 9999999999999999999999999997664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=192.72 Aligned_cols=149 Identities=30% Similarity=0.499 Sum_probs=127.4
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEec--Cee
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ--GEN 222 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 222 (318)
..++|+..+.||+|+||.||+|... +++.+|+|++... .......+..|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578889999999999999999875 5789999988542 223445677899999999 999999999998754 367
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||++ ++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588877732 26889999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=188.10 Aligned_cols=143 Identities=26% Similarity=0.403 Sum_probs=127.5
Q ss_pred ccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 156 QCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
..+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|||++++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35899999999999977 46889999988654444566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98773 235789999999999999999999987 99999999999999999999999999876644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=186.00 Aligned_cols=152 Identities=30% Similarity=0.456 Sum_probs=132.3
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecC------
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------ 220 (318)
+.++|+..+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999874 57889999887543 3456789999999999 6999999999997654
Q ss_pred eeEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875422 2457899999999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 021046 300 ARIFG 304 (318)
Q Consensus 300 a~~~~ 304 (318)
+....
T Consensus 160 ~~~~~ 164 (275)
T cd06608 160 SAQLD 164 (275)
T ss_pred ceecc
Confidence 97654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=182.36 Aligned_cols=150 Identities=33% Similarity=0.496 Sum_probs=133.7
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 226 (318)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+..+++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999875 688999999876432 4567899999999999999999999999988 8899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998843 237899999999999999999999977 999999999999999999999999999887654
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=186.74 Aligned_cols=140 Identities=28% Similarity=0.422 Sum_probs=125.1
Q ss_pred cccCCcccEEEEEecC-CcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||+|+||.||++.... ++.+++|.+..... .....+.+|+.++.+++|||++++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 89999999875433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 998843 236899999999999999999999987 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=183.75 Aligned_cols=141 Identities=27% Similarity=0.363 Sum_probs=125.4
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||.|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 488999998865322 3346789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 998843 345889999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=185.84 Aligned_cols=141 Identities=29% Similarity=0.353 Sum_probs=117.6
Q ss_pred ccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHHH---hccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 158 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLI---AKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.||+|+||.||++.. .+++.+|+|.+..... .....+..|..++ ...+|||++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 4588999998865321 1122344444333 34479999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|+|..++. ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..+.
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999998884 2346899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=188.38 Aligned_cols=152 Identities=29% Similarity=0.474 Sum_probs=129.5
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC----
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG---- 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 220 (318)
...++|++.+.||+|+||.||+|... +++.||+|.++... ......+..|+.++..++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999875 57899999987532 233356788999999999999999999987655
Q ss_pred ------eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 221 ------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 221 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
..++|+||+++ ++..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 56555532 2346899999999999999999999987 999999999999999999999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||++..+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=182.17 Aligned_cols=151 Identities=26% Similarity=0.417 Sum_probs=130.7
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999976 46788999988653 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~~~~ 306 (318)
+++++|.+++... ....+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++ .+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999998532 2445889999999999999999999987 99999999999998654 5899999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=185.67 Aligned_cols=147 Identities=26% Similarity=0.408 Sum_probs=129.8
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
+|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.++..++|||++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344557899999999999986 4688999998875544555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999998843 45888999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=186.21 Aligned_cols=157 Identities=29% Similarity=0.444 Sum_probs=132.3
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEe--
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE-- 218 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-- 218 (318)
+.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.++.++ +|||++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 334445668899999999999999999987 45788999988653 23445788899999998 69999999999863
Q ss_pred ----cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 219 ----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 219 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
.+..+++|||+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45779999999999999988543 2345788889999999999999999987 999999999999999999999
Q ss_pred eecccceeec
Q 021046 295 SDFGMARIFG 304 (318)
Q Consensus 295 ~DfGla~~~~ 304 (318)
+|||++....
T Consensus 163 ~dfg~~~~~~ 172 (282)
T cd06636 163 VDFGVSAQLD 172 (282)
T ss_pred eeCcchhhhh
Confidence 9999987553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=191.50 Aligned_cols=151 Identities=25% Similarity=0.389 Sum_probs=128.7
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC---
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--- 220 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 220 (318)
....++|...+.||+|+||.||++.. .++..||||++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999975 468899999886432 223456889999999999999999999987654
Q ss_pred ---eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 221 ---ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 221 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
..++||||+ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 778887763 346899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecC
Q 021046 298 GMARIFGG 305 (318)
Q Consensus 298 Gla~~~~~ 305 (318)
|+++....
T Consensus 163 g~~~~~~~ 170 (343)
T cd07880 163 GLARQTDS 170 (343)
T ss_pred cccccccc
Confidence 99987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=191.43 Aligned_cols=148 Identities=26% Similarity=0.450 Sum_probs=126.8
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----ee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----EN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 222 (318)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.++.+++||||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999976 468899999986432 234456889999999999999999999876543 57
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++++||+++ +|..++ ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 776665 2346899999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=198.55 Aligned_cols=153 Identities=24% Similarity=0.368 Sum_probs=120.8
Q ss_pred HhcCCccccccccCCcccEEEEEe-----------------cCCcEEEEEEccCCCCcCHHH--------------HHHH
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLTE--------------FKNE 197 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~e 197 (318)
..++|.+.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235679999987543222233 3446
Q ss_pred HHHHhccCCCcc-----ceEEEEEEe--------cCeeEEEEEeccCCChhhhhhcCCC---------------------
Q 021046 198 MMLIAKLQHRHL-----VRLFGCCIE--------QGENILIYEYMPNKSLDVFLFYPKK--------------------- 243 (318)
Q Consensus 198 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 243 (318)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 678888764 3568999999999999998863210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 244 KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 244 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
...++|..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||+|+.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123567888999999999999999987 9999999999999999999999999997654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=188.42 Aligned_cols=150 Identities=31% Similarity=0.461 Sum_probs=132.8
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (318)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+..|+.++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999874 6889999988653 2233467889999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998843 347999999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=183.33 Aligned_cols=156 Identities=27% Similarity=0.464 Sum_probs=130.2
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCeeEEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENILIY 226 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 226 (318)
+|+..+.||.|+||.||++.. .++..+|+|.+... .....+.+..|+.+++.++|||++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999975 46788999988643 22334578899999999999999999998864 34678999
Q ss_pred EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+++++|..++... .....+++.....++.|++.||.|||..+ ..+++|+||+|+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988542 23467899999999999999999999332 234999999999999999999999999999987
Q ss_pred cCCc
Q 021046 304 GGDE 307 (318)
Q Consensus 304 ~~~~ 307 (318)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=184.56 Aligned_cols=148 Identities=32% Similarity=0.527 Sum_probs=128.9
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeEEEEE
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIYE 227 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 227 (318)
|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++..++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999875 47899999997653 33446788999999999999999999999988 88999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++ +|..++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 787777432 257899999999999999999999987 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=198.62 Aligned_cols=150 Identities=23% Similarity=0.315 Sum_probs=120.1
Q ss_pred HHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC------CccceEEEEEEe
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH------RHLVRLFGCCIE 218 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~ 218 (318)
+....++|.+.++||+|+||.||+|... +++.||||+++... ....++..|+.++..++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445678999999999999999999864 57889999986532 233456677777777654 458899998876
Q ss_pred c-CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCC------
Q 021046 219 Q-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM------ 290 (318)
Q Consensus 219 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~------ 290 (318)
. +..++|||++ +++|.+++. ....+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4678999987 667877773 235689999999999999999999974 5 99999999999998765
Q ss_pred ----------CceEeecccceee
Q 021046 291 ----------NPKISDFGMARIF 303 (318)
Q Consensus 291 ----------~~ki~DfGla~~~ 303 (318)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=187.21 Aligned_cols=151 Identities=31% Similarity=0.466 Sum_probs=128.4
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (318)
..++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.+++|||++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999874 588999998864322 2233567899999999999999999998765 5689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++ +|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 787776432 356899999999999999999999987 999999999999999999999999999877
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 159 ~~ 160 (309)
T cd07845 159 GL 160 (309)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=184.07 Aligned_cols=149 Identities=28% Similarity=0.466 Sum_probs=125.9
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|||++++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999874 68899999886532 2334578899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~ 304 (318)
|++ ++|..++... ....+++.....++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 4777666332 2334678888899999999999999987 999999999999985 5679999999998654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=186.13 Aligned_cols=148 Identities=28% Similarity=0.364 Sum_probs=128.0
Q ss_pred CCccccccccCCcccEEEEEe----cCCcEEEEEEccCCC----CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
+|...+.||+|+||.||+++. .++..||||.++... ....+.+..|+.++.++ +|||++++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999974 356789999886432 22345688999999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|..++.. ...+++.....++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988842 346888999999999999999999877 99999999999999999999999999987
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=179.36 Aligned_cols=152 Identities=24% Similarity=0.431 Sum_probs=134.4
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|...+.||+|+||.||++... ++..+++|++..... .....+..|+..++.++|||++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999874 588999999875433 4556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885432 2467899999999999999999999987 999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=186.06 Aligned_cols=152 Identities=29% Similarity=0.488 Sum_probs=127.2
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC----
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG---- 220 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 220 (318)
...++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999864 58899999886432 222345678999999999999999999987654
Q ss_pred ----eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEee
Q 021046 221 ----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 296 (318)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~D 296 (318)
..++||||+.+ +|..++.. ....+++.+...++.|++.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 34999999975 77766632 2346899999999999999999999987 99999999999999999999999
Q ss_pred cccceeecC
Q 021046 297 FGMARIFGG 305 (318)
Q Consensus 297 fGla~~~~~ 305 (318)
||++..+..
T Consensus 163 fg~~~~~~~ 171 (310)
T cd07865 163 FGLARAFSL 171 (310)
T ss_pred CCCcccccC
Confidence 999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=183.99 Aligned_cols=147 Identities=30% Similarity=0.502 Sum_probs=127.6
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
|+..+.||.|++|.||+|... +|..||+|++.... ......+.+|+..++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999764 68999999887542 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+ ++|..++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68888874322 246899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=189.35 Aligned_cols=156 Identities=28% Similarity=0.342 Sum_probs=135.9
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..+.|..-+.||+|+||.||-++. .+|+.+|.|++.+. ..++....++|-.+|.+++.+.||.+--.+.+.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 345777888999999999999965 46889999988653 23455667899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+..|+||+|.-++... .+..++++....++.+|+.||++||... ||.||+||+|||+|+.|+++|+|+|||.-+.
T Consensus 263 VLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999998777433 3467999999999999999999999987 9999999999999999999999999998887
Q ss_pred CCcc
Q 021046 305 GDEL 308 (318)
Q Consensus 305 ~~~~ 308 (318)
..+.
T Consensus 339 ~g~~ 342 (591)
T KOG0986|consen 339 EGKP 342 (591)
T ss_pred CCCc
Confidence 6544
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=189.90 Aligned_cols=149 Identities=30% Similarity=0.418 Sum_probs=126.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----- 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 220 (318)
..++|+..+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.++.+++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999976 46889999998643 2233456788999999999999999999986543
Q ss_pred -eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 221 -ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
..++||||+++ +|...+.. .+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 46999999964 77776621 2788899999999999999999987 99999999999999999999999999
Q ss_pred ceeecCC
Q 021046 300 ARIFGGD 306 (318)
Q Consensus 300 a~~~~~~ 306 (318)
++.....
T Consensus 165 ~~~~~~~ 171 (353)
T cd07850 165 ARTAGTS 171 (353)
T ss_pred ceeCCCC
Confidence 9876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=182.64 Aligned_cols=141 Identities=30% Similarity=0.350 Sum_probs=117.7
Q ss_pred ccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHH---HHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 158 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMM---LIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.||+|+||.||++.. .+++.||+|.+..... .....+..|.. .+....|||++++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 4588999998865321 11223444443 3444579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|+|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999998873 3456899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=190.19 Aligned_cols=149 Identities=23% Similarity=0.399 Sum_probs=128.0
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 222 (318)
.++|+..+.||+|+||.||++... ++..||+|++.... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378898999999999999999764 58899999987532 2345677889999999999999999998763 3467
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+. |+|..++. ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 68888773 3345899999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
...
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=214.02 Aligned_cols=151 Identities=30% Similarity=0.446 Sum_probs=132.6
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
+-++.....||.|.||+||-|.. .+|...|+|-++.. .........+|+.++..|+|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34677788999999999999964 66888999977643 2344567789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|||++|+|.+.+ ..++..++.....+..|++.|+.|||+++ ||||||||.||+++.+|.+|++|||-|+.+.++
T Consensus 1314 EyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999988 34556777777888999999999999988 999999999999999999999999999888765
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=188.64 Aligned_cols=154 Identities=28% Similarity=0.386 Sum_probs=129.5
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
..++....++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 344556778999999999999999999975 568899999987532 22345688899999999999999999988643
Q ss_pred ------CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCce
Q 021046 220 ------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293 (318)
Q Consensus 220 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 293 (318)
+..+++++++ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467788776 788887763 235889999999999999999999987 99999999999999999999
Q ss_pred Eeecccceeec
Q 021046 294 ISDFGMARIFG 304 (318)
Q Consensus 294 i~DfGla~~~~ 304 (318)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=185.35 Aligned_cols=149 Identities=32% Similarity=0.493 Sum_probs=127.6
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..|...+.||+|+||.||++.. .++..+|+|.+..... .....+..|+.++++++|||++++++++..++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477788999999999999986 4578999998864322 23457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99974 67666532 2456899999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=192.82 Aligned_cols=158 Identities=26% Similarity=0.364 Sum_probs=131.8
Q ss_pred cCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCC--------cCHHHHHHHHHHHhccC---CCccceEEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--------QGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIE 218 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 218 (318)
.+|.....+|+|+||+|+.+.++. ...|+||.+.+..- ...-..-.|+.+|+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468888999999999999998754 56799998875321 11122457999999997 9999999999999
Q ss_pred cCeeEEEEEecc-CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 219 QGENILIYEYMP-NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 219 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
++..||+||-.. +-+|.+++ .....+++..+..|++|++-|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999875 44666666 34567899999999999999999999998 999999999999999999999999
Q ss_pred ccceeecCCccccccceeecC
Q 021046 298 GMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 298 Gla~~~~~~~~~~~~~~~~Gt 318 (318)
|-|.......+ ..++||
T Consensus 715 gsaa~~ksgpf----d~f~gt 731 (772)
T KOG1152|consen 715 GSAAYTKSGPF----DVFVGT 731 (772)
T ss_pred cchhhhcCCCc----ceeeee
Confidence 99988766554 356666
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=180.93 Aligned_cols=151 Identities=26% Similarity=0.459 Sum_probs=130.5
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999874 5788999988653 223456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC-ceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-~ki~DfGla~~~~~~ 306 (318)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||++..+..+
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999988532 2345789999999999999999999987 999999999999998864 699999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=187.45 Aligned_cols=148 Identities=28% Similarity=0.413 Sum_probs=126.4
Q ss_pred hcCCcc-ccccccCCcccEEEEEec-CCcEEEEEEccCCCCcC--------------HHHHHHHHHHHhccCCCccceEE
Q 021046 150 TENFST-QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LTEFKNEMMLIAKLQHRHLVRLF 213 (318)
Q Consensus 150 ~~~~~~-~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~ 213 (318)
.++|.. .+.||+|+||.||+|... +++.||||.+....... ...+.+|+.++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345653 467999999999999864 68899999886532211 12477899999999999999999
Q ss_pred EEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCce
Q 021046 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293 (318)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 293 (318)
+++..++..++||||++ |+|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 68888773 3446889999999999999999999987 99999999999999999999
Q ss_pred Eeecccceeec
Q 021046 294 ISDFGMARIFG 304 (318)
Q Consensus 294 i~DfGla~~~~ 304 (318)
|+|||+++.+.
T Consensus 160 l~dfg~~~~~~ 170 (335)
T PTZ00024 160 IADFGLARRYG 170 (335)
T ss_pred ECCccceeecc
Confidence 99999998775
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=179.01 Aligned_cols=149 Identities=23% Similarity=0.310 Sum_probs=122.0
Q ss_pred HHHHhcCCcccccc--ccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhc-cCCCccceEEEEEEecCe
Q 021046 146 VSAATENFSTQCKL--GEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 146 ~~~~~~~~~~~~~l--g~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~ 221 (318)
.....++|.+.+.+ |+|+||.||++.. .++..+|+|.+........ |+..... .+|||++++++.+..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34455677777776 9999999999976 4578899998865322211 2222221 279999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccc
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMA 300 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla 300 (318)
.++||||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999998843 337899999999999999999999987 99999999999999998 9999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+....
T Consensus 158 ~~~~~ 162 (267)
T PHA03390 158 KIIGT 162 (267)
T ss_pred eecCC
Confidence 87654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=179.88 Aligned_cols=142 Identities=25% Similarity=0.343 Sum_probs=119.5
Q ss_pred cccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHH-HhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMML-IAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999976 4578999999865322 122334455444 4455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999884 2346889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=188.16 Aligned_cols=149 Identities=25% Similarity=0.442 Sum_probs=127.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEec-----Ce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 221 (318)
.++|...+.||+|+||.||++.. .+++.||||.+... .......+..|+.++..++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788899999999999999976 46889999988753 233345678899999999999999999988754 34
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++|+||+. ++|..++. ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877773 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=180.93 Aligned_cols=146 Identities=26% Similarity=0.375 Sum_probs=122.7
Q ss_pred CccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccC-CCccceEEEEEEec--CeeEEEEE
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ--GENILIYE 227 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 227 (318)
|...+.||+|+||.||++.. .+++.+|+|+++... .........|+..+.++. |||++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999986 468899999887542 222234557888888885 99999999999987 88999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 577666632 2346899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=185.09 Aligned_cols=147 Identities=29% Similarity=0.412 Sum_probs=123.0
Q ss_pred CCccccccccCCcccEEEEEec-C--CcEEEEEEccCCC--CcCHHHHHHHHHHHhcc-CCCccceEEEEEEec----Ce
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-N--GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ----GE 221 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 221 (318)
+|...+.||+|+||.||++... . +..||+|++.... ....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999864 3 6789999887532 22345788899999999 599999999976543 35
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++++||+. ++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688888886 68888773 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=187.77 Aligned_cols=148 Identities=30% Similarity=0.436 Sum_probs=129.5
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC-----eeE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI 223 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 223 (318)
+|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+..++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999875 48899999987643 344567899999999999999999999998775 789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
++|||++ ++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 47877773 3347899999999999999999999987 999999999999999999999999999887
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=201.18 Aligned_cols=159 Identities=31% Similarity=0.465 Sum_probs=135.6
Q ss_pred HHHHhcCCccccccccCCcccEEEEEec----C----CcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEE
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLL----N----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGC 215 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~ 215 (318)
++...++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+.+|..+ +|||++.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4455566677779999999999999742 1 45799999986533 4567899999999998 69999999999
Q ss_pred EEecCeeEEEEEeccCCChhhhhhcCC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 021046 216 CIEQGENILIYEYMPNKSLDVFLFYPK-----K------K--RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKAS 282 (318)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~ 282 (318)
|..++..++|+||++.|+|..+|...+ . . ..+...+.+.++.|||.||+||++.. +|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997654 0 1 23888999999999999999999876 999999999
Q ss_pred CEEEcCCCCceEeecccceeecCCc
Q 021046 283 NILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 283 Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
|||++.+..+||+|||+||....++
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCC
Confidence 9999999999999999999665543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=179.82 Aligned_cols=152 Identities=30% Similarity=0.457 Sum_probs=132.2
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+|++.+.||+|+||.||++.. .+++.+++|.+.... .....++..|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999975 467899999887532 23345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999875422 2356899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=184.11 Aligned_cols=145 Identities=23% Similarity=0.210 Sum_probs=122.8
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 155 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++..++..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555556666666554 6889999998754 3445678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+|..++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999988543 2345788899999999999999999987 9999999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=183.79 Aligned_cols=149 Identities=31% Similarity=0.459 Sum_probs=127.5
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe-cCeeE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENI 223 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 223 (318)
..+++|+..+.||+|+||.||++... ++..||+|++... .......+..|+.++..++|||++++.+++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999754 6889999988642 22334678899999999999999999999876 45789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++||+ +++|..++. ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568887763 345788888899999999999999987 999999999999999999999999999865
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 159 ~ 159 (328)
T cd07856 159 D 159 (328)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=188.33 Aligned_cols=163 Identities=26% Similarity=0.353 Sum_probs=139.8
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccC--CCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (318)
....|++.++||+||.+.||++...+.+.+|+|++.. .+.+..+.|..|+..|.+|+ |.+|++|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3457889999999999999999988888899987653 35667788999999999996 99999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||= ..+|..+|... ......| .+..++.||+.++.+.|+++ |||.||||.|+|+ -.|.+||+|||+|+.+..
T Consensus 439 mE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 9984 45888888433 2333345 67789999999999999988 9999999999998 678999999999999999
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
|.........+||
T Consensus 512 DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 512 DTTSIVKDSQVGT 524 (677)
T ss_pred cccceeeccccCc
Confidence 8877777777887
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=181.37 Aligned_cols=148 Identities=31% Similarity=0.427 Sum_probs=127.3
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEec
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
|.+.+.||+|+||.||+|... +++.|+||++..... .......+|+..+.+++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999875 478899999875432 22234567999999999 999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 888988774332 346899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=182.19 Aligned_cols=150 Identities=34% Similarity=0.511 Sum_probs=127.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.+.|...+.||+|+||.||+|... ++..+|+|.+... ......++.+|+.+++.++|||++++++++..++..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777789999999999999864 5788999988642 222345688899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+. |++...+... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+..
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 5776666332 345789999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=179.13 Aligned_cols=149 Identities=19% Similarity=0.299 Sum_probs=110.1
Q ss_pred hcCCccccccccCCcccEEEEEecCC----cEEEEEEccCCCCcCHH-----------HHHHHHHHHhccCCCccceEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGLT-----------EFKNEMMLIAKLQHRHLVRLFG 214 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~l~~ 214 (318)
.++|.+.+.||+|+||.||+|...++ ..+|+|........... ....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999987543 45666653322211111 1223334556778999999999
Q ss_pred EEEecC----eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 215 CCIEQG----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 215 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
++.... ..++++|++.. ++.+.+. .....++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 877654 34677777643 4544442 1233577888999999999999999987 99999999999999999
Q ss_pred CceEeecccceeecC
Q 021046 291 NPKISDFGMARIFGG 305 (318)
Q Consensus 291 ~~ki~DfGla~~~~~ 305 (318)
.++|+|||+|+.+..
T Consensus 164 ~~~l~DFGla~~~~~ 178 (294)
T PHA02882 164 RGYIIDYGIASHFII 178 (294)
T ss_pred cEEEEEcCCceeecc
Confidence 999999999987753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=180.58 Aligned_cols=145 Identities=32% Similarity=0.485 Sum_probs=124.6
Q ss_pred CccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 153 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
|...+.||+|+||.||+|.. .++..|++|.+..... .....+.+|+.+++.++|||++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66667899999999999986 4588999998864322 2335688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 567666532 2346899999999999999999999987 999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=184.46 Aligned_cols=146 Identities=28% Similarity=0.442 Sum_probs=124.2
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++..++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999986 468999999986532 223456889999999999999999999987543
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++|+||+.. +|..+. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 665554 235889999999999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 021046 301 RIFG 304 (318)
Q Consensus 301 ~~~~ 304 (318)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=167.01 Aligned_cols=158 Identities=28% Similarity=0.415 Sum_probs=132.0
Q ss_pred HHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhc-cCCCccceEEEEEEecCee
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~ 222 (318)
++...++....+.||+|++|.|-+-++ .+|...|+|++... ..+...+.++|+.+..+ ...|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 445566777788999999999988865 67999999999754 33455677888886655 4799999999999999999
Q ss_pred EEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 223 ILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
|+.||.|+ .||+.+-... ..+...++...-+|+..+..||.|||++- .+||||+||+|||++.+|++||+|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 5777765322 34677899999999999999999999864 69999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+.++
T Consensus 198 ~L~dS 202 (282)
T KOG0984|consen 198 YLVDS 202 (282)
T ss_pred eehhh
Confidence 88654
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=183.82 Aligned_cols=141 Identities=25% Similarity=0.307 Sum_probs=121.6
Q ss_pred cccccC--CcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEG--GFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G--~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
..||+| +||+||++.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 8999999987 468999999986432 22346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99998875432 345889999999999999999999887 9999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=179.83 Aligned_cols=148 Identities=30% Similarity=0.501 Sum_probs=128.5
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
|...+.||+|++|.||++... +++.+++|.+..... .....+..|+.++++++|||++++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999864 688999998875432 24567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++ +|..++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 787776432 357899999999999999999999987 999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=181.12 Aligned_cols=152 Identities=26% Similarity=0.410 Sum_probs=125.7
Q ss_pred HhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCC-cCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (318)
..++|+..+.||+|+||.||+|...+ ++.||||.++.... ....++..|+.++.+.. ||||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999998864 88999999875432 23445677777676665 99999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++ +|..++.. ....+++..+..++.|++.||.|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 93 ~e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999854 66665532 2347899999999999999999999742 399999999999999999999999999986643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=186.18 Aligned_cols=147 Identities=27% Similarity=0.434 Sum_probs=126.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec---------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--------- 219 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 219 (318)
..+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36789999999999999999976 45889999998766556667889999999999999999999776543
Q ss_pred -----CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCce
Q 021046 220 -----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPK 293 (318)
Q Consensus 220 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~k 293 (318)
...++||||++ ++|..++. ...+++.....++.|++.||.|||+.+ ++||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58877762 335889999999999999999999987 999999999999974 56789
Q ss_pred Eeecccceeec
Q 021046 294 ISDFGMARIFG 304 (318)
Q Consensus 294 i~DfGla~~~~ 304 (318)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=175.65 Aligned_cols=141 Identities=30% Similarity=0.417 Sum_probs=125.6
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 159 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
||+|+||.||++... +++.+++|.+..... .....+..|+.+++.++|||++++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 488999998875432 2455789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 998843 346899999999999999999999977 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=177.31 Aligned_cols=149 Identities=34% Similarity=0.530 Sum_probs=124.0
Q ss_pred CccccccccCCcccEEEEEecC-CcEEEEEEccCCCC--cCHHHHHHHHHHHhcc---CCCccceEEEEEEecCe-----
Q 021046 153 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQGE----- 221 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 221 (318)
|+..+.||+|+||.||+|.... ++.+|+|++..... .....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999998764 88999999874322 2234566787776655 69999999999998776
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 7887774322 235899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=190.64 Aligned_cols=148 Identities=24% Similarity=0.381 Sum_probs=127.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
...|-.++.||-|+||+|.++.- .+...+|.|.|++.+ .......+.|-.+|+..+.+=||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34566778999999999999964 445678999987653 23445678899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|||++||++-.+| .....+++..+..++..+.+|+++.|.-| +|||||||+|||||.+|++||+||||+.=+
T Consensus 708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999998877 34567888888888889999999999877 999999999999999999999999998533
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=179.70 Aligned_cols=147 Identities=33% Similarity=0.498 Sum_probs=128.9
Q ss_pred CccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 153 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
|+..+.||+|+||.||+|... +++.+|+|.+.... ......+..|+.++++++|||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999875 48899999987643 334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+ ++|.+++... ...+++..+..++.|++.||.|||+++ |+||||+|+||++++++.++|+|||+++....
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 5898888532 246899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=190.76 Aligned_cols=169 Identities=27% Similarity=0.434 Sum_probs=141.7
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEe--
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE-- 218 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-- 218 (318)
+..+..+++.|++.+.||+|.+|+||+++. ++++.+|+|++... ....++...|..+++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 333445678899999999999999999974 56888999988764 34456778888888887 59999999999974
Q ss_pred ---cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 219 ---QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 219 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
++.+|||||||.+||.-++...-. ...+.|....+|...++.|+.+||... ++|||||-.|||++.++.+|+.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 468999999999999999886544 778999999999999999999999876 9999999999999999999999
Q ss_pred ecccceeecCCccccccceeecC
Q 021046 296 DFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 296 DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
|||++..+.....+ ..+.+||
T Consensus 166 DFGvSaQldsT~gr--RnT~iGt 186 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR--RNTFIGT 186 (953)
T ss_pred eeeeeeeeeccccc--ccCcCCC
Confidence 99999988654433 3345665
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=182.02 Aligned_cols=150 Identities=33% Similarity=0.502 Sum_probs=126.0
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
.++|.+.++||+|+||.||+|... +++.+|+|++..... .....+.+|+.++.+++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999864 578999998864322 22346788999999999999999999876543
Q ss_pred --eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 221 --ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 221 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
..++|+||++. +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45999999875 56555532 2446899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=180.35 Aligned_cols=152 Identities=29% Similarity=0.434 Sum_probs=124.7
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45666789999999999999764 57899999987532 234457889999999996 9999999999999999999999
Q ss_pred eccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|++. ++..+... ......+++.....++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 54443211 122356899999999999999999999752 399999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=183.42 Aligned_cols=163 Identities=29% Similarity=0.339 Sum_probs=131.6
Q ss_pred HHhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcC---HHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQG---LTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
....+|..+.+||+|+||+|.+|+.++ .+.+|||++++....+ .+--+.|-++|+-. +-|.+++|+.+|++.+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 445678888999999999999997654 5679999998753322 22234566666655 578999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
|+||||+.+|+|--.+ ..-..+.+..+..+|..||-||-|||+++ ||.||||.+||++|.+|++||+||||++.
T Consensus 426 yFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999996666 23445677788889999999999999998 99999999999999999999999999985
Q ss_pred ecCCccccccceeecC
Q 021046 303 FGGDELQGNTKRIVGT 318 (318)
Q Consensus 303 ~~~~~~~~~~~~~~Gt 318 (318)
---+. ..|++++||
T Consensus 500 ni~~~--~TTkTFCGT 513 (683)
T KOG0696|consen 500 NIFDG--VTTKTFCGT 513 (683)
T ss_pred cccCC--cceeeecCC
Confidence 43333 235677887
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=175.99 Aligned_cols=150 Identities=31% Similarity=0.444 Sum_probs=124.0
Q ss_pred CCccccccccCCcccEEEEEecC-CcEEEEEEccCC-----CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.+++.++|||++++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999997643 344555554431 122334567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 226 YEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887532 23457899999999999999999999987 999999999999975 569999999998764
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=183.58 Aligned_cols=149 Identities=28% Similarity=0.429 Sum_probs=128.0
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe----
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE---- 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 221 (318)
..++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999874 5789999988643 22234567789999999999999999998876654
Q ss_pred --eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 222 --NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 222 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 568888773 246899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
+..+..
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=165.73 Aligned_cols=138 Identities=22% Similarity=0.324 Sum_probs=106.7
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-----CCCccceEEEEEEecC---eeE-E
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-----QHRHLVRLFGCCIEQG---ENI-L 224 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 224 (318)
...+.||+|+||.||. ++.....+||++........+.+.+|+..+..+ +||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999996 443333479988765445567899999999999 5799999999999874 333 7
Q ss_pred EEEe--ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCEEEcC----CCCceEee-
Q 021046 225 IYEY--MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL-LYLHQYSRLRIIHRDLKASNILLDS----DMNPKISD- 296 (318)
Q Consensus 225 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~ki~D- 296 (318)
|+|| +++|+|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 568999999932 235544 35677888777 9999988 999999999999974 34799999
Q ss_pred ccccee
Q 021046 297 FGMARI 302 (318)
Q Consensus 297 fGla~~ 302 (318)
||.+..
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 554444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=168.41 Aligned_cols=146 Identities=22% Similarity=0.448 Sum_probs=126.4
Q ss_pred HhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecC--eeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG--ENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l 224 (318)
..++|++.+++|+|.|+.||.|. ..+.+.++||.++.. ..+.+.+|+.+|..|. ||||++|++...++. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 46789999999999999999996 466788999999764 3357889999999998 999999999988764 4579
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIF 303 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~ 303 (318)
++||+++.+..... ..++..++..++.+++.||.|+|+.| |+|||+||.|++||... .++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876544 45677788899999999999999998 99999999999998754 6999999999988
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
.+.
T Consensus 184 Hp~ 186 (338)
T KOG0668|consen 184 HPG 186 (338)
T ss_pred CCC
Confidence 654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=173.63 Aligned_cols=162 Identities=25% Similarity=0.377 Sum_probs=133.1
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (318)
...+|.+.+.||+|+|.+|..++++ +.+.+|+|++++. ..+..+=.+.|-.++... +||.+|.|+.+|.+...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4568999999999999999999874 5678999988753 223333445565555554 7999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|.||+++|+|--.+ ...+.++++-+..+...|..||.|||+++ ||.||||.+|||+|..|++|++|||+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999985444 45667899888889999999999999998 999999999999999999999999999853
Q ss_pred cCCccccccceeecC
Q 021046 304 GGDELQGNTKRIVGT 318 (318)
Q Consensus 304 ~~~~~~~~~~~~~Gt 318 (318)
-.+ ...+++++||
T Consensus 402 l~~--gd~tstfcgt 414 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGT 414 (593)
T ss_pred CCC--CcccccccCC
Confidence 322 2346677887
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-24 Score=176.59 Aligned_cols=150 Identities=29% Similarity=0.554 Sum_probs=121.2
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccC--CCCcCHHHHHHHHHHHhccCCCccceEEEEEEec-------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------- 219 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 219 (318)
.+.|+...+||+|.||.||+|+.. +++.||+|+.-- .....-....+|+.+|..++|+|++.++..|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 456777789999999999999764 477889886532 2222234568899999999999999999988643
Q ss_pred -CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 220 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 220 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
...++|+.+++. +|.-.|. .....++..++..++.++..||.|+|... |+|||+||+|+||+.++.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 247999999976 5555552 23456888999999999999999999876 9999999999999999999999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
+|+.+.-
T Consensus 170 lar~fs~ 176 (376)
T KOG0669|consen 170 LARAFST 176 (376)
T ss_pred cccceec
Confidence 9987753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=170.75 Aligned_cols=133 Identities=20% Similarity=0.154 Sum_probs=114.5
Q ss_pred CCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChhhhhhc
Q 021046 162 GGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY 240 (318)
Q Consensus 162 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 240 (318)
|.||.||++.. .+++.+|+|++.... .+..|...+....|||++++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999976 468899999987542 234455555566799999999999999999999999999999988843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 241 PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++++|||++..+..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 335899999999999999999999987 99999999999999999999999998866543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-24 Score=176.89 Aligned_cols=155 Identities=26% Similarity=0.413 Sum_probs=127.0
Q ss_pred CCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecC-----eeE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI 223 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 223 (318)
+.+..+.||-|+||.||..++ ++|+.||.|++.+.-. ...+.+.+|+.+|...+|.|++..++...-.. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455668999999999999976 5799999999876422 23467889999999999999999988776443 567
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+++|.|. .+|.+.+. +...++..-..-+..||++||+|||+.+ |.||||||.|.|++++..+||+|||||+.-
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 8888885 46777763 3456777777888999999999999987 999999999999999999999999999987
Q ss_pred cCCccccccc
Q 021046 304 GGDELQGNTK 313 (318)
Q Consensus 304 ~~~~~~~~~~ 313 (318)
..++...++.
T Consensus 207 e~d~~~hMTq 216 (449)
T KOG0664|consen 207 DQRDRLNMTH 216 (449)
T ss_pred chhhhhhhHH
Confidence 7666554443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-24 Score=174.94 Aligned_cols=153 Identities=28% Similarity=0.400 Sum_probs=125.4
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHh-ccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIA-KLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++.+....||.|+||.|++..+ +.|+..|||+++... ....++++.|.+... +-+.||||+++|.+..++.-|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4455567899999999999976 569999999998543 355678888888554 4578999999999999999999999
Q ss_pred eccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
.|+ .||+.+... ......+++...-.|......||.||-.. +.|||||+||+|||++..|.+||+|||++-.+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 467665432 23456788888888999999999999874 4699999999999999999999999999877654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
+
T Consensus 221 S 221 (361)
T KOG1006|consen 221 S 221 (361)
T ss_pred H
Confidence 3
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=163.94 Aligned_cols=149 Identities=36% Similarity=0.522 Sum_probs=131.9
Q ss_pred CccccccccCCcccEEEEEecC-CcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 153 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999998765 889999999865444 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++|.+++..... .+++.....++.+++.++.|||+.+ ++|+|++|.||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999998843221 1789999999999999999999986 999999999999999999999999999887654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=188.28 Aligned_cols=149 Identities=25% Similarity=0.307 Sum_probs=106.0
Q ss_pred HhcCCccccccccCCcccEEEEEecC-----CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEE------EE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC------CI 217 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 217 (318)
..++|...+.||+|+||.||+|.+.+ +..||||++...... +....| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999998744 689999987643211 111111 1122222333222211 24
Q ss_pred ecCeeEEEEEeccCCChhhhhhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 021046 218 EQGENILIYEYMPNKSLDVFLFYPKK-----------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280 (318)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 280 (318)
.+...++||||+++++|.+++..... ........+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56688999999999999888753211 001123345678999999999999987 9999999
Q ss_pred CCCEEEcC-CCCceEeecccceeec
Q 021046 281 ASNILLDS-DMNPKISDFGMARIFG 304 (318)
Q Consensus 281 ~~Nill~~-~~~~ki~DfGla~~~~ 304 (318)
|+|||++. ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5799999999998664
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-23 Score=168.18 Aligned_cols=154 Identities=26% Similarity=0.389 Sum_probs=124.4
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (318)
..++.+.+..||.|+.|.|++++.. +|..+|||.+.+... +..++++..+.++..- +.|.||+.+|+|..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3455666778999999999999874 588999999876433 3445677777765554 489999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||.|.- -++.++.. ...++++..+-++...+..||.||-+++ .|+|||+||+|||+|+.|++|++|||++-.+.+
T Consensus 170 MelMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 170 MELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 999853 34444432 3456888888899999999999999865 699999999999999999999999999977765
Q ss_pred Cc
Q 021046 306 DE 307 (318)
Q Consensus 306 ~~ 307 (318)
..
T Consensus 245 Sk 246 (391)
T KOG0983|consen 245 SK 246 (391)
T ss_pred cc
Confidence 43
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=160.13 Aligned_cols=143 Identities=14% Similarity=0.103 Sum_probs=116.7
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHH---------HHHHHHHHhccCCCccceEEEEEEe
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE---------FKNEMMLIAKLQHRHLVRLFGCCIE 218 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~ 218 (318)
...++|...+.+|.|+||.||+... ++..+|||.+.+........ +.+|+..+.++.||+|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999766 57789999997543332222 6899999999999999999988664
Q ss_pred c--------CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 219 Q--------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 219 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
. +..+++|||++|.+|.++.. ++. ....+++.+|..+|..+ ++|||++|+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999977641 222 24568999999999988 99999999999999988
Q ss_pred CceEeecccceeecCC
Q 021046 291 NPKISDFGMARIFGGD 306 (318)
Q Consensus 291 ~~ki~DfGla~~~~~~ 306 (318)
++|+|||..+....+
T Consensus 173 -i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 -LRIIDLSGKRCTAQR 187 (232)
T ss_pred -EEEEECCCcccccch
Confidence 999999998876433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=155.51 Aligned_cols=143 Identities=39% Similarity=0.634 Sum_probs=126.7
Q ss_pred cccCCcccEEEEEecC-CcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChhh
Q 021046 159 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDV 236 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 236 (318)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..+..++|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 889999999864332 35689999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecCC
Q 021046 237 FLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 237 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~~ 306 (318)
++.... ..+++..+..++.++++++.|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 884321 46889999999999999999999987 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=162.48 Aligned_cols=154 Identities=18% Similarity=0.142 Sum_probs=116.7
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEE--ecCCcEEEEEEccCCCCc------------------------CHHHHHH
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLTEFKN 196 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~ 196 (318)
..++......|.+.+.||+|+||.||+|. ..+|+.||+|.++..... ....+..
T Consensus 20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 33344444568888999999999999998 568999999988753210 0123568
Q ss_pred HHHHHhccCCC--ccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021046 197 EMMLIAKLQHR--HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274 (318)
Q Consensus 197 e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 274 (318)
|+..+.++.+. .+++.++. ...++||||+++++|..... ....+.......++.|++.++.|||+.+ .+
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~i 170 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--EL 170 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence 99999999753 34445443 24589999999988866542 1234555667789999999999999875 39
Q ss_pred eecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 275 IHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 275 vH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+||||||+||+++ ++.++|+|||+|...+..
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999999999 889999999999976554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-23 Score=182.41 Aligned_cols=161 Identities=24% Similarity=0.335 Sum_probs=138.2
Q ss_pred HhcCCccccccccCCcccEEEEEecCCc-EEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
...+++.+..||-|+||.|=+....+.. .+|+|.+++. +..+.+....|-.+|...+.|.||+||..|.++...|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3456677778999999999998775433 3788888754 33445567889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+||-|-||.|...| +....++..+...++..+.+|++|||.++ ||.|||||+|.+++.+|-+||.|||+|+.++
T Consensus 498 LmEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999998 45667888888899999999999999988 9999999999999999999999999999997
Q ss_pred CCccccccceeecC
Q 021046 305 GDELQGNTKRIVGT 318 (318)
Q Consensus 305 ~~~~~~~~~~~~Gt 318 (318)
.++ .|-+++||
T Consensus 572 ~g~---KTwTFcGT 582 (732)
T KOG0614|consen 572 SGR---KTWTFCGT 582 (732)
T ss_pred cCC---ceeeecCC
Confidence 655 35567887
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=158.75 Aligned_cols=136 Identities=19% Similarity=0.271 Sum_probs=114.3
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCc--------CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
+.||+|++|.||+|.. .+..+++|........ ....+.+|+.++..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678999976543221 123577899999999999998888888888889999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999887321 12 77889999999999999987 99999999999999 8899999999998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-22 Score=184.71 Aligned_cols=163 Identities=27% Similarity=0.451 Sum_probs=142.1
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.+.++|+....+|.|+||.||+++. .+++..|+|.++-.......-..+|+.+++..+||||+.++|-+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3567899999999999999999986 468899999998777777778889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+.+|+|.+.-+ -..++++.+..++.+...+|++|||+.+ -+|||||=.|||+++.+.+|++|||.+..++.-
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999988763 3567888899999999999999999988 899999999999999999999999999877643
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
-. ....++||
T Consensus 166 i~--KrksfiGt 175 (829)
T KOG0576|consen 166 IA--KRKSFIGT 175 (829)
T ss_pred hh--hhhcccCC
Confidence 22 23345565
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-22 Score=165.71 Aligned_cols=147 Identities=25% Similarity=0.331 Sum_probs=119.8
Q ss_pred HhcCCccc-cccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEe----cCe
Q 021046 149 ATENFSTQ-CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE----QGE 221 (318)
Q Consensus 149 ~~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 221 (318)
.+++|.+. ++||-|--|+|..+.. .+++.+|+|++... ....+|+++--.. .|||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667544 5799999999999965 56889999998642 2346677765444 59999999999864 356
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeecc
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFG 298 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfG 298 (318)
+++|||.|+||.|...+.. +....+++.++..|+.||+.|+.|||+.. |.||||||+|+|.+. +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999877743 23557999999999999999999999987 999999999999865 4469999999
Q ss_pred cceeec
Q 021046 299 MARIFG 304 (318)
Q Consensus 299 la~~~~ 304 (318)
+|+.-.
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=155.74 Aligned_cols=152 Identities=23% Similarity=0.390 Sum_probs=127.1
Q ss_pred HHhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC-CccceEEEEEEecCeeEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 225 (318)
.....|.++++||.|+||.+|.|. ..+|..||||.-+..... ..+.-|..+...|++ ..|..+..+..+.+...+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 346789999999999999999996 467999999987654322 356778889888976 7888888999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CCceEeeccccee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARI 302 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~ki~DfGla~~ 302 (318)
||.+ +-+|.+.... -.+.++.++.+-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.++|||||+.
T Consensus 90 MdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 9988 6688776643 2456888999999999999999999988 9999999999999654 4589999999998
Q ss_pred ecCCc
Q 021046 303 FGGDE 307 (318)
Q Consensus 303 ~~~~~ 307 (318)
+-+..
T Consensus 164 y~d~~ 168 (341)
T KOG1163|consen 164 YRDIR 168 (341)
T ss_pred hcccc
Confidence 86543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=159.36 Aligned_cols=138 Identities=33% Similarity=0.461 Sum_probs=123.7
Q ss_pred CcccEEEEEec-CCcEEEEEEccCCCCcC-HHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChhhhhhc
Q 021046 163 GFGPVYKGRLL-NGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY 240 (318)
Q Consensus 163 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 240 (318)
+||.||+|... +++.+++|++....... .+.+.+|+..+++++|+|++++++++..+...++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48899999998655444 68899999999999999999999999999999999999999999998843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 241 PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
. ..+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 2 23889999999999999999999987 999999999999999999999999999887653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=155.43 Aligned_cols=141 Identities=19% Similarity=0.175 Sum_probs=110.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCc----------------------CHHHHHHHHHHHhccCCC
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----------------------GLTEFKNEMMLIAKLQHR 207 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~e~~~l~~l~h~ 207 (318)
...|...+.||+|+||.||++...+|+.||||++...... ....+..|..++..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3347778899999999999999888999999986542210 011356788888888887
Q ss_pred --ccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 208 --HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 208 --niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
.+++.++ ....++||||+++++|...... .....++.+++.++.++|+.+ ++||||||+||+
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil 157 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL 157 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence 4455544 2456899999999998765410 234578899999999999977 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++.++|+|||+|..+..+
T Consensus 158 l~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred EcCCCcEEEEECCccccCCCc
Confidence 999999999999999776654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=178.35 Aligned_cols=140 Identities=19% Similarity=0.285 Sum_probs=113.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEE-ccCC-CC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQ-SG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~-l~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
...|...+.||+|+||.||+|.+.+.. +++|+ ..+. .. ...+++.+|+.++..++|++++....++...+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999875544 33343 2221 11 123468899999999999999998888888888
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+||++ +++.++|+|||+|+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988872 35678999999999999987 9999999999999 67899999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
....
T Consensus 476 ~~~~ 479 (535)
T PRK09605 476 YSDL 479 (535)
T ss_pred cCCc
Confidence 7543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=150.81 Aligned_cols=133 Identities=20% Similarity=0.184 Sum_probs=105.8
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccCCCCcC----HHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEec
Q 021046 155 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG----LTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
....|++|+||+||.+.. .+.+++.+.+.....-. ...+.+|+.+|.+|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999998766 56778877776533211 125789999999995 5889999886 4569999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-k~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+|.+|...+. . . ...++.|++.+|.++|.++ |+|||| ||.|||++.++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~----~-----~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP----R-----G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh----h-----h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9998864331 0 1 1357789999999999988 999999 79999999999999999999986543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=153.72 Aligned_cols=132 Identities=20% Similarity=0.318 Sum_probs=108.1
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccCCCC-c-------CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-Q-------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.||+|+||.||+|.+ ++..+++|....... . ...++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 567899998654221 1 1245778999999999988776666667777889999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++++|.+.+... . . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~---~----~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG---N----D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc---H----H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998876321 0 0 78999999999999987 99999999999999 8999999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-21 Score=178.15 Aligned_cols=149 Identities=31% Similarity=0.471 Sum_probs=118.4
Q ss_pred CccccccccCCccc-EEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEecc
Q 021046 153 FSTQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 153 ~~~~~~lg~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
|...+.+|.|+-|+ ||+|.. +|++||||++-. ...+-..+|+..|..- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44557899999886 799988 678999999864 2334567899988877 59999999998888899999999995
Q ss_pred CCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---C--CCceEeecccceeec
Q 021046 231 NKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---D--MNPKISDFGMARIFG 304 (318)
Q Consensus 231 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~--~~~ki~DfGla~~~~ 304 (318)
.+|.+++... .......-.....+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5899988553 11111111344677899999999999976 999999999999976 3 468999999999998
Q ss_pred CCccc
Q 021046 305 GDELQ 309 (318)
Q Consensus 305 ~~~~~ 309 (318)
.+...
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 77543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=166.28 Aligned_cols=159 Identities=25% Similarity=0.383 Sum_probs=133.4
Q ss_pred HHHHHHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEE
Q 021046 144 ASVSAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216 (318)
Q Consensus 144 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 216 (318)
.++.....++.....+.+|.||.||+|.+. +.+.|-+|.++.. +..+...++.|..++..+.|||+.+..+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344455667888888999999999999653 3456778877654 445677899999999999999999999999
Q ss_pred Eec-CeeEEEEEeccCCChhhhhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 217 IEQ-GENILIYEYMPNKSLDVFLF-----YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 217 ~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
.++ +..+.+|.++.-|+|..||. .....+.+.-.+...++.|++.||+|||.++ +||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 876 45688999999999999997 3334556777888899999999999999987 99999999999999999
Q ss_pred CceEeecccceeecC
Q 021046 291 NPKISDFGMARIFGG 305 (318)
Q Consensus 291 ~~ki~DfGla~~~~~ 305 (318)
++||+|=.|+|-+-+
T Consensus 434 qVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFP 448 (563)
T ss_pred eEEeccchhccccCc
Confidence 999999999986643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=157.93 Aligned_cols=151 Identities=25% Similarity=0.382 Sum_probs=127.0
Q ss_pred HhcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 226 (318)
..-+|.++++||+|.||.++.|+ +-++++||||.-...+. .-.+..|.+..+.|. .++|...+-+..++.+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34589999999999999999996 56899999997765432 345677888887775 699999998888888999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-----CceEeecccce
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-----NPKISDFGMAR 301 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-----~~ki~DfGla~ 301 (318)
|.+ |-||.++... -.+.++.++...+|.|+..-++|+|++. +|.|||||+|+||...+ .+.|.|||||+
T Consensus 104 dLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 988 6688776632 3677999999999999999999999988 99999999999997654 38999999999
Q ss_pred eecCCc
Q 021046 302 IFGGDE 307 (318)
Q Consensus 302 ~~~~~~ 307 (318)
.+.+.+
T Consensus 178 ~YrDp~ 183 (449)
T KOG1165|consen 178 EYRDPK 183 (449)
T ss_pred hhcCcc
Confidence 986653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=155.24 Aligned_cols=148 Identities=22% Similarity=0.439 Sum_probs=120.9
Q ss_pred HhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEE-EEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFG-CCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv 225 (318)
..+.|.+.+.+|+|.||.+-+++++. ...+++|-+.+. .....+|.+|..----| .|.||+.-++ .|...+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34678888999999999999998754 567888887653 34567899998754444 4899998665 46777888999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE-cC-CCCceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DS-DMNPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill-~~-~~~~ki~DfGla~~~ 303 (318)
+||+|.|+|..-+ ....+.+.....++.|+++|+.|+|++. +||||||.+|||| +. ...+||+|||+++..
T Consensus 101 qE~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999997766 3456778888999999999999999988 9999999999998 33 347999999999765
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
+
T Consensus 174 g 174 (378)
T KOG1345|consen 174 G 174 (378)
T ss_pred C
Confidence 4
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=160.73 Aligned_cols=145 Identities=26% Similarity=0.363 Sum_probs=120.8
Q ss_pred CCccccccccCCcccEEEEEecCC--cEEEEEEccCCCCcCHHHHHHHHHHHhccCC----CccceEEEEE-EecCeeEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH----RHLVRLFGCC-IEQGENIL 224 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 224 (318)
+|.+.++||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987553 4788887765433333367888888888863 6899999999 47778899
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-----CCceEeeccc
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGM 299 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-----~~~ki~DfGl 299 (318)
||+.+ +.+|.++..... ...++..+...|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 778888664333 578999999999999999999999988 9999999999999865 4599999999
Q ss_pred ce
Q 021046 300 AR 301 (318)
Q Consensus 300 a~ 301 (318)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 98
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=165.72 Aligned_cols=146 Identities=25% Similarity=0.328 Sum_probs=121.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++.|.....+|.|+|+.|-.+.. .+++..+||++.+... +-.+|+.++... +|||++++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56777888899999999998865 5678899999976522 234566555444 79999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE-cCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill-~~~~~~ki~DfGla~~~~~~ 306 (318)
++.+|-+.+.+... .... ..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.+.++
T Consensus 397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999876666432 2222 677789999999999999988 9999999999999 69999999999999988765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-19 Score=156.99 Aligned_cols=135 Identities=27% Similarity=0.357 Sum_probs=111.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-----C---CccceEEEEEEec-
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----H---RHLVRLFGCCIEQ- 219 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~- 219 (318)
..+|.+.++||.|.|++||++.. .+.+.||+|+.+.. ....+....|+.+|++++ | ..||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46888999999999999999976 45678999998753 344556789999999883 3 3599999999864
Q ss_pred ---CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC
Q 021046 220 ---GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 289 (318)
Q Consensus 220 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~ 289 (318)
.+.+||+|++ |-+|..++.+. ..+.++...+..|++||+.||.|||.++ +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 4789999998 44666666433 4667899999999999999999999977 69999999999999654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-19 Score=156.79 Aligned_cols=149 Identities=25% Similarity=0.473 Sum_probs=127.6
Q ss_pred HHHHhcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecC
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG 220 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 220 (318)
+....+.|...++||+|.|+.||++.+. ..+.||+|.+...+ ......+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678889999999999999999753 36789999987643 3357899999999995 899999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeeccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM 299 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~DfGl 299 (318)
...+|+||++.-...++. ..++......++..+..||.++|.++ ||||||||.|+|.+.. +.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999888877 24567888899999999999999998 9999999999999764 5689999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
|-..+.
T Consensus 180 A~~~d~ 185 (418)
T KOG1167|consen 180 AQRYDG 185 (418)
T ss_pred HHHHHh
Confidence 975443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-19 Score=144.13 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=99.8
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCc--CHHHH----------------------HHHHHHHhccCCCc--c
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLTEF----------------------KNEMMLIAKLQHRH--L 209 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~----------------------~~e~~~l~~l~h~n--i 209 (318)
.+.||+|+||.||+|...+++.||||.+...... ....+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988753221 11111 34555555554432 4
Q ss_pred ceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcC
Q 021046 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS 288 (318)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~ 288 (318)
.+.+++ ...++||||++++.+....... .... .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 445443 3468999999996543221110 0011 5567899999999999998 66 99999999999999
Q ss_pred CCCceEeecccceeecCC
Q 021046 289 DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 289 ~~~~ki~DfGla~~~~~~ 306 (318)
++.++|+|||.|......
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 999999999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-19 Score=153.23 Aligned_cols=154 Identities=23% Similarity=0.242 Sum_probs=126.7
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC--Cc----cceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RH----LVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~~~ 221 (318)
.+++|.+...+|+|+||.|-++... .+..||||++++. ....+..+-|+.+|.++.+ |+ +|++.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999763 4688999999864 3444567889999999942 33 7888899999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------------
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS------------- 288 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~------------- 288 (318)
.++|+|.+ |-|+.+++.. ....+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 4478888833 24567889999999999999999999987 999999999999832
Q ss_pred -------CCCceEeecccceeecCCcc
Q 021046 289 -------DMNPKISDFGMARIFGGDEL 308 (318)
Q Consensus 289 -------~~~~ki~DfGla~~~~~~~~ 308 (318)
+..+||+|||-|..-..+.+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs 267 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHS 267 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcc
Confidence 23489999999997765553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=135.64 Aligned_cols=136 Identities=22% Similarity=0.228 Sum_probs=115.6
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC--CccceEEEEEEecCeeEEEEEeccCCC
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| +++++++++...++..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999855 7899998865433 5678999999999977 589999998888888999999999887
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 234 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+..+ +......++.++++++++||.....+++|+|++|+||++++.+.+++.|||+++...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 7543 456677889999999999998654569999999999999999999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-19 Score=149.18 Aligned_cols=147 Identities=30% Similarity=0.405 Sum_probs=119.2
Q ss_pred hcCCccccccccCCcccEEEEE-ecCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
..+|.....+|.|.- .|-.+- .-.+++||+|++... .....++..+|..++..++|+|+++++.+++-+.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777778888877 555553 245789999987643 2344567889999999999999999999998653
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
+.|+|||||. ++|...+. -.++-.+..+|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 5699999995 47777764 23566788899999999999999988 999999999999999999999999999
Q ss_pred eeecCC
Q 021046 301 RIFGGD 306 (318)
Q Consensus 301 ~~~~~~ 306 (318)
+.-+.+
T Consensus 166 r~e~~~ 171 (369)
T KOG0665|consen 166 RTEDTD 171 (369)
T ss_pred cccCcc
Confidence 865444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=140.93 Aligned_cols=136 Identities=23% Similarity=0.243 Sum_probs=105.8
Q ss_pred cccc-cCCcccEEEEEecCCcEEEEEEccCCC-------------CcCHHHHHHHHHHHhccCCCcc--ceEEEEEEecC
Q 021046 157 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLTEFKNEMMLIAKLQHRHL--VRLFGCCIEQG 220 (318)
Q Consensus 157 ~~lg-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~ 220 (318)
..|| .|+.|+||..... +..++||++.... ......+.+|+.++..|+|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999874 6788999875311 1223567889999999998885 67777755432
Q ss_pred e----eEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 221 E----NILIYEYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 221 ~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
. .++||||+++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688887732 234433 3578999999999988 9999999999999999999999
Q ss_pred ecccceeec
Q 021046 296 DFGMARIFG 304 (318)
Q Consensus 296 DfGla~~~~ 304 (318)
|||.+....
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=154.10 Aligned_cols=158 Identities=25% Similarity=0.313 Sum_probs=130.6
Q ss_pred HHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccC------CCccceEEEEEEe
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ------HRHLVRLFGCCIE 218 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~ 218 (318)
.+....+|.+.-..|+|-|++|.+|... .|+.||||++.+.. ...+.=+.|+.+|.+|+ --|+++|+..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3445668888889999999999999763 47899999998743 23344478999999995 3589999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeec
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDF 297 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~Df 297 (318)
.+++|||+|-+. -+|.+.|..-..+..|....+..++.|+.-||..|-..+ |+|.||||+||||++.. .+|||||
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 999999999874 467777755445667888899999999999999999877 99999999999998865 5899999
Q ss_pred ccceeecCCcc
Q 021046 298 GMARIFGGDEL 308 (318)
Q Consensus 298 Gla~~~~~~~~ 308 (318)
|-|...+.++.
T Consensus 582 GSA~~~~enei 592 (752)
T KOG0670|consen 582 GSASFASENEI 592 (752)
T ss_pred ccccccccccc
Confidence 99988876654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.4e-17 Score=142.10 Aligned_cols=150 Identities=35% Similarity=0.534 Sum_probs=127.3
Q ss_pred CccccccccCCcccEEEEEecCCcEEEEEEccCCCCc---CHHHHHHHHHHHhccCCC-ccceEEEEEEecCeeEEEEEe
Q 021046 153 FSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHR-HLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 153 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 228 (318)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 78899988765333 367899999999999988 799999999777778999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceeecCCc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGDE 307 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~~~~~ 307 (318)
+.++++..++........+.......+..|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966532211136888999999999999999999988 99999999999999998 79999999998766543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.5e-17 Score=158.97 Aligned_cols=147 Identities=24% Similarity=0.335 Sum_probs=117.8
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC---CCccceEEEEEEecCeeEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 224 (318)
...+.|.+.+.||+|+||+||+|...+|+.||+|.-+..... +|.--..++.+|+ -+-|..+..+..-.+.-+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 445678888999999999999999888999999987654332 2333334444554 2445556666667788899
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------CCCceEeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------DMNPKISDF 297 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-------~~~~ki~Df 297 (318)
|+||.+-|+|.+++. ..+..+|.....++.|++.-++.||..+ |||+||||+|+||.. ...++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999883 6678999999999999999999999987 999999999999942 345899999
Q ss_pred ccceee
Q 021046 298 GMARIF 303 (318)
Q Consensus 298 Gla~~~ 303 (318)
|-|--+
T Consensus 846 G~siDm 851 (974)
T KOG1166|consen 846 GRSIDM 851 (974)
T ss_pred ccceee
Confidence 988544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=147.20 Aligned_cols=142 Identities=22% Similarity=0.247 Sum_probs=99.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcCH----------------------------------------HHHHH
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL----------------------------------------TEFKN 196 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 196 (318)
+.||.|++|+||+|++.+|+.||||+.+....... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999998865321100 02444
Q ss_pred HHHHHhccC-----CCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 021046 197 EMMLIAKLQ-----HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ-GLLYLHQYS 270 (318)
Q Consensus 197 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~~ 270 (318)
|+..+.++. ++++.-..-+....+..+|||||++|++|.++...... .. .+..++.+++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 555555442 33332111122234567999999999999887643211 11 23456666665 467888876
Q ss_pred CCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 271 ~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++|+|++|.||+++.++++++.|||++..+.++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=116.24 Aligned_cols=132 Identities=23% Similarity=0.170 Sum_probs=98.7
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccc-eEEEEEEecCeeEEEEEeccCCCh
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
.+.++.|.++.||+++.. +..+++|....... ....+..|+..+..+.+.+++ +++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999875 67899998765432 223567899999988765544 455443 3446899999999887
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
.... .....++.+++++|..||... ...++|+|++|.||+++ ++.+++.|||.|..-
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5421 011245678999999999876 23469999999999998 678999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-15 Score=138.02 Aligned_cols=145 Identities=18% Similarity=0.228 Sum_probs=94.3
Q ss_pred cCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCc--------------------------C--------H----
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ--------------------------G--------L---- 191 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--------------------------~--------~---- 191 (318)
.+|+. +.||.|++|+||+|++++ |+.||||+.++.... . .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999987 999999998753110 0 0
Q ss_pred --HHHHHHHHHHhccC----CCccceEEEEEEe-cCeeEEEEEeccCCChhhhhhcCCCC---CCCCHHHHHHHHHHHHH
Q 021046 192 --TEFKNEMMLIAKLQ----HRHLVRLFGCCIE-QGENILIYEYMPNKSLDVFLFYPKKK---RLLGWQARVRIIEGIAQ 261 (318)
Q Consensus 192 --~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~i~~ 261 (318)
-+|.+|+..+.+++ +.+.+.+-.++.+ .+..+|||||++|+.+.++......+ ..+.......++.|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 12344444444442 3333333333322 45678999999999997753211111 1222222333333333
Q ss_pred HHHHHHhcCCCCeeecCCCCCCEEEcCCC----CceEeecccceeecCC
Q 021046 262 GLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGMARIFGGD 306 (318)
Q Consensus 262 ~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~ki~DfGla~~~~~~ 306 (318)
..+ ++|+|++|.||+++.++ ++++.|||++..++++
T Consensus 278 ------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 344 99999999999999988 9999999999988654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-14 Score=138.08 Aligned_cols=145 Identities=23% Similarity=0.315 Sum_probs=111.1
Q ss_pred ccccccccCCcccEEEEEec-CCcEEEEEEcc----CC-CCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQ-SGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~----~~-~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
...+.+|.|++|.|+..... .....+.|... .. ... ....+..|+.+-..++|||++..+....+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35578999999988777542 23334444332 11 111 1122566777888899999988887777776666669
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++ +|..++.. ...+...++..+++|+..|+.|+|+.+ |.|||+||+|++++.++.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99887732 235777888899999999999999998 99999999999999999999999999987753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.8e-14 Score=141.73 Aligned_cols=94 Identities=19% Similarity=0.256 Sum_probs=73.7
Q ss_pred ccCC-CccceEEEEE-------EecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021046 203 KLQH-RHLVRLFGCC-------IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274 (318)
Q Consensus 203 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 274 (318)
.++| +||.+++++| ...+..++++||+ +++|.+++.. ....+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3456 6888888887 3334567888987 5699999853 2456899999999999999999999987 9
Q ss_pred eecCCCCCCEEEcC-------------------CCCceEeeccccee
Q 021046 275 IHRDLKASNILLDS-------------------DMNPKISDFGMARI 302 (318)
Q Consensus 275 vH~Dlk~~Nill~~-------------------~~~~ki~DfGla~~ 302 (318)
+||||||+||||+. ++.+||+|||+++.
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 99999999999965 44566666666654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.3e-12 Score=108.29 Aligned_cols=142 Identities=17% Similarity=0.258 Sum_probs=110.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCC--CccceEEEEEEecC---eeEEEEEecc
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQG---ENILIYEYMP 230 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 230 (318)
+.|+.|.++.||+++..+|..+++|....... .....+..|+.++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778899998765332 235678999999999976 45677887766542 5689999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 270 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------- 270 (318)
+.++...+. ...++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 998876542 134677777788888888888888521
Q ss_pred -------------CCCeeecCCCCCCEEEcC--CCCceEeeccccee
Q 021046 271 -------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARI 302 (318)
Q Consensus 271 -------------~~~ivH~Dlk~~Nill~~--~~~~ki~DfGla~~ 302 (318)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.2e-12 Score=103.06 Aligned_cols=139 Identities=14% Similarity=0.100 Sum_probs=100.1
Q ss_pred cccccCCcccEEEEEecC-------CcEEEEEEccCC-------------CC---------cCHHHHH----HHHHHHhc
Q 021046 157 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQ-------------SG---------QGLTEFK----NEMMLIAK 203 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~l~~~-------------~~---------~~~~~~~----~e~~~l~~ 203 (318)
..||.|.-+.||.|...+ +..+|||..+.. +. .....+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 478999976421 00 0122333 79999998
Q ss_pred cCC--CccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCC
Q 021046 204 LQH--RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL-HQYSRLRIIHRDLK 280 (318)
Q Consensus 204 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlk 280 (318)
+.. -++++++++ ...++||||+.++.+..... ....++......+..+++.+|..| |..+ +||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 567777764 56789999998754422111 112344456667889999999999 7666 9999999
Q ss_pred CCCEEEcCCCCceEeecccceeecCC
Q 021046 281 ASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 281 ~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+.||+++ ++.+.|+|||-|......
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCCC
Confidence 9999996 578999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-13 Score=91.36 Aligned_cols=40 Identities=60% Similarity=1.419 Sum_probs=35.2
Q ss_pred CChhHHHHHhhccCCccceecccccCCCCceEEeccccccc
Q 021046 1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDL 41 (318)
Q Consensus 1 ~~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~C~~w~~~l~~~ 41 (318)
+++++|++.||+||||+||+|.+.. ++.+|++|+++|+|+
T Consensus 27 ~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 27 VSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 4689999999999999999997654 668999999999875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.1e-12 Score=100.50 Aligned_cols=136 Identities=21% Similarity=0.283 Sum_probs=103.3
Q ss_pred cccccCCcccEEEEEecCCcEEEEE-EccCCCC-c------CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQSG-Q------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK-~l~~~~~-~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..+++|+-+.+|.+.+.+ .++.+| ++++.-. . ...+-.+|+.++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997744 345555 3433211 1 123467899999999877777666677888888999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+.+-...+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~E 145 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVE 145 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHH
Confidence 9999998888322 2456777888889999988 99999999999996655 9999999999655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-13 Score=126.50 Aligned_cols=145 Identities=26% Similarity=0.340 Sum_probs=117.5
Q ss_pred ccccCCcccEEEEE----ecCCcEEEEEEccCCCCc--CHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEecc
Q 021046 158 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.+|+|.||.|++.. ...+..+|.|.+++.... .......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999874 234667888877654221 1124566778888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCcc
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 308 (318)
+|+|...+ .....+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-..+.
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99987665 34556667777777778999999999887 99999999999999999999999999998765543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-13 Score=132.45 Aligned_cols=142 Identities=21% Similarity=0.239 Sum_probs=116.1
Q ss_pred CCccccccccCCcccEEEEEecCCcEEEEEEccCCC-CcCHHHHHHHHHH--HhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-GQGLTEFKNEMML--IAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++...+.||.+.|=+|.+|++++|. |+||++-+.. ....+.|.++++- ...++|||.+.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998887 8899887654 4455666555443 4556899999998877777777888888
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
+.+ +|.+.+ ..+..+...+...|+.|++.||.-+|..+ |.|||||.+||||++..-+.|+||.--|
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 865 566666 34556777888899999999999999988 9999999999999999999999998654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-11 Score=95.43 Aligned_cols=150 Identities=24% Similarity=0.288 Sum_probs=109.0
Q ss_pred cccccccCCcccEEEEEecCCcEEEEE-EccCCCC-------cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 155 TQCKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQSG-------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~~~~~vavK-~l~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
....+-||+-+.|+++.+. |+...|| ++.+.-. -...+.++|++.+.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3467889999999999884 5665666 4443211 12346788999999987666666666677778889999
Q ss_pred EeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC---ceEeeccccee
Q 021046 227 EYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARI 302 (318)
Q Consensus 227 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~ki~DfGla~~ 302 (318)
||+++ -++.+++...-.....+ .....++.+|-+.+.-||..+ |+|+||..+||++.+++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46777765432222222 223578889999999999988 999999999999976554 58999999976
Q ss_pred ecCCccc
Q 021046 303 FGGDELQ 309 (318)
Q Consensus 303 ~~~~~~~ 309 (318)
-..++.+
T Consensus 166 s~~~EDK 172 (229)
T KOG3087|consen 166 SRLPEDK 172 (229)
T ss_pred ccCcccc
Confidence 5544433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.8e-12 Score=108.31 Aligned_cols=151 Identities=23% Similarity=0.319 Sum_probs=98.1
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCC----------CccceEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH----------RHLVRLFGCC 216 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~ 216 (318)
..+...+.||.|+|+.||.+++. +++++|+|.+.-. .....+.+++|......+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35566789999999999999885 4899999977532 23345677777765555322 2233223322
Q ss_pred Eec--------C---------eeEEEEEeccCCChhhhhh---cCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021046 217 IEQ--------G---------ENILIYEYMPNKSLDVFLF---YPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275 (318)
Q Consensus 217 ~~~--------~---------~~~lv~e~~~~g~L~~~l~---~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 275 (318)
... . +.+++|+-+ .+||..++. ... ....+....++.+..|+.+.+++||+.+ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 211 1 225566665 567776643 111 1234555667788899999999999998 99
Q ss_pred ecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 276 HRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 276 H~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+||+|+|++++.+|.++|+||+-....+.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 999999999999999999999998776543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-12 Score=113.08 Aligned_cols=89 Identities=28% Similarity=0.484 Sum_probs=68.4
Q ss_pred CCCccceEEEEEEec---------------------------CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 021046 205 QHRHLVRLFGCCIEQ---------------------------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 257 (318)
Q Consensus 205 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 257 (318)
+|||||++.++|.+. ..+|+||.-.+ -+|..++. ....+.....-|..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 599999999988542 23467776543 36777773 34455667777899
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCCEEE--cCCC--CceEeecccce
Q 021046 258 GIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDM--NPKISDFGMAR 301 (318)
Q Consensus 258 ~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~--~~ki~DfGla~ 301 (318)
|+++|+.|||.++ +.|||+|++|||+ |++. .+.|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999988 9999999999998 4444 36899999663
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-12 Score=107.54 Aligned_cols=138 Identities=24% Similarity=0.435 Sum_probs=112.6
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
...-+|.+...|..|+|++..+ .+++|++.-. .....++|..|.-.|+...||||+.++|.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445788999999999999654 4555766532 233346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee-cCCCCCCEEEcCCCCceEe
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH-RDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH-~Dlk~~Nill~~~~~~ki~ 295 (318)
|+|...|+.. .....+-.++.+++.+||+||+|||+.. +++- --|.+..+++|++.+++|+
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence 9999998654 3445677888999999999999999976 3443 4578899999999998875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-11 Score=113.03 Aligned_cols=100 Identities=32% Similarity=0.489 Sum_probs=90.4
Q ss_pred HhccCCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 021046 201 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280 (318)
Q Consensus 201 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 280 (318)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+.. ....++|.....+.++++.||.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999854 4567899999999999999999999753 23999999
Q ss_pred CCCEEEcCCCCceEeecccceeec
Q 021046 281 ASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 281 ~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++|+++|..+.+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-11 Score=84.37 Aligned_cols=51 Identities=25% Similarity=0.491 Sum_probs=41.5
Q ss_pred CChhHHHHHhhc---cCCccceecccccCCCCceEEecccc-ccccCcccCCCCceEEEe
Q 021046 1 MNLNQCQAKCLK---NCSCRAYANSKLTGGGSGCLMWFGDL-IDLRKPISNFTGQSVYIR 56 (318)
Q Consensus 1 ~~~~~C~~~Cl~---~C~C~a~~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~~~~~~~ 56 (318)
.+.+||++.|++ ||||+||+|.+ .+.+|.+|++++ +|++... ..|.++|+|
T Consensus 25 ~s~~eC~~~Cl~~~~nCsC~Aya~~~---~~~gC~~W~~~l~~d~~~~~--~~g~~Ly~r 79 (80)
T cd00129 25 NTADECANRCEKNGLPFSCKAFVFAK---ARKQCLWFPFNSMSGVRKEF--SHGFDLYEN 79 (80)
T ss_pred cCHHHHHHHHhcCCCCCCceeeeccC---CCCCeEEecCcchhhHHhcc--CCCceeEeE
Confidence 368999999999 99999999964 235899999999 8887642 237788886
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.2e-10 Score=93.16 Aligned_cols=127 Identities=25% Similarity=0.315 Sum_probs=82.8
Q ss_pred cEEEEEecCCcEEEEEEccCCC-------------C--------cC-----HHHHHHHHHHHhccCCC--ccceEEEEEE
Q 021046 166 PVYKGRLLNGQEVAVKRLSNQS-------------G--------QG-----LTEFKNEMMLIAKLQHR--HLVRLFGCCI 217 (318)
Q Consensus 166 ~Vy~~~~~~~~~vavK~l~~~~-------------~--------~~-----~~~~~~e~~~l~~l~h~--niv~l~~~~~ 217 (318)
.||.|...+|..+|||..+... . .. .....+|...|.++..- ++++++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999765310 0 01 12356899999999765 56677654
Q ss_pred ecCeeEEEEEecc--CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 218 EQGENILIYEYMP--NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 218 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
+...+||||++ +..+..+.... ++......++.+++..+..+ |..+ |+|+||.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 25589999999 55554433111 11234456777788866654 6665 9999999999999887 9999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||.|.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.2e-09 Score=92.45 Aligned_cols=140 Identities=17% Similarity=0.094 Sum_probs=99.2
Q ss_pred cccCCcccEEEEEecCCcEEEEEEccCCCC-----------cCHHHHHHHHHHHhccCCCc--cceEEEEEEe-----cC
Q 021046 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-----------QGLTEFKNEMMLIAKLQHRH--LVRLFGCCIE-----QG 220 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~~ 220 (318)
+-......|++.++ +|+.+.||+...... .....+.+|...+.++...+ .++++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667666 577899997753221 11124788999998885433 4455666543 23
Q ss_pred eeEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------CCCc
Q 021046 221 ENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------DMNP 292 (318)
Q Consensus 221 ~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-------~~~~ 292 (318)
..++|||++++. +|.+++..-. ....+......++.+++..+.-||..+ |+|+|+++.|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 468999999986 7888873211 233455677789999999999999998 999999999999975 4679
Q ss_pred eEeecccceee
Q 021046 293 KISDFGMARIF 303 (318)
Q Consensus 293 ki~DfGla~~~ 303 (318)
.++||+.++..
T Consensus 185 ~LIDl~r~~~~ 195 (268)
T PRK15123 185 SVIDLHRAQIR 195 (268)
T ss_pred EEEECCccccc
Confidence 99999999653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-11 Score=116.27 Aligned_cols=155 Identities=23% Similarity=0.311 Sum_probs=119.2
Q ss_pred cCCccccccccCCcccEEEEEecC--CcEEEEEEccCCC--CcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (318)
..|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999999886533 3456666665432 222334445666666666 99999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCEEEcCCC-CceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~ 303 (318)
.||..++++...+. .......+......++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999877663 112224455667788999999999999 766 99999999999999999 9999999999887
Q ss_pred cC-Cccc
Q 021046 304 GG-DELQ 309 (318)
Q Consensus 304 ~~-~~~~ 309 (318)
.. ++..
T Consensus 176 ~~~~g~~ 182 (601)
T KOG0590|consen 176 RNKNGAE 182 (601)
T ss_pred cccCCcc
Confidence 66 4433
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.8e-10 Score=80.44 Aligned_cols=52 Identities=44% Similarity=0.986 Sum_probs=41.9
Q ss_pred ChhHHHHHhhccCCccceecccccCCCCceEEeccccccccCcccCCCCceEEEeec
Q 021046 2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58 (318)
Q Consensus 2 ~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~C~~w~~~l~~~~~~~~~~~~~~~~~~~~ 58 (318)
+.++|++.|++||+|+||+|.+ ++.+|.+|.+++.+.+.+. ..+...|++++
T Consensus 33 s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~--~~~~~~yiKv~ 84 (84)
T cd01098 33 SLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLS--SGGGTLYLRLA 84 (84)
T ss_pred CHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeec--CCCcEEEEEeC
Confidence 6789999999999999999874 4568999999998876642 22567888864
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=96.99 Aligned_cols=140 Identities=20% Similarity=0.293 Sum_probs=112.4
Q ss_pred ccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCeeEEEEEeccC-CChhhhh
Q 021046 165 GPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIYEYMPN-KSLDVFL 238 (318)
Q Consensus 165 g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~l 238 (318)
.+.|++.. .+|..+++|++.....+.......-++.++++.|+|+|++..++.. +..+++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788864 5789999999954433333334556788999999999999999873 3567999999986 5665544
Q ss_pred hcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 239 FYP------------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 239 ~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+.. ..+...++...|.++.|+..||.++|+.| +.-+-|.|++|+++.+.+++|+..|+..++..|
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 22345778999999999999999999998 888999999999999999999999999998877
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.8e-09 Score=98.29 Aligned_cols=123 Identities=16% Similarity=0.214 Sum_probs=98.8
Q ss_pred ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHH
Q 021046 172 LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 251 (318)
Q Consensus 172 ~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 251 (318)
..++.+|.|...+.......+...+-+..|+.++||||++++..+...+..|+|+|-+.. |..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH------hHHHH
Confidence 346788999888776553445567888899999999999999999999999999998743 4444421 22344
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 252 ~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
...-+.||+.||.|||+.+ .++|++|..+.|+|+..|..||++|-++....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 5556789999999999766 59999999999999999999999999885443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-08 Score=85.56 Aligned_cols=150 Identities=19% Similarity=0.186 Sum_probs=100.2
Q ss_pred ccHHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCC--------------------CCc--CHHHHHHHH
Q 021046 141 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--------------------SGQ--GLTEFKNEM 198 (318)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~--------------------~~~--~~~~~~~e~ 198 (318)
..+..+.....=..++.+||-|.-+.||.|..++|.++|||.=+.. +.. ......+|.
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 3344433333334566899999999999999999999999943211 000 122457888
Q ss_pred HHHhccCCC--ccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021046 199 MLIAKLQHR--HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276 (318)
Q Consensus 199 ~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 276 (318)
..|.+|.-. .+++.+++ +...+||||+++-.|...-. +....-.++..|++-+.-+-..| +||
T Consensus 161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVH 225 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVH 225 (304)
T ss_pred HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccc
Confidence 899888655 67766654 56789999999876643220 11122223333444333333444 999
Q ss_pred cCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 277 RDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 277 ~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+|+.+-||+++++|.+.++||-=+...+.
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccCCC
Confidence 99999999999999999999987765543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.1e-09 Score=95.88 Aligned_cols=143 Identities=16% Similarity=0.169 Sum_probs=92.6
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCc--------------------------CH----H----------HHHH
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------GL----T----------EFKN 196 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~----~----------~~~~ 196 (318)
+.|+.++-|+||+|++++|+.||||+.++.-.. .. + ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 589999999999999999999999988653111 00 1 1223
Q ss_pred HHHHHhcc-----CCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 021046 197 EMMLIAKL-----QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271 (318)
Q Consensus 197 e~~~l~~l-----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 271 (318)
|...+.++ +.|++.-..=++.-.+...|+|||++|-.+.+...... ..++.+.......++.--.-+- .+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~~--dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLLR--DG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHHh--cC-
Confidence 33333333 13333222223334567899999999999988754333 3344332222222222112222 24
Q ss_pred CCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 272 ~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+.|.|..|-||+++.++.+-+.|||+...+++.
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.1e-08 Score=83.44 Aligned_cols=109 Identities=24% Similarity=0.225 Sum_probs=85.9
Q ss_pred CHHHHHHHHHHHhccCC--CccceEEEEEEecC----eeEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 021046 190 GLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQG----ENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262 (318)
Q Consensus 190 ~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 262 (318)
......+|...+..+.. -..++.+++..... ..++|+|++++. +|.+++... ...+......++.+++..
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHH
Confidence 34567888888888853 44566777766532 348999999984 788887431 125556778899999999
Q ss_pred HHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEeecccceeec
Q 021046 263 LLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIFG 304 (318)
Q Consensus 263 l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~DfGla~~~~ 304 (318)
+.-||..+ |+|+|++|.|||++.+. .+.++||+-++...
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999998 99999999999999887 89999999988765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-09 Score=99.67 Aligned_cols=149 Identities=24% Similarity=0.280 Sum_probs=119.2
Q ss_pred HHhcCCccccccccCCcccEEEEEe--cCCcEEEEEEccCCCCcCHHH--HHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLTE--FKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
....+|..+..||.|.|+.|+.... .++..+++|.+.+.......+ -..|+.+...+ .|.+.++....|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4456888899999999999998853 457789999877653333222 23455555555 489999988888888888
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeecccce
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR 301 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~DfGla~ 301 (318)
++--||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999999987766 23455777888899999999999999877 9999999999999886 888999999986
Q ss_pred e
Q 021046 302 I 302 (318)
Q Consensus 302 ~ 302 (318)
.
T Consensus 416 ~ 416 (524)
T KOG0601|consen 416 R 416 (524)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.5e-09 Score=102.07 Aligned_cols=111 Identities=29% Similarity=0.450 Sum_probs=75.9
Q ss_pred hcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..+|..++.|-.|+||.||..+++. .+.+|.| +++.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 4689999999999999999998754 5678873 33321 11110 22223344443
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+=...+ +....++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++.-
T Consensus 136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 3333333 12222322 2377999999887 999999999999999999999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.3e-09 Score=95.67 Aligned_cols=152 Identities=24% Similarity=0.288 Sum_probs=118.7
Q ss_pred cCCcccccccc--CCcccEEEEEe---cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCee
Q 021046 151 ENFSTQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 151 ~~~~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 222 (318)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+....+++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566678999 99999999976 45778999874432 2222233356666666664 99999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeec
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDF 297 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~Df 297 (318)
++-+|++. .+|..+.+. ....++....+.+..+... ||..+|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999986 677666632 3445666777777777777 999999987 9999999999999999 88999999
Q ss_pred ccceeecCCcc
Q 021046 298 GMARIFGGDEL 308 (318)
Q Consensus 298 Gla~~~~~~~~ 308 (318)
|+...++...+
T Consensus 268 ~~v~~i~~~~~ 278 (524)
T KOG0601|consen 268 GLVSKISDGNF 278 (524)
T ss_pred ceeEEccCCcc
Confidence 99998887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.5e-07 Score=73.99 Aligned_cols=139 Identities=16% Similarity=0.154 Sum_probs=102.1
Q ss_pred cccCCcccEEEEEecCCcEEEEEEccCC---C---CcCHHHHHHHHHHHhccCC--CccceEEEEEEecC----eeEEEE
Q 021046 159 LGEGGFGPVYKGRLLNGQEVAVKRLSNQ---S---GQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQG----ENILIY 226 (318)
Q Consensus 159 lg~G~fg~Vy~~~~~~~~~vavK~l~~~---~---~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~ 226 (318)
-|+||-+.|++-.+. |..+-+|+-.+. + +.+...|.+|+..+..+.. -.+++...+..... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888889998774 447889976521 1 4567789999999999864 33555552222221 357999
Q ss_pred EeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC--ceEeeccccee
Q 021046 227 EYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARI 302 (318)
Q Consensus 227 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~ki~DfGla~~ 302 (318)
|-+++ -+|.+++... .....+...+..++.+++..+.-||+.+ +.|+|+-+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5787776321 1234566777899999999999999988 999999999999986667 99999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.6e-07 Score=77.02 Aligned_cols=139 Identities=18% Similarity=0.183 Sum_probs=86.0
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc--cceEEEEEEecCeeEEEEEeccCCC-
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQGENILIYEYMPNKS- 233 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 233 (318)
.+||+|..+.||+. .+..+++|...... ......+|..++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 24466778776422 3456788999999886443 4677888877778889999999963
Q ss_pred hhhhh---------------------hcCCCCCCCCHHHHH-HHHHH----------HHH-HHHHHHh-cCCCCeeecCC
Q 021046 234 LDVFL---------------------FYPKKKRLLGWQARV-RIIEG----------IAQ-GLLYLHQ-YSRLRIIHRDL 279 (318)
Q Consensus 234 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~~----------i~~-~l~yLH~-~~~~~ivH~Dl 279 (318)
+...+ +... ....+..... .+..+ +.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 0011111100 01000 001 1222221 12345789999
Q ss_pred CCCCEEEcCCCCceEeeccccee
Q 021046 280 KASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 280 k~~Nill~~~~~~ki~DfGla~~ 302 (318)
.|.||++++++ +.|.||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-08 Score=79.30 Aligned_cols=62 Identities=26% Similarity=0.144 Sum_probs=53.6
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+|.+++.. ....+++..+..++.|++.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 688888843 2456999999999999999999999865 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-08 Score=87.39 Aligned_cols=96 Identities=29% Similarity=0.365 Sum_probs=80.9
Q ss_pred HHHhccCCCccceEEEEEEecC-----eeEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 021046 199 MLIAKLQHRHLVRLFGCCIEQG-----ENILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272 (318)
Q Consensus 199 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 272 (318)
.-|-.+.|.|||+++.||.+.. +..+++|||+.|++..+|...+ ....+......+++.||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3455567999999999997643 4689999999999999997543 345677778889999999999999996 47
Q ss_pred CeeecCCCCCCEEEcCCCCceEe
Q 021046 273 RIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 273 ~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
+|+|+++..+-|++..++-+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999988875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=77.04 Aligned_cols=106 Identities=21% Similarity=0.194 Sum_probs=84.2
Q ss_pred HHHHHHHhccCC-CccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 021046 195 KNEMMLIAKLQH-RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273 (318)
Q Consensus 195 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 273 (318)
..|..++..+++ +++++++|.|- .++|.||.+.+++...-..-..-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 69999999994 3789999998766421100012234689999999999999999999865556
Q ss_pred eeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 274 IIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 274 ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+.-.|++|+|+.+++++++|+.|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999999876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.1e-09 Score=94.81 Aligned_cols=81 Identities=28% Similarity=0.379 Sum_probs=73.3
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++.|+++.-.+|.+++...+.....++...+.++.|++.|++| ++ .+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999777667778889999999999999999 55 999999999999999999999999999
Q ss_pred eeecCCc
Q 021046 301 RIFGGDE 307 (318)
Q Consensus 301 ~~~~~~~ 307 (318)
.....++
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8877665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.5e-07 Score=74.80 Aligned_cols=139 Identities=15% Similarity=0.178 Sum_probs=90.8
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHH---------HHHHHHHhccCCCc---cceEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEF---------KNEMMLIAKLQHRH---LVRLFGCC 216 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~e~~~l~~l~h~n---iv~l~~~~ 216 (318)
...+|...+.+-......|.+-.. +|..+.+|..+.......+.| .+++..+.+++... .+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456777777777777777777766 467888887765433322222 23344444443222 22222222
Q ss_pred Ee-----cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 217 IE-----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 217 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
.. ....+|+|||++|-.|.++.. ++. .++..+.+++.-||+.| +.|+|..|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 21 234579999999988866541 222 24566778899999988 9999999999999854 4
Q ss_pred ceEeecccceee
Q 021046 292 PKISDFGMARIF 303 (318)
Q Consensus 292 ~ki~DfGla~~~ 303 (318)
+++.||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999987643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.3e-07 Score=75.83 Aligned_cols=141 Identities=15% Similarity=0.134 Sum_probs=86.8
Q ss_pred ccccCCc-ccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEeccCCChh
Q 021046 158 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLD 235 (318)
Q Consensus 158 ~lg~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (318)
.|..|.. ..||+.... +..+.+|...... .....+|+.++..+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555665 778999764 4678888876543 345677888888774 344667888777767789999999998876
Q ss_pred hhh-------------------hcCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 021046 236 VFL-------------------FYPKK-KRLLGW--QARVRIIE--------------------GIAQGLLYLHQ----Y 269 (318)
Q Consensus 236 ~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~i~~~l~yLH~----~ 269 (318)
... +.... ...+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11000 001110 00000000 01111222211 1
Q ss_pred CCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 270 ~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
..+.++|+|+.|.||+++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.2e-07 Score=84.09 Aligned_cols=140 Identities=17% Similarity=0.210 Sum_probs=90.5
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcC-------------------------------------HHHHHHHHH
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------------LTEFKNEMM 199 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~e~~ 199 (318)
+.||..+.|+||+|++++|+.||||+-++.-... .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5899999999999999999999999765431110 012334444
Q ss_pred HHhc----cCCCc------cceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 021046 200 LIAK----LQHRH------LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269 (318)
Q Consensus 200 ~l~~----l~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~ 269 (318)
-..+ ++|-+ |++++.. -...+.|+||||+|..+.+.....+ ..++......-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc--
Confidence 3322 23444 3344322 2357899999999998877654332 23444433333333322222222
Q ss_pred CCCCeeecCCCCCCEEEcC----CCCceEeecccceeecC
Q 021046 270 SRLRIIHRDLKASNILLDS----DMNPKISDFGMARIFGG 305 (318)
Q Consensus 270 ~~~~ivH~Dlk~~Nill~~----~~~~ki~DfGla~~~~~ 305 (318)
+++|+|-.|-||+++. ++++.+-|||+.+.+..
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3999999999999984 67899999999887653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=1e-06 Score=74.35 Aligned_cols=145 Identities=23% Similarity=0.210 Sum_probs=86.0
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC--ccceEEEEEEec---CeeEEEEEecc
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR--HLVRLFGCCIEQ---GENILIYEYMP 230 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 230 (318)
++.++.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999877 58999987653 3456778888888888533 356777655433 34689999999
Q ss_pred CCChhh----------------hh---hcC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 021046 231 NKSLDV----------------FL---FYP-KKKRLLGWQAR---------VRI------------IEGIAQ-GLLYLHQ 268 (318)
Q Consensus 231 ~g~L~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~i~~-~l~yLH~ 268 (318)
+..+.. .+ +.. .......+... ... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988876 11 111 01111111100 000 011222 2333332
Q ss_pred ----cCCCCeeecCCCCCCEEEc-CCCCceEeecccceee
Q 021046 269 ----YSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIF 303 (318)
Q Consensus 269 ----~~~~~ivH~Dlk~~Nill~-~~~~~ki~DfGla~~~ 303 (318)
.....++|+|+.|.||+++ +++.+.|.||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1345699999999999999 5666689999988654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.1e-06 Score=84.72 Aligned_cols=79 Identities=18% Similarity=0.393 Sum_probs=58.3
Q ss_pred ccccccCCcccEEEEEecCC---cEEEEEEccCCC-CcCHHHHHHHHHHHhccC-CCcc--ceEEEEEEec---CeeEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ-HRHL--VRLFGCCIEQ---GENILI 225 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 225 (318)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+.++..+. |+++ ++++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 367777765432 223457889999999995 6665 7888888764 467899
Q ss_pred EEeccCCCh
Q 021046 226 YEYMPNKSL 234 (318)
Q Consensus 226 ~e~~~~g~L 234 (318)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.5e-06 Score=71.32 Aligned_cols=154 Identities=19% Similarity=0.222 Sum_probs=99.1
Q ss_pred cHHHHHHHhcCCcccc---ccccCCcccEEEEEecCCcEEEEEEccCCCCc-------------------CHHH-----H
Q 021046 142 SLASVSAATENFSTQC---KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-------------------GLTE-----F 194 (318)
Q Consensus 142 ~~~~~~~~~~~~~~~~---~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~-----~ 194 (318)
+...+....++..+.. .|.+|.-+.||+|...++..+|||+++..... .... .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4444444444444444 45567777899998888999999988643211 1111 1
Q ss_pred HHHHHHHhccC--CCccceEEEEEEecCeeEEEEEeccCCCh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 021046 195 KNEMMLIAKLQ--HRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271 (318)
Q Consensus 195 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 271 (318)
.+|..-|.++. +-.+++.+++. +..|||||+..... .-.| ....+...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 34555565553 34445555443 45799999965421 1111 1122233356677888888888887633
Q ss_pred CCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 272 ~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++||+||..-|||+. ++.+.|+|||=|......
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 499999999999998 999999999998776543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=8e-06 Score=69.39 Aligned_cols=73 Identities=12% Similarity=0.198 Sum_probs=46.2
Q ss_pred cccccCCcc-cEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC---ccceEEEEEEec---CeeEEEEEec
Q 021046 157 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR---HLVRLFGCCIEQ---GENILIYEYM 229 (318)
Q Consensus 157 ~~lg~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 229 (318)
+.++.|+.. .||+. +..+.+|.... ......+..|..++..+... -+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 48875 23466676543 22345788999998877532 344555544332 2348899999
Q ss_pred cCCChh
Q 021046 230 PNKSLD 235 (318)
Q Consensus 230 ~~g~L~ 235 (318)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.7e-05 Score=68.50 Aligned_cols=78 Identities=13% Similarity=0.125 Sum_probs=57.7
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC---CccceEEEEEEe---cCeeEEEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH---RHLVRLFGCCIE---QGENILIYE 227 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e 227 (318)
...+.||.|..+.||+....+++ +.+|..+. ......+..|...++.|.- ..+++.++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34568999999999999776664 55666433 1133578899999988853 468888888764 366899999
Q ss_pred eccCCCh
Q 021046 228 YMPNKSL 234 (318)
Q Consensus 228 ~~~~g~L 234 (318)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.5e-05 Score=63.78 Aligned_cols=125 Identities=24% Similarity=0.385 Sum_probs=91.0
Q ss_pred cCCccccccccCCc-ccEEEEEecCCcEEEEEEccC---CC--------C----------cCHHHHHHHHHHHhccC---
Q 021046 151 ENFSTQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---QS--------G----------QGLTEFKNEMMLIAKLQ--- 205 (318)
Q Consensus 151 ~~~~~~~~lg~G~f-g~Vy~~~~~~~~~vavK~l~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 205 (318)
.+++..+.||.|.- |.||+++. +|+.+|+|.++. .. . ...+.|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999998 567999998321 00 0 12346889999888886
Q ss_pred CCcc--ceEEEEEEecC------------------eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 021046 206 HRHL--VRLFGCCIEQG------------------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265 (318)
Q Consensus 206 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y 265 (318)
+.++ |+.+||..-.. .+.+|.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4466 89999985331 1357888776543 111 1234567788889
Q ss_pred HHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 266 LH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99877 999999999976 3589999875
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=65.26 Aligned_cols=141 Identities=21% Similarity=0.294 Sum_probs=81.8
Q ss_pred cccccCCcccEEEEEecC--CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEEeccCCC
Q 021046 157 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
+.|..|-...+|+....+ +..+.+|........ ..+..+|+.++..+...++ +++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999998764 567888876543222 2234578888888854333 44444322 248999999877
Q ss_pred hhhh-----------------hhcCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 021046 234 LDVF-----------------LFYPKKK--------RLLG-WQARVRIIE----------------------GIAQGLLY 265 (318)
Q Consensus 234 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~i~~~l~y 265 (318)
+... ++..... .... +.....+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0111100 0111 222111111 11111111
Q ss_pred ----HHhc-CCCCeeecCCCCCCEEEcC-CCCceEeeccccee
Q 021046 266 ----LHQY-SRLRIIHRDLKASNILLDS-DMNPKISDFGMARI 302 (318)
Q Consensus 266 ----LH~~-~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~ 302 (318)
+-.. ....++|+|+.+.|||++. ++.+.+.||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 2345999999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=5e-05 Score=62.39 Aligned_cols=133 Identities=19% Similarity=0.274 Sum_probs=88.5
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCC----------------CcCHHHHHHHHHHHhccC------CCccceEE
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLTEFKNEMMLIAKLQ------HRHLVRLF 213 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~ 213 (318)
...||+|+.=.||. +++.....||+..... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999986 4555667888876544 223456777777555554 88999999
Q ss_pred EEEEecCeeEEEEEeccC--C----ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc
Q 021046 214 GCCIEQGENILIYEYMPN--K----SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 287 (318)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 287 (318)
|+..++.-.-+|+|.+.+ | +|.+++ ....++. . +...+-+-..||-+.+ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999888999998743 3 344455 2223443 2 2233334455666555 99999999999995
Q ss_pred CCC----CceEee-cccce
Q 021046 288 SDM----NPKISD-FGMAR 301 (318)
Q Consensus 288 ~~~----~~ki~D-fGla~ 301 (318)
... .+.|.| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 432 355555 44433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.5e-05 Score=66.35 Aligned_cols=139 Identities=16% Similarity=0.091 Sum_probs=79.6
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEEeccCCChhh
Q 021046 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYMPNKSLDV 236 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~ 236 (318)
.+..|-...+|+... ++..+++|..........-+..+|..++..+....+ .++++.. ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355677888998874 566788887654322211245778888888864433 3444443 2479999999877642
Q ss_pred h-----------------hhcCC-CCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeeecCCCCCC
Q 021046 237 F-----------------LFYPK-KKRLLGWQA-RVRIIEGI---------AQGLLYLHQY-----SRLRIIHRDLKASN 283 (318)
Q Consensus 237 ~-----------------l~~~~-~~~~l~~~~-~~~i~~~i---------~~~l~yLH~~-----~~~~ivH~Dlk~~N 283 (318)
. +|... ....++... ...+..++ ...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 111222211 11111111 1112222111 12358999999999
Q ss_pred EEEcCCCCceEeeccccee
Q 021046 284 ILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 284 ill~~~~~~ki~DfGla~~ 302 (318)
|++++++ +.|.||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.9e-05 Score=59.18 Aligned_cols=130 Identities=20% Similarity=0.236 Sum_probs=87.5
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccce-EEEEEEecCeeEEEEEeccCC
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR-LFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g 232 (318)
...+.|++|++|.||++.+.+ .++|+|.=+.+ .....+..|+++|..++-.++.+ ++.+. ..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 345689999999999999854 48888876543 34467899999999998766643 55443 334569999998
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCCEEEcCCCCceEeecccceee
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk-~~Nill~~~~~~ki~DfGla~~~ 303 (318)
.|.+.-.. .+.+.... +++.---|-..+ |-|+.|. |...++..+..+.|+||--|..-
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 87654411 12233333 333322222223 8888884 66666667779999999999843
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00013 Score=64.22 Aligned_cols=143 Identities=19% Similarity=0.160 Sum_probs=86.4
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc--cceEEEE------EEecCeeEEEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGC------CIEQGENILIYE 227 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 227 (318)
.+.+..|....+|+....+ ..+++|.... ........|+.++..+.+.+ +++++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987654 4688888764 23345667888777775332 4454432 233456789999
Q ss_pred eccCCChhhh--------------hhcCC--------CCCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 021046 228 YMPNKSLDVF--------------LFYPK--------KKRLLGWQARV----------RIIEGIAQGLLYLHQ----YSR 271 (318)
Q Consensus 228 ~~~~g~L~~~--------------l~~~~--------~~~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~ 271 (318)
|++|..+... ++... ......|.... .....+..++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776320 01000 00112222211 011123344455443 123
Q ss_pred CCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 272 LRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 272 ~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
..++|+|+.|.|+++++++.+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.6e-05 Score=54.80 Aligned_cols=38 Identities=47% Similarity=1.145 Sum_probs=31.0
Q ss_pred ChhHHHHHhhc-cCCccceecccccCCCCceEEec-ccccccc
Q 021046 2 NLNQCQAKCLK-NCSCRAYANSKLTGGGSGCLMWF-GDLIDLR 42 (318)
Q Consensus 2 ~~~~C~~~Cl~-~C~C~a~~~~~~~~~~~~C~~w~-~~l~~~~ 42 (318)
+.++|++.|+. +|+|.||.|.+ ++.+|.+|. +.+.+..
T Consensus 26 s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 26 SLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR 65 (78)
T ss_pred CHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence 67899999999 99999999864 456899999 6555543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00055 Score=60.92 Aligned_cols=141 Identities=18% Similarity=0.206 Sum_probs=76.9
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC--ccceEEE------EEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR--HLVRLFG------CCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~ 228 (318)
+.++.|....+|+....+| .+++|++... ..+....|+.++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999887655 6788887521 223334455555555321 2334332 12335667899999
Q ss_pred ccCCChhh-----h---------hhcCCC--------CCCCCH-HHHHH-H-----------H-HHHHHHHHHHHhc---
Q 021046 229 MPNKSLDV-----F---------LFYPKK--------KRLLGW-QARVR-I-----------I-EGIAQGLLYLHQY--- 269 (318)
Q Consensus 229 ~~~g~L~~-----~---------l~~~~~--------~~~l~~-~~~~~-i-----------~-~~i~~~l~yLH~~--- 269 (318)
++|..+.. . ++.... ...+.| ..... + . ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 0 111000 011112 11111 0 1 1111122233211
Q ss_pred -CCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 270 -SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 270 -~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
-+..++|+|+.|.||+++.+...-|.||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999876666899999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00032 Score=63.83 Aligned_cols=75 Identities=15% Similarity=0.220 Sum_probs=54.4
Q ss_pred cccccCCcccEEEEEecCC-cEEEEEEccCC------C-CcCHHHHHHHHHHHhccC---CCccceEEEEEEecCeeEEE
Q 021046 157 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ------S-GQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 225 (318)
+.||.|.+..||+....+| +.+.||.-... . +...+++..|...|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 48999975321 1 224567788888877763 3457777766 44567899
Q ss_pred EEeccCCC
Q 021046 226 YEYMPNKS 233 (318)
Q Consensus 226 ~e~~~~g~ 233 (318)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0012 Score=58.31 Aligned_cols=143 Identities=20% Similarity=0.210 Sum_probs=82.4
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC--ccceEEEEE------EecCeeEEEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR--HLVRLFGCC------IEQGENILIYE 227 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e 227 (318)
.+.++.|.-..+|+....++ .+.+|..... ...++...|+.++..|... .+++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876555 5667876542 1234455667777666422 244444321 22456789999
Q ss_pred eccCCChhhh--------------hhcCCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 021046 228 YMPNKSLDVF--------------LFYPKKK---------RLLGWQARV------------RIIEGIAQGLLYLHQ---- 268 (318)
Q Consensus 228 ~~~~g~L~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~i~~~l~yLH~---- 268 (318)
|++|..+... ++..... ..-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654210 1110000 011121110 011123345555542
Q ss_pred cCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 269 ~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
..+..++|+|+.+.|++++.++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988877899999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00033 Score=61.82 Aligned_cols=141 Identities=27% Similarity=0.356 Sum_probs=83.4
Q ss_pred cccccCCcccEEEEEecC-------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 228 (318)
+.+..|-...+|+....+ ++.+++|...... ....+..+|..++..+....+ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 455566667899887654 4788888875533 233455778888877753333 34555543 2468999
Q ss_pred ccCCChhhh-----------------hhcCCCCC------CCC--HHHHHH--------------------------HHH
Q 021046 229 MPNKSLDVF-----------------LFYPKKKR------LLG--WQARVR--------------------------IIE 257 (318)
Q Consensus 229 ~~~g~L~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 257 (318)
++|..+... +|...... ..+ |..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 11111000 010 111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeeecCCCCCCEEEcCC----CCceEeeccccee
Q 021046 258 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARI 302 (318)
Q Consensus 258 ~i~~~l~yLH~------~~~~~ivH~Dlk~~Nill~~~----~~~ki~DfGla~~ 302 (318)
.+...+.+|-. ..+..++|+|+.|.||+++++ +.+.++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234578999999999999985 8899999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=57.84 Aligned_cols=75 Identities=16% Similarity=0.213 Sum_probs=48.8
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC---CCccceEEEEEEecCeeEEEEEecc
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
...+.++.|....+|+.. .+++.+.||.-.. .....|..|..-|+.|. --.+++.+++...++..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678889999999987 5677899997763 22346888888777773 4568889999988888899999998
Q ss_pred CC
Q 021046 231 NK 232 (318)
Q Consensus 231 ~g 232 (318)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0019 Score=58.11 Aligned_cols=142 Identities=17% Similarity=0.218 Sum_probs=82.8
Q ss_pred cccccCCcccEEEEEecC-----CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccc-eEEEEEEecCeeEEEEEecc
Q 021046 157 CKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 230 (318)
..+-.|-.-.+|+....+ ++.+.+|..........+ -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 355557778899987543 357888877654433323 37788888888654444 455655322 5899998
Q ss_pred CCChhhh-----------------hhcCC-C--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 021046 231 NKSLDVF-----------------LFYPK-K--KRLLGWQARVRIIEG-----------------IAQGLLYL----HQ- 268 (318)
Q Consensus 231 ~g~L~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~-----------------i~~~l~yL----H~- 268 (318)
+.++... +|... . .....|.....+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 11111 0 111123332222211 11112222 21
Q ss_pred cCCCCeeecCCCCCCEEEcC-CCCceEeecccceee
Q 021046 269 YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIF 303 (318)
Q Consensus 269 ~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~ 303 (318)
.....++|+|+++.||++++ ++.+.++||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22346899999999999986 478999999988743
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0024 Score=56.30 Aligned_cols=144 Identities=17% Similarity=0.235 Sum_probs=80.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccC--CCCcCHHHHHHHHHHHhccCC--CccceEEEEEEecC--eeEEEEEecc
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQG--ENILIYEYMP 230 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~ 230 (318)
+.+..|.--.+|..... ++++++. ... ..........+|..+++.+.- .-+...++.|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 33433333345555443 6677777 331 223344566778888877743 33445667777665 6699999998
Q ss_pred CCChhhhhhcCCCC-----------------------------------CCCCHHHHHHHH--------HHHHHHHHHHH
Q 021046 231 NKSLDVFLFYPKKK-----------------------------------RLLGWQARVRII--------EGIAQGLLYLH 267 (318)
Q Consensus 231 ~g~L~~~l~~~~~~-----------------------------------~~l~~~~~~~i~--------~~i~~~l~yLH 267 (318)
+......+...... +.-.|......+ -....-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 85443322110000 000111111000 01122233443
Q ss_pred hc-----CCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 268 QY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 268 ~~-----~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++ ++..++|+|+.+.|++++.+..+-|.||+++.+
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 32 234699999999999999999999999999975
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=57.77 Aligned_cols=31 Identities=29% Similarity=0.562 Sum_probs=26.2
Q ss_pred CCeeecCCCCCCEEEcCCCC-ceEeeccccee
Q 021046 272 LRIIHRDLKASNILLDSDMN-PKISDFGMARI 302 (318)
Q Consensus 272 ~~ivH~Dlk~~Nill~~~~~-~ki~DfGla~~ 302 (318)
..++|+|+.|.||++++++. .-|.||+.|.+
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=2.5e-05 Score=76.84 Aligned_cols=150 Identities=18% Similarity=0.185 Sum_probs=100.1
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
...+.+.+.+.+-+|.|+.++.+.-. .|...++|..... .....+....+-.++-..++|.+++..--+.-..+.+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567777788889999999987532 2323333322211 1112222223333333345566666555555667889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|+++|..+++|...|+... ..+..........+..+++|||..- +.|+|++|.|.+...++..+++|||+....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988885432 3444444455566888999999865 899999999999999999999999965443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.002 Score=57.33 Aligned_cols=142 Identities=18% Similarity=0.157 Sum_probs=96.4
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCC------C----------------CcCHHH----HHHHHHHHhccCCCcc
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ------S----------------GQGLTE----FKNEMMLIAKLQHRHL 209 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~------~----------------~~~~~~----~~~e~~~l~~l~h~ni 209 (318)
.-.|..|.-+.||.+.-.+|..+|||+++-. . ....+. ...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3467788899999999989999999977521 0 000111 2457778888866554
Q ss_pred ceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC
Q 021046 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 289 (318)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~ 289 (318)
...--... ....|||+|+..-.- -.-.-....++...+..+-.|++.-|.-|-+.+ ++||.||.--|+|+ .+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence 42211111 345799999963221 111113345666677778888888888888877 59999999999998 67
Q ss_pred CCceEeecccceeecC
Q 021046 290 MNPKISDFGMARIFGG 305 (318)
Q Consensus 290 ~~~ki~DfGla~~~~~ 305 (318)
|.+.|+|.+-+.-...
T Consensus 301 G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDH 316 (520)
T ss_pred CEEEEEEccccccCCC
Confidence 8899999987765443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00066 Score=59.26 Aligned_cols=145 Identities=16% Similarity=0.148 Sum_probs=95.4
Q ss_pred cccHHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccC----------C----------CCcCH--HHHHHH
Q 021046 140 LFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN----------Q----------SGQGL--TEFKNE 197 (318)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~----------~----------~~~~~--~~~~~e 197 (318)
...+.++.....-+..++.||-|.-+.||.+-..+|.+.++|.-+- . +.... -...+|
T Consensus 81 yLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kE 160 (465)
T KOG2268|consen 81 YLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKE 160 (465)
T ss_pred HHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHH
Confidence 3445555544455678899999999999999998899988872210 0 01111 134567
Q ss_pred HHHHhccCC--CccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021046 198 MMLIAKLQH--RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275 (318)
Q Consensus 198 ~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 275 (318)
...|+.|.- --+++.+++ +..++|||++.+-.|...-+ ..+..++. ..+..-+.-|..+| +|
T Consensus 161 fafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G---lI 224 (465)
T KOG2268|consen 161 FAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG---LI 224 (465)
T ss_pred HHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC---ce
Confidence 777877753 224444444 45689999998877754321 22233332 23333344555555 99
Q ss_pred ecCCCCCCEEEcCCCCceEeecccc
Q 021046 276 HRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 276 H~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
|+|..-=||+++++..++++||--.
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ecccchheeEEecCCCEEEeechHh
Confidence 9999999999999999999999743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0001 Score=69.23 Aligned_cols=142 Identities=16% Similarity=0.082 Sum_probs=95.2
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc-cceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 228 (318)
+..+...+-+++|+++++++.+....+....+.+... ....-++++|.+++||| .+..++-+..++..+++++|
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3444445678899999999986533333335544321 34566888999999999 77777777777888999999
Q ss_pred ccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+..+ +-.... ......+...+...+...-+++++|||+.. -+|+| ||+.. ++..|..||+.+..+.+.
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGS-EEEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----ccccc-ccccccccccCCcccCcc
Confidence 9887 221111 011112333334455666778899999754 58998 76664 488999999998877653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.021 Score=52.12 Aligned_cols=73 Identities=11% Similarity=0.073 Sum_probs=49.6
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCC----CC---cCHHHHHHHHHHHhccC---CCccceEEEEEEecCeeEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SG---QGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 225 (318)
.+.||-|....||+.... +..+.||.-... .. ....+-..|+..|..+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998864 456889865521 11 13344455566665553 357888888877 456889
Q ss_pred EEeccC
Q 021046 226 YEYMPN 231 (318)
Q Consensus 226 ~e~~~~ 231 (318)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.019 Score=51.52 Aligned_cols=73 Identities=16% Similarity=0.243 Sum_probs=47.6
Q ss_pred ccccCCcccEEEEEecCC-cEEEEEEccC------CC-CcCHHHHHHHHHHHhccC--CC-ccceEEEEEEecCeeEEEE
Q 021046 158 KLGEGGFGPVYKGRLLNG-QEVAVKRLSN------QS-GQGLTEFKNEMMLIAKLQ--HR-HLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~~-~~vavK~l~~------~~-~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 226 (318)
.||-|...-||++..++| +.|.||.-.. .+ +-..++...|...|.... -| .+++++ +.+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 478999999999998654 5799995431 11 334456667777776553 24 344454 34555667999
Q ss_pred EeccCC
Q 021046 227 EYMPNK 232 (318)
Q Consensus 227 e~~~~g 232 (318)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.039 Score=48.72 Aligned_cols=29 Identities=28% Similarity=0.357 Sum_probs=25.3
Q ss_pred CCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 272 ~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0013 Score=44.70 Aligned_cols=33 Identities=24% Similarity=0.578 Sum_probs=26.9
Q ss_pred ChhHHHHHhhccCCccceecccccCCCCceEEeccc
Q 021046 2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGD 37 (318)
Q Consensus 2 ~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~C~~w~~~ 37 (318)
+.++|++.|+.+|+|.||.|.. +...|+++.+.
T Consensus 26 s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 26 SAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 5689999999999999999853 34579987764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.036 Score=49.39 Aligned_cols=136 Identities=25% Similarity=0.326 Sum_probs=80.1
Q ss_pred CcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc------cceEEEEE--EecC--eeEEEEEeccCC
Q 021046 163 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH------LVRLFGCC--IEQG--ENILIYEYMPNK 232 (318)
Q Consensus 163 ~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~--~~~~--~~~lv~e~~~~g 232 (318)
.-..+|+....+|+. ++|..... ....+...|+..+..|.-.+ +..+=|-. ...+ ..+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789988877776 77877664 44456667777776663211 22222211 1223 778899999998
Q ss_pred Chhh-h--------------hhc--------C-CCCCCCCHHH---H----------HHHHHHHHHHHHHHHhc----CC
Q 021046 233 SLDV-F--------------LFY--------P-KKKRLLGWQA---R----------VRIIEGIAQGLLYLHQY----SR 271 (318)
Q Consensus 233 ~L~~-~--------------l~~--------~-~~~~~l~~~~---~----------~~i~~~i~~~l~yLH~~----~~ 271 (318)
.+.. . ++. . .......|.. . .....++...++.+.+. -+
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8872 1 010 0 0011233431 0 11233444444444432 11
Q ss_pred C-C--eeecCCCCCCEEEcCCCC-ceEeecccce
Q 021046 272 L-R--IIHRDLKASNILLDSDMN-PKISDFGMAR 301 (318)
Q Consensus 272 ~-~--ivH~Dlk~~Nill~~~~~-~ki~DfGla~ 301 (318)
. + +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 2 899999999999999885 9999999764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.052 Score=45.39 Aligned_cols=74 Identities=19% Similarity=0.293 Sum_probs=50.3
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc---CCCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
.+.-|.--.-|.... +..++-||+-.. .....|..|+.-|..| +.-++.+.+.+....+..|+|+||++-|.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 343333333343333 346788886433 4456788887755555 556788899999999999999999998877
Q ss_pred h
Q 021046 235 D 235 (318)
Q Consensus 235 ~ 235 (318)
+
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.012 Score=49.05 Aligned_cols=123 Identities=20% Similarity=0.223 Sum_probs=60.3
Q ss_pred CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEEeccCCChhhhh---------------
Q 021046 175 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYMPNKSLDVFL--------------- 238 (318)
Q Consensus 175 ~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~~l--------------- 238 (318)
++.|.|+..... ....-.-..|..+++.+...++ +++++.+.. .+|+||+++..|..--
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 356777777654 3444566788888888865555 445555432 3677999776653210
Q ss_pred --hcC----CCCCCCCHHHHHHH----------------------HHHHHHHHHHHHh----c-CCCCeeecCCCCCCEE
Q 021046 239 --FYP----KKKRLLGWQARVRI----------------------IEGIAQGLLYLHQ----Y-SRLRIIHRDLKASNIL 285 (318)
Q Consensus 239 --~~~----~~~~~l~~~~~~~i----------------------~~~i~~~l~yLH~----~-~~~~ivH~Dlk~~Nil 285 (318)
|.. .....--|.....+ ...+..-+..+.. . .+..+.|+|+.|.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 000 00111112222121 0111112222211 1 1234789999999999
Q ss_pred E-cCCCCceEeeccccee
Q 021046 286 L-DSDMNPKISDFGMARI 302 (318)
Q Consensus 286 l-~~~~~~ki~DfGla~~ 302 (318)
+ +.++.++++||-.|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8999999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.037 Score=49.49 Aligned_cols=141 Identities=16% Similarity=0.236 Sum_probs=79.3
Q ss_pred cccccCCcccEEEEEecC----CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccc-eEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.|..|-.-.+|+....+ +..+.+|........ .-+-.+|..++..+..-++. ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345456667788886543 237888877554332 22346788888888655553 5565553 22 58999987
Q ss_pred CChhhh-----------------hhcCC-C-CC-CCCHHHHHHHHHHH----------------------HHHHH----H
Q 021046 232 KSLDVF-----------------LFYPK-K-KR-LLGWQARVRIIEGI----------------------AQGLL----Y 265 (318)
Q Consensus 232 g~L~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~i----------------------~~~l~----y 265 (318)
..|..- +|... . .. .--|.....+..++ ..-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 11111 0 01 11233222222111 11111 2
Q ss_pred HHh-cCCCCeeecCCCCCCEEEcC-CCCceEeeccccee
Q 021046 266 LHQ-YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARI 302 (318)
Q Consensus 266 LH~-~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~ 302 (318)
+.. ..+.-+.|+|+-|.||++++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 211 12234789999999999975 57899999998864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.083 Score=54.44 Aligned_cols=141 Identities=21% Similarity=0.265 Sum_probs=75.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC--CCc--cceEEE--------EEEe-cC--e
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ--HRH--LVRLFG--------CCIE-QG--E 221 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--h~n--iv~l~~--------~~~~-~~--~ 221 (318)
+.|+ |..-.+|+.+..+|..+++|+.+.... ......|...+..|. ++. +.+.+- .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 456788998887888899999876432 223344444554442 122 222221 1111 22 4
Q ss_pred eEEEEEeccCCChhhhh-----------------h-------cCCCCCCCCHHH-----------------HHHHHHHHH
Q 021046 222 NILIYEYMPNKSLDVFL-----------------F-------YPKKKRLLGWQA-----------------RVRIIEGIA 260 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l-----------------~-------~~~~~~~l~~~~-----------------~~~i~~~i~ 260 (318)
.+-+++|++|..+.... + .......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 57789999998775410 0 000112233321 111222222
Q ss_pred HHHH-----HHHhcCCCCeeecCCCCCCEEEcCCC--Cce-Eeecccce
Q 021046 261 QGLL-----YLHQYSRLRIIHRDLKASNILLDSDM--NPK-ISDFGMAR 301 (318)
Q Consensus 261 ~~l~-----yLH~~~~~~ivH~Dlk~~Nill~~~~--~~k-i~DfGla~ 301 (318)
.... .+. .-+..+||+|+.+.|||++.+. .+. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 121 1234599999999999999875 454 99999764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.015 Score=52.54 Aligned_cols=62 Identities=18% Similarity=0.213 Sum_probs=41.2
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 288 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 288 (318)
+..|+=+|+.+-++..++.. ...+++....++.-.++|+.-+---. .++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 34577788888888888732 23344556666666666654333222 3999999999999943
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.049 Score=48.20 Aligned_cols=32 Identities=25% Similarity=0.349 Sum_probs=28.3
Q ss_pred CCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 271 ~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
+..++|+|+.+.|++++.++.+.++||-.+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.027 Score=51.17 Aligned_cols=74 Identities=12% Similarity=0.162 Sum_probs=49.2
Q ss_pred ccccccCCcccEEEEEecC-CcEEEEEEccC-----CC-CcCHHHHHHHHHHHhccC--CC-ccceEEEEEEecCeeEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSN-----QS-GQGLTEFKNEMMLIAKLQ--HR-HLVRLFGCCIEQGENILI 225 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~-----~~-~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 225 (318)
.+.||-|.-.-||++...+ ++.|.||.-.. .+ +-..++..-|...|.... -| .+++++. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4578999999999998753 56799984321 11 334566777877777653 24 4555553 344566789
Q ss_pred EEeccC
Q 021046 226 YEYMPN 231 (318)
Q Consensus 226 ~e~~~~ 231 (318)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.24 Score=44.17 Aligned_cols=72 Identities=15% Similarity=0.105 Sum_probs=45.3
Q ss_pred CCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC--ccceEE---E--EEEecCeeEEEEEeccCCCh
Q 021046 162 GGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR--HLVRLF---G--CCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 162 G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~g~L 234 (318)
+.-..||+....++..+++|..+.. .....+...|+..+..|... .++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3446799998877888999987532 23455677788777666321 122211 2 22335667889999987654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.031 Score=49.88 Aligned_cols=56 Identities=23% Similarity=0.250 Sum_probs=46.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 246 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 246 ~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
.-.|++...++.+-+.-+.-+... .++=|||+.-.||||+ +|++-|+||-++|+-.
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 456788888888877777766653 4799999999999999 9999999999999543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.06 Score=44.82 Aligned_cols=101 Identities=17% Similarity=0.126 Sum_probs=65.1
Q ss_pred EEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHH
Q 021046 178 VAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 256 (318)
Q Consensus 178 vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~ 256 (318)
..+|+++...-. ...-|..+.+++++++ .|++|..- ..-..-++.|+|-.-.. .. ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHHH
Confidence 455666554333 4456788888888875 46666521 22244578888743211 00 1122
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 257 ~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
..=..+|.-.|+.. .+.+|+|-.|+||+-|+.|-+||.|-+-
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 22246777888643 4699999999999999999999999873
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.25 Score=45.13 Aligned_cols=74 Identities=18% Similarity=0.293 Sum_probs=45.6
Q ss_pred cccccCCcccEEEEEecCCc-------EEEEEEccCCCCcCHHHHHHHHHHHhccCCCccc-eEEEEEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLNGQ-------EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~-------~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 228 (318)
+.|..|-...+|++...++. .|.++......... -+-.+|+.++..+...++. ++++.+. .++++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 45656778889998764431 24444332221111 2336788899888765554 4555553 2699999
Q ss_pred ccCCChh
Q 021046 229 MPNKSLD 235 (318)
Q Consensus 229 ~~~g~L~ 235 (318)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9998774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 318 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 4e-94
Identities = 74/191 (38%), Positives = 99/191 (51%), Gaps = 14/191 (7%)
Query: 138 LPLFSLASVSAATENFSTQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSN----QS 187
FS + T NF + K+GEGGFG VYKG + N VAVK+L+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 188 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL 247
+ +F E+ ++AK QH +LV L G + + L+Y YMPN SL L L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 248 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
W R +I +G A G+ +LH+ IHRD+K++NILLD KISDFG+AR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 308 LQGNTKRIVGT 318
T RIVGT
Sbjct: 188 QTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 2e-89
Identities = 79/184 (42%), Positives = 110/184 (59%), Gaps = 3/184 (1%)
Query: 137 WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT-EFK 195
L FSL + A++NFS + LG GGFG VYKGRL +G VAVKRL + QG +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 196 NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF-YPKKKRLLGWQARVR 254
E+ +I+ HR+L+RL G C+ E +L+Y YM N S+ L P+ + L W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 255 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
I G A+GL YLH + +IIHRD+KA+NILLD + + DFG+A++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194
Query: 315 IVGT 318
+ GT
Sbjct: 195 VRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 5e-83
Identities = 72/179 (40%), Positives = 106/179 (59%), Gaps = 4/179 (2%)
Query: 141 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMML 200
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG+ EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 201 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-LGWQARVRIIEGI 259
++ +H HLV L G C E+ E ILIY+YM N +L L+ + + W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
A+GL YLH + IIHRD+K+ NILLD + PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-65
Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 141 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMML 200
++ + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 201 IAKLQHRHLVRLFGCCIE----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 256
+ ++H ++++ G + LI + SL FL K ++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 257 EGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
E +A+GL YLH+ + I HRD+K+ N+LL +++ I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 310 GNTKRIVGT 318
G+T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-57
Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 141 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--M 198
+ + S +N +G G +G VYKG L + + VAVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 199 MLIAKLQHRHLVRLFGCCIEQGENI-----LIYEYMPNKSLDVFLFYPKKKRLLGWQARV 253
+ ++H ++ R + L+ EY PN SL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 254 RIIEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG-- 305
R+ + +GL YLH + + I HRDL + N+L+ +D ISDFG++ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 306 ----DELQGNTKRIVGT 318
E VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-48
Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 6/163 (3%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H ++V G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
+ ++ EY+ SL L + L + R+ + +A+G+ YLH I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 276 HRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
HR+LK+ N+L+D K+ DFG++R+ L +K GT
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-46
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
+G G FG V K + ++VA+K++ ++S + F E+ ++++ H ++V+L+G C+
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL 71
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
L+ EY SL L + + +QG+ YLH +IHR
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 278 DLKASNILLDSDMN-PKISDFGMARIFGGDELQGNTKRIVGT 318
DLK N+LL + KI DFG A ++Q + G+
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-45
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 6/158 (3%)
Query: 158 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
LG+G FG K G+ + +K L + F E+ ++ L+H ++++ G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ I EY+ +L + W RV + IA G+ YLH + IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
RDL + N L+ + N ++DFG+AR+ ++ Q R
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-44
Identities = 48/174 (27%), Positives = 89/174 (51%), Gaps = 23/174 (13%)
Query: 158 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LTEFKNEMMLIAKLQHRHL 209
++G+GGFG V+KGRL+ + VA+K L +G EF+ E+ +++ L H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
V+L+G ++ E++P L L K + W ++R++ IA G+ Y+
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQN- 140
Query: 270 SRLRIIHRDLKASNILLDS-----DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRDL++ NI L S + K++DFG+++ + + ++G
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-44
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
+G GGFG VY+ G EVAVK Q + + E L A L+H +++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
G C+++ L+ E+ L+ L + + V IA+G+ YLH + +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 274 IIHRDLKASNILLDSDMNP--------KISDFGMARIFGGDELQGNT 312
IIHRDLK+SNIL+ + KI+DFG+AR +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-44
Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 7/150 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
KL E G ++KGR G ++ VK L + S + +F E + H +++ + G
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 216 CIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
C I +MP SL L + ++ V+ +A+G+ +LH L
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIF 303
I L + ++++D DM +IS + F
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
++G G FG VYKG+ +G +VAVK L+ + Q L FKNE+ ++ K +H +++ G
Sbjct: 31 RIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 216 CIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
+ ++ ++ SL L + K + + I A+G+ YLH I
Sbjct: 89 STA--PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 275 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IHRDLK++NI L D KI DFG+A +++ G+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 21/174 (12%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--MMLIAKLQHRHLVRLFGC 215
+G+G +G V++G G+ VAVK S++ + E + L+H +++
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIAS 70
Query: 216 CIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH---- 267
+ + LI Y SL +L + L + +RI+ IA GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 268 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 318
+ I HRDLK+ NIL+ + I+D G+A + ++L VGT
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 21/174 (12%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--MMLIAKLQHRHLVRLFGC 215
++G+G +G V+ G+ G++VAVK + E + ++H +++
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99
Query: 216 CIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH---- 267
I+ + LI +Y N SL +L K L ++ +++ GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 268 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 318
+ I HRDLK+ NIL+ + I+D G+A F +E+ VGT
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
+G+G FG VY GR +G EVA++ + + + L FK E+M + +H ++V G
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
C+ +I ++L + K +L +I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 276 HRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
H+DLK+ N+ D + I+DFG+ I G + +
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 21/174 (12%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--MMLIAKLQHRHLVRLFGC 215
+G+G FG V++G+ G+EVAVK S++ + E + L+H +++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 216 CIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ--- 268
+ L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 269 --YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 318
+ I HRDLK+ NIL+ + I+D G+A D + VGT
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LGEG FG V R G++VAVK L G + + K E+ ++ L H ++V+
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 212 LFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
G C E G N LI E++P+ SL +L PK K + + +++ I +G+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--- 142
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ +HRDL A N+L++S+ KI DFG+ + D+
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 158 KLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LGEG FG V G+ VAVK L ++ Q + +K E+ ++ L H H+++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 212 LFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
GCC + G L+ EY+P SL +L + +G + + I +G+ YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA- 152
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
IHRDL A N+LLD+D KI DFG+A+
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+LG+G FG V R G+ VAVK+L + + + L +F+ E+ ++ LQH ++V+
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 213 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
G C G LI EY+P SL +L K K + ++ I +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R IHRDL NIL++++ KI DFG+ ++ D+
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+LG+G FG V R G+ VAVK+L + + + L +F+ E+ ++ LQH ++V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 213 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
G C G LI EY+P SL +L K K + ++ I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R IHRDL NIL++++ KI DFG+ ++ D+
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 158 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+LG+G FG V R G VAVK+L + +F+ E+ ++ L +V+
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 213 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
G G L+ EY+P+ L FL + + L + I +G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R +HRDL A NIL++S+ + KI+DFG+A++ D+
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 7/159 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRH 208
E+ ++G G FG V+ GRL + VAVK +F E ++ + H +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+VRL G C ++ ++ E + FL + L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
IHRDL A N L+ KISDFGM+R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 12/156 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LG G FG VYKG + E VA+K L S + E +E ++A + + H+ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L G C+ LI + MP L ++ + K +G Q + IA+G+ YL
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---ED 135
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R++HRDL A N+L+ + + KI+DFG+A++ G +E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-37
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ ++G G FG V+ G LN +VA+K + + +F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L+G C+EQ L+ E+M + L +L ++ L + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+IHRDL A N L+ + K+SDFGM R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E + +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+ +G C ++ ++ EY+ N L +L + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ IHRDL A N L+D D+ K+SDFGM R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ +G+G FG V G G +VAVK + ++ F E ++ +L+H +LV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 211 RLFGCCIEQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L G +E+ + I EYM SL +L + + +LG ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+HRDL A N+L+ D K+SDFG+ +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 158 KLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LGEG FG V+ N VAVK L + + +F+ E L+ LQH H+V+
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRIIEG 258
+G C + I+++EYM + L+ FL + K LG + I
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IA G++YL + +HRDL N L+ +++ KI DFGM+R
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-36
Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 158 KLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LGEG FG V+ N VAVK L S +F+ E L+ LQH+H+VR
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFL------------FYPKKKRLLGWQARVRIIEGI 259
FG C E ++++EYM + L+ FL LG + + +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
A G++YL + L +HRDL N L+ + KI DFGM+R
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-36
Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVR 211
LG G FG V+KG + E V +K + ++SG Q + M+ I L H H+VR
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L G C L+ +Y+P SL + + + LG Q + IA+G+ YL
Sbjct: 80 LLGLCPGS-SLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYL---EE 133
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
++HR+L A N+LL S +++DFG+A + D+
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 156 QCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+LG G FG V +G ++ VA+K L E E ++ +L + ++VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 212 LFGCCIEQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
L G C Q E +++ E L FL K+ + ++ ++ G+ YL
Sbjct: 75 LIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+HRDL A N+LL + KISDFG+++ G D+
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-36
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ +G+G FG V G G +VAVK + ++ F E ++ +L+H +LV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L G +E+ + ++ EYM SL +L + L G ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 305
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+HRDL A N+L+ D K+SDFG+ +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L+G C +Q +I EYM N L +L + + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ +HRDL A N L++ K+SDFG++R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 12/156 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
LG G FG VYKG + E VA+K L S + E +E ++A + + H+ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L G C+ LI + MP L ++ + K +G Q + IA+G+ YL
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL---ED 135
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R++HRDL A N+L+ + + KI+DFG+A++ G +E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 158 KLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+G G G V GRL VA+K L + + + +F +E ++ + H +++RL
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G +++ EYM N SLD FL V ++ G+ G+ YL S L
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+HRDL A N+L+DS++ K+SDFG++R+ D
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 158 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+LG G FG V KG + VAVK L E E ++ +L + ++VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 213 FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
G C + E+ L+ E L+ +L ++ R + + + ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+HRDL A N+LL + KISDFG+++ DE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
+ + + KLG G +G VY+G VAVK L + + EF E ++ +++H +L
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
V+L G C + +I E+M +L +L ++ + + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 127
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ IHRDL A N L+ + K++DFG++R+ GD
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 158 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+LGE FG VYKG L Q VA+K L G EF++E ML A+LQH ++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRIIE 257
L G + +I+ Y + L FL K L V ++
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
IA G+ YL S ++H+DL N+L+ +N KISD G+ R
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E+ + KLG G FG V+ +VAVK + + F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L ++ I I E+M SL FL + + + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI---E 301
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ IHRDL+A+NIL+ + + KI+DFG+AR+ +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 56/157 (35%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
RL+ ++ I I EYM N SL FL P +L + + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFI---E 126
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-35
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 11/163 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKL 204
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 205 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
H +++RL G + ++I EYM N +LD FL +K V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
YL + + +HRDL A NIL++S++ K+SDFG++R+ D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-35
Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 158 KLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHLVRL 212
+GEG FG V K R+ A+KR+ S +F E+ ++ KL H +++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRIIEGI 259
G C +G L EY P+ +L FL L Q + +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-35
Identities = 54/162 (33%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQ 205
N S +G G FG V GRL + VA+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H +++RL G + +++ EYM N SLD FL K V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
L S + +HRDL A NIL++S++ K+SDFG+ R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLTEFKNEMMLIA 202
E+ LG+G F ++KG L+ EV +K L F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
KL H+HLV +G C+ ENIL+ E++ SLD +L K K + ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--------KISDFGMARIFGGDE 307
+ +L +IH ++ A NILL + + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-34
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 158 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
KLG G +G VY+G VAVK L + + EF E ++ +++H +LV+L G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ +I E+M +L +L ++ + + + I+ + YL + IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL---EKKNFIH 341
Query: 277 RDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R+L A N L+ + K++DFG++R+ GD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 158 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+G G FG VY G LL+ AVK L +++F E +++ H +++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 213 FGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
G C+ + L + YM + L F+ + + + +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +HRDL A N +LD K++DFG+AR
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 158 KLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLV 210
KLG+G FG V +G VAVK L + + +F E+ + L HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
RL+G + + + E P SL L K + R +A+G+ YL
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL---E 138
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R IHRDL A N+LL + KI DFG+ R ++
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 158 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+LG+G FG VY+G + VA+K + S + EF NE ++ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGWQARVRIIEGIAQGL 263
RL G + ++I E M L +L +++ IA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
YL + + +HRDL A N ++ D KI DFGM R I+ D
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 155 TQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+LG G FG V +G ++ VA+K L E E ++ +L + ++V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
RL G C + +L+ E L FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+HR+L A N+LL + KISDFG+++ G D+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 158 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+G G FG VY G LL+ AVK L +++F E +++ H +++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 213 FGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
G C+ + L + YM + L F+ + + + +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +HRDL A N +LD K++DFG+AR
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+G+G FG VY G ++ + A+K L Q + F E +L+ L H +++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 213 FGCCIEQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
G + + YM + L F+ P++ + + +A+G+ YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---AE 142
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ +HRDL A N +LD K++DFG+AR
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 18/171 (10%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLTEFKNEMMLIAKL 204
LGEG FG V +G L VAVK + N S + + EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 205 QHRHLVRLFGCCIEQG-----ENILIYEYMPNKSLDVFLFY---PKKKRLLGWQARVRII 256
H +++RL G CIE + ++I +M L +L Y + + Q ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
IA G+ YL S +HRDL A N +L DM ++DFG+++ I+ GD
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQ 205
E +GEG FG V++G ++ + VA+K + S +F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H H+V+L G E +I E L FL +K L + + ++ L Y
Sbjct: 75 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
L R +HRD+ A N+L+ S+ K+ DFG++R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLTEFKNEMMLIAKL 204
+ F+ LG+G FG V + +L +VAVK L + + EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 205 QHRHLVRLFGCCIEQGENI------LIYEYMPNKSLDVFL---FYPKKKRLLGWQARVRI 255
H H+ +L G + +I +M + L FL + L Q VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
+ IA G+ YL S IHRDL A N +L DM ++DFG++R I+ GD
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
KLG+G FG V+ G VA+K L F E ++ KL+H LV+L+
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
E+ I + EYM SL FL + + L V + IA G+ Y+ R+ +HR
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387
Query: 278 DLKASNILLDSDMNPKISDFGMARIFGGDE 307
DL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
KLG+G FG V+ G VA+K L F E ++ KL+H LV+L+
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 277
E+ I + EYM SL FL + + L V + IA G+ Y+ R+ +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304
Query: 278 DLKASNILLDSDMNPKISDFGMARIFGGDE 307
DL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQ 205
E+ LGEG FG VY+G N + VAVK + + +F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H H+V+L G E+ +I E P L +L + K L V I + + Y
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
L + +HRD+ NIL+ S K+ DFG++R ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 32/178 (17%)
Query: 158 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+GEG FG V++ R VAVK L S +F+ E L+A+ + ++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFL---------------------FYPKKKRLLGW 249
+L G C L++EYM L+ FL L
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 250 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I+ D
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 158 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG G FG VY+G++ +VAVK L S Q +F E ++I+K H+++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYL 266
R G ++ ++ E M L FL P + L + + IA G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 267 HQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 301
IHRD+ A N LL KI DFGMAR
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-33
Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 158 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG G FG VY+G++ +VAVK L S Q +F E ++I+K H+++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYL 266
R G ++ ++ E M L FL P + L + + IA G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 267 HQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 301
IHRD+ A N LL KI DFGMAR
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQH-- 206
+S ++G GG V++ Q A+K L Q L ++NE+ + KLQ
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++RL+ I ++ E N L+ +L KKK + W+ + + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 143
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
HQ+ I+H DLK +N L+ D K+ DFG+A D VGT
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 212
+GEG FG V++G ++ + VA+K + S +F E + + + H H+V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G E +I E L FL +K L + + ++ L YL
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
R +HRD+ A N+L+ S+ K+ DFG++R
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 27/181 (14%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLTEFKNEMMLI 201
+ + LGEG FG V + VAVK L + + + L++ +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 202 AKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLL 247
+ +H++++ L G C + G +I EY +L +L + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 248 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 306
++ V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR I D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 307 E 307
Sbjct: 212 Y 212
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLF 213
++G GG V++ Q A+K L Q L ++NE+ + KLQ ++RL+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
I ++ E N L+ +L KKK + W+ + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+H DLK +N L+ D K+ DFG+A D VG
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 58/249 (23%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 85 YIFRRRR-RKHKEKENMEANWDLLAFDINMSITTRTNELCEADGEGNDKSKDSW-LPLFS 142
RR+ + +M +N L+ +S T T L + W P
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPE-DPKWEFPR-- 80
Query: 143 LASVSAATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLTE 193
+ + LGEG FG V + VAVK L + + + L++
Sbjct: 81 --------DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 194 FKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-------------F 239
+EM ++ + +H++++ L G C + G +I EY +L +L
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 240 YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299
+ + ++ V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 300 AR-IFGGDE 307
AR I D
Sbjct: 250 ARDINNIDY 258
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 32/186 (17%)
Query: 158 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
LGEG FG V K + VAVK L N S L + +E ++ ++ H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG------------ 258
+L+G C + G +LI EY SL FL +K +
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 259 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDEL 308
I+QG+ YL + ++++HRDL A NIL+ KISDFG++R ++ D
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 309 QGNTKR 314
++
Sbjct: 207 VKRSQG 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 25/166 (15%)
Query: 158 KLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 209
LG G FG V + + VAVK L + +E+ ++ + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 210 VRLFGCCIEQGENI-LIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRI 255
V L G C + G + +I E+ +L +L K L + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L + + IHRDL A NILL KI DFG+AR
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 214
LG+GGF ++ + A K + E E+ + L H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
E + + ++ E +SL + ++K L +AR + I G YLH R R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNR 135
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMA 300
+IHRDLK N+ L+ D+ KI DFG+A
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 214
LG+GGF ++ + A K + E E+ + L H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
E + + ++ E +SL + ++K L +AR + I G YLH+ R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+IHRDLK N+ L+ D+ KI DFG+A D
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQH-- 206
+S ++G GG V++ Q A+K L Q L ++NE+ + KLQ
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++RL+ I ++ E N L+ +L KKK + W+ + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 124
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
HQ+ I+H DLK +N L+ D K+ DFG+A D VGT
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 11/164 (6%)
Query: 146 VSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL 204
V +++ KLGEGGF V L +G A+KR+ Q E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 205 QHRHLVRLFGCCIEQGEN----ILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEG 258
H +++RL C+ + L+ + +L + K L Q ++ G
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
I +GL +H HRDLK +NILL + P + D G
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 9/171 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
E + K+GEG FG + +G++ +K +S S + E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++V+ E G ++ +Y L + +K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+I+HRD+K+ NI L D ++ DFG+AR+ +GT
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
LG+G +G VY GR L N +A+K + + + E+ L L+H+++V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 218 EQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRII-EGIAQGLLYLHQYSRLRII 275
E I I+ E +P SL L K L + + + I +GL YLH +I+
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 276 HRDLKASNILLDSDM-NPKISDFGMARIFGGDELQGNTKRIVGT 318
HRD+K N+L+++ KISDFG ++ G + T+ GT
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 47/170 (27%), Positives = 69/170 (40%), Gaps = 23/170 (13%)
Query: 158 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 209
LG G FG V + + VAVK L S +E+ +++ L QH ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKKKRLLGWQARVRIIEG 258
V L G C G ++I EY L FL + + +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDE 307
+AQG+ +L + IHRD+ A N+LL + KI DFG+AR I
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 27/181 (14%)
Query: 158 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 209
LG G FG V + + VAVK L + +E+ +++ L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG----------- 258
V L G C G ++I EY L FL + + + + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 259 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGNTK 313
+A+G+ +L + IHRDL A NILL KI DFG+AR I
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 314 R 314
Sbjct: 207 A 207
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 32/187 (17%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
+F +G GGFG V+K + ++G+ +K + +N+ + + E+ +AKL H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHV 64
Query: 208 HLVRLFGCCIEQGENI----------------LIYEYMPNKSLDVFLFYPKKKRLLGWQA 251
++V GC + + E+ +L+ ++ + ++L A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 311
+ E I +G+ Y+H ++I+RDLK SNI L KI DFG+ D G
Sbjct: 125 L-ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GK 177
Query: 312 TKRIVGT 318
R GT
Sbjct: 178 RTRSKGT 184
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 32/170 (18%)
Query: 158 KLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHR 207
LGEG FG V + +VAVK L S+ + + L++ +EM ++ + +H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG--------- 258
+++ L G C + G +I EY +L +L + +R G +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 259 -------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
++G G F VYKG EVA + + FK E ++ LQH ++VR +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 215 CCIEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+ +L+ E M + +L +L K+ +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 271 RLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IIHRDLK NI + + KI D G+A + K ++GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
+F LG+G FG V K R L+ + A+K++ + + L+ +E+ML+A L H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 209 LVRLFGCCIEQGENIL----------IY---EYMPNKSLDVFLFYPKKKRLLGWQARVRI 255
+VR + +E+ + ++ EY N +L + + R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YDLIHSENLNQQRDEYWRL 121
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
I + L Y+H IIHRDLK NI +D N KI DFG+A+
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 17/176 (9%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRH 208
+F LG GGFG V++ + ++ A+KR+ + E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 209 LVRLFGCCIE---------QGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRII 256
+VR F +E + +Y + ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQH 206
NF + K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 265
++++ + IE E ++ E L + + KK++ L + V + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+H R++HRD+K +N+ + + K+ D G+ R F ++ +VGT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 43/172 (25%), Positives = 63/172 (36%), Gaps = 31/172 (18%)
Query: 158 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 209
LG G FG V + VAVK L +E+ ++ +L H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG----------- 258
V L G C G LI+EY L +L ++K
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 259 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 10/176 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
E++ +G G +G K R +G+ + K + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 208 HLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLL 264
++VR + I++ L + EY L + K+R + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 265 YLHQ--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H+ ++HRDLK +N+ LD N K+ DFG+ARI D T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 11/147 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 214
LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H ++ L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
E + L+ E N ++ +L + K +AR + I G+LYLH +
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLYLHSH---G 132
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMA 300
I+HRDL SN+LL +MN KI+DFG+A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 144 ASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIA 202
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 203 KLQHRHLVRLFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IA 260
L +V L+G E G + I+ E + SL + K+ L + R G
Sbjct: 106 GLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQAL 160
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDELQGNTKR---IV 316
+GL YLH RI+H D+KA N+LL SD + + DFG A D L + I
Sbjct: 161 EGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 317 GT 318
GT
Sbjct: 218 GT 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 147 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKL 204
S + + LG+G V++GR G A+K +N S + E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 205 QHRHLVRLFGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
H+++V+LF E+ E+ P SL L P L + ++ +
Sbjct: 65 NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 262 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARIFGGDEL 308
G+ +L + I+HR++K NI+ D K++DFG AR DE
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 147 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKL 204
S + + LG+G V++GR G A+K +N S + E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 205 QHRHLVRLFGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
H+++V+LF E+ E+ P SL L P L + ++ +
Sbjct: 65 NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 262 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARIFGGDEL 308
G+ +L + I+HR++K NI+ D K++DFG AR DE
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 8/170 (4%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
E + +LG+G FG VYK + G A K + +S + L ++ E+ ++A H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V+L G G+ ++ E+ P ++D + + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
RIIHRDLKA N+L+ + + +++DFG++ + ++ +GT
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 45/171 (26%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
+ ++ K+G+G G VY + GQEVA+++++ Q NE++++ + ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+V + E ++ EY+ SL DV + + Q + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAA-VCRECLQALEFLH 133
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
++IHRD+K+ NILL D + K++DFG ++ + +T +VGT
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 215
L EGGF VY+ + + +G+E A+KRL + + E+ + KL H ++V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 216 CI--------EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
Q E +L+ E + ++ + L +I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH 153
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+ IIHRDLK N+LL + K+ DFG A
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 12/171 (7%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
+ K+GEG G V R +G++VAVK + + Q NE++++ QH +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+V ++ + E ++ E++ +L D+ + RL Q + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIAT-VCEAVLQALAYLH 158
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+IHRD+K+ +ILL D K+SDFG D + + +VGT
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 41/177 (23%), Positives = 63/177 (35%), Gaps = 15/177 (8%)
Query: 147 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAK 203
S ++F +LG G +G V+K R +G+ AVK + + E+ K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 204 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG-WQARVRIIEGIAQ 261
+ QH VRL E G L E + L Q + +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGP---SLQQHCEAWGASLPEAQVWGYLRD-TLL 168
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
L +LH ++H D+K +NI L K+ DFG+ G + G
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGD 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 29/176 (16%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLTEFKNEMML 200
L +G F + + + A+K+ +FKNE+ +
Sbjct: 38 TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 201 IAKLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSL------DVFLFYPKKKRLLGWQARV 253
I +++ + + G I + + +IYEYM N S+ L + +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154
Query: 254 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
II+ + Y+H + I HRD+K SNIL+D + K+SDFG + +++
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 145 SVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLTEFKNEM-MLI 201
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----LGWQARVRI 255
+ V +G +G+ + E M + SLD F K + + LG +I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KI 114
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI 315
I + L +LH S+L +IHRD+K SN+L+++ K+ DFG++ D++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 316 VGT 318
G
Sbjct: 170 AGC 172
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRH 208
++F +LG G G V+K +G +A K + + E+ ++ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V +G GE + E+M SLD L KK + Q ++ + +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLR- 148
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+ +I+HRD+K SNIL++S K+ DFG++
Sbjct: 149 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ 205
+ FS ++G G FG VY R + N + VA+K++S QS + + E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H + ++ GC + + L+ EY + D+ + K L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAA-VTHGALQGLAY 169
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
LH +IHRD+KA NILL K+ DFG A
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LGEG +G V + AVK L + G K E+ L+ +L+H+++++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 214 GCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQAR---VRIIEGIAQGLLYLHQ 268
+ + ++ EY ++ +KR QA ++I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
I+H+D+K N+LL + KIS G+A
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLI 201
ENF K+GEG +G VYK R L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRI 255
+L H ++V+L + + L++E++ + + + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI 315
+ QGL + H + R++HRDLK N+L++++ K++DFG+AR F G ++ T +
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 316 V 316
V
Sbjct: 165 V 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRH 208
+++ Q +G G V ++VA+KR++ + Q + E E+ +++ H +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEG-IA------ 260
+V + + + E L+ + + S+ D+ K G + E IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII----KHIVAKGEHKSGVLDESTIATILREV 130
Query: 261 -QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARIFGGDELQGNTKR--IV 316
+GL YLH + IHRD+KA NILL D + +I+DFG+ A + G ++ N R V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 317 GT 318
GT
Sbjct: 188 GT 189
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 6e-26
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 16/169 (9%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHL 209
+ + +LG GGFG V + G++VA+K+ + E + E+ ++ KL H ++
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 210 VRLFGCCIEQGENI-------LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
V + + + L EY L +L + L ++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDEL 308
L YLH+ RIIHRDLK NI+L + KI D G A+ EL
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLTEFKNEMMLIA 202
E+F LG+G FG VY R + +A+K L + Q + E+ + +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ----LRREVEIQS 64
Query: 203 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
L+H +++RL+G + LI EY P ++ + K + + I +A
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTA-TYITELAN 120
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
L Y H R+IHRD+K N+LL S KI+DFG +
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-26
Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 12/175 (6%)
Query: 148 AATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKL 204
+++ F KLG G + VYKG G VA+K +L ++ G T + E+ L+ +L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60
Query: 205 QHRHLVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
+H ++VRL+ + + L++E+M N K +D + L + + + Q
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-LLQ 119
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
GL + H+ +I+HRDLK N+L++ K+ DFG+AR F G + + +V
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 31/179 (17%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLIA 202
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPN---KSLDVF--LFYPKKKRLLGWQARVRIIE 257
+L H ++V L + L++E+M K LD + ++ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
+ +G+ + HQ+ RI+HRDLK N+L++SD K++DFG+AR F G ++ T +V
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 34/176 (19%)
Query: 146 VSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKN------ 196
V + + + LGEG F VYK R Q VA+K +L ++S E K+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTA 59
Query: 197 --EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLG 248
E+ L+ +L H +++ L + L++++M K + L K +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM- 118
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
QGL YLHQ+ I+HRDLK +N+LLD + K++DFG+A+ FG
Sbjct: 119 LM--------TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 43/180 (23%), Positives = 84/180 (46%), Gaps = 32/180 (17%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLI 201
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPN---KSLDV--FLFYPKKKRLLGWQARVRII 256
+L+H+++VRL + L++E+ K D P+ + +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
+ +GL + H ++HRDLK N+L++ + K+++FG+AR F G ++ + +V
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 8/153 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLTEFKNEM-MLIAKLQHR 207
E+ ++G G +G V K +GQ +AVKR+ S + + ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 265
++V+ +G +G+ + E M + S D F Y + +I + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298
L L+IIHRD+K SNILLD N K+ DFG
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 18/175 (10%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEM-MLIAKLQHRHLV 210
+F + LG G G + + + ++VAVKR+ + + E+ +L +H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
R F C + + + E + K LG + +++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCAATLQEYVE--QKDFAHLGLEPI-TLLQQTTSGLAHLHS- 136
Query: 270 SRLRIIHRDLKASNILL-----DSDMNPKISDFGMARIFGGDEL-QGNTKRIVGT 318
L I+HRDLK NIL+ + ISDFG+ + + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 12/171 (7%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
E F KLGEG +G VYK GQ VA+K++ + L E E+ ++ + H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+V+ +G + + ++ EY S+ D+ + + L I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+R IHRD+KA NILL+++ + K++DFG+A + NT ++GT
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 37/171 (21%)
Query: 157 CKLGEGGFGPVYKGR---LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
CK+G G +G VYK + + ++ A+K++ +G ++ + E+ L+ +L+H +++ L
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQ 84
Query: 214 GCCIEQGENI--LIYEYM--------------PNKSLDVFLFYPKKKRLLGWQARVRIIE 257
+ + L+++Y V L K LL +Q
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ------- 136
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFG 304
I G+ YLH ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 137 -ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ-SGQGLTEFKNEMMLIAKLQH 206
E + K+GEG +G V+K R GQ VA+K S + E+ ++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKH 61
Query: 207 RHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRIIEGIA 260
+LV L + L++EY + + K + WQ
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQ--------TL 112
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
Q + + H++ IHRD+K NIL+ K+ DFG AR+
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 46/201 (22%), Positives = 69/201 (34%), Gaps = 33/201 (16%)
Query: 142 SLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLTEFKNEM 198
++ S T F K+G G FG V+K L+G A+KR E+
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 199 MLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 256
A L QH H+VR F E ++ EY SL D + ++
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KISDF 297
+ +GL Y+H + ++H D+K SNI + P KI D
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 298 GMARIFGGDELQGNTKRIVGT 318
G + + G
Sbjct: 179 GHVTRI------SSPQVEEGD 193
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
E + KLGEG + VYKG+ L VA+K RL ++ G T + E+ L+ L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 208 HLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
++V L + L++EY+ + K L +Q + +
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQ--------LLR 111
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
GL Y H+ +++HRDLK N+L++ K++DFG+AR
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 38/177 (21%), Positives = 73/177 (41%), Gaps = 8/177 (4%)
Query: 127 GEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-S 184
G K + A + ++G G G V+K R G +AVK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 185 NQSGQGLTEFKNEM-MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK 243
+ + + ++ +++ ++V+ FG I + + E M + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRM 117
Query: 244 KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+ + + ++ I + L YL + +IHRD+K SNILLD K+ DFG++
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.9 bits (250), Expect = 1e-24
Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 33/180 (18%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLIA 202
E + K+GEG +G VYK + G+ A+K++ L + E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRII 256
+L+H ++V+L+ + +L++E++ + L K L Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQ------ 108
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
+ G+ Y H R++HRDLK N+L++ + KI+DFG+AR F G ++ T IV
Sbjct: 109 --LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 11/171 (6%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHR 207
E F+ K+G+G FG V+KG + VA+K + + + + + + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++ + +G ++ + +I EY+ S L + L I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ IHRD+KA+N+LL K++DFG+A +++ NT VGT
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ-SGQGLTEFKNEMMLIAKLQH 206
E + +GEG +G V K R G+ VA+K S+ + E+ L+ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRH 83
Query: 207 RHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRIIEGIA 260
+LV L C ++ L++E++ + + L Y ++ L +Q I
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQ--------II 134
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
G+ + H + IIHRD+K NIL+ K+ DFG AR
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 44/182 (24%), Positives = 72/182 (39%), Gaps = 29/182 (15%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEM-MLIAKLQHRHLVRLFGCC 216
LG G G V G+ VAVKR+ E+ +L H +++R + C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY-CS 77
Query: 217 IEQGENI-LIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
+ + E N +L + + +L + ++ IA G+ +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 272 LRIIHRDLKASNILLDS-------------DMNPKISDFGMARIFGGDE--LQGNTKRIV 316
L+IIHRDLK NIL+ + ++ ISDFG+ + + + N
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 317 GT 318
GT
Sbjct: 194 GT 195
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-24
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 16/167 (9%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLTEFKNEMMLIA 202
+ST LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 203 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
+++H +++++ E L+ E + LD+F F + RL A I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVS 141
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
+ YL IIHRD+K NI++ D K+ DFG A +L
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 20/149 (13%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG VY R N +A+K L Q + E+ + + L+H +++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHPNIL 77
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
R++ + I L+ E+ P L + K R ++ +E +A L Y H
Sbjct: 78 RMYNY-FHDRKRIYLMLEFAPRGEL--YKELQKHGRFDEQRSA-TFMEELADALHYCH-- 131
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFG 298
++IHRD+K N+L+ KI+DFG
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-24
Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 28/180 (15%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQS-GQGLTEFKNEMMLIAKLQH 206
+ + KLGEG +G VYK + + VA+K RL ++ G T + E+ L+ +LQH
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQH 92
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-----FYPKKKRLLGWQARVRIIEGIAQ 261
R+++ L LI+EY L ++ + + +Q +
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ--------LIN 143
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIFGGDELQGNTKRIV 316
G+ + H R +HRDLK N+LL KI DFG+AR F G ++ T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-24
Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
+G+G F V R +L G+EVA+K + + L + E+ ++ L H ++V+LF
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 216 CIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274
IE + + LI EY + F + R+ +AR I + Y H + RI
Sbjct: 83 -IETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QKRI 135
Query: 275 IHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
+HRDLKA N+LLD+DMN KI+DFG + F
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-24
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHR 207
F +G G +G VYKGR + GQ A+K + + +G E K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHR 81
Query: 208 HLVRLFGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
++ +G I++ L+ E+ S+ + K L I I +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILR 140
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
GL +LHQ ++IHRD+K N+LL + K+ DFG++ + NT +GT
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 192
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 216
LGEG +G V + + VAVK + + E K E+ + L H ++V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 217 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV---RIIEGIAQGLLYLHQYSRL 272
+G L EY L F + A+ +++ G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I HRD+K N+LLD N KISDFG+A +F + + ++ GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 34/183 (18%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRH 208
++ +G G FG V++ +L+ EVA+K++ FKN E+ ++ ++H +
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPN 93
Query: 209 LVRLFGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKK--------RLLGWQARVR 254
+V L G+ L+ EY+P Y K K +L +Q
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ---- 149
Query: 255 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDELQGNTK 313
+ + L Y+H + I HRD+K N+LLD K+ DFG A+I + N
Sbjct: 150 ----LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 314 RIV 316
I
Sbjct: 201 YIC 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 216
LGEG +G V + + VAVK + + E K E+ + L H ++V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 217 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV---RIIEGIAQGLLYLHQYSRL 272
+G L EY L F + A+ +++ G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I HRD+K N+LLD N KISDFG+A +F + + ++ GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 2e-23
Identities = 21/199 (10%), Positives = 42/199 (21%), Gaps = 36/199 (18%)
Query: 139 PLFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEF 194
+ +S L G V+ R + ++ A+K + S L
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 195 KNEMMLIAKLQHRHLVRLFGCC----------IEQGENI----------------LIYEY 228
A+L ++ L+
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 229 MP---NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285
F + G A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 286 LDSDMNPKISDFGMARIFG 304
+ D + D G
Sbjct: 227 IMPDGRLMLGDVSALWKVG 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 33/175 (18%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHR 207
+++ +G G FG VY+ +L +G+ VA+K++ FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107
Query: 208 HLVRLFGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKK--------RLLGWQARV 253
++VRL GE L+ +Y+P V Y + K +L +Q
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--- 164
Query: 254 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDE 307
+ + L Y+H I HRD+K N+LLD D K+ DFG A+ E
Sbjct: 165 -----LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLF 213
KLG GG VY + +VA+K + + L F+ E+ ++L H+++V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
E L+ EY+ +L ++ + L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRD+K NIL+DS+ KI DFG+A+ L T ++GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGT 175
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 26/194 (13%), Positives = 56/194 (28%), Gaps = 38/194 (19%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ--------- 205
LG+ + G+ V + + K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 206 -HRHLVRLFGCCIEQGENILI--------------YEYMPNKSLDVFLF------YPKKK 244
H + F + + +I + P ++ F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 245 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
+ L AR+++ + + L LH ++H L+ +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 305 GDELQGNTKRIVGT 318
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 9/164 (5%)
Query: 142 SLASVSAATENFSTQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLTEFKN 196
++S + +G+G V R G+ V V+R L S + +T +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 197 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 256
E+ + H ++V I E ++ +M S + + I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-IL 134
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
+G+ + L Y+H + +HR +KAS+IL+ D +S
Sbjct: 135 QGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 12/155 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H H+++L+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
I + ++ EY+ L F + K R+ +AR R+ + I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHM 131
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
++HRDLK N+LLD+ MN KI+DFG++ + E
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 23/169 (13%)
Query: 158 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRL-- 212
+ GG G +Y +NG+ V +K L + E +A++ H +V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 213 FGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
F ++ + + Y EY+ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ +++ DLK NI+L + K+ D G + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 33/179 (18%)
Query: 147 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKN----EMM 199
S AT + ++G G +G VYK R +G VA+K R+ N G G E+
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVA 63
Query: 200 LIAKLQ---HRHLVRLFGCCIEQGENI-----LIYEYMPN------KSLDVFLFYPKKKR 245
L+ +L+ H ++VRL C + L++E++ + +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 246 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
L Q +GL +LH I+HRDLK NIL+ S K++DFG+ARI+
Sbjct: 124 DLMRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 12/155 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H H+++L+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
I +I ++ EY+ L F + K RL ++R R+ + I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESR-RLFQQILSGVDYCH---RHM 136
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
++HRDLK N+LLD+ MN KI+DFG++ + E
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 39/181 (21%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLTEFKNEMML 200
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 201 ------IA---KLQHRHLVRLFGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLG 248
IA KL H ++V+L ++ +Y E + + + P K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF-GGDE 307
QAR + + +G+ YLH +IIHRD+K SN+L+ D + KI+DFG++ F G D
Sbjct: 137 DQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 308 L 308
L
Sbjct: 193 L 193
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 45/172 (26%), Positives = 86/172 (50%), Gaps = 31/172 (18%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQH 206
+ K+G+G FG V+K R GQ+VA+K++ + + G +T + E+ ++ L+H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKH 75
Query: 207 RHLVRLFGCCIEQGENI--------LIYEYMPN------KSLDVFLFYPKKKRLLGWQAR 252
++V L C + L++++ + ++ V + KR++
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM-QM-- 132
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
+ GL Y+H+ +I+HRD+KA+N+L+ D K++DFG+AR F
Sbjct: 133 ------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTE-FKNEMMLIAKLQHRHLVRLFG 214
LGEG FG V Q+VA+K +S Q + + E+ + L+H H+++L+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
I +I ++ EY ++F + +KKR+ + R R + I + Y H R +
Sbjct: 77 V-ITTPTDIVMVIEYA---GGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHK 128
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
I+HRDLK N+LLD ++N KI+DFG++ I
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLF 213
LG GG V+ R L + ++VAVK L + F+ E A L H +V ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 GCCIEQGENILIY----EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ + EY+ +L + + + + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG-NTKRIVGT 318
+ IIHRD+K +NI++ + K+ DFG+AR T ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 42/212 (19%), Positives = 76/212 (35%), Gaps = 11/212 (5%)
Query: 110 DINMSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYK 169
D I + + P +++ +LG G FG V++
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175
Query: 170 GR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228
G A K + + E+ ++ L+H LV L + E ++IYE+
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235
Query: 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 288
M L F + + V + + +GL ++H+ +H DLK NI+ +
Sbjct: 236 MSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTT 290
Query: 289 DMNP--KISDFGMARIFGGDELQGNTKRIVGT 318
+ K+ DFG+ + + K GT
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-22
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 33/174 (18%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSGQGLT---EFKNEMMLIA 202
+ + ++GEG +G V+K R G+ VA+KR+ + + G L+ E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 203 KLQHRHLVRLFGCCIEQGENI-----LIYEYMPN--KSL-----DVFLFYPKKKRLLGWQ 250
+H ++VRLF C + L++E++ + + + K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 251 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
+ +GL +LH + R++HRDLK NIL+ S K++DFG+ARI+
Sbjct: 129 --------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-22
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHR--HL 209
LG GGFG VY G + + VA+K + T E++L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 210 VRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+RL E+ ++ LI E P D+F F ++ L AR + + + + H
Sbjct: 111 IRLLDW-FERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 166
Query: 269 YSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQ 309
++HRD+K NIL+D + K+ DFG +
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 19/163 (11%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNE----------MMLIAKLQHR 207
LG+GGFG V+ G L + +VA+K + G + + + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 208 HLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++RL E E L+ E P + D+F + +K L +R + + +
Sbjct: 99 GVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDEL 308
H ++HRD+K NIL+D K+ DFG + +
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 11/172 (6%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
+ + +LG G FG V++ G+ K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
L+ L ++ E +LI E++ L F + + + + +GL ++H+
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 269 YSRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVGT 318
I+H D+K NI+ ++ KI DFG+A DE K T
Sbjct: 168 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 13/166 (7%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLF 213
+G GG G VY+ + + VA+K +S T + E +LQ H+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
G+ + + L L +++ L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL-QGNTKRIVGT 318
HRD+K NIL+ +D + DFG+A ++L Q VGT
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGT 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 25/180 (13%), Positives = 55/180 (30%), Gaps = 37/180 (20%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ--------- 205
LG+ + G+ V + + K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 206 ----------------HRHLVRLFGCC-IEQGENILIYEYMPNKSL----DVFLFYPKKK 244
+ ++R+ + +L +V L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 245 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
+ L AR+++ + + L LH Y ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
S LG G FG V+K G ++A K + + + E KNE+ ++ +L H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 211 RLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L+ + + +L+ EY+ L D + + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 270 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVGT 318
+ I+H DLK NIL + KI DFG+AR + E K GT
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 37/180 (20%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKR-LSNQSGQGLTEFKN----EMMLIAK 203
+ F + G+G FG V G+ G VA+K+ + + F+N M +A
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75
Query: 204 LQHRHLVRLFGCCIEQGEN-------ILIYEYMPNKSLDVFLFYPKKK--------RLLG 248
L H ++V+L GE ++ EY+P+ Y +++ ++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGGDE 307
+Q + + + LH S + + HRD+K N+L++ +D K+ DFG A+ E
Sbjct: 136 FQ--------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 133 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL 191
++D+ LP S EN+ + LG G V + +E AVK + G
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 192 TE---------FKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP 241
+ E+ ++ K+ H ++++L L+++ M L F +
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLT 116
Query: 242 KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+K L + R +I+ + + + LH+ L I+HRDLK NILLD DMN K++DFG +
Sbjct: 117 EKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 302 IFGGDELQGNTKRIVGT 318
E + + GT
Sbjct: 173 QLDPGEK---LREVCGT 186
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-21
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
+G G +G V A K++ + + FK E+ ++ L H +++RL+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74
Query: 217 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
E +I L+ E L F K+ A RI++ + + Y H+ L +
Sbjct: 75 FEDNTDIYLVMELCTGGEL--FERVVHKRVFRESDAA-RIMKDVLSAVAYCHK---LNVA 128
Query: 276 HRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
HRDLK N L + D K+ DFG+A F ++ + VGT
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 215
KLG G FG V+ +G E +K ++ ++S + + + E+ ++ L H +++++F
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 216 CIEQGENI-LIYEYMPNKSL--DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
E N+ ++ E L + + K L +++ + L Y H
Sbjct: 89 -FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHS---Q 143
Query: 273 RIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
++H+DLK NIL KI DFG+A +F DE GT
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 43/179 (24%), Positives = 67/179 (37%), Gaps = 31/179 (17%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+G+G F V + GQ+ AVK + ++ G + K E + L+H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 212 LFGCCIEQGENILIYEYMP---------NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
L G +++E+M ++ F++ Q I +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ--------ILEA 142
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
L Y H IIHRD+K +LL S K+ FG+A G VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGT 196
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 22/181 (12%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLTEFKNEMML 200
+ + LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 201 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 260
+ KL H ++++ + + ++ E M L F KRL + +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCK-LYFYQML 249
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVG 317
+ YLH+ IIHRDLK N+LL S D KI+DFG ++I G L + + G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 318 T 318
T
Sbjct: 304 T 304
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 22/173 (12%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE---FKNEMMLIAKLQHRH 208
LG G G V ++VA+K + + S + + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
++++ + + ++ E M L F KRL + + + YLH
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCK-LYFYQMLLAVQYLH- 131
Query: 269 YSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IIHRDLK N+LL S D KI+DFG ++I G L + + GT
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGT 179
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 27/172 (15%), Positives = 52/172 (30%), Gaps = 24/172 (13%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 203
++ LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLD---VFLFYPKKKRLLGWQARVRIIEGIA 260
++ + + Q ++L+ E +L +K + + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-ML 182
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILL-----------DSDMNPKISDFGMAR 301
+ +H IIH D+K N +L D + D G +
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 202
+++ +LG G F V K R G+E A K RLS+ E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
+++H +++ L + + +LI E + L F F +K+ L +A + ++ I G
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEAT-QFLKQILDG 120
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 318
+ YLH RI H DLK NI+L P K+ DFG+A K I GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGT 174
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 206
E ++ C LG+G FG V K + + QE AVK + ++ + + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++++LF + ++ E L F K+KR A RII+ + G+ Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAA-RIIKQVFSGITYM 137
Query: 267 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H+ I+HRDLK NILL+S D + KI DFG++ F + K +GT
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 206
+E + KLG G +G V R + E A+K + ++ S ++ E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++++L+ ++ L+ E L F + + A II+ + G+ YL
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL--FDEIIHRMKFNEVDAA-VIIKQVLSGVTYL 152
Query: 267 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H+ I+HRDLK N+LL+S D KI DFG++ +F + K +GT
Sbjct: 153 HK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 21/180 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSNQSGQGLTE-FKNEMML 200
+ + + +G G V + G E AVK RLS + + + E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 201 IAKL-QHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 258
+ ++ H H++ L E + L+++ M L F + +K L + R I+
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGEL--FDYLTEKVALSEKETR-SIMRS 208
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ + + +LH I+HRDLK NILLD +M ++SDFG + E + + GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 206
E ++ C LG+G FG V K + + QE AVK + ++ + + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++++LF + ++ E L F K+KR A RII+ + G+ Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAA-RIIKQVFSGITYM 137
Query: 267 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H+ I+HRDLK NILL+S D + KI DFG++ F + K +GT
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 20/180 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 202
+ + +LG G F V K R G E A K + E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
++ H +++ L + + +LI E + L F F +K+ L +A I+ I G
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEAT-SFIKQILDG 127
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 318
+ YLH +I H DLK NI+L P K+ DFG+A K I GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-20
Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 20/180 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 202
+ + +LG G F V K R G E A K + E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
++ H +++ L + + +LI E + L F F +K+ L +A I+ I G
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEAT-SFIKQILDG 127
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 318
+ YLH +I H DLK NI+L P K+ DFG+A K I GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 34/172 (19%), Positives = 67/172 (38%), Gaps = 12/172 (6%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
E + LG G FG V++ + + K + G K E+ ++ +HR+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
++ L E ++I+E++ + F L + V + + + L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI--FERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 269 YSRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVGT 318
I H D++ NI+ + + KI +FG AR + + +
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 18/149 (12%), Positives = 48/149 (32%), Gaps = 14/149 (9%)
Query: 158 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRL 212
G ++ L ++VA+ + Q L E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
+ +++ E++ SL A +R ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ S + + D + ++
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 21/178 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLIAK 203
++N+ + +LG+G F V + G E A K +LS + Q L + E + K
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREARICRK 61
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
LQH ++VRL E+ + L+++ + L F ++ A I+ I + +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADAS-HCIQQILESI 118
Query: 264 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
Y H I+HR+LK N+LL S K++DFG+A E GT
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 54/174 (31%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEF---KNEMMLIAKLQH 206
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 207 RHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
V+L+ Q + L Y N L + K R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
YLH IIHRDLK NILL+ DM+ +I+DFG A++ + Q VGT
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLVRLF 213
LG+G FG V + + GQE AVK +S + E+ L+ +L H ++++L+
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
++G L+ E L F +KR A RII + G+ Y+H+ +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAA-RIIRQVLSGITYMHK---NK 146
Query: 274 IIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRDLK N+LL+S D N +I DFG++ F + K +GT
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGT 191
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-19
Identities = 39/211 (18%), Positives = 65/211 (30%), Gaps = 56/211 (26%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+G+G +G V A+K ++ + + + K E+ L+ KL H ++ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 212 LFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV----------------- 253
L+ E + I L+ E L + +
Sbjct: 93 LYEV-YEDEQYICLVMELCHGGHL--LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 254 ----------------------RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-- 289
I+ I L YLH I HRD+K N L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKS 206
Query: 290 MNPKISDFGMARIFGGDELQGNT--KRIVGT 318
K+ DFG+++ F GT
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-19
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 202
+ + T +LG G F V K R G + A K R + E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 203 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
++QH +++ L + + ILI E + L F F +K+ L +A ++ I G
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEAT-EFLKQILNG 126
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 318
+ YLH L+I H DLK NI+L P KI DFG+A K I GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 12/154 (7%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 216
+G G FG R L + VAVK + G + E + E++ L+H ++VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+ +I EY L + R +AR + + G+ Y H ++I H
Sbjct: 86 LTPTHLAIIMEYASGGEL--YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQICH 139
Query: 277 RDLKASNILLDSD--MNPKISDFGMARIFGGDEL 308
RDLK N LLD KI DFG ++
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 15/175 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 206
++N+ + +LG+G F V + G E A K + S + + + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++VRL E+ + L+++ + L F ++ A I+ I + + Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADAS-HCIQQILESIAYC 144
Query: 267 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H I+HR+LK N+LL S K++DFG+A E GT
Sbjct: 145 HS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 26/174 (14%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR-HLVRLF 213
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 214 GCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
E ILI EY + ++ + R+I+ I +G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND------VI-RLIKQILEGVYYLH 148
Query: 268 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
Q I+H DLK NILL + KI DFGM+R G + I+GT
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 28/179 (15%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLTEFKNEMMLIAK 203
KLG G +G V + E A+K + + E NE+ L+
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 204 LQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
L H ++++LF E + L+ E+ L F + + A I++ I G
Sbjct: 103 LDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDAA-NIMKQILSG 158
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ YLH+ I+HRD+K NILL++ +N KI DFG++ F D + +GT
Sbjct: 159 ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGT 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 14/173 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
+ F LG G F V+ + L G+ A+K + + +NE+ ++ K++H +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V L L+ + + L F ++ A +I+ + + YLH+
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL--FDRILERGVYTEKDAS-LVIQQVLSAVKYLHE 124
Query: 269 YSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRDLK N+L + + I+DFG++++ + GT
Sbjct: 125 ---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGT 170
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 43/218 (19%), Positives = 67/218 (30%), Gaps = 56/218 (25%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRH 208
+F +G GGFG V++ + ++ A+KR+ + E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI------------- 255
+VR F +E E D +P V+I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 256 --IEGIAQGLLY----------LHQYSRLR-----------------------------I 274
+ LY L + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 275 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
+HRDLK SNI D K+ DFG+ DE +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 22/187 (11%)
Query: 143 LASVSAA--TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEF 194
+A+++ TE + +LG+G F V + +L GQE A +LS + Q L
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL--- 57
Query: 195 KNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR 254
+ E + L+H ++VRL E+G + LI++ + L F ++ A
Sbjct: 58 EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADAS-H 114
Query: 255 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGN 311
I+ I + +L+ HQ + ++HR+LK N+LL S K++DFG+A G+ Q
Sbjct: 115 CIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169
Query: 312 TKRIVGT 318
GT
Sbjct: 170 WFGFAGT 176
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 47/182 (25%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ + + +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 200 LIAKLQHRHLVRLFGCCI-EQGENI----LIYEYMP---------NKSLDVFLFYPKKKR 245
++ +L H H+V++ I + E ++ E L +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT-----ELHIK 159
Query: 246 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305
L + + G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR
Sbjct: 160 TLLYN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208
Query: 306 DE 307
E
Sbjct: 209 PE 210
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 40/207 (19%), Positives = 77/207 (37%), Gaps = 65/207 (31%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHR 207
++ +S LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 208 HLVRLFGCCIEQGENI--------------------------------------LIYEYM 229
++++L G+ +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 230 PNKSLDVFLFYPKKK--------RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKA 281
P+ V + + + +Q + + + ++H L I HRD+K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ--------LFRAVGFIHS---LGICHRDIKP 169
Query: 282 SNILLDSDMNP-KISDFGMARIFGGDE 307
N+L++S N K+ DFG A+ E
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSE 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 16/170 (9%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 216
LGEG V L+ QE AVK + Q G + E+ ++ + Q HR+++ L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
E+ L++E M S+ K++ +A +++ +A L +LH I H
Sbjct: 81 EEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGIAH 134
Query: 277 RDLKASNILL---DSDMNPKISDFGMARIF-----GGDELQGNTKRIVGT 318
RDLK NIL + KI DF + G+
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 16/174 (9%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
T+ + + +G G + + E AVK + E +L+ QH +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
++ L + ++ E M L ++K +A ++ I + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREAS-AVLFTITKTVEYLHA 134
Query: 269 YSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 318
++HRDLK SNIL + +I DFG A+ + G T
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 21/169 (12%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+G GGFG VY R + ++ A+K L L E + + L++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ + + I + M D+ + R E I GL ++H
Sbjct: 256 CMS-YAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAE-IILGLEHMHN- 310
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+++RDLK +NILLD + +ISD G+A F + VGT
Sbjct: 311 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG+GGFG V ++ ++ A K+L + +G NE ++ K+ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273
E + + L+ M L +++ + +A E I GL LH R R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RER 306
Query: 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I++RDLK NILLD + +ISD G+A + K VGT
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
LG GGFG V+ ++ ++ A K+L+ + +G E ++AK+ R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI-IEGIAQGLLYLHQYSRL 272
E ++ L+ M + ++ + + R I GL +LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
II+RDLK N+LLD D N +ISD G+A + TK GT
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGT 352
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 4e-15
Identities = 34/199 (17%), Positives = 57/199 (28%), Gaps = 46/199 (23%)
Query: 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLTEFKNEMML 200
TE K+GEG FG V++ + VA+K + + + E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 201 IAKLQ---------HRHLVRLFGCCIEQG-------------------ENILIYEYMPNK 232
+L + L QG N + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 233 SLDVFLF-------YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285
V F + +L I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 286 LDSDMNPKISDFGMARIFG 304
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 37/186 (19%), Positives = 65/186 (34%), Gaps = 54/186 (29%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 215
LG G G V + GQ+ A+K L + + + E+ + H+V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILD- 89
Query: 216 CIEQGENILIYEYMPNKSLDVFL--------------------FYPKKKRLLGWQARVRI 255
+YE M + + + + ++ +A I
Sbjct: 90 ---------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER------EAA-EI 133
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNT 312
+ I + +LH I HRD+K N+L + D K++DFG A+ + LQ
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-- 188
Query: 313 KRIVGT 318
T
Sbjct: 189 --PCYT 192
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 215
LGEG F K + Q AVK +S + + E+ + + H ++V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 275
+Q L+ E + L F KKK +A I+ + + ++H + ++
Sbjct: 75 FHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VGVV 128
Query: 276 HRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 34/180 (18%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE--FKN---------EM 198
++ Q + G +G V G G VA+KR+ N G T + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 199 MLIAKLQHRHLVRLFGCCIEQGENI-----LIYEYMPN------KSLDVFLFYPKKKRLL 247
L+ H +++ L + E L+ E M + + P+ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYF 139
Query: 248 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ I GL LH+ ++HRDL NILL + + I DF +AR D
Sbjct: 140 MYH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 15/173 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
++ F + +LG G VY+ + + A+K L + + + E+ ++ +L H +
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+++L E L+ E + L F +K A ++ I + + YLH+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL--FDRIVEKGYYSERDAA-DAVKQILEAVAYLHE 166
Query: 269 YSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
I+HRDLK N+L D KI+DFG+++I L K + GT
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 36/182 (19%), Positives = 76/182 (41%), Gaps = 47/182 (25%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+N+ + +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 200 LIAKLQHRHLVRLFGCCI----EQGENI-LIYEYMP---------NKSLDVFLFYPKKKR 245
++ +L+ +++RL+ I + + + ++ E L + +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT-----EEHIK 132
Query: 246 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305
+ + + G ++H IIHRDLK +N LL+ D + K+ DFG+AR
Sbjct: 133 TILYN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 306 DE 307
++
Sbjct: 182 EK 183
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 38/176 (21%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ + + +G G +G V +G++VA+K+LS F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 200 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMPNKSLDVFL---FYPKKKRLLGWQ 250
L+ +QH +++ L + + L+ +M L + F +K + L +Q
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQ 134
Query: 251 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
+ +GL Y+H ++HRDLK N+ ++ D KI DFG+AR +
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 37/176 (21%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 200 LIAKLQHRHLVRLFGC----CIEQGENI-LIYEYMP---NKSLDVFLFYPKKKRLLGWQA 251
++ + +H +++ + IEQ +++ ++ + M K L +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 252 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
I +GL Y+H S ++HRDLK SN+LL++ + KI DFG+AR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 116 TTRTNELCEADGEGNDKSKDSWLPLFSLASVSAAT-ENFSTQCKLGEGGFGPVYKGRL-L 173
+ E+ E K+K+ +L + S + A + F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 174 NGQEVAVKRLSNQSGQGLTEF---KNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230
+G A+K L Q L + NE ++ + LV+L + ++ EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290
+ F + R AR + I YLH +I+RDLK N+L+D
Sbjct: 125 GGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 291 NPKISDFGMARIFGGDELQGNTKRIVGT 318
+++DFG A+ ++G T + GT
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGT 201
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 200 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV 253
L+ + H++++ L +E+ +++ L+ E M D L + L +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168
Query: 254 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ + + G+ +LH IIHRDLK SNI++ SD KI DFG+AR G
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 45/210 (21%), Positives = 78/210 (37%), Gaps = 25/210 (11%)
Query: 123 CEADGEGNDKSKDSWLPLFSLASVSAAT-----ENFSTQCKLGEGGFGPVYKGRLLNGQE 177
A DK +L V ++F +G G F V ++ +
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ 87
Query: 178 V-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI-LIYEY 228
V A+K ++ + F+ E ++ R + +L + + L+ EY
Sbjct: 88 VYAMKIMNKWDMLKRGEVSC----FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142
Query: 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 288
L + L +R+ AR + E I + +H+ L +HRD+K NILLD
Sbjct: 143 YVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDR 197
Query: 289 DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ +++DFG D + VGT
Sbjct: 198 CGHIRLADFGSCLKLRADGTVR-SLVAVGT 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 12/173 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTE---FKNEMMLIAKLQH 206
E+F +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 207 RHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
+ + L + N+ L+ +Y L + L + RL AR + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+HQ L +HRD+K NIL+D + + +++DFG D + VGT
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 21/207 (10%)
Query: 123 CEADGEGNDKSKDSWLPLFSLASVSAAT-----ENFSTQCKLGEGGFGPVYKGRLLNGQE 177
+ +K+ D++L + E++ +G G FG V R + ++
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 178 V-AVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLFGCCIEQGENIL--IYEYMPN 231
V A+K LS ++ F E ++A +V+LF Q + L + EYMP
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRYLYMVMEYMPG 153
Query: 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291
L + + AR E + L +H + IHRD+K N+LLD +
Sbjct: 154 GDL---VNLMSNYDVPEKWARFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGH 206
Query: 292 PKISDFGMARIFGGDELQGNTKRIVGT 318
K++DFG + + VGT
Sbjct: 207 LKLADFGTCMKMNKEGMVR-CDTAVGT 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 33/161 (20%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HR 207
+++ KLG G + V++ + N ++V VK L + + K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 208 HLVRLFGCCIEQGEN--ILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGL 263
+++ L + L++E++ N R ++ I + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKAL 143
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIF 303
Y H S I+HRD+K N+++D + ++ D+G+A +
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 36/176 (20%), Positives = 63/176 (35%), Gaps = 33/176 (18%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 215
LG G G V + ++ A+K L + + + E+ L + H+VR+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 123
Query: 216 CIEQGENILIYEYMPNKSLDVF-------LF---YPKKKRLLGWQARVRIIEGIAQGLLY 265
E + V LF + + + I++ I + + Y
Sbjct: 124 Y-ENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 266 LHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LH + I HRD+K N+L S + K++DFG A+ + T
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 22/173 (12%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQ 205
+ LG GG G V+ + VA+K++ K+ E+ +I +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLD 66
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP----------KKKRLLGWQARVRI 255
H ++V++F G + + V++ ++ LL AR+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-F 125
Query: 256 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDE 307
+ + +GL Y+H + ++HRDLK +N+ +++ D+ KI DFG+ARI
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 37/176 (21%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ +G G +G V G +VA+K+L F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 200 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK---------KKRLLGWQ 250
L+ ++H +++ L ++ + + D +L P K LG
Sbjct: 77 LLKHMRHENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 251 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
++ + +GL Y+H IIHRDLK N+ ++ D KI DFG+AR +
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 46/182 (25%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 200 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMP-------NKSLDVFLFYPKKKRL 246
L+ + H++++ L +E+ +++ ++ E M LD ++
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-----HERMSY 131
Query: 247 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
L +Q + G+ +LH IIHRDLK SNI++ SD KI DFG+AR G
Sbjct: 132 LLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 307 EL 308
+
Sbjct: 181 FM 182
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 47/177 (26%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ +F + LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 200 LIAKLQHRHLVRLFGC----CIEQGENI-LIYEYMP--------NKSLDVFLFYPKKKRL 246
++ +H +++ +F E + +I E M + L +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS-----DDHIQY 116
Query: 247 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303
+Q + + LH + +IHRDLK SN+L++S+ + K+ DFG+ARI
Sbjct: 117 FIYQ--------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 36/161 (22%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGC 215
LG G G V + ++ A+K L + + + E+ L + Q H+VR+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD- 78
Query: 216 CIEQGENILIYEYMPNKSLDVF----------LF---YPKKKRLLGWQARVRIIEGIAQG 262
+YE + + LF + + + I++ I +
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 300
+ YLH + I HRD+K N+L S + K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
+ KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 200 LIAKLQ-HRHLVRLFGCCI-EQGENI-LIYEYMP--------NKSLDVFLFYPKKKRLLG 248
++ +L H ++V L + ++ L+++YM L+ P K+ +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE-----PVHKQYVV 115
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
+Q + + + YLH S ++HRD+K SNILL+++ + K++DFG++R F
Sbjct: 116 YQ--------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 309 QGNTKR 314
N
Sbjct: 165 VTNNIP 170
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 3e-12
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEF---KNEMMLIAKLQH 206
++F LG G FG V+ R + A+K L + L + +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++R++G + + +I +Y+ L F K +R A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H II+RDLK NILLD + + KI+DFG A+ + T + GT
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 37/171 (21%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 199
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 200 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMP---NKSLDVFLFYPKKKRLLGWQ 250
L+ ++H +++ L +E+ ++ L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 251 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
I +GL Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 27/165 (16%)
Query: 152 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHL 209
NF K+G G FG + G+ L + VA+K +S + E +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 210 VRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGL 263
+++ N ++ E + SL D+F + L + Q + +E
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARIF 303
Y+H + +I+RD+K N L+ N I DF +A+ +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFG 214
+G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H LV L+
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 215 CCIEQGENI-LIYEYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
+ E++ ++ + + L Y + ++ I E + L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICE-LVMALDYLQN--- 133
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
RIIHRD+K NILLD + I+DF +A + +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 25/176 (14%), Positives = 56/176 (31%), Gaps = 43/176 (24%)
Query: 158 KLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLTEFK-----------NE 197
G +Y+ Q+ ++K L + G+ E N+
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 198 MMLIAKLQHRHLVRLFGCCIEQGE-NILIYEYMPNKSL-DVFLFYPKKK------RLLGW 249
+ + G + Q + L+ + +SL PK +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166
Query: 250 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARIF 303
+ + +E +LH+ +H ++ A NI +D + ++ + +G A +
Sbjct: 167 RL-LDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 29/160 (18%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFG 214
++GEG FG +++G LLN Q+VA+K +S Q E++ +L + ++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNVYY 73
Query: 215 CCIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGLLYLHQ 268
E N+L+ + + SL D+ +K + Q + ++ +H+
Sbjct: 74 FGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQM-LARVQ-------SIHE 124
Query: 269 YSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARIF 303
S +++RD+K N L+ + + DFGM + +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 35/175 (20%), Positives = 67/175 (38%), Gaps = 41/175 (23%)
Query: 158 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 211
+G+GGFG +Y + + + VK + +G TE K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 212 L-------------FGCCIEQGE--NILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQ 250
G + G+ +I + L ++ K+ L +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 251 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARIF 303
+ I+E Y+H++ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 161 I-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 25/157 (15%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 215
K+G G FG +Y G + +EVA+K + ++ + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 216 CIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGLLYLHQY 269
+E N+L+ + + SL D+F F +K L L Q + +E ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM-INRVE-------FVHSK 122
Query: 270 SRLRIIHRDLKASNILLDSDMNPK---ISDFGMARIF 303
S +HRD+K N L+ I DFG+A+ +
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 25/157 (15%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGC 215
K+G G FG +Y G + G+EVA+K ++ E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 216 CIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGLLYLHQY 269
E N+++ E + SL D+F F +K L L Q + IE Y+H
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM-ISRIE-------YIHSK 124
Query: 270 SRLRIIHRDLKASNILLDSDMNPK---ISDFGMARIF 303
+ IHRD+K N L+ I DFG+A+ +
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 33/160 (20%), Positives = 55/160 (34%), Gaps = 19/160 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LTEFKNEM-MLIA 202
+ LG G FG V + + VAVK L + +E+ +LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 203 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
H ++V L G C + G + +I E+ +L +L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
G + + I DLK + S + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+A+G+ +L + + IHRDL A NILL KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG V + A+K L ++ LTE + ++ +H L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR----VLQNSRHPFLT 211
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
L + + + + EY ++F +++ +AR E I L YLH
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAE-IVSALDYLH-- 265
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
S +++RDLK N++LD D + KI+DFG+
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 21/159 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+G G + V RL + A+K + TE K+ + H LV
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQASN--HPFLV 73
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
L C + + + EY+ D+ ++++L AR E I+ L YLH+
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE- 128
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 306
II+RDLK N+LLDS+ + K++D+GM + + GD
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+G+G FG V R + AVK L + ++E +N +L+ ++H LV
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE-RN--VLLKNVKHPFLV 102
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
L + + + + +Y+ ++F +++ L +AR E IA L YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAE-IASALGYLHS- 157
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
L I++RDLK NILLDS + ++DFG+
Sbjct: 158 --LNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFK-------NEMMLIAKLQH 206
KLG G F V+ + ++N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 207 RHLVRLFGCCIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 262
H+++L +G N +++E + ++L + + + + + +I + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 263 LLYLHQYSRLRIIHRDLKASNILLDSDMNP------KISDFGMA 300
L Y+H R IIH D+K N+L++ +P KI+D G A
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 21/159 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
+G G + V RL + A++ + TE K+ + H LV
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE-KHVFEQASN--HPFLV 116
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
L C + + + EY+ D+ ++++L AR E I+ L YLH+
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE- 171
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 306
II+RDLK N+LLDS+ + K++D+GM + + GD
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 21/159 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG V+ + A+K L + + E K +L +H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE-KR--VLSLAWEHPFLT 81
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+F C + EN+ + EY+ D+ + +A E I GL +LH
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAE-IILGLQFLHS- 136
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 306
I++RDLK NILLD D + KI+DFGM + + G
Sbjct: 137 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 48/237 (20%), Positives = 90/237 (37%), Gaps = 22/237 (9%)
Query: 82 PSFYIFRRRRRKHKEKENMEANWDLLAFDINMSITTRTNELCEADGEGNDKSKDSWLPLF 141
F+ ++ E N+ + + + ++ + +K+ ++
Sbjct: 271 GVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330
Query: 142 SLASVSAAT-ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLT 192
+ + +F+ LG+G FG V E+ AVK L + +
Sbjct: 331 NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV 390
Query: 193 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 252
E K +L + L +L C + EY+ L +++ ++ +
Sbjct: 391 E-KR--VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPH 443
Query: 253 VRIIEG-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 306
IA GL +L II+RDLK N++LDS+ + KI+DFGM + I+ G
Sbjct: 444 AVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 21/159 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG V E+ AVK L + + E K + L K L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE-KRVLALPGK--PPFLT 84
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L C + + + + EY+ D+ + R A E IA GL +L
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQS- 139
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 306
II+RDLK N++LDS+ + KI+DFGM + I+ G
Sbjct: 140 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG V R+ ++ AVK L + +TE K +L H L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE-KR--ILSLARNHPFLT 87
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+LF C + E++ D+ K +R +AR E I L++LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAE-IISALMFLHD-- 142
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMA--RIFGGD 306
II+RDLK N+LLD + + K++DFGM I G
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 22/159 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+G FG V R A+K L ++ +TE ++ +H L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE-SR---VLQNTRHPFLT 68
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
L + + + + EY ++F +++ +AR E I L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE-IVSALEYLHS- 123
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 306
+++RD+K N++LD D + KI+DFG+ + I G
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 23/157 (14%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR------ 207
+G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHDTEMKY 116
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLLY 265
++V L + + L++E + S +++ + G R + + LL+
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML---SYNLYDLL-RNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 300
L L IIH DLK NILL + KI DFG +
Sbjct: 173 LAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 159 LGEGGFGPVYKGRLLNGQEV----AVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRL 212
LG+G FG V+ + ++G + A+K L + + K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 213 FGCCIEQGENI-LIYEYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ + LI +++ L F K+ + + E +A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE-LALALDHLHS- 144
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
L II+RDLK NILLD + + K++DFG++
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 34/168 (20%), Positives = 66/168 (39%), Gaps = 30/168 (17%)
Query: 158 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLTEFKNEMML-----IAKLQHRH 208
K+G GGFG +Y ++ A VK ++G +E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 209 L--------VRLFGCCIEQGE--NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 257
G +G ++ E + L + K+ Q +R+++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 258 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARIF 303
+ Y+H+ +H D+KA+N+LL ++ +D+G++ +
Sbjct: 163 VLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 159 LGEGGFGPVYKGRLLNGQEV----AVKRLS--------NQSGQGLTEFKNEMMLIAKLQH 206
LG G +G V+ R ++G + A+K L + TE + +L Q
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE-RQ--VLEHIRQS 118
Query: 207 RHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
LV L + + LI +Y+ L F +++R + ++ + E I L +
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVLALEH 174
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LH+ L II+RD+K NILLDS+ + ++DFG+++ F DE + GT
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 4e-09
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 159 LGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIAKLQHRHLV 210
LG+GG+G V++ R + G A+K L ++ + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
L + G + LI EY+ L F+ ++ + A + E I+ L +LHQ
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQ- 139
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 300
II+RDLK NI+L+ + K++DFG+
Sbjct: 140 --KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR------H 208
+G+G FG V K Q VA+K + N+ Q E + ++ L+ + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLLYL 266
++ + + + +E + S++++ KK + G+ VR I Q L L
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELI-KKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 300
H + RIIH DLK NILL K+ DFG +
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 18/172 (10%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ--------HRH 208
KLG G F V+ + + VA+K + + T +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 209 LVRLFGCCIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
+V+L G N +++E + L ++ + L + +II+ + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
YLH ++ RIIH D+K NILL + A + + V
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 22/168 (13%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR-----H 208
K+G+G FG V + + N + AVK + N E ++ K+Q+ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDDINNNN 97
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVR-IIEGIAQGLLYL 266
+V+ G + LI+E + ++ + G+ ++ I + L YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPL---GPSLYEII-TRNNYNGFHIEDIKLYCIEILKALNYL 153
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
++ + H DLK NILLD K G TK
Sbjct: 154 R---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 32/157 (20%), Positives = 57/157 (36%), Gaps = 24/157 (15%)
Query: 158 KLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR----- 207
LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEKDKENK 81
Query: 208 -HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLL 264
V + G + +E + K+ FL K+ + VR + + L
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFL---KENNFQPYPLPHVRHMAYQLCHALR 137
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+LH ++ H DLK NIL + + + +
Sbjct: 138 FLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 24/157 (15%)
Query: 158 KLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR----- 207
LGEG FG V + G+ VAVK + N +E + ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTTDPNST 76
Query: 208 -HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLL 264
V++ G +++E + L + F K+ L ++ +R + I + +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELL---GLSTYDFI-KENGFLPFRLDHIRKMAYQICKSVN 132
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+LH ++ H DLK NIL + + + R
Sbjct: 133 FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 3e-04
Identities = 42/286 (14%), Positives = 83/286 (29%), Gaps = 78/286 (27%)
Query: 35 FGDLIDLRKPISNFTGQSV--YIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRR 92
D+ D+ K I + + + I G +L W +
Sbjct: 35 CKDVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTL-------------------LS 73
Query: 93 KHKE------KENMEANWDLLAFDINMSITTRTNELCEADGEGNDKSKDSWLPLFSLASV 146
K +E +E + N+ L I + + + D+ +F+ +V
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN--QVFAKYNV 131
Query: 147 SAATENFSTQCKL------------GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEF 194
S + L G G G K VA+ + Q +
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K------TWVALDVCLSYKVQ--CKM 180
Query: 195 KNEMMLIAKLQHRHLVRLFGCC------IEQGENILIYEYMPNKSLDVFLFYPKKKRLLG 248
++ + C +E + L+Y+ PN + K R+
Sbjct: 181 DFKIFWLN----------LKNCNSPETVLEMLQK-LLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294
QA +R LL Y ++ +++ + +++ KI
Sbjct: 230 IQAELRR-------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 318 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.94 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.94 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.94 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.94 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.93 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.93 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.68 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.66 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.27 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.09 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.63 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.21 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 83.3 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 80.7 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.65 Aligned_cols=166 Identities=31% Similarity=0.516 Sum_probs=141.6
Q ss_pred hcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|.+.+.||+|+||.||+|++. ++..||||+++..+....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467888999999999999999864 46789999998766666778999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCce
Q 021046 224 LIYEYMPNKSLDVFLFYP----------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 293 (318)
+||||+++|+|.++|... .....++|..+..|+.|||.||+|||+++ ||||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999643 22457999999999999999999999987 99999999999999999999
Q ss_pred EeecccceeecCCccccccceeecC
Q 021046 294 ISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 294 i~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
|+|||+|+..........+....||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred ECCcccceecCCCCceeecCceecC
Confidence 9999999987654433333344554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=296.10 Aligned_cols=166 Identities=31% Similarity=0.512 Sum_probs=134.4
Q ss_pred hcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|.+.++||+|+||.||+|++. +++.||||+++..+....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888899999999999999864 47789999998766666788999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 224 LIYEYMPNKSLDVFLFYPKK------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
|||||+++|+|.+++..... ...++|.+++.|+.|||.||+|||+++ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999865321 246999999999999999999999987 999999999999999999
Q ss_pred ceEeecccceeecCCccccccceeecC
Q 021046 292 PKISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 292 ~ki~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
+||+|||+|+.+........+....||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EEECCCC----------------CCCC
T ss_pred EEEcccccceeccCCCcceecCccccc
Confidence 999999999987655433333444554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.74 Aligned_cols=165 Identities=32% Similarity=0.474 Sum_probs=139.7
Q ss_pred cCCccccccccCCcccEEEEEec------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++...++||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667789999999999999863 46789999997543 345678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 224 LIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
+||||+++|+|.++|..... ...++|..+..|+.|||.||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 246899999999999999999999987 99999999999999999
Q ss_pred CceEeecccceeecCCccccccceeecC
Q 021046 291 NPKISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 291 ~~ki~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
.+||+|||+|+.+...+....+....||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred CEEECCcccceeccCCCceeEecccccC
Confidence 9999999999987655433334444554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.30 Aligned_cols=163 Identities=30% Similarity=0.424 Sum_probs=146.1
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|++.+.||+|+||+||+|+. .+++.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999986 56899999999753 344567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999984 3456999999999999999999999988 99999999999999999999999999999876
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
+.....+..++||
T Consensus 185 ~~~~~~~~~~~GT 197 (311)
T 4aw0_A 185 ESKQARANSFVGT 197 (311)
T ss_dssp TTTCCCBCCCCSC
T ss_pred CCCcccccCcccC
Confidence 6555556677887
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.71 Aligned_cols=160 Identities=26% Similarity=0.395 Sum_probs=142.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999874 6899999999766566667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCcc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 308 (318)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998843 45899999999999999999999988 99999999999999999999999999998865432
Q ss_pred ccccceeecC
Q 021046 309 QGNTKRIVGT 318 (318)
Q Consensus 309 ~~~~~~~~Gt 318 (318)
....++||
T Consensus 226 --~~~~~~GT 233 (346)
T 4fih_A 226 --RRKSLVGT 233 (346)
T ss_dssp --CBCCCCSC
T ss_pred --cccccccC
Confidence 23456777
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.17 Aligned_cols=162 Identities=28% Similarity=0.459 Sum_probs=132.5
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..+++.+.++||+|+||.||+|++.+ .||||+++... ....++|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 45678889999999999999998753 69999987432 3345689999999999999999999998864 5789999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++... ...++|..+..|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999998543 356999999999999999999999987 999999999999999999999999999987654
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (307)
T 3omv_A 186 SGSQQVEQPTGS 197 (307)
T ss_dssp --------CCCC
T ss_pred CcceeecccccC
Confidence 433344556676
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=289.89 Aligned_cols=160 Identities=26% Similarity=0.396 Sum_probs=143.5
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.+.|+..++||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35799999999999999999987 46899999999876666677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCcc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 308 (318)
|++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998842 35899999999999999999999988 99999999999999999999999999998865433
Q ss_pred ccccceeecC
Q 021046 309 QGNTKRIVGT 318 (318)
Q Consensus 309 ~~~~~~~~Gt 318 (318)
....++||
T Consensus 303 --~~~~~~GT 310 (423)
T 4fie_A 303 --RRKSLVGT 310 (423)
T ss_dssp --CBCCCEEC
T ss_pred --cccccccC
Confidence 23456787
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.46 Aligned_cols=163 Identities=24% Similarity=0.379 Sum_probs=135.2
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999986 468999999997542 234567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++... ....+++..+..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999998543 3456789999999999999999999988 999999999999999999999999999987543
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
.. .++.++||
T Consensus 179 ~~--~~~~~~GT 188 (350)
T 4b9d_A 179 VE--LARACIGT 188 (350)
T ss_dssp HH--HHHHHHSC
T ss_pred cc--cccccCCC
Confidence 21 22345565
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=275.25 Aligned_cols=155 Identities=26% Similarity=0.409 Sum_probs=127.8
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCe------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE------ 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 221 (318)
.++|+..+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35699999999999999999986 4689999999875433 334678999999999999999999999986553
Q ss_pred ------eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 222 ------NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 222 ------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
.|+||||+++|+|.+++.........++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 6899999999999999965544455677888999999999999999988 9999999999999999999999
Q ss_pred ecccceeecCCc
Q 021046 296 DFGMARIFGGDE 307 (318)
Q Consensus 296 DfGla~~~~~~~ 307 (318)
|||+|+.+..+.
T Consensus 161 DFGla~~~~~~~ 172 (299)
T 4g31_A 161 DFGLVTAMDQDE 172 (299)
T ss_dssp CCCCC-------
T ss_pred cCccceecCCCc
Confidence 999999887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=275.62 Aligned_cols=162 Identities=27% Similarity=0.350 Sum_probs=130.3
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC----eeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----ENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 226 (318)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 589999999975321 1122345666677899999999999998764 579999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
||+++|+|.+++.. ..++|..+..++.|++.||+|||++ +.++||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 4589999999999999999999986 23469999999999999999999999999999
Q ss_pred eecCCccc--cccceeecC
Q 021046 302 IFGGDELQ--GNTKRIVGT 318 (318)
Q Consensus 302 ~~~~~~~~--~~~~~~~Gt 318 (318)
........ ..+...+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 88654322 223345666
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=269.02 Aligned_cols=159 Identities=30% Similarity=0.505 Sum_probs=125.7
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|++.+.||+|+||.||+|.. .+++.||||++.+. .......+.+|+.++++++|||||++++++.+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999986 46899999998753 233456799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 6889888843 456999999999999999999999988 99999999999999999999999999998765
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
... ....+||
T Consensus 165 ~~~---~~~~~GT 174 (275)
T 3hyh_A 165 GNF---LKTSCGS 174 (275)
T ss_dssp -------------
T ss_pred CCc---cCCeeEC
Confidence 432 2345666
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=273.00 Aligned_cols=157 Identities=29% Similarity=0.444 Sum_probs=132.3
Q ss_pred ccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCeeEEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIY 226 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 226 (318)
...++||+|+||.||+|.+. ++..||+|++... .....+.|.+|+.++++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999874 5889999998653 23345679999999999999999999999875 34579999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999943 457899999999999999999999875 46999999999999985 79999999999986543
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
. .+..++||
T Consensus 185 ~----~~~~~~GT 193 (290)
T 3fpq_A 185 S----FAKAVIGT 193 (290)
T ss_dssp T----SBEESCSS
T ss_pred C----ccCCcccC
Confidence 3 23455676
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=277.94 Aligned_cols=158 Identities=28% Similarity=0.351 Sum_probs=132.9
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.+.|...++||+|+||.||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688889999999999999987 4689999999975322 24699999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceeecCCc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGDE 307 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~~~~~ 307 (318)
+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999843 356999999999999999999999987 99999999999999987 69999999999887653
Q ss_pred ccc---ccceeecC
Q 021046 308 LQG---NTKRIVGT 318 (318)
Q Consensus 308 ~~~---~~~~~~Gt 318 (318)
... ....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 321 22345676
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=280.83 Aligned_cols=174 Identities=26% Similarity=0.361 Sum_probs=144.7
Q ss_pred cHHHHHHHhcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCC-CccceEE
Q 021046 142 SLASVSAATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQH-RHLVRLF 213 (318)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~ 213 (318)
....++.+.++|++.+.||+|+||.||+|.+.. ++.||||++..... ...++|.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344556677899999999999999999998643 35799999976433 335679999999999965 9999999
Q ss_pred EEEEec-CeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 021046 214 GCCIEQ-GENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL 279 (318)
Q Consensus 214 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 279 (318)
|+|.+. +..++|||||++|+|.++|..... ...++|..+..++.|||.||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999775 568999999999999999964321 345899999999999999999999987 999999
Q ss_pred CCCCEEEcCCCCceEeecccceeecCCccccccceeecC
Q 021046 280 KASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 280 k~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
||+|||+++++.+||+|||+|+.+..+.....+....||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 999999999999999999999988665443334445565
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.46 Aligned_cols=160 Identities=27% Similarity=0.343 Sum_probs=130.8
Q ss_pred cCCccccccccCCcccEEEEEec----CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|++.+.||+|+||.||+|+.. +++.||||++++.. ......+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999762 46789999987532 2233468899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999843 456899999999999999999999988 9999999999999999999999999999765
Q ss_pred CCccccccceeecC
Q 021046 305 GDELQGNTKRIVGT 318 (318)
Q Consensus 305 ~~~~~~~~~~~~Gt 318 (318)
.... ....++||
T Consensus 178 ~~~~--~~~~~~GT 189 (304)
T 3ubd_A 178 DHEK--KAYSFCGT 189 (304)
T ss_dssp ---C--CCCSCCCC
T ss_pred CCCc--cccccccC
Confidence 4432 23345676
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=265.91 Aligned_cols=161 Identities=25% Similarity=0.421 Sum_probs=134.5
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEec------Ce
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------GE 221 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 221 (318)
++|++.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.+|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999987 5689999999975432 2345688999999999999999999998643 57
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.|+||||++ |+|..++. ....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67888883 4567999999999999999999999988 9999999999999999999999999999
Q ss_pred eecCCcc--ccccceeecC
Q 021046 302 IFGGDEL--QGNTKRIVGT 318 (318)
Q Consensus 302 ~~~~~~~--~~~~~~~~Gt 318 (318)
.+..... .......+||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 8754322 2234456676
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=256.79 Aligned_cols=148 Identities=22% Similarity=0.361 Sum_probs=131.7
Q ss_pred HHhcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
...++|++.++||+|+||.||+|+.+ +++.||||++... .....+.+|+.+|..+ +||||+++++++.+++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999753 4678999998653 3456788999999998 699999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeecccce
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR 301 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~DfGla~ 301 (318)
++||||+++|+|.+++ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999988 24889999999999999999999988 9999999999999877 799999999999
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.....
T Consensus 167 ~~~~~ 171 (361)
T 4f9c_A 167 GTHDT 171 (361)
T ss_dssp ECTTC
T ss_pred ccCCc
Confidence 77543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=272.95 Aligned_cols=159 Identities=29% Similarity=0.349 Sum_probs=135.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHH---HHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKN---EMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+. .......+.+ ++.++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999874 6899999998643 1223333333 46677788999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
|+||||++||+|..++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999843 456899999999999999999999988 99999999999999999999999999998
Q ss_pred ecCCccccccceeecC
Q 021046 303 FGGDELQGNTKRIVGT 318 (318)
Q Consensus 303 ~~~~~~~~~~~~~~Gt 318 (318)
+..+. +..++||
T Consensus 342 ~~~~~----~~t~~GT 353 (689)
T 3v5w_A 342 FSKKK----PHASVGT 353 (689)
T ss_dssp CSSCC----CCSCCSC
T ss_pred cCCCC----CCCccCC
Confidence 86543 3345777
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=268.13 Aligned_cols=161 Identities=24% Similarity=0.387 Sum_probs=141.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999987 46899999999765555567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC--CCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..+
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999988842 3456899999999999999999999988 9999999999999864 89999999999988654
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
.. ....+||
T Consensus 311 ~~---~~~~~GT 319 (573)
T 3uto_A 311 QS---VKVTTGT 319 (573)
T ss_dssp SE---EEEECSS
T ss_pred Cc---eeeeEEC
Confidence 32 2344565
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=242.41 Aligned_cols=157 Identities=44% Similarity=0.725 Sum_probs=142.2
Q ss_pred HHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
...+++|...+.||+|+||.||+|.+.+++.||||++........+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 44678999999999999999999998889999999998766666788999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999885432 2346899999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 192 ~ 192 (321)
T 2qkw_B 192 L 192 (321)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=238.53 Aligned_cols=171 Identities=43% Similarity=0.716 Sum_probs=149.5
Q ss_pred CCCCcccHHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEE
Q 021046 136 SWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFG 214 (318)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~ 214 (318)
..+..++..++....++|...+.||+|+||.||+|...+++.||||++..... .....+.+|+.++..++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567888999999999999999999999999999988899999999976432 23347899999999999999999999
Q ss_pred EEEecCeeEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCce
Q 021046 215 CCIEQGENILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293 (318)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 293 (318)
++..++..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||++...+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999986543 345699999999999999999999998333499999999999999999999
Q ss_pred EeecccceeecCC
Q 021046 294 ISDFGMARIFGGD 306 (318)
Q Consensus 294 i~DfGla~~~~~~ 306 (318)
|+|||+|+.+...
T Consensus 175 l~Dfg~~~~~~~~ 187 (326)
T 3uim_A 175 VGDFGLAKLMDYK 187 (326)
T ss_dssp ECCCSSCEECCSS
T ss_pred eccCccccccCcc
Confidence 9999999987644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=232.59 Aligned_cols=167 Identities=41% Similarity=0.635 Sum_probs=147.8
Q ss_pred CCCCcccHHHHHHHhcCCccc------cccccCCcccEEEEEecCCcEEEEEEccCCC----CcCHHHHHHHHHHHhccC
Q 021046 136 SWLPLFSLASVSAATENFSTQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQ 205 (318)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~ 205 (318)
...+.|+..++...+++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++..++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345678889999999998876 8899999999999987 67899999987532 223567899999999999
Q ss_pred CCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 206 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
||||+++++++.+++..++||||+++|+|.+++........+++..+..++.|++.||.|||+++ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999865545567999999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
++.++.+||+|||+++.....
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSC
T ss_pred EcCCCcEEEeecccccccccc
Confidence 999999999999999887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=233.34 Aligned_cols=160 Identities=28% Similarity=0.413 Sum_probs=141.8
Q ss_pred cccHHHHHHHhcC----------CccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc
Q 021046 140 LFSLASVSAATEN----------FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208 (318)
Q Consensus 140 ~~~~~~~~~~~~~----------~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n 208 (318)
.++.+++...++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.+++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3555555555543 667789999999999999875 68999999998766667788999999999999999
Q ss_pred cceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 021046 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 288 (318)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 288 (318)
|+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999883 346899999999999999999999987 999999999999999
Q ss_pred CCCceEeecccceeecCC
Q 021046 289 DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 289 ~~~~ki~DfGla~~~~~~ 306 (318)
++.+||+|||+++.+..+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp TCCEEECCCTTCEECCSS
T ss_pred CCcEEEeeeeeeeecccC
Confidence 999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=231.88 Aligned_cols=152 Identities=25% Similarity=0.401 Sum_probs=138.5
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999986 5689999999976666667789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999998843 35889999999999999999999987 9999999999999999999999999998876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=233.49 Aligned_cols=152 Identities=27% Similarity=0.460 Sum_probs=137.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|...+.||+|+||.||++... +++.||+|++........+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468899999999999999999874 5889999998776666677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999998542 456899999999999999999999988 999999999999999999999999999987544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=247.15 Aligned_cols=159 Identities=21% Similarity=0.279 Sum_probs=138.9
Q ss_pred HHHHHHhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 144 ASVSAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 144 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
..+....++|+..++||+|+||.||+|+... ++.||+|++.+. .......+.+|..++..++||||+++++++.++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3344556899999999999999999998754 788999998642 122334588999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
+..++||||+++|+|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999999999853 2456899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCc
Q 021046 300 ARIFGGDE 307 (318)
Q Consensus 300 a~~~~~~~ 307 (318)
|+.+..+.
T Consensus 222 a~~~~~~~ 229 (437)
T 4aw2_A 222 CLKLMEDG 229 (437)
T ss_dssp CEECCTTS
T ss_pred hhhcccCC
Confidence 98876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=233.81 Aligned_cols=155 Identities=25% Similarity=0.379 Sum_probs=136.0
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCe-----
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----- 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 221 (318)
..++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3567999999999999999999875 789999999875433 345679999999999999999999999876542
Q ss_pred ----------------------------------------------------eEEEEEeccCCChhhhhhcCCCCCCCCH
Q 021046 222 ----------------------------------------------------NILIYEYMPNKSLDVFLFYPKKKRLLGW 249 (318)
Q Consensus 222 ----------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 249 (318)
.++||||+++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7999999999999999976655566788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 250 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 250 ~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 889999999999999999987 999999999999999999999999999988654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=235.11 Aligned_cols=151 Identities=30% Similarity=0.421 Sum_probs=133.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++..++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 688999999865432 334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999883 3456899999999999999999999987 999999999999999999999999999877544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=236.99 Aligned_cols=152 Identities=32% Similarity=0.468 Sum_probs=136.1
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999987 67899999998754 223456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998843 345899999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
+
T Consensus 167 ~ 167 (328)
T 3fe3_A 167 G 167 (328)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=238.64 Aligned_cols=155 Identities=29% Similarity=0.506 Sum_probs=135.6
Q ss_pred HhcCCccccccccCCcccEEEEEec--------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
..++|.+.+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999762 345799999976432 3456789999999999 89999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
++..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999864321 245899999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
++.++.+||+|||+|+.+...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCC
T ss_pred ECCCCCEEEccccCCcccCcc
Confidence 999999999999999977653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=235.35 Aligned_cols=150 Identities=25% Similarity=0.307 Sum_probs=134.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|+..+.||+|+||.||+++.. +++.||+|.+++. .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999874 6899999999753 334567789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988843 356899999999999999999999987 99999999999999999999999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=244.12 Aligned_cols=155 Identities=24% Similarity=0.282 Sum_probs=136.7
Q ss_pred HHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
+....++|...+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++..++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3445678999999999999999999875 5889999998642 22334568899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++|+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999998842 35889999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCc
Q 021046 302 IFGGDE 307 (318)
Q Consensus 302 ~~~~~~ 307 (318)
.+..+.
T Consensus 217 ~~~~~~ 222 (410)
T 3v8s_A 217 KMNKEG 222 (410)
T ss_dssp ECCTTS
T ss_pred eeccCC
Confidence 876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=234.53 Aligned_cols=164 Identities=30% Similarity=0.458 Sum_probs=135.9
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe----eEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----NIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~l 224 (318)
..++|++.+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++..... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999875 7899999996532 333456678999999999999999999998653 699
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ...+|+||||||+|||++.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999843 3489999999999999999999987 0113999999999999999999999999
Q ss_pred ccceeecCCccccccceeecC
Q 021046 298 GMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 298 Gla~~~~~~~~~~~~~~~~Gt 318 (318)
|+|+.+.............||
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCC
T ss_pred CcccccccccCccccccCccC
Confidence 999988765433333333443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=243.19 Aligned_cols=159 Identities=21% Similarity=0.281 Sum_probs=138.9
Q ss_pred HHHHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 144 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 144 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
.+.....++|+..+.||+|+||.||+++.. +++.||+|++++.. ......+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 334455689999999999999999999874 68999999986521 22334588999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
+..++||||+++|+|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 9999999999999999998532 346899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCc
Q 021046 300 ARIFGGDE 307 (318)
Q Consensus 300 a~~~~~~~ 307 (318)
|+.+..+.
T Consensus 209 a~~~~~~~ 216 (412)
T 2vd5_A 209 CLKLRADG 216 (412)
T ss_dssp CEECCTTS
T ss_pred heeccCCC
Confidence 99876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=236.26 Aligned_cols=151 Identities=28% Similarity=0.389 Sum_probs=133.2
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
...++|+..+.||+|+||.||+++.. +++.||||++++. .......+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34678999999999999999999874 5889999998753 234556788999999988 699999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999988843 356899999999999999999999987 99999999999999999999999999986
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
..
T Consensus 174 ~~ 175 (353)
T 3txo_A 174 GI 175 (353)
T ss_dssp SC
T ss_pred cc
Confidence 44
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=236.63 Aligned_cols=151 Identities=24% Similarity=0.365 Sum_probs=136.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999864 5789999998643 234567889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999884 3456899999999999999999999988 99999999999999999999999999998764
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
+
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=231.84 Aligned_cols=152 Identities=28% Similarity=0.385 Sum_probs=135.7
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||++... +|+.||+|.+..... ...+.+.+|+.++..++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999875 588999999875432 235789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----CceEeec
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDF 297 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~ki~Df 297 (318)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999983 3457899999999999999999999987 99999999999998877 7999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+|+.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=237.98 Aligned_cols=150 Identities=25% Similarity=0.359 Sum_probs=131.9
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (318)
..++|++.+.||+|+||.||+++.. +++.||+|++++.. ....+.+..|..++.++ +||||+++++++.+++..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3578999999999999999999875 57889999987542 23345688899999887 8999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999988843 356899999999999999999999988 999999999999999999999999999864
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 204 ~ 204 (396)
T 4dc2_A 204 L 204 (396)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.08 Aligned_cols=150 Identities=28% Similarity=0.414 Sum_probs=135.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|...+.||+|+||.||+++.. +++.||+|.+++. .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999874 6899999998753 234567788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999843 356899999999999999999999987 99999999999999999999999999997654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=233.08 Aligned_cols=151 Identities=27% Similarity=0.366 Sum_probs=133.9
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 222 (318)
...++|...+.||+|+||.||+|+.. +++.||||++++. .......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45689999999999999999999875 5889999999753 234566788899999877 899999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999998843 346899999999999999999999987 99999999999999999999999999986
Q ss_pred ec
Q 021046 303 FG 304 (318)
Q Consensus 303 ~~ 304 (318)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=230.81 Aligned_cols=152 Identities=31% Similarity=0.533 Sum_probs=134.3
Q ss_pred hcCCccccccccCCcccEEEEEec----CCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|.+.+.||+|+||.||+|.+. .+..||||.++.. .....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999874 3456999999764 23345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 2356899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
.+
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=238.18 Aligned_cols=153 Identities=29% Similarity=0.451 Sum_probs=135.9
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|...+.||+|+||.||+|.+. +++.||||.++.... ....+|.+|+.++++++||||+++++++..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4578999999999999999999885 688999999875422 23457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....+
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999853 2346899999999999999999999987 999999999999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=226.97 Aligned_cols=151 Identities=28% Similarity=0.448 Sum_probs=133.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+++. .+++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999986 4688999998865332 2345789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=230.40 Aligned_cols=157 Identities=29% Similarity=0.505 Sum_probs=131.6
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
...++|.+.+.||+|+||.||+|+. +++.||||++..... ...+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999987 678999999875432 3345789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++........+++..+..++.|++.||+|||+++ .+|+||||||+||+++.++.+||+|||+|+....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999864433345899999999999999999999874 3499999999999999999999999999986654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 192 ~ 192 (309)
T 3p86_A 192 T 192 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=225.19 Aligned_cols=150 Identities=25% Similarity=0.401 Sum_probs=128.9
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--------------------------cCHHHHHHHHHHHh
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------------------------QGLTEFKNEMMLIA 202 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------------------~~~~~~~~e~~~l~ 202 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999986 4588999999865321 12356899999999
Q ss_pred ccCCCccceEEEEEEe--cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 021046 203 KLQHRHLVRLFGCCIE--QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280 (318)
Q Consensus 203 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 280 (318)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.|++.||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3457899999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCceEeecccceeecCC
Q 021046 281 ASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 281 ~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+|||++.++.+||+|||+|+.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999887643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.02 Aligned_cols=152 Identities=34% Similarity=0.558 Sum_probs=128.0
Q ss_pred hcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|.+.+.||+|+||.||+|+.. ++..||||.++... ....++|.+|+.++.+++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999864 46789999997542 2345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999853 2456899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
.+
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=227.27 Aligned_cols=155 Identities=29% Similarity=0.418 Sum_probs=136.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecC--eeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--ENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 225 (318)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999875 48899999997543 345678899999999999999999999998765 67999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCCceEeecccce
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR 301 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~ki~DfGla~ 301 (318)
|||+++|+|.+++........+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999965544455999999999999999999999987 9999999999999 788889999999999
Q ss_pred eecCCc
Q 021046 302 IFGGDE 307 (318)
Q Consensus 302 ~~~~~~ 307 (318)
.+..+.
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=231.23 Aligned_cols=150 Identities=25% Similarity=0.325 Sum_probs=135.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++..++||||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 6899999998653 234567889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999998843 345899999999999999999999988 99999999999999999999999999997754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=222.62 Aligned_cols=151 Identities=32% Similarity=0.553 Sum_probs=137.1
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|...+.||+|+||.||+|...+++.||+|++... ....+++.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4689999999999999999999988899999999763 345578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+....+
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999853 2356899999999999999999999988 999999999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=236.17 Aligned_cols=151 Identities=19% Similarity=0.263 Sum_probs=132.3
Q ss_pred HHhcCCccccccccCCcccEEEEE------ecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC---CCccceEEEEEEe
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIE 218 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 218 (318)
...++|.+.+.||+|+||.||+|. ..+++.||||++... ...++..|+.++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 456889999999753 4567888888888886 9999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--------
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPK--KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------- 288 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-------- 288 (318)
++..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999986422 3467999999999999999999999987 999999999999998
Q ss_pred ---CCCceEeecccceeec
Q 021046 289 ---DMNPKISDFGMARIFG 304 (318)
Q Consensus 289 ---~~~~ki~DfGla~~~~ 304 (318)
++.+||+|||+|+.+.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ---CTTEEECCCTTCEEGG
T ss_pred ccccCCEEEeeCchhhhhh
Confidence 8999999999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=236.56 Aligned_cols=162 Identities=28% Similarity=0.421 Sum_probs=137.8
Q ss_pred cHHHHHHHhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEE
Q 021046 142 SLASVSAATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLF 213 (318)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~ 213 (318)
.........++|.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+.++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445556778999999999999999999974 3457899999976432 3345799999999999 789999999
Q ss_pred EEEEecCe-eEEEEEeccCCChhhhhhcCCC-------------------------------------------------
Q 021046 214 GCCIEQGE-NILIYEYMPNKSLDVFLFYPKK------------------------------------------------- 243 (318)
Q Consensus 214 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------- 243 (318)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99988654 8999999999999999865322
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 244 --------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 244 --------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999987 999999999999999999999999999877544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-30 Score=226.03 Aligned_cols=151 Identities=28% Similarity=0.401 Sum_probs=135.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999874 588999999875422 2467899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----CceEeecc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 298 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~ki~DfG 298 (318)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999983 3456899999999999999999999987 99999999999999887 79999999
Q ss_pred cceeecCC
Q 021046 299 MARIFGGD 306 (318)
Q Consensus 299 la~~~~~~ 306 (318)
+|+.+..+
T Consensus 164 ~a~~~~~~ 171 (326)
T 2y0a_A 164 LAHKIDFG 171 (326)
T ss_dssp TCEECCTT
T ss_pred CCeECCCC
Confidence 99987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-30 Score=225.98 Aligned_cols=151 Identities=22% Similarity=0.316 Sum_probs=134.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 5789999998753 33445788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.+..+
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998842 2346899999999999999999999987 999999999999987 789999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=231.61 Aligned_cols=149 Identities=26% Similarity=0.353 Sum_probs=132.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (318)
.++|...+.||+|+||.||+++.. +++.||+|++.+... ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999875 588999999975432 2345678899999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999988843 346899999999999999999999987 9999999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=230.34 Aligned_cols=150 Identities=29% Similarity=0.377 Sum_probs=125.6
Q ss_pred hcCCccccccccCCcccEEEEEe----cCCcEEEEEEccCCC----CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
.++|+..+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++..++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 57899999999999999999987 478999999997542 2334567899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998843 346889999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 6543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-30 Score=221.17 Aligned_cols=153 Identities=31% Similarity=0.473 Sum_probs=138.1
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|...+.||+|+||.||++...++..||+|.+... ....+++.+|+.++.+++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 35789999999999999999999988889999999764 34557899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+....+.
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999988532 346899999999999999999999987 9999999999999999999999999998776543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=231.08 Aligned_cols=150 Identities=27% Similarity=0.326 Sum_probs=133.9
Q ss_pred HhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (318)
..++|...+.||+|+||.||+++... ++.||+|++++. .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999998754 788999998753 234567788999999988 7999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999998843 346899999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=222.02 Aligned_cols=149 Identities=26% Similarity=0.451 Sum_probs=130.2
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999874 588999999875432 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|++++ +..++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 99864 4444422 2456899999999999999999999987 99999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.47 Aligned_cols=156 Identities=30% Similarity=0.491 Sum_probs=137.0
Q ss_pred HHHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
....++|...+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+.++.+++||||+++++++.++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 445689999999999999999999874 347899999976432 3356789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD 278 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~D 278 (318)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999864321 256899999999999999999999987 99999
Q ss_pred CCCCCEEEcCCCCceEeecccceeecC
Q 021046 279 LKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 279 lk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+||+++.++.+||+|||+++.+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred CCcceEEECCCCeEEEeecCCCccccc
Confidence 999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=239.90 Aligned_cols=155 Identities=28% Similarity=0.488 Sum_probs=138.8
Q ss_pred HHhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
...++|...+.||+|+||.||+|.+.. +..||||.++.. ....++|.+|+.++.+++||||+++++++...+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345678889999999999999998864 789999999764 345788999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999998543 2356899999999999999999999987 999999999999999999999999999987654
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 372 ~ 372 (495)
T 1opk_A 372 T 372 (495)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-31 Score=235.46 Aligned_cols=150 Identities=20% Similarity=0.284 Sum_probs=126.5
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--------CcCHHHHHHHHHHHhccC---------CCccce
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLTEFKNEMMLIAKLQ---------HRHLVR 211 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~ 211 (318)
..++|.+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356799999999999999999988 78999999987542 233478899999998886 777777
Q ss_pred EEEEEE-----------------e-------------cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 021046 212 LFGCCI-----------------E-------------QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261 (318)
Q Consensus 212 l~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~ 261 (318)
+.+++. + .+..++||||+++|++.+.+. ...+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 777643 2 678999999999997666552 256899999999999999
Q ss_pred HHHHHH-hcCCCCeeecCCCCCCEEEcCCC--------------------CceEeecccceeecCC
Q 021046 262 GLLYLH-QYSRLRIIHRDLKASNILLDSDM--------------------NPKISDFGMARIFGGD 306 (318)
Q Consensus 262 ~l~yLH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~ki~DfGla~~~~~~ 306 (318)
||.||| +.+ |+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~ 235 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC
Confidence 999999 887 99999999999999887 8999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=225.10 Aligned_cols=151 Identities=32% Similarity=0.444 Sum_probs=132.1
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|+..+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++.+++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3578999999999999999999998899999999875422 22467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 77776643 3456899999999999999999999987 99999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=235.99 Aligned_cols=151 Identities=30% Similarity=0.515 Sum_probs=136.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999875 6899999998653 223456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999884 3456899999999999999999999987 99999999999999999999999999998765
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
+
T Consensus 169 ~ 169 (476)
T 2y94_A 169 G 169 (476)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=225.85 Aligned_cols=155 Identities=34% Similarity=0.530 Sum_probs=135.9
Q ss_pred HhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457899999999999999999976 235789999997543 2345678999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 021046 222 NILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 280 (318)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999864322 234889999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCceEeecccceeecCC
Q 021046 281 ASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 281 ~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+||+++.++.+||+|||+++.....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTT
T ss_pred hheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999987554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=232.64 Aligned_cols=155 Identities=30% Similarity=0.487 Sum_probs=135.6
Q ss_pred HhcCCccccccccCCcccEEEEEec--------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
..++|.+.+.||+|+||.||+|+.. .+..||||++..... .....+.+|+.++.++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578999999999999999999852 235799999976432 3346789999999999 99999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
++..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999864321 245899999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
++.++.+||+|||+|+.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCC
T ss_pred EcCCCcEEEcccCcccccccc
Confidence 999999999999999877643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=229.49 Aligned_cols=153 Identities=25% Similarity=0.365 Sum_probs=135.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999874 6889999999765444556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||+|+.+..+
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988843 2346899999999999999999999987 999999999999974 477999999999988654
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=227.62 Aligned_cols=153 Identities=32% Similarity=0.540 Sum_probs=132.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec--Ce
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 221 (318)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++.+++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 347899999999999999999984 35789999999876555667899999999999999999999998654 55
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999998543 345899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+..+
T Consensus 163 ~~~~~ 167 (295)
T 3ugc_A 163 VLPQD 167 (295)
T ss_dssp -----
T ss_pred cccCC
Confidence 87544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=234.28 Aligned_cols=152 Identities=34% Similarity=0.500 Sum_probs=132.1
Q ss_pred hcCCccccccccCCcccEEEEEec------CCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++.+++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999853 4668999999754 233445789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEe
Q 021046 223 ILIYEYMPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS 295 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~ 295 (318)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986432 2346899999999999999999999988 99999999999999555 59999
Q ss_pred ecccceeec
Q 021046 296 DFGMARIFG 304 (318)
Q Consensus 296 DfGla~~~~ 304 (318)
|||+|+.+.
T Consensus 227 DFG~a~~~~ 235 (367)
T 3l9p_A 227 DFGMARDIY 235 (367)
T ss_dssp CCHHHHHHH
T ss_pred CCccccccc
Confidence 999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=221.05 Aligned_cols=152 Identities=30% Similarity=0.473 Sum_probs=134.8
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|...+.||+|+||.||++.+.++..||+|++... ....+++.+|+.++.+++||||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45789999999999999999999988889999999764 34457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....+
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999998532 346899999999999999999999987 999999999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=227.06 Aligned_cols=155 Identities=26% Similarity=0.372 Sum_probs=134.8
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-----CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++..++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999986 46899999988532 2235678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC---ceEeeccc
Q 021046 224 LIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGM 299 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~ki~DfGl 299 (318)
+||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999987775322 3446899999999999999999999987 999999999999987655 99999999
Q ss_pred ceeecCCc
Q 021046 300 ARIFGGDE 307 (318)
Q Consensus 300 a~~~~~~~ 307 (318)
|+.+....
T Consensus 180 a~~~~~~~ 187 (351)
T 3c0i_A 180 AIQLGESG 187 (351)
T ss_dssp CEECCTTS
T ss_pred eeEecCCC
Confidence 99876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=228.35 Aligned_cols=156 Identities=30% Similarity=0.448 Sum_probs=133.6
Q ss_pred HHhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
...++|...+.||+|+||.||+|.. .++..||||.+... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999986 24568999999754 233456899999999999 899999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKK--------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL 279 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 279 (318)
+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999865322 134899999999999999999999987 999999
Q ss_pred CCCCEEEcCCCCceEeecccceeecCC
Q 021046 280 KASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 280 k~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+||+++.++.+||+|||+|+.+..+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccC
Confidence 999999999999999999999877544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=237.33 Aligned_cols=154 Identities=31% Similarity=0.462 Sum_probs=137.2
Q ss_pred HHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
....++|...+.||+|+||.||+|.+.++..||||+++.. ....+.|.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3456789999999999999999999988899999999764 356788999999999999999999999986 66789999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999998532 1235788999999999999999999987 999999999999999999999999999887543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=229.49 Aligned_cols=156 Identities=31% Similarity=0.515 Sum_probs=122.2
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCc----EEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
...++|...+.||+|+||.||+|...... .||||.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34578999999999999999999865432 7999999754 33446789999999999999999999999988766
Q ss_pred e------EEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCc
Q 021046 222 N------ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 292 (318)
Q Consensus 222 ~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 292 (318)
. ++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999885432 2236899999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeecCC
Q 021046 293 KISDFGMARIFGGD 306 (318)
Q Consensus 293 ki~DfGla~~~~~~ 306 (318)
||+|||+|+.+...
T Consensus 177 kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 177 CVADFGLSRKIYSG 190 (323)
T ss_dssp EECCCCC-------
T ss_pred EEeecccccccccc
Confidence 99999999877544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=228.58 Aligned_cols=149 Identities=24% Similarity=0.303 Sum_probs=130.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|...+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468999999999999999999875 68899999997643 334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC--ceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~ki~DfGla~~~~ 304 (318)
|+++|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+|+...
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999998843 346899999999999999999999987 999999999999987765 9999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=239.62 Aligned_cols=151 Identities=25% Similarity=0.294 Sum_probs=125.3
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|+..+.||+|+||.||++.. .+++.||||++... .......+.+|+.++..++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 356899999999999999999986 46889999998753 33445678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||||+++|+|..++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999988843 3568999999999999999999998 66 999999999999999999999999999865
Q ss_pred cC
Q 021046 304 GG 305 (318)
Q Consensus 304 ~~ 305 (318)
..
T Consensus 300 ~~ 301 (446)
T 4ejn_A 300 IK 301 (446)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=228.14 Aligned_cols=150 Identities=29% Similarity=0.476 Sum_probs=133.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999986 56889999998643 223346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+ +|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6888887743 346899999999999999999999988 99999999999999999999999999987755
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 161 ~ 161 (336)
T 3h4j_B 161 G 161 (336)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=226.91 Aligned_cols=151 Identities=26% Similarity=0.389 Sum_probs=129.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc---CHHHHHHHHHHHhccCCCccceEEEEEEecCee---
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN--- 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 222 (318)
.++|.+.+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++.+++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 56889999999764332 235788999999999999999999999876543
Q ss_pred -EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 223 -ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 223 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999843 346899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 77543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=225.05 Aligned_cols=155 Identities=29% Similarity=0.511 Sum_probs=134.7
Q ss_pred HhcCCccccccccCCcccEEEEEec--------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
..++|.+.+.||+|+||.||+|... ++..||||++..... .....+.+|+.++.++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 467899999975432 3456789999999999 89999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
++..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999864321 234899999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
++.++.+||+|||+++.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=237.02 Aligned_cols=155 Identities=28% Similarity=0.391 Sum_probs=137.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|...+.||+|+||.||+++.. +|+.||+|++.+. .......+..|+.++.+++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999874 6899999999653 234567789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 226 YEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999886432 2457999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=228.07 Aligned_cols=152 Identities=26% Similarity=0.425 Sum_probs=134.1
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999874 58899999987542 23346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEeeccccee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARI 302 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~DfGla~~ 302 (318)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999988884 3456899999999999999999999987 99999999999998654 599999999988
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=238.70 Aligned_cols=154 Identities=28% Similarity=0.350 Sum_probs=136.9
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|...+.||+|+||.||++... +|+.||+|++... .......+.+|+.++..++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467899999999999999999874 6899999998653 23455678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|..++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999988543 2345899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
.+
T Consensus 338 ~~ 339 (576)
T 2acx_A 338 EG 339 (576)
T ss_dssp TT
T ss_pred cC
Confidence 54
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=218.39 Aligned_cols=152 Identities=24% Similarity=0.404 Sum_probs=137.7
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999875 467899999987666677899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~~~~ 304 (318)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+|..+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999888743 345899999999999999999999987 9999999999999 888999999999998876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 161 ~~ 162 (277)
T 3f3z_A 161 PG 162 (277)
T ss_dssp TT
T ss_pred Cc
Confidence 54
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=217.46 Aligned_cols=151 Identities=30% Similarity=0.411 Sum_probs=135.3
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3568999999999999999999875 688999999875432 33567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..+..
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999883 3456899999999999999999999987 99999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=221.68 Aligned_cols=149 Identities=28% Similarity=0.471 Sum_probs=132.6
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|...+.||+|+||.||+|...+++.||+|++.... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999998889999999986532 23346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 985 88887743 2356889999999999999999999987 99999999999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=230.60 Aligned_cols=150 Identities=27% Similarity=0.310 Sum_probs=124.0
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHH-HhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMML-IAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..++|+..+.||+|+||.||+++.. +++.||+|++.+.. ......+..|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3578999999999999999999875 57899999997542 2233456667766 57789999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999988843 346888999999999999999999987 999999999999999999999999999864
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 190 ~ 190 (373)
T 2r5t_A 190 I 190 (373)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=228.78 Aligned_cols=149 Identities=30% Similarity=0.422 Sum_probs=127.0
Q ss_pred ccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccCC
Q 021046 154 STQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 232 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (318)
...+.||+|+||.||+|.. .+++.||+|+++.......+.+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3457899999999999986 468999999998755555678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE--cCCCCceEeecccceeecCCc
Q 021046 233 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~~~ki~DfGla~~~~~~~ 307 (318)
+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99888743 2346899999999999999999999987 9999999999999 567889999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=222.70 Aligned_cols=150 Identities=23% Similarity=0.301 Sum_probs=133.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.++.++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 5688999999875432 34688999999999 99999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC-----ceEeeccccee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARI 302 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~ki~DfGla~~ 302 (318)
|+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 457899999999999999999999987 999999999999998887 99999999998
Q ss_pred ecCCc
Q 021046 303 FGGDE 307 (318)
Q Consensus 303 ~~~~~ 307 (318)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 76543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=219.77 Aligned_cols=147 Identities=29% Similarity=0.426 Sum_probs=127.1
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhc--cCCCccceEEEEEEec----CeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK--LQHRHLVRLFGCCIEQ----GENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~ 223 (318)
.++|...+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... +..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999988 6889999998653 33456666666655 7999999999997653 4579
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
+||||+++|+|.+++. ...+++..+..++.|++.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346899999999999999999999 655 9999999999999999999999
Q ss_pred ecccceeecCCc
Q 021046 296 DFGMARIFGGDE 307 (318)
Q Consensus 296 DfGla~~~~~~~ 307 (318)
|||+|+......
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999998876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=232.72 Aligned_cols=150 Identities=29% Similarity=0.498 Sum_probs=133.2
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC-eeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-ENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 227 (318)
..++|...+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+.++.+++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4568889999999999999999885 6799999997643 4578999999999999999999999988765 7899999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999643 2345789999999999999999999987 99999999999999999999999999986543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=230.44 Aligned_cols=155 Identities=29% Similarity=0.418 Sum_probs=136.2
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecC--eeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--ENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 225 (318)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999875 48999999997543 345677889999999999999999999998765 67999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCCceEeecccce
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR 301 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~ki~DfGla~ 301 (318)
|||+++|+|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999865444445999999999999999999999987 9999999999999 778889999999999
Q ss_pred eecCCc
Q 021046 302 IFGGDE 307 (318)
Q Consensus 302 ~~~~~~ 307 (318)
.+..+.
T Consensus 165 ~~~~~~ 170 (396)
T 4eut_A 165 ELEDDE 170 (396)
T ss_dssp ECCCGG
T ss_pred EccCCC
Confidence 876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-30 Score=225.57 Aligned_cols=152 Identities=32% Similarity=0.526 Sum_probs=130.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCc----EEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|...+.||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467899999999999999999864 344 38888876432 334467889999999999999999999886 56789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999988532 356888999999999999999999987 999999999999999999999999999987
Q ss_pred cCCc
Q 021046 304 GGDE 307 (318)
Q Consensus 304 ~~~~ 307 (318)
..+.
T Consensus 166 ~~~~ 169 (325)
T 3kex_A 166 PPDD 169 (325)
T ss_dssp CCCT
T ss_pred Cccc
Confidence 6544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=225.01 Aligned_cols=153 Identities=25% Similarity=0.386 Sum_probs=135.1
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--------cCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
..++|...+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999986 5688999999875421 1334678899999999999999999999999
Q ss_pred CeeEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 220 GENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 220 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
+..++||||+.+| +|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 9988884 3456899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCc
Q 021046 299 MARIFGGDE 307 (318)
Q Consensus 299 la~~~~~~~ 307 (318)
+++.+..+.
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=221.12 Aligned_cols=152 Identities=31% Similarity=0.484 Sum_probs=119.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999864 58899999987543 2344678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|++ |+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988875321 2346899999999999999999999987 9999999999999999999999999998875
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=233.29 Aligned_cols=153 Identities=27% Similarity=0.413 Sum_probs=133.3
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
...++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999976 568899999987543 2234578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCCceEeecccce
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 301 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~ki~DfGla~ 301 (318)
||||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999888843 356899999999999999999999987 99999999999998 46789999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+..+
T Consensus 162 ~~~~~ 166 (444)
T 3soa_A 162 EVEGE 166 (444)
T ss_dssp CCCTT
T ss_pred EecCC
Confidence 87654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=223.03 Aligned_cols=156 Identities=31% Similarity=0.435 Sum_probs=136.4
Q ss_pred HhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEecC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 220 (318)
..++|...+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++.++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 457899999999999999999975 3467899999975432 3356789999999999 9999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKK---------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999864322 225899999999999999999999987 999999999999
Q ss_pred EcCCCCceEeecccceeecCCc
Q 021046 286 LDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~~ 307 (318)
++.++.+||+|||+++....+.
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCT
T ss_pred EcCCCCEEEccccccccccccc
Confidence 9999999999999998876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=227.86 Aligned_cols=157 Identities=29% Similarity=0.474 Sum_probs=136.1
Q ss_pred HHHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
....++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++..++||||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999764 367899999975432 3345689999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCc
Q 021046 220 GENILIYEYMPNKSLDVFLFYPK-------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 292 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 292 (318)
+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999885321 1245789999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeecCC
Q 021046 293 KISDFGMARIFGGD 306 (318)
Q Consensus 293 ki~DfGla~~~~~~ 306 (318)
||+|||+++.....
T Consensus 178 kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 178 KIGDFGMTRDIYET 191 (322)
T ss_dssp EECCTTCCCGGGGG
T ss_pred EECcCccccccccc
Confidence 99999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=225.49 Aligned_cols=152 Identities=34% Similarity=0.573 Sum_probs=128.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCc----EEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|...+.||+|+||.||+|.+. +++ +||+|.+... .....+++.+|+.++++++||||+++++++..++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999863 343 4688888643 3355678999999999999999999999998754 78
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|+||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999988543 356899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCc
Q 021046 304 GGDE 307 (318)
Q Consensus 304 ~~~~ 307 (318)
....
T Consensus 168 ~~~~ 171 (327)
T 3poz_A 168 GAEE 171 (327)
T ss_dssp TTTC
T ss_pred cCCc
Confidence 6543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=235.08 Aligned_cols=153 Identities=32% Similarity=0.523 Sum_probs=133.2
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
...++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4567899999999999999999999888889999998643 456789999999999999999999999876 67899999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999998432 2345899999999999999999999987 999999999999999999999999999887644
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=235.23 Aligned_cols=149 Identities=23% Similarity=0.391 Sum_probs=121.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec-----Ce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 221 (318)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++..++||||+++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999764 68899999987532 23346789999999999999999999999544 56
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+. |+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999984 68888873 3456899999999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=225.16 Aligned_cols=150 Identities=25% Similarity=0.393 Sum_probs=122.0
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999875 57899999997542 34568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfGla~~~~ 304 (318)
|+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999884 3456899999999999999999999987 999999999999976 8899999999998775
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 203 ~~ 204 (349)
T 2w4o_A 203 HQ 204 (349)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=228.98 Aligned_cols=151 Identities=28% Similarity=0.369 Sum_probs=134.1
Q ss_pred hcCCccccccccCCcccEEEEEe----cCCcEEEEEEccCCC----CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecC
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 220 (318)
.++|.+.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 368899999987532 23445678899999999 6999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999853 346889999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 021046 301 RIFGGD 306 (318)
Q Consensus 301 ~~~~~~ 306 (318)
+.+..+
T Consensus 207 ~~~~~~ 212 (355)
T 1vzo_A 207 KEFVAD 212 (355)
T ss_dssp EECCGG
T ss_pred eecccC
Confidence 877543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=227.17 Aligned_cols=152 Identities=20% Similarity=0.272 Sum_probs=135.4
Q ss_pred HhcCCccccccccC--CcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999875 68999999987542 233467888999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998543 2345899999999999999999999987 999999999999999999999999999765
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 179 ~ 179 (389)
T 3gni_B 179 I 179 (389)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=219.59 Aligned_cols=149 Identities=29% Similarity=0.411 Sum_probs=132.8
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc--CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|...+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67899999999999999999875 5899999988654322 24568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999988874 3456899999999999999999999987 99999999999999999999999999988764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=222.10 Aligned_cols=151 Identities=27% Similarity=0.270 Sum_probs=128.0
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|+..++||+|+||.||+|... +++.||||++..... .....+..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999875 689999999865322 2233455666666555 899999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+ +++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67888877432 356999999999999999999999987 99999999999999999999999999988754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 210 ~ 210 (311)
T 3p1a_A 210 A 210 (311)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=231.83 Aligned_cols=150 Identities=25% Similarity=0.428 Sum_probs=130.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec-----Ce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 221 (318)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++..++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999864 57889999997542 23346789999999999999999999999876 56
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||++ |+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 58988884 3456899999999999999999999988 9999999999999999999999999999
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.....
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=218.98 Aligned_cols=149 Identities=27% Similarity=0.358 Sum_probs=131.2
Q ss_pred hcCCccc-cccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEE
Q 021046 150 TENFSTQ-CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 150 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.+.|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999986 46899999999876666678899999999885 7999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC---ceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~ki~DfGla~~~ 303 (318)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999853 346899999999999999999999987 999999999999998776 999999999876
Q ss_pred c
Q 021046 304 G 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 165 ~ 165 (316)
T 2ac3_A 165 K 165 (316)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=225.63 Aligned_cols=151 Identities=26% Similarity=0.366 Sum_probs=130.5
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCC--CccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999998889999999987542 2334678999999999987 9999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|| +.+|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899998853 456899999999999999999999987 99999999999997 67899999999998765
Q ss_pred Ccc
Q 021046 306 DEL 308 (318)
Q Consensus 306 ~~~ 308 (318)
+..
T Consensus 160 ~~~ 162 (343)
T 3dbq_A 160 DTT 162 (343)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=219.94 Aligned_cols=152 Identities=28% Similarity=0.385 Sum_probs=135.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999875 588999999875422 136789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----CceEeec
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDF 297 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~ki~Df 297 (318)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999843 456899999999999999999999987 99999999999999888 7999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+++.+...
T Consensus 164 g~~~~~~~~ 172 (321)
T 2a2a_A 164 GLAHEIEDG 172 (321)
T ss_dssp TTCEECCTT
T ss_pred ccceecCcc
Confidence 999887654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=229.21 Aligned_cols=152 Identities=25% Similarity=0.354 Sum_probs=128.4
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--------CcCHHHHHHHHHHHhccCCCccceEEEEEEe
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 218 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 218 (318)
...++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4567899999999999999999986 457899999986431 122335889999999999999999999975
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEe
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS 295 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~ 295 (318)
.+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999988873 3457899999999999999999999987 99999999999997544 59999
Q ss_pred ecccceeecCC
Q 021046 296 DFGMARIFGGD 306 (318)
Q Consensus 296 DfGla~~~~~~ 306 (318)
|||+|+.+...
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999887543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=241.69 Aligned_cols=162 Identities=28% Similarity=0.338 Sum_probs=138.2
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (318)
..++|.+.+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999874 5788999998753 234556788999999987 7999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999998853 346899999999999999999999987 999999999999999999999999999975
Q ss_pred cCCccccccceeecC
Q 021046 304 GGDELQGNTKRIVGT 318 (318)
Q Consensus 304 ~~~~~~~~~~~~~Gt 318 (318)
..+.. .+..++||
T Consensus 493 ~~~~~--~~~~~~GT 505 (674)
T 3pfq_A 493 IWDGV--TTKTFCGT 505 (674)
T ss_dssp CCTTC--CBCCCCSC
T ss_pred ccCCc--ccccccCC
Confidence 44332 23344555
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=225.04 Aligned_cols=156 Identities=23% Similarity=0.315 Sum_probs=133.1
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-----CCcCHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
....++|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 45678899999999999999999987 45789999988643 2345578999999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 021046 221 ENILIYEYMPNKSLDVFLFYPK-------------------------------------KKRLLGWQARVRIIEGIAQGL 263 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~l 263 (318)
..++||||+++|+|.+++.... ....+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999884110 022345677889999999999
Q ss_pred HHHHhcCCCCeeecCCCCCCEEEcCCC--CceEeecccceeecC
Q 021046 264 LYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARIFGG 305 (318)
Q Consensus 264 ~yLH~~~~~~ivH~Dlk~~Nill~~~~--~~ki~DfGla~~~~~ 305 (318)
.|||+.+ |+||||||+||+++.++ .+||+|||+|+.+..
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 9999987 99999999999998776 899999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=214.78 Aligned_cols=152 Identities=30% Similarity=0.451 Sum_probs=133.2
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
++|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3445556899999999999986 467899999998766666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGla~~~~~ 305 (318)
++++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999865544456788999999999999999999987 999999999999988 89999999999987754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=218.76 Aligned_cols=152 Identities=32% Similarity=0.551 Sum_probs=132.2
Q ss_pred hcCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEec--Ce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 221 (318)
.++|+..+.||+|+||.||++.+ .+++.||+|++... .....+.+.+|+.++..++||||+++++++... +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688999999999999999983 46889999999754 334567899999999999999999999999877 66
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998432 345899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+..+
T Consensus 175 ~~~~~ 179 (302)
T 4e5w_A 175 AIETD 179 (302)
T ss_dssp ECCTT
T ss_pred cccCC
Confidence 87654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=214.91 Aligned_cols=152 Identities=34% Similarity=0.522 Sum_probs=125.6
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC----CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|...+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999974 7899999987542 23457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--------CCCceEeec
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--------DMNPKISDF 297 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--------~~~~ki~Df 297 (318)
|||+++++|.+++. ...+++..+..++.|++.||.|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 456899999999999999999999987556999999999999986 778999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=220.02 Aligned_cols=150 Identities=29% Similarity=0.459 Sum_probs=134.0
Q ss_pred hcCCccccccccCCcccEEEEEecC-C-------cEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
.++|...+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++.+++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999997643 3 4799999987666667889999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC--------ce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PK 293 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--------~k 293 (318)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998542 344899999999999999999999988 999999999999998887 99
Q ss_pred Eeecccceeec
Q 021046 294 ISDFGMARIFG 304 (318)
Q Consensus 294 i~DfGla~~~~ 304 (318)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=215.28 Aligned_cols=150 Identities=31% Similarity=0.528 Sum_probs=136.2
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|...+.||+|+||.||++...+++.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46789999999999999999999888999999997643 34578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999998532 346889999999999999999999987 99999999999999999999999999987644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=216.78 Aligned_cols=155 Identities=23% Similarity=0.398 Sum_probs=134.0
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|...+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 346899999999999999999987 458899999987543 345678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeeccccee
Q 021046 227 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARI 302 (318)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~~ 302 (318)
||+++|+|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+|+.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999887532 12467899999999999999999999987 9999999999999 5568899999999987
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+..+
T Consensus 177 ~~~~ 180 (285)
T 3is5_A 177 FKSD 180 (285)
T ss_dssp ----
T ss_pred cCCc
Confidence 7554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=214.28 Aligned_cols=152 Identities=36% Similarity=0.537 Sum_probs=134.8
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|...+.||+|+||.||+|...++..||||.+... ....+.+.+|+.++.+++||||+++++++. ++..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 45789999999999999999999988889999999753 345678999999999999999999999976 4568999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999998431 1236899999999999999999999987 999999999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=214.18 Aligned_cols=152 Identities=30% Similarity=0.495 Sum_probs=135.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|.+.+.||+|+||.||+|+. .+++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346899999999999999999987 57899999998643 22345789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..+.
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999998853 2356899999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 164 ~ 164 (278)
T 3cok_A 164 M 164 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=222.20 Aligned_cols=161 Identities=28% Similarity=0.423 Sum_probs=136.5
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEE
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFG 214 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~ 214 (318)
........++|.+.+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445678999999999999999999974 3467899999976432 2345789999999999 7999999999
Q ss_pred EEEecC-eeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 021046 215 CCIEQG-ENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280 (318)
Q Consensus 215 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 280 (318)
++...+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 998765 48999999999999999864332 123889999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCceEeecccceeecCC
Q 021046 281 ASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 281 ~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+||+++.++.+||+|||+++.+..+
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred cceEEECCCCCEEECCCccccccccC
Confidence 99999999999999999999877544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=225.94 Aligned_cols=150 Identities=27% Similarity=0.497 Sum_probs=123.3
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccC-CCccceEEEEEEecC--e
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG--E 221 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 221 (318)
...++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999986 46899999998653 2233456789999999997 999999999998654 6
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||++ |+|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 588888742 46889999999999999999999988 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
.+..
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 7643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=227.52 Aligned_cols=150 Identities=27% Similarity=0.368 Sum_probs=129.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccC--CCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999998889999999986532 234567899999999996 59999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 578899998853 346888999999999999999999987 99999999999995 58999999999998765
Q ss_pred Cc
Q 021046 306 DE 307 (318)
Q Consensus 306 ~~ 307 (318)
+.
T Consensus 207 ~~ 208 (390)
T 2zmd_A 207 DT 208 (390)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=214.83 Aligned_cols=155 Identities=27% Similarity=0.353 Sum_probs=134.7
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (318)
..++|...+.||+|+||.||+|... +++.||||.+.... .....++.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999875 68999999987542 23356788999999999 99999999999999999999
Q ss_pred EEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---------------
Q 021046 225 IYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--------------- 288 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--------------- 288 (318)
||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999985432 1256899999999999999999999987 999999999999984
Q ss_pred ----CCCceEeecccceeecCC
Q 021046 289 ----DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 289 ----~~~~ki~DfGla~~~~~~ 306 (318)
...+||+|||++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS
T ss_pred ccCCceEEEEcccccccccCCc
Confidence 447999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=213.27 Aligned_cols=152 Identities=28% Similarity=0.440 Sum_probs=136.7
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..+.|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++..++||||+++++++..++..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 346789999999999999999986 468899999987543 345678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999883 346899999999999999999999987 999999999999999999999999999887654
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 173 ~ 173 (303)
T 3a7i_A 173 Q 173 (303)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=223.39 Aligned_cols=160 Identities=28% Similarity=0.293 Sum_probs=136.8
Q ss_pred cccHHHHHHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-----CCccceEE
Q 021046 140 LFSLASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----HRHLVRLF 213 (318)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~ 213 (318)
.++........++|.+.++||+|+||.||+|+. .+++.||||++... ......+..|+.++..++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344444445678999999999999999999987 46889999999742 334456788999999886 99999999
Q ss_pred EEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----
Q 021046 214 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----- 288 (318)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~----- 288 (318)
+++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 99999988543 2345899999999999999999999987 999999999999975
Q ss_pred --------------------CCCceEeecccceeecC
Q 021046 289 --------------------DMNPKISDFGMARIFGG 305 (318)
Q Consensus 289 --------------------~~~~ki~DfGla~~~~~ 305 (318)
++.+||+|||+|+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999987554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=221.37 Aligned_cols=152 Identities=30% Similarity=0.476 Sum_probs=135.2
Q ss_pred hcCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 222 (318)
.++|+..+.||+|+||.||++++ .+++.||||++........+.+.+|+.++.+++||||+++++++.. .+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 4678999999987655566779999999999999999999999874 4568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998532 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 177 ~~~~ 180 (327)
T 3lxl_A 177 LPLD 180 (327)
T ss_dssp CCTT
T ss_pred cccC
Confidence 7644
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=237.50 Aligned_cols=153 Identities=32% Similarity=0.523 Sum_probs=136.0
Q ss_pred HHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
...++|.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4567889999999999999999999888889999997643 456789999999999999999999999876 67899999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999998432 2345889999999999999999999987 999999999999999999999999999877543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=222.24 Aligned_cols=154 Identities=27% Similarity=0.351 Sum_probs=133.9
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCee
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 222 (318)
...++|...+.||+|+||.||++.. .+++.||||++........+.+.+|+.++..++||||+++++++.. .+..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999987 5789999999876555566789999999999999999999999973 3477
Q ss_pred EEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 223 ILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
++||||+++|+|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999988542 23467899999999999999999999987 9999999999999999999999999987
Q ss_pred eec
Q 021046 302 IFG 304 (318)
Q Consensus 302 ~~~ 304 (318)
...
T Consensus 183 ~~~ 185 (317)
T 2buj_A 183 QAC 185 (317)
T ss_dssp ESC
T ss_pred hcc
Confidence 653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=231.04 Aligned_cols=152 Identities=27% Similarity=0.416 Sum_probs=130.0
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..++|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999875 68899999987542 34457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CCceEeeccccee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARI 302 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~ki~DfGla~~ 302 (318)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.. +.+||+|||+|+.
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999887743 346889999999999999999999987 9999999999999764 4599999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 189 ~~~~ 192 (494)
T 3lij_A 189 FENQ 192 (494)
T ss_dssp CBTT
T ss_pred CCCC
Confidence 7654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=220.23 Aligned_cols=142 Identities=26% Similarity=0.344 Sum_probs=125.3
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEeccCCC
Q 021046 156 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
.+.||+|+||.||++... +++.||||++... ....+.+|+.++..+. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999874 5889999998653 3467889999999997 9999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---CceEeecccceeecCC
Q 021046 234 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIFGGD 306 (318)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~ki~DfGla~~~~~~ 306 (318)
|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+....+
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9998843 456899999999999999999999987 99999999999997765 7999999999876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=216.85 Aligned_cols=152 Identities=27% Similarity=0.419 Sum_probs=124.2
Q ss_pred HhcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..++|.+.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.++.+++||||+++++++ .++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 45789999999999999999998743 45799999876432 3356789999999999999999999997 456789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998532 346899999999999999999999987 999999999999999999999999999887
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 167 ~~~ 169 (281)
T 1mp8_A 167 EDS 169 (281)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=218.43 Aligned_cols=156 Identities=29% Similarity=0.528 Sum_probs=126.0
Q ss_pred HHhcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
...++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35678999999999999999999764 34589999987542 2334678999999999999999999999987653
Q ss_pred -----eEEEEEeccCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCce
Q 021046 222 -----NILIYEYMPNKSLDVFLFYP---KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 293 (318)
Q Consensus 222 -----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 293 (318)
.++||||+++|+|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 49999999999999988533 23467999999999999999999999987 99999999999999999999
Q ss_pred EeecccceeecCC
Q 021046 294 ISDFGMARIFGGD 306 (318)
Q Consensus 294 i~DfGla~~~~~~ 306 (318)
|+|||+++.+...
T Consensus 188 l~Dfg~~~~~~~~ 200 (313)
T 3brb_A 188 VADFGLSKKIYSG 200 (313)
T ss_dssp ECSCSCC------
T ss_pred EeecCcceecccc
Confidence 9999999877543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=220.38 Aligned_cols=155 Identities=24% Similarity=0.365 Sum_probs=136.5
Q ss_pred HHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc--------CHHHHHHHHHHHhcc-CCCccceEEEE
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKL-QHRHLVRLFGC 215 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~ 215 (318)
.....++|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999885 6899999998754321 134678899999999 79999999999
Q ss_pred EEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
+...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999998843 346899999999999999999999987 9999999999999999999999
Q ss_pred ecccceeecCC
Q 021046 296 DFGMARIFGGD 306 (318)
Q Consensus 296 DfGla~~~~~~ 306 (318)
|||++..+...
T Consensus 243 DfG~~~~~~~~ 253 (365)
T 2y7j_A 243 DFGFSCHLEPG 253 (365)
T ss_dssp CCTTCEECCTT
T ss_pred ecCcccccCCC
Confidence 99999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=215.20 Aligned_cols=151 Identities=25% Similarity=0.347 Sum_probs=134.3
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3468999999999999999999875 47889999886542 2334678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999988743 346899999999999999999999987 9999999999999999999999999998875
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 167 ~ 167 (294)
T 2rku_A 167 Y 167 (294)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=215.97 Aligned_cols=154 Identities=29% Similarity=0.498 Sum_probs=137.7
Q ss_pred HhcCCccccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|...+.||+|+||.||+|.... +..||+|.+... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 46789999999999999999998754 788999999753 3445789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
|+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+....+.
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 3456899999999999999999999988 9999999999999999999999999998776543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=222.99 Aligned_cols=150 Identities=33% Similarity=0.499 Sum_probs=131.5
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.+.|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688899999999999999986 5788999999875422 2345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||++ |+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 677776642 2356899999999999999999999987 99999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=216.97 Aligned_cols=149 Identities=33% Similarity=0.503 Sum_probs=123.2
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|.+.+.||+|+||.||+|... ..||||.++... ....+.+.+|+.++.+++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4578999999999999999999864 369999987543 23346789999999999999999999965 556789999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999998843 3456899999999999999999999987 99999999999999999999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=219.97 Aligned_cols=151 Identities=25% Similarity=0.347 Sum_probs=134.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3568999999999999999999875 47899999986542 2335678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998743 356899999999999999999999987 9999999999999999999999999998875
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=229.70 Aligned_cols=152 Identities=29% Similarity=0.446 Sum_probs=132.1
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-------------cCHHHHHHHHHHHhccCCCccceEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLTEFKNEMMLIAKLQHRHLVRLFG 214 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 214 (318)
..++|.+.++||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999874 578999999875321 33567899999999999999999999
Q ss_pred EEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---C
Q 021046 215 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---N 291 (318)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~ 291 (318)
++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999888843 356899999999999999999999987 99999999999998876 6
Q ss_pred ceEeecccceeecCC
Q 021046 292 PKISDFGMARIFGGD 306 (318)
Q Consensus 292 ~ki~DfGla~~~~~~ 306 (318)
+||+|||+|+.+..+
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=221.04 Aligned_cols=152 Identities=27% Similarity=0.400 Sum_probs=134.9
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcC-----------------HHHHHHHHHHHhccCCCccceE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-----------------LTEFKNEMMLIAKLQHRHLVRL 212 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 212 (318)
.++|.+.+.||+|+||.||+|.. +++.||||.+....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 89999999986432111 1789999999999999999999
Q ss_pred EEEEEecCeeEEEEEeccCCChhhh------hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEE
Q 021046 213 FGCCIEQGENILIYEYMPNKSLDVF------LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNIL 285 (318)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nil 285 (318)
++++.+.+..++||||+++|+|.++ +.. .....+++..+..++.|++.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 421 125679999999999999999999998 77 999999999999
Q ss_pred EcCCCCceEeecccceeecCC
Q 021046 286 LDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~ 306 (318)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999887543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=216.13 Aligned_cols=148 Identities=36% Similarity=0.563 Sum_probs=130.7
Q ss_pred CCccccccccCCcccEEEEEec-----CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI 223 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (318)
.|...+.||+|+||.||++.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3488999999999999998652 678999999986432 3356789999999999999999999999984 5789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999843 34899999999999999999999988 999999999999999999999999999987
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 185 ~~~ 187 (318)
T 3lxp_A 185 PEG 187 (318)
T ss_dssp CTT
T ss_pred ccc
Confidence 654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=216.62 Aligned_cols=153 Identities=24% Similarity=0.293 Sum_probs=130.4
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc---CHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
...++|.+.+.||+|+||.||++... +++.||+|.+...... ..+.+.+|+.++.+++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999874 6889999999754322 2467899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999853 346899999999999999999999987 999999999999999999999999999876
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 185 ~~~ 187 (309)
T 2h34_A 185 TDE 187 (309)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=212.46 Aligned_cols=151 Identities=27% Similarity=0.392 Sum_probs=133.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC------cCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999875 689999998865321 2467899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----CceEeecc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 298 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~ki~DfG 298 (318)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 346899999999999999999999987 99999999999998877 89999999
Q ss_pred cceeecCC
Q 021046 299 MARIFGGD 306 (318)
Q Consensus 299 la~~~~~~ 306 (318)
+++.+...
T Consensus 158 ~~~~~~~~ 165 (283)
T 3bhy_A 158 IAHKIEAG 165 (283)
T ss_dssp TCEECC--
T ss_pred cceeccCC
Confidence 99877543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=219.25 Aligned_cols=152 Identities=33% Similarity=0.560 Sum_probs=134.5
Q ss_pred hcCCccccccccCCcccEEEEEe-----cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC--ee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--EN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 222 (318)
.++|.+.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++.+++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999999984 368899999998765556678999999999999999999999987654 68
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+..+
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-28 Score=217.19 Aligned_cols=150 Identities=29% Similarity=0.520 Sum_probs=129.8
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec-------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------- 219 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 219 (318)
.++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999987 568999999986543 23345788999999999999999999999873
Q ss_pred -CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 220 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 220 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
+..++||||+++ +|...+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 66655532 2346899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
+|+.+..
T Consensus 170 ~a~~~~~ 176 (351)
T 3mi9_A 170 LARAFSL 176 (351)
T ss_dssp TCEECCC
T ss_pred hcccccc
Confidence 9988753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=223.72 Aligned_cols=156 Identities=30% Similarity=0.446 Sum_probs=134.8
Q ss_pred HHhcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
...++|...+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+.++..+ +||||+++++++.++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 446789999999999999999998643 24799999976432 3456789999999999 899999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 021046 220 GENILIYEYMPNKSLDVFLFYPK-----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 288 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 288 (318)
+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 99999999999999999885321 1345799999999999999999999987 999999999999999
Q ss_pred CCCceEeecccceeecCC
Q 021046 289 DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 289 ~~~~ki~DfGla~~~~~~ 306 (318)
++.+||+|||+|+.+..+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMND 217 (333)
T ss_dssp GGEEEBCCCGGGCCGGGC
T ss_pred CCeEEECccccccccccc
Confidence 999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=217.91 Aligned_cols=150 Identities=29% Similarity=0.471 Sum_probs=130.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc--CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.++|...+.||+|+||.||++... +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 568999999999999999999875 4889999988654322 2456789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+++++|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988763 2346899999999999999999999987 99999999999999999999999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-29 Score=230.15 Aligned_cols=148 Identities=28% Similarity=0.400 Sum_probs=124.1
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEec------C
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------G 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 220 (318)
.++|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999976 45889999999754 223456788999999999999999999999765 3
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||++++ |...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999875 544442 24889999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 021046 301 RIFGGD 306 (318)
Q Consensus 301 ~~~~~~ 306 (318)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 977543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=215.72 Aligned_cols=149 Identities=28% Similarity=0.492 Sum_probs=132.3
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999875 588999999987666778899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
|+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999887432 356899999999999999999999987 99999999999999999999999999854
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=235.85 Aligned_cols=149 Identities=30% Similarity=0.495 Sum_probs=128.7
Q ss_pred CCcccc-ccccCCcccEEEEEec---CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 152 NFSTQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 152 ~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++.+++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333334 7999999999999764 45679999998653 3456789999999999999999999999876 5689999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999843 3456899999999999999999999987 999999999999999999999999999877543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=216.83 Aligned_cols=152 Identities=26% Similarity=0.385 Sum_probs=127.8
Q ss_pred HHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc--CCCccceEEEEEEec----C
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL--QHRHLVRLFGCCIEQ----G 220 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~ 220 (318)
....++|.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... +
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 345578999999999999999999885 889999998643 234455566655554 899999999999987 7
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCEEEcCCCCceEe
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++. ..+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 88999999999999999843 35899999999999999999999871 1139999999999999999999999
Q ss_pred ecccceeecCC
Q 021046 296 DFGMARIFGGD 306 (318)
Q Consensus 296 DfGla~~~~~~ 306 (318)
|||+|+.+..+
T Consensus 185 Dfg~a~~~~~~ 195 (337)
T 3mdy_A 185 DLGLAVKFISD 195 (337)
T ss_dssp CCTTCEECC--
T ss_pred eCCCceeeccc
Confidence 99999877554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=212.44 Aligned_cols=153 Identities=31% Similarity=0.509 Sum_probs=127.5
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-----CcCHHHHHHHHHHHhccC---CCccceEEEEEEec
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQ 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 219 (318)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999986 568899999986422 122346778888777765 99999999999876
Q ss_pred C-----eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 220 G-----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 220 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
. ..++||||++ |+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 5998888543 2334899999999999999999999988 999999999999999999999
Q ss_pred eecccceeecCC
Q 021046 295 SDFGMARIFGGD 306 (318)
Q Consensus 295 ~DfGla~~~~~~ 306 (318)
+|||+|+.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999877543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=221.94 Aligned_cols=152 Identities=20% Similarity=0.346 Sum_probs=126.1
Q ss_pred HhcCCccccccccCCcccEEEEEecC------CcEEEEEEccCCCCc-----------CHHHHHHHHHHHhccCCCccce
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-----------GLTEFKNEMMLIAKLQHRHLVR 211 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~ 211 (318)
..++|.+.+.||+|+||.||+|.+.. ++.||||.+...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 468999998754321 1122345566677888999999
Q ss_pred EEEEEEec----CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc
Q 021046 212 LFGCCIEQ----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 287 (318)
Q Consensus 212 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 287 (318)
+++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4579999999 9999999854 2356999999999999999999999987 99999999999999
Q ss_pred --CCCCceEeecccceeecCC
Q 021046 288 --SDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 288 --~~~~~ki~DfGla~~~~~~ 306 (318)
.++.+||+|||+|+.+..+
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=212.35 Aligned_cols=151 Identities=28% Similarity=0.472 Sum_probs=135.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999875 6899999998643 234566889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999998843 345889999999999999999999988 99999999999999999999999999987754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=212.37 Aligned_cols=151 Identities=26% Similarity=0.431 Sum_probs=133.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999874 58899999986532 233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC---ceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~ki~DfGla~~~ 303 (318)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 356899999999999999999999987 999999999999987655 999999999877
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 159 ~~~ 161 (284)
T 3kk8_A 159 NDS 161 (284)
T ss_dssp CSS
T ss_pred ccC
Confidence 644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=220.23 Aligned_cols=149 Identities=28% Similarity=0.454 Sum_probs=127.5
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|...+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.+++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999875 6889999998754322 122456799999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+....
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 98 588887743 2456899999999999999999999987 99999999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=214.12 Aligned_cols=151 Identities=30% Similarity=0.404 Sum_probs=132.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999864 5778999998643 22345678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999988843 345899999999999999999999887 9999999999999999999999999986654
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 161 ~ 161 (279)
T 3fdn_A 161 S 161 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=220.69 Aligned_cols=158 Identities=27% Similarity=0.384 Sum_probs=131.5
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcC-----------HHHHHHHHHHHhccCCCccce
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-----------LTEFKNEMMLIAKLQHRHLVR 211 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 211 (318)
..++....++|.+.+.||+|+||.||+|...+++.||||++....... .+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 455667789999999999999999999998889999999986532211 267899999999999999999
Q ss_pred EEEEEEec-----CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 021046 212 LFGCCIEQ-----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 286 (318)
Q Consensus 212 l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 286 (318)
+++++... ...++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999653 35799999998 577777742 3456899999999999999999999987 9999999999999
Q ss_pred cCCCCceEeecccceeecCC
Q 021046 287 DSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 287 ~~~~~~ki~DfGla~~~~~~ 306 (318)
+.++.+||+|||+|+....+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~ 187 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD 187 (362)
T ss_dssp CTTCCEEECCTTC-------
T ss_pred cCCCCEEEEecCcccccccc
Confidence 99999999999999865443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=211.56 Aligned_cols=150 Identities=28% Similarity=0.470 Sum_probs=132.5
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe---------
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--------- 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 218 (318)
...+|...+.||+|+||.||+|... +++.||+|.+.... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4568999999999999999999875 68999999987543 467889999999999999999999865
Q ss_pred -------cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 219 -------QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 219 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
....++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999998543 2356899999999999999999999987 999999999999999999
Q ss_pred ceEeecccceeecCC
Q 021046 292 PKISDFGMARIFGGD 306 (318)
Q Consensus 292 ~ki~DfGla~~~~~~ 306 (318)
+||+|||+++.+..+
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999887654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-29 Score=217.20 Aligned_cols=155 Identities=25% Similarity=0.394 Sum_probs=120.9
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
...++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+++.+|+.++.+++||||+++++++..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4567899999999999999999986 468899999886532 33456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 226 YEYMPNKSLDVFLFYP-----KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
|||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12456899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+.+..
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-29 Score=219.90 Aligned_cols=151 Identities=29% Similarity=0.451 Sum_probs=127.4
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
...++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.+++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4567899999999999999999986 4688999999975432 234567899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-----CCCCceEeeccc
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----SDMNPKISDFGM 299 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-----~~~~~ki~DfGl 299 (318)
||||++ |+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 489888843 345899999999999999999999987 99999999999994 455599999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
|+.+..
T Consensus 184 a~~~~~ 189 (329)
T 3gbz_A 184 ARAFGI 189 (329)
T ss_dssp HHHHC-
T ss_pred ccccCC
Confidence 987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=218.22 Aligned_cols=151 Identities=34% Similarity=0.569 Sum_probs=126.5
Q ss_pred hcCCccccccccCCcccEEEEEec-CCc----EEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|...+.||+|+||.||+|.+. +++ +||+|.+... .......+.+|+.++.+++||||+++++++..++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999864 344 3688877643 3456778999999999999999999999998754 78
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+|+||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988543 356899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-29 Score=223.22 Aligned_cols=151 Identities=28% Similarity=0.492 Sum_probs=122.8
Q ss_pred cCCccccccccCCcccEEEEEec--CC--cEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEe-cCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL--NG--QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 224 (318)
..|...+.||+|+||.||+|.+. ++ ..||||.++... ....+.|.+|+.++++++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999863 22 368999987543 3345789999999999999999999999765 457899
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 3456789999999999999999999987 9999999999999999999999999998765
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 244 ~~ 245 (373)
T 3c1x_A 244 DK 245 (373)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=218.93 Aligned_cols=152 Identities=35% Similarity=0.550 Sum_probs=128.4
Q ss_pred hcCCccccccccCCcccEEEEEecC-----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.++|...+.||+|+||.||+|.... +..||||.+..... .....+.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4577888999999999999997643 23699999975432 33457899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999853 2356899999999999999999999987 999999999999999999999999999887
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
..+
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=215.64 Aligned_cols=151 Identities=28% Similarity=0.436 Sum_probs=126.8
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|++.+.||+|+||.||++... ++.||||.+... ...+.+.+|+.++.+++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 467889999999999999999884 688999998643 34568999999999999999999999887 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC-ceEeecccceeecC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGG 305 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-~ki~DfGla~~~~~ 305 (318)
++|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.+..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999975544456889999999999999999999943334999999999999998887 79999999986643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=216.85 Aligned_cols=148 Identities=22% Similarity=0.348 Sum_probs=128.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|...+.||+|+||.||++... +++.||||.+..... ...+|+.++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999874 588999999976433 235688888887 7999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC----CCceEeeccccee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARI 302 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~ki~DfGla~~ 302 (318)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+|+.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999988843 356899999999999999999999987 9999999999998543 3499999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=219.89 Aligned_cols=152 Identities=31% Similarity=0.450 Sum_probs=125.9
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc-----CHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
...++|...+.||+|+||.||+|... +++.||||++...... ....+.+|+.++..++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44678999999999999999999874 5899999998753211 13468899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++ +|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78777732 3356888899999999999999999988 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
.+..
T Consensus 161 ~~~~ 164 (346)
T 1ua2_A 161 SFGS 164 (346)
T ss_dssp TTTS
T ss_pred eccC
Confidence 7754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=211.70 Aligned_cols=151 Identities=30% Similarity=0.507 Sum_probs=131.6
Q ss_pred hcCCcccc-ccccCCcccEEEEEec---CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|.+.+ .||+|+||.||+|... ++..||||.++... ....+.+.+|+.++.+++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 8999999999999753 57789999997643 23456789999999999999999999999 5667899
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998843 3456899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
.+
T Consensus 162 ~~ 163 (287)
T 1u59_A 162 AD 163 (287)
T ss_dssp TC
T ss_pred cC
Confidence 44
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=214.56 Aligned_cols=152 Identities=28% Similarity=0.491 Sum_probs=130.6
Q ss_pred hcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEe-cCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 223 (318)
..+|...+.||+|+||.||+|...+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568888999999999999998643 23589999876433 345678999999999999999999998654 46789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999853 3456889999999999999999999987 999999999999999999999999999877
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 179 ~~~ 181 (298)
T 3f66_A 179 YDK 181 (298)
T ss_dssp SCG
T ss_pred ccc
Confidence 544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=212.49 Aligned_cols=152 Identities=28% Similarity=0.359 Sum_probs=134.5
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---------cCHHHHHHHHHHHhccC-CCccceEEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCI 217 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 217 (318)
..++|...+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999874 588999999875421 12356789999999996 999999999999
Q ss_pred ecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
.++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999843 356899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|++..+..+
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999887644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=218.22 Aligned_cols=154 Identities=32% Similarity=0.488 Sum_probs=130.3
Q ss_pred HhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||+|.+ .++..||||.+.... .....++.+|+.++.+++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999974 346789999997542 3345678999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceE
Q 021046 222 NILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKI 294 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki 294 (318)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999865321 245899999999999999999999987 999999999999984 456999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||+++....
T Consensus 185 ~Dfg~~~~~~~ 195 (327)
T 2yfx_A 185 GDFGMARDIYR 195 (327)
T ss_dssp CCCHHHHHHHC
T ss_pred Ccccccccccc
Confidence 99999986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=209.74 Aligned_cols=151 Identities=31% Similarity=0.579 Sum_probs=129.5
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcC-------HHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQG-------LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
.++|...+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 47899999999999999999987 468899999986543221 267899999999999999999999986554
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC-----ceEee
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISD 296 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~ki~D 296 (318)
++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ .+|+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888753 3457899999999999999999999874 34999999999999988776 99999
Q ss_pred cccceeecC
Q 021046 297 FGMARIFGG 305 (318)
Q Consensus 297 fGla~~~~~ 305 (318)
||+|+....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=229.29 Aligned_cols=152 Identities=30% Similarity=0.500 Sum_probs=134.5
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..++|.+.+.||+|+||.||++... +++.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999874 6889999998643 334567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCCceEeeccccee
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARI 302 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~ki~DfGla~~ 302 (318)
|||+++|+|.+.+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999888743 346899999999999999999999987 99999999999995 456799999999987
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 7544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=211.14 Aligned_cols=149 Identities=22% Similarity=0.361 Sum_probs=132.2
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+|+..+..+ +|||++++++++..+...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999986 568999999986532 334688999999999 79999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC-----ceEeeccccee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARI 302 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~ki~DfGla~~ 302 (318)
|+ +++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||+|+.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998542 345899999999999999999999987 999999999999987776 99999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 161 ~~~~ 164 (298)
T 1csn_A 161 YRDP 164 (298)
T ss_dssp SBCT
T ss_pred cccc
Confidence 8654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=228.41 Aligned_cols=152 Identities=30% Similarity=0.475 Sum_probs=135.6
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
..++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999875 68999999986532 3456789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeecccce
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMAR 301 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~ 301 (318)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999888843 456899999999999999999999987 9999999999999 567899999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 178 ~~~~~ 182 (484)
T 3nyv_A 178 HFEAS 182 (484)
T ss_dssp HBCCC
T ss_pred Ecccc
Confidence 77544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=215.21 Aligned_cols=151 Identities=22% Similarity=0.366 Sum_probs=132.0
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
..++|...+.||+|+||.||++... +++.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3568999999999999999999874 689999999986554455678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~~~~ 304 (318)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999988843 346889999999999999999999987 9999999999999 788999999999998654
Q ss_pred C
Q 021046 305 G 305 (318)
Q Consensus 305 ~ 305 (318)
.
T Consensus 161 ~ 161 (304)
T 2jam_A 161 N 161 (304)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=215.08 Aligned_cols=150 Identities=27% Similarity=0.403 Sum_probs=132.2
Q ss_pred HHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhc--cCCCccceEEEEEEecC----
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK--LQHRHLVRLFGCCIEQG---- 220 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---- 220 (318)
....++|.+.+.||+|+||.||+|.. +++.||||.+... ....+.+|+.++.. ++||||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999988 5889999998643 34577888888877 78999999999998876
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCEEEcCCCCc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNP 292 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlk~~Nill~~~~~~ 292 (318)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+ |+||||||+||+++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35899999999999999999999 555 9999999999999999999
Q ss_pred eEeecccceeecCCc
Q 021046 293 KISDFGMARIFGGDE 307 (318)
Q Consensus 293 ki~DfGla~~~~~~~ 307 (318)
||+|||+|+......
T Consensus 187 kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 187 CIADLGLAVRHDSAT 201 (342)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEEECCCceeccccc
Confidence 999999998876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=221.20 Aligned_cols=148 Identities=26% Similarity=0.404 Sum_probs=124.1
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999987 568999999996532 223457889999999999999999999998763
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899988843 45889999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=217.24 Aligned_cols=154 Identities=30% Similarity=0.464 Sum_probs=133.4
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEe------
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE------ 218 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------ 218 (318)
....++|.+.+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34568899999999999999999987 46889999998753 34457889999999999 79999999999987
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46789999999999999998543 2356889999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 021046 299 MARIFGG 305 (318)
Q Consensus 299 la~~~~~ 305 (318)
++..+..
T Consensus 175 ~~~~~~~ 181 (326)
T 2x7f_A 175 VSAQLDR 181 (326)
T ss_dssp TTC----
T ss_pred CceecCc
Confidence 9987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=214.22 Aligned_cols=160 Identities=29% Similarity=0.396 Sum_probs=135.8
Q ss_pred HHHHHHHhcCCccc-cccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccC-CCccceEEEEEE
Q 021046 143 LASVSAATENFSTQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCI 217 (318)
Q Consensus 143 ~~~~~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 217 (318)
+.......++|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.++..++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445566777776 88999999999999875 5899999998753 2344678999999999995 699999999999
Q ss_pred ecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceE
Q 021046 218 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKI 294 (318)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki 294 (318)
..+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||+++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999988432 3457899999999999999999999987 999999999999988 789999
Q ss_pred eecccceeecCC
Q 021046 295 SDFGMARIFGGD 306 (318)
Q Consensus 295 ~DfGla~~~~~~ 306 (318)
+|||+|+.+...
T Consensus 176 ~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 176 VDFGMSRKIGHA 187 (327)
T ss_dssp CCGGGCEEC---
T ss_pred eeCccccccCCc
Confidence 999999987644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=212.73 Aligned_cols=145 Identities=22% Similarity=0.381 Sum_probs=130.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEe--cCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIE--QGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 225 (318)
.++|++.+.||+|+||.||+|.. .+++.||||.+.. ...+.+.+|+.++.+++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999976 5688999999874 34578999999999997 9999999999998 5678999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceeec
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFG 304 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~~ 304 (318)
|||+++++|..++. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998872 3788999999999999999999987 99999999999999777 89999999999876
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 183 ~~ 184 (330)
T 3nsz_A 183 PG 184 (330)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=211.87 Aligned_cols=151 Identities=25% Similarity=0.349 Sum_probs=128.6
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC----CcCHHHHHHHHHHHhccCCCccceEEEEEE--ecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCI--EQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 222 (318)
.++|.+.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999987 468899999987532 334567999999999999999999999985 44578
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||++++ |.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 65655432 3456899999999999999999999987 99999999999999999999999999988
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=220.09 Aligned_cols=149 Identities=27% Similarity=0.354 Sum_probs=133.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999875 68899999987642 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+|+.+.
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999843 34688999999999999999999985 6 9999999999999999999999999997653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=211.96 Aligned_cols=152 Identities=31% Similarity=0.519 Sum_probs=130.5
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
...++|...+.||+|+||.||+|... +++.||+|.+... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34678999999999999999999875 5899999999753 34568899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998842 2456899999999999999999999987 999999999999999999999999999887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=226.59 Aligned_cols=151 Identities=17% Similarity=0.237 Sum_probs=124.8
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHH---HHHhccCCCccceEE-------EE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEM---MLIAKLQHRHLVRLF-------GC 215 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 215 (318)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999986 56899999998743 333457789999 556666899999998 66
Q ss_pred EEecCe-----------------eEEEEEeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021046 216 CIEQGE-----------------NILIYEYMPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 274 (318)
Q Consensus 216 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 274 (318)
+...+. .++||||+ +|+|.+++.... ....+++..+..++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 655432 78999999 689999885321 1234556888899999999999999987 9
Q ss_pred eecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 275 IHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 275 vH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
+||||||+|||++.++.+||+|||+|+..+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=213.76 Aligned_cols=151 Identities=25% Similarity=0.361 Sum_probs=128.4
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--------CcCHHHHHHHHHHHhccCCCccceEEEEEEec
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 219 (318)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999874 57899999986532 12234688999999999999999999998765
Q ss_pred CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC---ceEee
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISD 296 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~ki~D 296 (318)
+ .++||||+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999998883 3457899999999999999999999987 999999999999987664 99999
Q ss_pred cccceeecCC
Q 021046 297 FGMARIFGGD 306 (318)
Q Consensus 297 fGla~~~~~~ 306 (318)
||+++.+...
T Consensus 161 fg~~~~~~~~ 170 (322)
T 2ycf_A 161 FGHSKILGET 170 (322)
T ss_dssp CTTCEECCCC
T ss_pred Cccceecccc
Confidence 9999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=214.69 Aligned_cols=151 Identities=34% Similarity=0.558 Sum_probs=130.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcE--EEEEEccCC-CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (318)
.++|...+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999864 4554 499988753 334456789999999999 89999999999999999999
Q ss_pred EEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 225 IYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999986432 2347899999999999999999999987 999999999999999999
Q ss_pred ceEeecccceee
Q 021046 292 PKISDFGMARIF 303 (318)
Q Consensus 292 ~ki~DfGla~~~ 303 (318)
+||+|||+++..
T Consensus 181 ~kL~Dfg~~~~~ 192 (327)
T 1fvr_A 181 AKIADFGLSRGQ 192 (327)
T ss_dssp EEECCTTCEESS
T ss_pred EEEcccCcCccc
Confidence 999999999744
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=210.76 Aligned_cols=150 Identities=27% Similarity=0.402 Sum_probs=133.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 5778999998643 233456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999998843 345899999999999999999999987 99999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=218.12 Aligned_cols=150 Identities=17% Similarity=0.278 Sum_probs=123.6
Q ss_pred hcCCccccccccCCcccEEEEEec----CCcEEEEEEccCCCCc-----------CHHHHHHHHHHHhccCCCccceEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLTEFKNEMMLIAKLQHRHLVRLFG 214 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 214 (318)
.++|.+.+.||+|+||.||+|... ++..+|||.+...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 5678999988754321 1234667888899999999999999
Q ss_pred EEEe----cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 021046 215 CCIE----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 215 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 290 (318)
++.. .+..++||||+ +++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 9999998843 337899999999999999999999987 99999999999999887
Q ss_pred --CceEeecccceeecCC
Q 021046 291 --NPKISDFGMARIFGGD 306 (318)
Q Consensus 291 --~~ki~DfGla~~~~~~ 306 (318)
.+||+|||+|+.+..+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999887543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=213.47 Aligned_cols=150 Identities=32% Similarity=0.521 Sum_probs=132.2
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe---------
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--------- 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 218 (318)
..++|+..+.||+|+||.||+|.. .+++.||||.+.. .....+.+.+|+.++.+++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356899999999999999999987 4689999999864 23445678999999999999999999999875
Q ss_pred ----cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 219 ----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 219 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
.+..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999853 2356788999999999999999999987 999999999999999999999
Q ss_pred eecccceeec
Q 021046 295 SDFGMARIFG 304 (318)
Q Consensus 295 ~DfGla~~~~ 304 (318)
+|||+++...
T Consensus 158 ~dfg~~~~~~ 167 (303)
T 1zy4_A 158 GDFGLAKNVH 167 (303)
T ss_dssp CCCCCCSCTT
T ss_pred eeCcchhhcc
Confidence 9999998765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=214.44 Aligned_cols=148 Identities=28% Similarity=0.438 Sum_probs=124.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEE-----------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI----------- 217 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 217 (318)
.++|...+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999875 48899999997665556678999999999999999999999873
Q ss_pred ---ecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCCce
Q 021046 218 ---EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK 293 (318)
Q Consensus 218 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~k 293 (318)
+.+..++||||++ |+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 69998883 346889999999999999999999987 99999999999997 567999
Q ss_pred EeecccceeecC
Q 021046 294 ISDFGMARIFGG 305 (318)
Q Consensus 294 i~DfGla~~~~~ 305 (318)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999987753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=221.77 Aligned_cols=151 Identities=27% Similarity=0.449 Sum_probs=127.4
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe------eE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE------NI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 223 (318)
..+|...+.||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999977778999988653322 2369999999999999999999976543 78
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCCceEeeccccee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARI 302 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~ki~DfGla~~ 302 (318)
+||||++++.+............+++..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998755544433334567899999999999999999999987 99999999999999 799999999999998
Q ss_pred ecCCc
Q 021046 303 FGGDE 307 (318)
Q Consensus 303 ~~~~~ 307 (318)
+..+.
T Consensus 192 ~~~~~ 196 (394)
T 4e7w_A 192 LIAGE 196 (394)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=213.22 Aligned_cols=150 Identities=28% Similarity=0.437 Sum_probs=129.4
Q ss_pred CCccccccccCCcccEEEEEecC-C---cEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCee-EEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN-ILI 225 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 225 (318)
.|...+.||+|+||.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999997532 2 3799999876433 3456789999999999999999999999877665 999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+.+|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999853 3456889999999999999999999987 99999999999999999999999999986654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 177 ~ 177 (298)
T 3pls_A 177 R 177 (298)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=209.08 Aligned_cols=143 Identities=10% Similarity=0.053 Sum_probs=126.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc---CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|+..+.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999875 4899999999865332 236789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
|||+++++|.+++.. . ........++.|++.||.|||+++ |+||||||+|||++.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999832 2 345568889999999999999988 999999999999999999999988754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=220.37 Aligned_cols=147 Identities=23% Similarity=0.308 Sum_probs=124.3
Q ss_pred hcCCccc-cccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhc-cCCCccceEEEEEEe----cCee
Q 021046 150 TENFSTQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 150 ~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 222 (318)
.++|... +.||+|+||.||++... +++.||||++... ..+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567665 68999999999999874 5889999998642 467788888744 589999999999876 5678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeeccc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM 299 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfGl 299 (318)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998542 2346899999999999999999999987 999999999999998 78999999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
|+....
T Consensus 211 a~~~~~ 216 (400)
T 1nxk_A 211 AKETTS 216 (400)
T ss_dssp CEECC-
T ss_pred ccccCC
Confidence 997654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=211.45 Aligned_cols=151 Identities=30% Similarity=0.478 Sum_probs=130.2
Q ss_pred HhcCCcccc-ccccCCcccEEEEEe---cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 149 ATENFSTQC-KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 149 ~~~~~~~~~-~lg~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
..++|.+.+ .||+|+||.||+|.+ .+++.||||.+..... ...+++.+|+.++..++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788877 999999999999964 3467899999976432 2356799999999999999999999999 66788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999853 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+..+
T Consensus 167 ~~~~ 170 (291)
T 1xbb_A 167 LRAD 170 (291)
T ss_dssp CCTT
T ss_pred eccC
Confidence 7654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=212.40 Aligned_cols=154 Identities=25% Similarity=0.447 Sum_probs=127.6
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999986 568999999987532 23346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 226 YEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988532 23456899999999999999999999987 9999999999999999999999999998765
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 188 ~~ 189 (310)
T 2wqm_A 188 SK 189 (310)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=216.05 Aligned_cols=150 Identities=33% Similarity=0.538 Sum_probs=123.1
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHH--HhccCCCccceEEEEEEec-----Ce
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMML--IAKLQHRHLVRLFGCCIEQ-----GE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~-----~~ 221 (318)
..++|.+.+.||+|+||.||+|+. +++.||||++... ....+..|..+ +..++||||+++++.+... ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 357899999999999999999987 6789999998643 23444445444 4558999999999866532 25
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCEEEcCCCCceEe
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS------RLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
.++||||+++|+|.+++.. ...++..+..++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 6899999999999999843 33588999999999999999999871 0139999999999999999999999
Q ss_pred ecccceeecCC
Q 021046 296 DFGMARIFGGD 306 (318)
Q Consensus 296 DfGla~~~~~~ 306 (318)
|||+|+.+..+
T Consensus 163 DFG~a~~~~~~ 173 (336)
T 3g2f_A 163 DFGLSMRLTGN 173 (336)
T ss_dssp CCTTCEECSSS
T ss_pred eccceeecccc
Confidence 99999987643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=235.75 Aligned_cols=143 Identities=31% Similarity=0.492 Sum_probs=125.6
Q ss_pred cccccCCcccEEEEEec---CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
+.||+|+||.||+|.+. +++.||||+++... ....+++.+|+.++.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46789999997643 234578999999999999999999999986 4568899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 99999984 3456899999999999999999999987 999999999999999999999999999887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=217.25 Aligned_cols=149 Identities=26% Similarity=0.407 Sum_probs=130.2
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec-----Cee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 222 (318)
.++|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999864 678899999975332 2346789999999999999999999999765 367
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||++ |+|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 58888873 245899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
...+
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=218.94 Aligned_cols=148 Identities=29% Similarity=0.407 Sum_probs=115.5
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec------C
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------G 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 220 (318)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999986 568899999997532 23346788999999999999999999998754 5
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++|+||+ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 689988873 246899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=216.38 Aligned_cols=157 Identities=27% Similarity=0.367 Sum_probs=134.3
Q ss_pred HHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEe-------
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIE------- 218 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~------- 218 (318)
....+|.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3456899999999999999999986 468899999987655555678899999999996 9999999999953
Q ss_pred -cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 219 -QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 219 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
....++||||++ |+|.+++........+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 334789999996 789888855344567999999999999999999999864 35999999999999999999999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+++.+...
T Consensus 183 g~~~~~~~~ 191 (337)
T 3ll6_A 183 GSATTISHY 191 (337)
T ss_dssp TTCBCCSSC
T ss_pred ccceecccc
Confidence 999887643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=209.58 Aligned_cols=153 Identities=28% Similarity=0.415 Sum_probs=130.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 222 (318)
.+.|...+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++..++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34577888999999999999987 45788999988753 23345678999999999999999999999876 3457
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCCceEeecccce
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMAR 301 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~ki~DfGla~ 301 (318)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||+|.
T Consensus 105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999843 356889999999999999999999874 3599999999999997 78999999999997
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.....
T Consensus 181 ~~~~~ 185 (290)
T 1t4h_A 181 LKRAS 185 (290)
T ss_dssp GCCTT
T ss_pred ccccc
Confidence 65443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=218.16 Aligned_cols=153 Identities=24% Similarity=0.363 Sum_probs=126.1
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec------
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------ 219 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 219 (318)
....++|...+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 5689999999865432 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHH
Q 021046 220 --------------------------------GENILIYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYL 266 (318)
Q Consensus 220 --------------------------------~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yL 266 (318)
...++||||++ |+|.+.+.. ......+++..+..++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 577766642 12356789999999999999999999
Q ss_pred HhcCCCCeeecCCCCCCEEEc-CCCCceEeecccceeecCCc
Q 021046 267 HQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 267 H~~~~~~ivH~Dlk~~Nill~-~~~~~ki~DfGla~~~~~~~ 307 (318)
|+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9987 99999999999998 68899999999999875543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=214.81 Aligned_cols=159 Identities=24% Similarity=0.328 Sum_probs=121.4
Q ss_pred HHHHHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCe--
Q 021046 145 SVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-- 221 (318)
Q Consensus 145 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 221 (318)
......++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34567789999999999999999999874 6889999988653 2334567788888999999999999999987544
Q ss_pred -----eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCEEEcC-CCCce
Q 021046 222 -----NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH--QYSRLRIIHRDLKASNILLDS-DMNPK 293 (318)
Q Consensus 222 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivH~Dlk~~Nill~~-~~~~k 293 (318)
.++||||++++.+............+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543333222234567889999999999999999999 766 999999999999997 89999
Q ss_pred EeecccceeecCCc
Q 021046 294 ISDFGMARIFGGDE 307 (318)
Q Consensus 294 i~DfGla~~~~~~~ 307 (318)
|+|||+|+.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=206.91 Aligned_cols=152 Identities=24% Similarity=0.381 Sum_probs=132.6
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec--CeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 225 (318)
.++|...+.||+|+||.||+|++. ++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 468999999999999999999984 7899999987543 23346799999999999999999999999887 778999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||+++|+|.+++... ....+++..+..++.|++.||.|||+++ .+++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999542 2336899999999999999999999864 459999999999999999999999999876543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=209.09 Aligned_cols=150 Identities=30% Similarity=0.506 Sum_probs=130.1
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 67899999999999999999875 68999999987532 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|++ |+|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 6898888543 2345889999999999999999999987 99999999999999999999999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=233.96 Aligned_cols=148 Identities=22% Similarity=0.345 Sum_probs=128.2
Q ss_pred hcCCccccccccCCcccEEEEEec--CCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCe-----
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----- 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 221 (318)
.++|.+.+.||+|+||.||++.+. +++.||||++.... ......+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999875 58899999987532 2334578899999999999999999999998765
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999988762 26899999999999999999999987 9999999999999885 99999999999
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=210.06 Aligned_cols=152 Identities=32% Similarity=0.450 Sum_probs=129.9
Q ss_pred HhcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..++|...+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998643 3369999987642 2345678999999999999999999999764 5678
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998532 345889999999999999999999987 999999999999999999999999999876
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=209.07 Aligned_cols=157 Identities=27% Similarity=0.445 Sum_probs=131.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 224 (318)
.++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999874 68899999987542 2335678999999999999999999998865 567899
Q ss_pred EEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 225 IYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985432 2445899999999999999999999875 2349999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 76543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=220.21 Aligned_cols=149 Identities=29% Similarity=0.471 Sum_probs=122.6
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC------ee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------EN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 222 (318)
..+|...+.||+|+||.||+|.+. +++.||||++..... .+.+|+.+++.++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999875 589999999865322 2347999999999999999999986532 36
Q ss_pred EEEEEeccCCChhhhhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CCceEeecccc
Q 021046 223 ILIYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA 300 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ki~DfGla 300 (318)
++||||+++ +|...+. .......+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 4544432 2234567899999999999999999999987 9999999999999965 56899999999
Q ss_pred eeecCC
Q 021046 301 RIFGGD 306 (318)
Q Consensus 301 ~~~~~~ 306 (318)
+.+..+
T Consensus 205 ~~~~~~ 210 (420)
T 1j1b_A 205 KQLVRG 210 (420)
T ss_dssp EECCTT
T ss_pred hhcccC
Confidence 987544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=210.73 Aligned_cols=154 Identities=27% Similarity=0.382 Sum_probs=121.5
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc-C-HHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-G-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..++|+..+.||+|+||.||++.. .+++.||||++...... . .+.+..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999987 56889999999754221 2 23344555568889999999999999999999999
Q ss_pred EEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 226 YEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
|||++ |+|.+++.. ......+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+|+.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99998 478776643 12356799999999999999999999997 7 999999999999999999999999999877
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
..+
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=216.57 Aligned_cols=148 Identities=28% Similarity=0.388 Sum_probs=123.9
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
.++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999986 468899999987532 233457889999999999999999999998765
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||+++ +|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 6777663 34889999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 021046 301 RIFGGD 306 (318)
Q Consensus 301 ~~~~~~ 306 (318)
+.....
T Consensus 175 ~~~~~~ 180 (371)
T 2xrw_A 175 RTAGTS 180 (371)
T ss_dssp ------
T ss_pred cccccc
Confidence 876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=209.38 Aligned_cols=150 Identities=30% Similarity=0.517 Sum_probs=126.1
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec-CeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 227 (318)
..++|...+.||+|+||.||++.. +++.||||.++.. ...+.+.+|+.++.+++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357899999999999999999987 4789999999753 3457899999999999999999999997655 47899999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+++|+|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999988432 1234788999999999999999999987 99999999999999999999999999986654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=232.73 Aligned_cols=154 Identities=27% Similarity=0.409 Sum_probs=132.7
Q ss_pred HHHhcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
....++|.+.+.||+|+||.||+|.+.. +..||||.+..... ...+.+.+|+.++.+++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999998742 45799999875432 33467899999999999999999999984 567
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 89999999999999998532 346899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+...
T Consensus 540 ~~~~~ 544 (656)
T 2j0j_A 540 YMEDS 544 (656)
T ss_dssp SCCC-
T ss_pred ecCCC
Confidence 87544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=231.30 Aligned_cols=141 Identities=16% Similarity=0.218 Sum_probs=110.2
Q ss_pred ccccCCcccEEEEE-ecCCcEEEEEEccCCC----------CcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEE
Q 021046 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS----------GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 158 ~lg~G~fg~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (318)
..+.|++|.+..++ .-.|+.+++|.+.... ....++|.+|+.+|.++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666666553 3357889999986532 12345799999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||++|++|.+++.. ...++.. .|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999943 3456654 58899999999999998 99999999999999999999999999998765
Q ss_pred Cc
Q 021046 306 DE 307 (318)
Q Consensus 306 ~~ 307 (318)
+.
T Consensus 392 ~~ 393 (569)
T 4azs_A 392 DC 393 (569)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=214.45 Aligned_cols=148 Identities=27% Similarity=0.429 Sum_probs=129.7
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEec-----Cee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 222 (318)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999875 688999999975332 2345788999999999999999999998764 678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||++ |+|..++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 688888743 46899999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 021046 303 FGG 305 (318)
Q Consensus 303 ~~~ 305 (318)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-27 Score=206.02 Aligned_cols=149 Identities=23% Similarity=0.326 Sum_probs=128.9
Q ss_pred hcCCccc-cccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHH-hccCCCccceEEEEEEe----cCee
Q 021046 150 TENFSTQ-CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLI-AKLQHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 150 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 222 (318)
.++|... +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ ..++||||+++++++.. .+..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4667776 7899999999999987 56889999998642 4677888887 55689999999999987 6778
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeeccc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM 299 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfGl 299 (318)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998643 2346899999999999999999999987 999999999999998 78899999999
Q ss_pred ceeecCCc
Q 021046 300 ARIFGGDE 307 (318)
Q Consensus 300 a~~~~~~~ 307 (318)
|+...+..
T Consensus 167 a~~~~~~~ 174 (299)
T 3m2w_A 167 AKETTGEK 174 (299)
T ss_dssp CEECTTCG
T ss_pred cccccccc
Confidence 99876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=206.19 Aligned_cols=153 Identities=30% Similarity=0.494 Sum_probs=135.0
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
...++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++.+++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 45678999999999999999999875 6889999998653 23456789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CCceEeecccce
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMAR 301 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~ki~DfGla~ 301 (318)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888743 346899999999999999999999987 9999999999999764 469999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.....
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 76543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=214.63 Aligned_cols=153 Identities=26% Similarity=0.359 Sum_probs=131.6
Q ss_pred HHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccC--CCccceEEEEEEecCe
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQGE 221 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 221 (318)
+....++|.+.+.||+|+||.||++...+++.||||.+.... ....+.+.+|+.++.+++ ||||+++++++..++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 345567899999999999999999998889999999986532 234567899999999997 5999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++++ +.+||+|||+++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 999999 678899998853 346889999999999999999999987 999999999999964 899999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.+..+
T Consensus 175 ~~~~~ 179 (313)
T 3cek_A 175 QMQPD 179 (313)
T ss_dssp C----
T ss_pred cccCc
Confidence 87654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=208.88 Aligned_cols=151 Identities=32% Similarity=0.457 Sum_probs=124.2
Q ss_pred hcCCccccccccCCcccEEEEEec--CCc--EEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL--NGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|++.+.||+|+||.||+|.+. ++. .||||.++.. .....+.+.+|+.++.+++||||+++++++..++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999853 233 6899988754 2234568899999999999999999999998765 8
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999988532 346889999999999999999999987 99999999999999999999999999988
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=218.42 Aligned_cols=149 Identities=28% Similarity=0.485 Sum_probs=115.9
Q ss_pred cCCcc-ccccccCCcccEEEEEec---CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCeeEE
Q 021046 151 ENFST-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENIL 224 (318)
Q Consensus 151 ~~~~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 224 (318)
+.|.. .++||+|+||.||+|... +++.||||++... .....+.+|+.++.+++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 568999999999999865 5788999999753 223578899999999999999999999965 568899
Q ss_pred EEEeccCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCCceE
Q 021046 225 IYEYMPNKSLDVFLFYP------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKI 294 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~ki 294 (318)
||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 676666421 12235899999999999999999999988 9999999999999 77899999
Q ss_pred eecccceeecC
Q 021046 295 SDFGMARIFGG 305 (318)
Q Consensus 295 ~DfGla~~~~~ 305 (318)
+|||+|+.+..
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999988764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-28 Score=217.09 Aligned_cols=147 Identities=16% Similarity=0.255 Sum_probs=128.3
Q ss_pred hcCCccccccccCCcccEEEEEecC---------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccce---------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR--------- 211 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 211 (318)
.++|.+.+.||+|+||.||+|.... ++.||||.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998753 789999998753 46889999999999999988
Q ss_pred ------EEEEEEe-cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 021046 212 ------LFGCCIE-QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 284 (318)
Q Consensus 212 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 284 (318)
+++++.. ++..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778876 67889999999 99999999543 2357999999999999999999999987 99999999999
Q ss_pred EEcCCC--CceEeecccceeecCC
Q 021046 285 LLDSDM--NPKISDFGMARIFGGD 306 (318)
Q Consensus 285 ll~~~~--~~ki~DfGla~~~~~~ 306 (318)
|++.++ .+||+|||+|+.+..+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 8999999999877643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=203.47 Aligned_cols=150 Identities=23% Similarity=0.404 Sum_probs=125.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEE-EecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC-IEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 226 (318)
..++|...+.||+|+||.||+|.. .+++.||||.+..... ...+.+|+.++..++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 5688999998765322 24688999999999988877766665 5667889999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~~~ 303 (318)
||+ +++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999988532 346899999999999999999999987 9999999999999 78999999999999987
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 159 ~~~ 161 (296)
T 4hgt_A 159 RDA 161 (296)
T ss_dssp BCT
T ss_pred cCc
Confidence 654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=212.95 Aligned_cols=147 Identities=24% Similarity=0.433 Sum_probs=125.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCee----
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN---- 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 222 (318)
.++|...+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999864 688999999976422 2346788999999999999999999999887655
Q ss_pred --EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 223 --ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 223 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
++||||++ ++|..++ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 6787766 234899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+....
T Consensus 192 ~~~~~ 196 (371)
T 4exu_A 192 RHADA 196 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=207.94 Aligned_cols=152 Identities=30% Similarity=0.499 Sum_probs=128.6
Q ss_pred HhcCCccccccccCCcccEEEEEe--cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhcc---CCCccceEEEEEE----
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCI---- 217 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 217 (318)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 467899999886432 22234567788777766 8999999999997
Q ss_pred -ecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEee
Q 021046 218 -EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 296 (318)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~D 296 (318)
.....++||||++ |+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6998888543 2345899999999999999999999987 99999999999999999999999
Q ss_pred cccceeecC
Q 021046 297 FGMARIFGG 305 (318)
Q Consensus 297 fGla~~~~~ 305 (318)
||+++.+..
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=215.39 Aligned_cols=151 Identities=13% Similarity=0.135 Sum_probs=112.8
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC---cCHHHHHHHHHHHhcc--CCCccceEE-------EEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKL--QHRHLVRLF-------GCC 216 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~ 216 (318)
..+|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456889999999999999999864 688999999986432 2345677785444444 699988755 455
Q ss_pred Eec-----------------CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 021046 217 IEQ-----------------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR------VRIIEGIAQGLLYLHQYSRLR 273 (318)
Q Consensus 217 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~ 273 (318)
... ...++||||++ |+|.+++... ...+++..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 8999998543 223455556 788899999999999987
Q ss_pred eeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 274 ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+||||||+|||++.++.+||+|||+|+..+..
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999977543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=209.90 Aligned_cols=155 Identities=25% Similarity=0.379 Sum_probs=125.5
Q ss_pred HHHhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc------CHHHHHHHHHHHhcc----CCCccceEEEE
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ------GLTEFKNEMMLIAKL----QHRHLVRLFGC 215 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~ 215 (318)
....++|.+.+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999986 46889999999754321 223466789998888 89999999999
Q ss_pred EEecCeeEEEEEe-ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCCce
Q 021046 216 CIEQGENILIYEY-MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK 293 (318)
Q Consensus 216 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~k 293 (318)
+...+..++|+|| +++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999853 345899999999999999999999987 99999999999999 889999
Q ss_pred EeecccceeecCCc
Q 021046 294 ISDFGMARIFGGDE 307 (318)
Q Consensus 294 i~DfGla~~~~~~~ 307 (318)
|+|||+++.+....
T Consensus 181 l~dfg~~~~~~~~~ 194 (312)
T 2iwi_A 181 LIDFGSGALLHDEP 194 (312)
T ss_dssp ECCCSSCEECCSSC
T ss_pred EEEcchhhhcccCc
Confidence 99999999876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=201.02 Aligned_cols=150 Identities=23% Similarity=0.405 Sum_probs=129.2
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEE-EecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC-IEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 227 (318)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++..++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999986 6789999999875432 34689999999999998877666555 56678899999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~~~~ 304 (318)
|+ +++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+|+.+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999988532 346899999999999999999999987 9999999999999 488999999999999876
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=210.47 Aligned_cols=147 Identities=24% Similarity=0.424 Sum_probs=126.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecCe-----
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----- 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 221 (318)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++..++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36789999999999999999987 4688999999975322 234578899999999999999999999987654
Q ss_pred -eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 222 -NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
.++||||++ |+|..++. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 68877762 34899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=214.50 Aligned_cols=150 Identities=23% Similarity=0.385 Sum_probs=129.5
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC-CccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|.+.++||+|+||.||+|.. .+++.||||++..... ...+..|+.++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999986 5689999998765432 2468899999999987 566667777778889999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~ki~DfGla~~~~ 304 (318)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 356899999999999999999999987 9999999999999 688999999999999886
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=213.19 Aligned_cols=150 Identities=23% Similarity=0.267 Sum_probs=128.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhcc------CCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL------QHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 222 (318)
..+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999764 5889999999753 23345677888888777 577999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC--ceEeecccc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMA 300 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~ki~DfGla 300 (318)
++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6888877543 2345899999999999999999999987 999999999999999987 999999999
Q ss_pred eeecC
Q 021046 301 RIFGG 305 (318)
Q Consensus 301 ~~~~~ 305 (318)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 86543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=211.36 Aligned_cols=150 Identities=29% Similarity=0.501 Sum_probs=128.0
Q ss_pred HHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
....++|...+.||+|+||.||+|...+ .+|+|.+... .....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3456789999999999999999998754 4999988753 23344568889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++ ++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999843 2346889999999999999999999987 99999999999998 6899999999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=206.46 Aligned_cols=153 Identities=27% Similarity=0.412 Sum_probs=126.3
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHH-HHhccCCCccceEEEEEEecCeeEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
.++|...+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478899999999999999999874 688999999975432 23345556665 777889999999999999999999999
Q ss_pred EeccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 227 EYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 227 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77766642 11246789999999999999999999997 7 999999999999999999999999999877
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=206.90 Aligned_cols=152 Identities=24% Similarity=0.356 Sum_probs=132.4
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc------CHHHHHHHHHHHhccC--CCccceEEEEEEec
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ------GLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQ 219 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 219 (318)
..++|.+.+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.++.+++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457899999999999999999986 56889999998754221 2346778999999996 59999999999999
Q ss_pred CeeEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCCceEeec
Q 021046 220 GENILIYEYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDF 297 (318)
Q Consensus 220 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~ki~Df 297 (318)
+..++|+||+.+ ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 899998843 356899999999999999999999987 99999999999999 7899999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+++.+...
T Consensus 195 g~~~~~~~~ 203 (320)
T 3a99_A 195 GSGALLKDT 203 (320)
T ss_dssp TTCEECCSS
T ss_pred ccccccccc
Confidence 999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=211.96 Aligned_cols=135 Identities=24% Similarity=0.328 Sum_probs=113.2
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC--------CCccceEEEEEE---
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ--------HRHLVRLFGCCI--- 217 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 217 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999986 45889999999753 334567889999999985 788999999998
Q ss_pred -ecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCC
Q 021046 218 -EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM 290 (318)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~ 290 (318)
.....++||||+ +++|..++... ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 456789999999 55555555332 235689999999999999999999997 6 99999999999999775
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=204.03 Aligned_cols=150 Identities=23% Similarity=0.320 Sum_probs=130.1
Q ss_pred hcCCccccccccCCcccEEEEEe--cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc------cceEEEEEEecCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH------LVRLFGCCIEQGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 221 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++..++|+| ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 36889999999753 234567889999999987665 9999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------------
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS------------- 288 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~------------- 288 (318)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888543 2346889999999999999999999987 999999999999988
Q ss_pred ------CCCceEeecccceeecC
Q 021046 289 ------DMNPKISDFGMARIFGG 305 (318)
Q Consensus 289 ------~~~~ki~DfGla~~~~~ 305 (318)
++.+||+|||+|+....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 67899999999987653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=214.44 Aligned_cols=149 Identities=26% Similarity=0.317 Sum_probs=120.1
Q ss_pred CCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEEecc
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998777778999999998652 245678999999876 89999999999999999999999996
Q ss_pred CCChhhhhhcCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-------------CCce
Q 021046 231 NKSLDVFLFYPKKKR----LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-------------MNPK 293 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-------------~~~k 293 (318)
|+|.+++....... ..++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999885432211 1133345789999999999999987 9999999999999754 4799
Q ss_pred EeecccceeecCCc
Q 021046 294 ISDFGMARIFGGDE 307 (318)
Q Consensus 294 i~DfGla~~~~~~~ 307 (318)
|+|||+|+.+..+.
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999886543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=225.14 Aligned_cols=155 Identities=28% Similarity=0.363 Sum_probs=131.6
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEe------cC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE------QG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 220 (318)
..++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.+++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 347899999999999999999986 46889999998754 23345678999999999999999999999765 66
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC---ceEeec
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDF 297 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~ki~Df 297 (318)
..++||||+++|+|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 78999999999999999976554556889999999999999999999987 999999999999997765 899999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+|+.+...
T Consensus 169 G~a~~~~~~ 177 (676)
T 3qa8_A 169 GYAKELDQG 177 (676)
T ss_dssp CCCCBTTSC
T ss_pred ccccccccc
Confidence 999887544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=213.70 Aligned_cols=149 Identities=23% Similarity=0.381 Sum_probs=121.5
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 227 (318)
...+|...+.||+|+||+||.....+++.||||++.... ...+.+|+.++..+ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345788899999999999776656688999999996532 23467899999999 79999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----CCCceEeeccccee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARI 302 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-----~~~~ki~DfGla~~ 302 (318)
|++ |+|.+++.... ..+.+..+..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+|+.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 58988885432 23344456789999999999999987 999999999999953 23578999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+..+
T Consensus 173 ~~~~ 176 (432)
T 3p23_A 173 LAVG 176 (432)
T ss_dssp C---
T ss_pred ccCC
Confidence 7644
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-26 Score=201.66 Aligned_cols=150 Identities=23% Similarity=0.273 Sum_probs=121.3
Q ss_pred HhcCCcccc-ccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCee
Q 021046 149 ATENFSTQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 149 ~~~~~~~~~-~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 222 (318)
..++|.+.+ .||+|+||.||+|... +++.||||++... ..........+..++||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457888854 6999999999999875 6899999998652 1222223334566799999999999986 4458
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeeccc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM 299 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfGl 299 (318)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998543 2356899999999999999999999987 999999999999976 45599999999
Q ss_pred ceeecCC
Q 021046 300 ARIFGGD 306 (318)
Q Consensus 300 a~~~~~~ 306 (318)
|+.....
T Consensus 178 ~~~~~~~ 184 (336)
T 3fhr_A 178 AKETTQN 184 (336)
T ss_dssp CEEC---
T ss_pred ceecccc
Confidence 9876543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=201.63 Aligned_cols=152 Identities=24% Similarity=0.371 Sum_probs=116.1
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCc-C-HHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-G-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
..++|...+.||+|+||.||+|... +++.||||.+...... . .+.+..+..++..++||||+++++++..++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3578899999999999999999875 6899999999754322 1 23344555678888999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
|||+ ++.+..+... ....+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4445444321 245689999999999999999999985 6 9999999999999999999999999998765
Q ss_pred CC
Q 021046 305 GD 306 (318)
Q Consensus 305 ~~ 306 (318)
..
T Consensus 177 ~~ 178 (318)
T 2dyl_A 177 DD 178 (318)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=200.44 Aligned_cols=150 Identities=24% Similarity=0.324 Sum_probs=127.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CC-cEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc------cceEEEEEEecCe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH------LVRLFGCCIEQGE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 221 (318)
.++|.+.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.++..++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999874 34 68999999753 334567889999999998766 9999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---------------
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--------------- 286 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--------------- 286 (318)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55666655332 2346899999999999999999999987 9999999999999
Q ss_pred ----cCCCCceEeecccceeecC
Q 021046 287 ----DSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 287 ----~~~~~~ki~DfGla~~~~~ 305 (318)
+.++.+||+|||+|+....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 6688999999999987543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=216.22 Aligned_cols=137 Identities=19% Similarity=0.251 Sum_probs=109.4
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCCCCc--------CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
...+.||+|+||.||++.. .+..+++|+....... ..+.+.+|+.++.+++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999955 5678899976543211 124589999999999999999777777788889999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+|+.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999832 4589999999999999987 999999999999998 999999999998866
Q ss_pred Cc
Q 021046 306 DE 307 (318)
Q Consensus 306 ~~ 307 (318)
.+
T Consensus 482 ~~ 483 (540)
T 3en9_A 482 DE 483 (540)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=197.32 Aligned_cols=146 Identities=19% Similarity=0.180 Sum_probs=116.4
Q ss_pred HHHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCc------------------CHHHHHHHHHHHhcc
Q 021046 143 LASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ------------------GLTEFKNEMMLIAKL 204 (318)
Q Consensus 143 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~e~~~l~~l 204 (318)
+.........|...+.||+|+||.||+|...+|+.||||.++..... ....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 33444455667778999999999999999877999999998643211 235688999999999
Q ss_pred CCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 021046 205 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 284 (318)
Q Consensus 205 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 284 (318)
+ | +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 56666543 356799999999999987 411 123469999999999999987 99999999999
Q ss_pred EEcCCCCceEeecccceeecCC
Q 021046 285 LLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 285 ll~~~~~~ki~DfGla~~~~~~ 306 (318)
|++ ++.+||+|||+|+.....
T Consensus 225 Ll~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EEE-TTEEEECCCTTCEETTST
T ss_pred EEE-CCcEEEEECCCCeECCCC
Confidence 999 999999999999977543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=201.98 Aligned_cols=153 Identities=27% Similarity=0.345 Sum_probs=127.7
Q ss_pred HhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CC-----ccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HR-----HLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||+|... +++.||||+++.. .....++..|+.++..++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999864 5789999999753 233456778888888875 44 49999999999999
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCCceEeeccc
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGM 299 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~ki~DfGl 299 (318)
.++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 58988885432 34589999999999999999999953 23499999999999995 478899999999
Q ss_pred ceeecC
Q 021046 300 ARIFGG 305 (318)
Q Consensus 300 a~~~~~ 305 (318)
|+.+..
T Consensus 208 a~~~~~ 213 (382)
T 2vx3_A 208 SCQLGQ 213 (382)
T ss_dssp CEETTC
T ss_pred ceeccc
Confidence 988754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=203.96 Aligned_cols=150 Identities=23% Similarity=0.389 Sum_probs=128.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-----------CCccceEEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----------HRHLVRLFGCCI 217 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 217 (318)
.++|.+.+.||+|+||.||+|.. .+++.||||.+... ......+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999986 56889999999752 233467889999998886 899999999998
Q ss_pred ecC----eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEc-----
Q 021046 218 EQG----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLD----- 287 (318)
Q Consensus 218 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~----- 287 (318)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 764 789999999 89999988543 234589999999999999999999997 7 99999999999994
Q ss_pred -CCCCceEeecccceeecC
Q 021046 288 -SDMNPKISDFGMARIFGG 305 (318)
Q Consensus 288 -~~~~~ki~DfGla~~~~~ 305 (318)
..+.+||+|||+|+.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 445799999999987754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=192.88 Aligned_cols=153 Identities=16% Similarity=0.217 Sum_probs=115.0
Q ss_pred HhcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCC-Ccc---------ce---
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQH-RHL---------VR--- 211 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h-~ni---------v~--- 211 (318)
...+|...+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.++..++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345678889999999999999985 568999999987432 2336789999999999987 221 11
Q ss_pred ---------EEEEEEe-----cCeeEEEEEeccCCChhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 021046 212 ---------LFGCCIE-----QGENILIYEYMPNKSLDVFLFY----PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 273 (318)
Q Consensus 212 ---------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 273 (318)
+..++.. ....+++|++ .+++|.+++.. ......+++..++.++.|++.||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 1234566665 46889888731 223456888999999999999999999987
Q ss_pred eeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 274 IIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 274 ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|+||||||+|||++.++.+||+|||+|+..+.
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 99999999999999999999999999987543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=178.04 Aligned_cols=140 Identities=16% Similarity=0.166 Sum_probs=107.6
Q ss_pred CCccccccccCCcccEEEEEe-cCCcE--EEEEEccCCCCcC------------------------HHHHHHHHHHHhcc
Q 021046 152 NFSTQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQG------------------------LTEFKNEMMLIAKL 204 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~~------------------------~~~~~~e~~~l~~l 204 (318)
-|.+.+.||+|+||.||+|.. .+|+. ||||.++...... ...+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999987 78888 9999875431110 12578999999999
Q ss_pred CCCcc--ceEEEEEEecCeeEEEEEeccC-C----ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 021046 205 QHRHL--VRLFGCCIEQGENILIYEYMPN-K----SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-QYSRLRIIH 276 (318)
Q Consensus 205 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH 276 (318)
+|+++ +.+++. +..++||||+.+ | +|.+.... .++.....++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 98864 444432 367899999952 4 55544311 224456789999999999999 877 999
Q ss_pred cCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 277 RDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 277 ~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|||||+|||++. .++|+|||+|......
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999988 9999999999877543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-20 Score=165.93 Aligned_cols=147 Identities=13% Similarity=0.144 Sum_probs=102.6
Q ss_pred HHHHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCC--------------cCHHHH--------HHHHHHH
Q 021046 144 ASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLTEF--------KNEMMLI 201 (318)
Q Consensus 144 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~~--------~~e~~~l 201 (318)
..+.....-|.+..+||+|+||.||+|...+|+.||||+++.... ...... ..|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 334444445889999999999999999998999999998753210 011112 2344555
Q ss_pred hccCCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 021046 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKA 281 (318)
Q Consensus 202 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~ 281 (318)
.++.++++....-+.. +..+|||||+++++|...... .....++.|++.+|.|||+.+ ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 5554433321111111 234799999999888654411 123467899999999999987 99999999
Q ss_pred CCEEEcCCCC----------ceEeecccceeec
Q 021046 282 SNILLDSDMN----------PKISDFGMARIFG 304 (318)
Q Consensus 282 ~Nill~~~~~----------~ki~DfGla~~~~ 304 (318)
.|||+++++. +.|+||+=+.-..
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999988774 8999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-14 Score=122.97 Aligned_cols=147 Identities=16% Similarity=0.090 Sum_probs=115.4
Q ss_pred HHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEE
Q 021046 147 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 147 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (318)
......|.....++.|+++.||+.... +..+++|............+.+|+.++..+. +..++++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888888888899999999764 6789999987532233346889999999884 67888999999998999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------------------------------------ 269 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------ 269 (318)
|||++|.+|...+. +......++.+++.+|..||+.
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999876531 1122346788999999999981
Q ss_pred --------------------CCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 270 --------------------SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 270 --------------------~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
.+..++|+|++|.||+++++..+.|+||+.|..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998766678999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.9e-13 Score=116.38 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=102.6
Q ss_pred CCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc--cceEEEEEEecCeeEEEEEec
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 229 (318)
++......+.|..+.||+....+|..+++|..... ....+..|+.++..+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333456669999998777888999987653 2346788999998886544 566888888878889999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS--------------------------------------- 270 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------- 270 (318)
+|.+|. .. . .+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~--~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SS--H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TS--C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cC--c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 21 0 11 2256778888888888643
Q ss_pred ----------------CCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 271 ----------------RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 271 ----------------~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+..++|+|++|.||+++.+..+.|.|||.|..-
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988766789999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.34 E-value=5.7e-12 Score=112.68 Aligned_cols=142 Identities=13% Similarity=0.238 Sum_probs=107.4
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEcc--CCC-CcCHHHHHHHHHHHhccC--CCccceEEEEEEec---CeeEEEE
Q 021046 155 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQ---GENILIY 226 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 226 (318)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+.++..+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45689999999999998754 578888775 322 123356888999999887 45688899988776 4579999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS------------------------------------ 270 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 270 (318)
||+++..+.+.. ...++...+..++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874322 234677888899999999999999731
Q ss_pred -------------------CCCeeecCCCCCCEEEcCCCC--ceEeeccccee
Q 021046 271 -------------------RLRIIHRDLKASNILLDSDMN--PKISDFGMARI 302 (318)
Q Consensus 271 -------------------~~~ivH~Dlk~~Nill~~~~~--~ki~DfGla~~ 302 (318)
...++|+|++|.||+++.++. +.|.||++|..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.9e-09 Score=92.78 Aligned_cols=137 Identities=21% Similarity=0.227 Sum_probs=99.1
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCc--cceEEEEEEecC---eeEEEEEec
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRH--LVRLFGCCIEQG---ENILIYEYM 229 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 229 (318)
.+.++.|....||+.. ..+++|+.... .....+.+|..++..+. +.. +.+.+......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568899999999863 45788876432 33467889999998873 333 445555543333 348999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY---------------------------------------- 269 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------------------------------------- 269 (318)
+|.+|..... ..++..++..++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865331 2356677778888888888888861
Q ss_pred ---------------CCCCeeecCCCCCCEEEcC--CCCceEeecccceee
Q 021046 270 ---------------SRLRIIHRDLKASNILLDS--DMNPKISDFGMARIF 303 (318)
Q Consensus 270 ---------------~~~~ivH~Dlk~~Nill~~--~~~~ki~DfGla~~~ 303 (318)
....++|+|++|.||+++. ...+.|.||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999998 556899999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=3.7e-08 Score=85.88 Aligned_cols=137 Identities=22% Similarity=0.199 Sum_probs=94.1
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC---ccceEEEEEE-ecCeeEEEEEeccC
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR---HLVRLFGCCI-EQGENILIYEYMPN 231 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 231 (318)
.+.++.|....||+. +..+++|+... ......+..|..+|..+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 46677887432 23346789999999999752 3667777764 34567899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------------------------------------------ 269 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------------ 269 (318)
.++..... ..++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1223444445555555555555532
Q ss_pred ---------------CCCCeeecCCCCCCEEEcC---CCC-ceEeecccceee
Q 021046 270 ---------------SRLRIIHRDLKASNILLDS---DMN-PKISDFGMARIF 303 (318)
Q Consensus 270 ---------------~~~~ivH~Dlk~~Nill~~---~~~-~ki~DfGla~~~ 303 (318)
.+..++|+|+.|.||+++. ++. +.|.||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 489999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=7.1e-08 Score=85.83 Aligned_cols=81 Identities=7% Similarity=-0.006 Sum_probs=56.6
Q ss_pred cccc-ccCCcccEEEEEec-------CCcEEEEEEccCCC---CcCHHHHHHHHHHHhccCC---CccceEEEEEEec--
Q 021046 156 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQH---RHLVRLFGCCIEQ-- 219 (318)
Q Consensus 156 ~~~l-g~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~-- 219 (318)
.+.| +.|....+|+.... ++..+++|...... ......+..|+.++..+.. ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998764 25678888765432 1112467888888888742 3577888887655
Q ss_pred -CeeEEEEEeccCCChhh
Q 021046 220 -GENILIYEYMPNKSLDV 236 (318)
Q Consensus 220 -~~~~lv~e~~~~g~L~~ 236 (318)
+..++||||++|..+..
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.1e-07 Score=81.09 Aligned_cols=136 Identities=19% Similarity=0.160 Sum_probs=95.9
Q ss_pred ccccCCcc-cEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 158 KLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 158 ~lg~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
.+..|..+ .||+.... ++..+.+|+-... ...++.+|...|..+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 58988764 4567888876542 3457888999888774 33477899999999999999999999887
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY--------------------------------------------- 269 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------- 269 (318)
.+..... ......+..+++..|.-||..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6543211 112234555566666666632
Q ss_pred ----------CCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 270 ----------SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 270 ----------~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
....++|+|+.|.||+++.++.+-|.||+.|..-
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1123899999999999998877789999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.7e-06 Score=76.19 Aligned_cols=141 Identities=14% Similarity=0.165 Sum_probs=81.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC--CccceEEE------EEEecCeeEEEEEe
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLFG------CCIEQGENILIYEY 228 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 228 (318)
+.|+.|..+.||+....++ .+++|+.... ..++..|..++..|.. -.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 5888988652 2344455555555431 12333432 12346778999999
Q ss_pred ccCCChhh--------------hhhcC-C----C------CCCCCHHHHH------------------------------
Q 021046 229 MPNKSLDV--------------FLFYP-K----K------KRLLGWQARV------------------------------ 253 (318)
Q Consensus 229 ~~~g~L~~--------------~l~~~-~----~------~~~l~~~~~~------------------------------ 253 (318)
++|..+.. .++.. . . ...-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876530 01110 0 0 0112332211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 254 -RIIEGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 254 -~i~~~i~~~l~yLH~----------~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
.+..++..++.+|+. ..+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223445667763 1245699999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.8e-06 Score=77.86 Aligned_cols=75 Identities=12% Similarity=0.182 Sum_probs=50.5
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEccCCC-------CcCHHHHHHHHHHHhccCC--Cc-cceEEEEEEecCeeEE
Q 021046 156 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-------GQGLTEFKNEMMLIAKLQH--RH-LVRLFGCCIEQGENIL 224 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 224 (318)
.+.+|.|.++.||++... +++.++||...... ....+.+..|..++..+.. |. +++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 46789999765321 1233567788888887742 33 4456543 4556789
Q ss_pred EEEeccCC
Q 021046 225 IYEYMPNK 232 (318)
Q Consensus 225 v~e~~~~g 232 (318)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.1e-06 Score=72.09 Aligned_cols=80 Identities=16% Similarity=0.226 Sum_probs=60.5
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC---CccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH---RHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 227 (318)
..+...+.+|.|..+.||+.+..+|+.+.+|+...........|..|...|+.|.- --+++.+++ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 45666778999999999999999999999998776544445578899998888742 234555554 23479999
Q ss_pred eccCCCh
Q 021046 228 YMPNKSL 234 (318)
Q Consensus 228 ~~~~g~L 234 (318)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.27 E-value=6.8e-06 Score=71.57 Aligned_cols=145 Identities=20% Similarity=0.165 Sum_probs=96.2
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC---CCccceEEEEEEecCeeEEEEEeccC
Q 021046 155 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
..+.|+.|.+..+|+... ++..+++|..... ....+..|...|..|. ...+++.+.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 446789999999999986 4667888877542 3567889998888874 36788899998888889999999999
Q ss_pred CChhh-----------hhhcCCC-------------------CCCCCHHHHH---HHH----------------HHHHHH
Q 021046 232 KSLDV-----------FLFYPKK-------------------KRLLGWQARV---RII----------------EGIAQG 262 (318)
Q Consensus 232 g~L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~~i~~~ 262 (318)
..+.. .++.... ...-+|.... ++. .++...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 87631 1222111 0012454332 111 111111
Q ss_pred -HHHHHh-cCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 263 -LLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 263 -l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
...|.. ..++.++|+|+.+.|++++.++ +.|.||. + .++..
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~-~-~~g~~ 238 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA-C-YWGDR 238 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC-C-EEECT
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc-c-ccCCh
Confidence 223421 2356799999999999999887 8999984 3 34443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.6e-05 Score=70.85 Aligned_cols=73 Identities=14% Similarity=0.204 Sum_probs=46.2
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCC------C-C--cCHHHHHHHHHHHh-ccCCCccceEEEEEEecCeeEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ------S-G--QGLTEFKNEMMLIA-KLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~------~-~--~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.+.+|.|....||+... ++..++||..... . . .....+..|+..+. ......+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999965 4678999943221 1 1 12233444444332 22335667777665 5677999
Q ss_pred EEec-cC
Q 021046 226 YEYM-PN 231 (318)
Q Consensus 226 ~e~~-~~ 231 (318)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.93 E-value=4.4e-05 Score=66.56 Aligned_cols=158 Identities=14% Similarity=0.127 Sum_probs=87.0
Q ss_pred cHHHHHHHhcCCcc-----ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc--cceEEE
Q 021046 142 SLASVSAATENFST-----QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFG 214 (318)
Q Consensus 142 ~~~~~~~~~~~~~~-----~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~ 214 (318)
+.+.+......|.. .+.|+.|....+|+....++ .+++|..... .....+..|+.++..+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 34567788889999987665 5778887652 12235566777776664222 333332
Q ss_pred E------EEecCeeEEEEEeccCCChhhh--------------hhcC--C---CC----CCCCHHHHHH-----------
Q 021046 215 C------CIEQGENILIYEYMPNKSLDVF--------------LFYP--K---KK----RLLGWQARVR----------- 254 (318)
Q Consensus 215 ~------~~~~~~~~lv~e~~~~g~L~~~--------------l~~~--~---~~----~~l~~~~~~~----------- 254 (318)
. ....+..+++++|++|..+... ++.. . .. ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1234667899999998764210 1110 0 00 0012322111
Q ss_pred -HHHHHHHHHHHHHhc----CCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 255 -IIEGIAQGLLYLHQY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 255 -i~~~i~~~l~yLH~~----~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
+...+...++++... .+..++|+|+.+.||+++.+..+.|.||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234699999999999998876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00011 Score=63.39 Aligned_cols=138 Identities=11% Similarity=0.093 Sum_probs=75.9
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEEec-cCCC
Q 021046 156 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYM-PNKS 233 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 233 (318)
.+.|+.|....+|+. ..+.+|+........ .+...|+..+..+...++ .++++. ..+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 457788776432221 233568777776643233 456554 344467999999 6555
Q ss_pred hhhh------------------hhcCCC--CCCCCH-HHHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 021046 234 LDVF------------------LFYPKK--KRLLGW-QARVRIIE--------------GIAQGLL----YLHQ-YSRLR 273 (318)
Q Consensus 234 L~~~------------------l~~~~~--~~~l~~-~~~~~i~~--------------~i~~~l~----yLH~-~~~~~ 273 (318)
+... +|.... ....+. .....+.. .+...+. .+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5321 111100 000111 11111100 0111111 1111 22345
Q ss_pred eeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 274 IIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 274 ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++|+|+.|.||+ ..++.+.|+||..|..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5677889999998874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.74 E-value=7.8e-05 Score=67.90 Aligned_cols=73 Identities=22% Similarity=0.350 Sum_probs=50.2
Q ss_pred ccccccCCcccEEEEEecC--------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIY 226 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 226 (318)
.+.|+.|....+|+....+ +..+.+|+.... .....+..|..++..+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 468888887431 122566689988888754344 567765532 3899
Q ss_pred EeccCCCh
Q 021046 227 EYMPNKSL 234 (318)
Q Consensus 227 e~~~~g~L 234 (318)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00022 Score=62.18 Aligned_cols=142 Identities=15% Similarity=0.174 Sum_probs=82.3
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCC--ccceEEEE-----EEecCeeEEEEEec
Q 021046 157 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR--HLVRLFGC-----CIEQGENILIYEYM 229 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 229 (318)
..++ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. ...++..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 77889999877777789999886431 2345677788877776422 23444432 22345668899999
Q ss_pred cCCChhh-----h---------hhc--CC----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 021046 230 PNKSLDV-----F---------LFY--PK----KKRLLGWQAR----VRI---------------IEGIAQGLLYLHQ-- 268 (318)
Q Consensus 230 ~~g~L~~-----~---------l~~--~~----~~~~l~~~~~----~~i---------------~~~i~~~l~yLH~-- 268 (318)
+|..+.. . ++. .. .....++... ..+ ...+...++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 0 110 00 0112222211 000 0111122233322
Q ss_pred --cCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 269 --YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 269 --~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
..+..++|+|+++.||+++ + .+.|.||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999998 4 899999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00025 Score=62.06 Aligned_cols=142 Identities=13% Similarity=0.119 Sum_probs=71.9
Q ss_pred cccccCCccc-EEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC--CccceEEEEEEecCeeEEEEEeccCCC
Q 021046 157 CKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 157 ~~lg~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
+.|+.|.... +|+....++..+++|....... .++..|+.++..+.. -.+.+++.+.... -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 6677654466777775543221 234456666665532 3356677664333 378999997765
Q ss_pred hhhhhh---------------------cCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 021046 234 LDVFLF---------------------YPKK--KRLLGWQARV-------R-------------IIEGIAQGLLYLH--- 267 (318)
Q Consensus 234 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~~i~~~l~yLH--- 267 (318)
+...+. .... ...++..... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543221 1000 0112111100 0 0001111222221
Q ss_pred hcCCCCeeecCCCCCCEEEcCC----CCceEeecccceee
Q 021046 268 QYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARIF 303 (318)
Q Consensus 268 ~~~~~~ivH~Dlk~~Nill~~~----~~~ki~DfGla~~~ 303 (318)
......++|+|+.+.||+++.+ ..+.|.||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124469999999999999875 67899999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00023 Score=63.60 Aligned_cols=141 Identities=21% Similarity=0.254 Sum_probs=83.5
Q ss_pred cccccCCcccEEEEEecC--------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc-cceEEEEEEecCeeEEEEE
Q 021046 157 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 227 (318)
+.+..|-...+|+....+ ++.+.+|+.-. .......+.+|..+++.|.-.+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467777788899998752 46788888633 2234566778999888875322 3566666543 29999
Q ss_pred eccCCChhhh-----------------hhcCC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 021046 228 YMPNKSLDVF-----------------LFYPK--KKRLLG--WQARVRIIEGIAQ-------------------GLLYLH 267 (318)
Q Consensus 228 ~~~~g~L~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l~yLH 267 (318)
|++|..|..- ++... -..... |....++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666321 11111 011122 3444444433321 233332
Q ss_pred ----hc-CCCCeeecCCCCCCEEEcCC----CCceEeeccccee
Q 021046 268 ----QY-SRLRIIHRDLKASNILLDSD----MNPKISDFGMARI 302 (318)
Q Consensus 268 ----~~-~~~~ivH~Dlk~~Nill~~~----~~~ki~DfGla~~ 302 (318)
.. .+..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23468999999999999876 7899999998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0003 Score=64.49 Aligned_cols=74 Identities=11% Similarity=0.095 Sum_probs=48.3
Q ss_pred ccccccCCcccEEEEEecC-CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEEeccCCC
Q 021046 156 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYMPNKS 233 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 233 (318)
.+.|+.|-...+|+....+ +..+.+|+........ -+...|..++..|...++ +++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578888889999998765 4678888775432221 123578888888865444 56777662 2 35999998755
Q ss_pred h
Q 021046 234 L 234 (318)
Q Consensus 234 L 234 (318)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00024 Score=63.18 Aligned_cols=74 Identities=12% Similarity=0.118 Sum_probs=44.6
Q ss_pred ccccccCCcccEEEEEecC---------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc-cceEEEEEEecCeeEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQGENILI 225 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 225 (318)
.+.++.|....+|+....+ +..+.+|+....... ..+...|..++..+...+ .+++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567788888999998654 267888876543221 123467888887775334 44666543 2 3789
Q ss_pred EEeccCCCh
Q 021046 226 YEYMPNKSL 234 (318)
Q Consensus 226 ~e~~~~g~L 234 (318)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999997654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0052 Score=53.88 Aligned_cols=33 Identities=21% Similarity=0.379 Sum_probs=28.6
Q ss_pred CCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 271 ~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
...++|+|+.+.||+++.++.+.|.||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998889999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.039 Score=49.82 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=84.2
Q ss_pred ccccccCCcccEEEEEecC--------CcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCc-cceEEEEEEecCeeEEEE
Q 021046 156 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQGENILIY 226 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 226 (318)
.+.+..|-...+|+....+ +..+.+++....... .-+..+|..+++.+.-.+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888899998753 577888886543222 223467888887774323 35566533 2 37899
Q ss_pred EeccCCChhhh-----------------hhc--------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 021046 227 EYMPNKSLDVF-----------------LFY--------PK--KKRLLGWQARVRIIEGI-------------------A 260 (318)
Q Consensus 227 e~~~~g~L~~~-----------------l~~--------~~--~~~~l~~~~~~~i~~~i-------------------~ 260 (318)
||++|..|..- +|. .. ...+.-|.....+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765210 010 00 11111233333333221 2
Q ss_pred HHHHHHH---------------------hcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 261 QGLLYLH---------------------QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 261 ~~l~yLH---------------------~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
..+.+|. ...+..++|+|+.+.||+ +.++.+.++||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233332 112345899999999999 8888999999998874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.09 E-value=0.19 Score=44.95 Aligned_cols=30 Identities=27% Similarity=0.382 Sum_probs=25.5
Q ss_pred CeeecCCCCCCEEE------cCCCCceEeeccccee
Q 021046 273 RIIHRDLKASNILL------DSDMNPKISDFGMARI 302 (318)
Q Consensus 273 ~ivH~Dlk~~Nill------~~~~~~ki~DfGla~~ 302 (318)
.++|+|+.+.||++ +++..+.++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.63 E-value=0.024 Score=51.91 Aligned_cols=61 Identities=11% Similarity=0.109 Sum_probs=18.3
Q ss_pred cccccccCCcccEEEEEecC-CcEEEE------EEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe
Q 021046 155 TQCKLGEGGFGPVYKGRLLN-GQEVAV------KRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 218 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~~~-~~~vav------K~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 218 (318)
..+.|| ||.||+|.+.. ..+||| |..... +.+....|.+|..++..++|||+++.+++-..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999998754 357888 665532 22334568889999999999999999887654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.30 E-value=0.53 Score=38.13 Aligned_cols=90 Identities=10% Similarity=0.067 Sum_probs=61.7
Q ss_pred CCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCCC
Q 021046 205 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL-YLHQYSRLRIIHRDLKASN 283 (318)
Q Consensus 205 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivH~Dlk~~N 283 (318)
.||++ -...-.+++...+.|+.-+++.-...+ ..++...+++++..|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57887 333335566666666654333211122 34677888888888877766 5543 6888899999
Q ss_pred EEEcCCCCceEeecccceeecCCc
Q 021046 284 ILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 284 ill~~~~~~ki~DfGla~~~~~~~ 307 (318)
++++.++.++|.=.|+-..+.+.+
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP~e 138 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPPDE 138 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSSCS
T ss_pred EEEeCCCcEEEEEcCCcccCCCCC
Confidence 999999999999999876664433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.21 E-value=0.37 Score=38.93 Aligned_cols=90 Identities=9% Similarity=0.022 Sum_probs=63.7
Q ss_pred CCCccceEEEEEEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 021046 205 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 284 (318)
Q Consensus 205 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 284 (318)
.||+++.. .+-.+.+...+.|+.- .+...+- .-..++...+++++..|+....+++. -+|--+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888866 3445555555555443 3333332 12456788999999999888866653 57888999999
Q ss_pred EEcCCCCceEeecccceeecCC
Q 021046 285 LLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 285 ll~~~~~~ki~DfGla~~~~~~ 306 (318)
+++.++.+++.=.|+-..+.+.
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp EECTTSCEEESCCEETTTBSCC
T ss_pred EEcCCCCEEEEEccCccCCCCC
Confidence 9999999999999986655444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=83.30 E-value=0.063 Score=49.41 Aligned_cols=33 Identities=18% Similarity=0.011 Sum_probs=26.0
Q ss_pred CcCHHHHHHHHHHHhccCCCccceEEEEEEecC
Q 021046 188 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG 220 (318)
Q Consensus 188 ~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 220 (318)
..+.++|..|++.+.+++|+|+|+++|||....
T Consensus 320 ~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 320 GQGSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 345678999999999999999999999998653
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=80.70 E-value=1.3 Score=29.66 Aligned_cols=32 Identities=25% Similarity=0.567 Sum_probs=25.6
Q ss_pred ChhHHHHHhhccCCccceecccccCCCCceEEecc
Q 021046 2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFG 36 (318)
Q Consensus 2 ~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~C~~w~~ 36 (318)
++++|+..|+.+=.|++|.|.- ..-.|++..+
T Consensus 31 sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 31 SLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp SHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred CHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 6899999999999999998742 2235887765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 318 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-48
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 6/168 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ ++G G FG VYKG+ V + ++ + Q L FKNE+ ++ K +H +++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
G + ++ ++ SL L + K + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IIHRDLK++NI L D+ KI DFG+A + +++ G+
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 7e-48
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 11/172 (6%)
Query: 149 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQH 206
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++V +G GE + E+M SLD L KK + Q ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ +I+HRD+K SNIL++S K+ DFG++ VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 6/164 (3%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 208
+ + +LG+G FG VYK + A K + +S + L ++ E+ ++A H +
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V+L + ++ E+ ++D + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
+IIHRDLKA NIL D + K++DFG++ + ++
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 8e-46
Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ 205
+ FS ++G G FG VY R + N + VA+K++S QS + + E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H + ++ GC + + L+ EY + D+ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LH +IHRD+KA NILL K+ DFG A I VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
RL+ + +I EYM N SL FL P +L + + IA+G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 7/168 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ ++G G FG V+ G LN +VA+K + + +F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L+G C+EQ L++E+M + L + ++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+IHRDL A N L+ + K+SDFGM R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-44
Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 8/170 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHR 207
E++ +G G +G K R +G+ + K L + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 208 HLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLL 264
++VR + I++ L + EY L + K+++ L + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
H+ S ++HRDLK +N+ LD N K+ DFG+ARI D
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 3e-44
Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
+ + + KLG G +G VY+G VAVK L + + + EF E ++ +++H +L
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
V+L G C + +I E+M +L +L ++ + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
+ IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-44
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 8/170 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRH 208
E++ LGEG +G V + VAVK + + E K E+ + L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V+ +G E L EY L + + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ I HRD+K N+LLD N KISDFG+A +F + + ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 4e-44
Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 19/191 (9%)
Query: 141 FSLASVSAATENFSTQC---------KLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 186
F+ + A F+ + +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 187 SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 246
+ + +F +E ++ + H +++ L G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 247 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
V ++ GIA G+ YL +HRDL A NIL++S++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 307 ELQGNTKRIVG 317
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-43
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L+G C +Q +I EYM N L +L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ +HRDL A N L++ K+SDFG++R DE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-43
Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 17/172 (9%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 217
+G+G FG V++G+ G+EVAVK S++ + + E+ L+H +++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 218 EQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ----- 268
+ L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 318
+ I HRDLK+ NIL+ + I+D G+A D + VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-43
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 6/162 (3%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
E+ + KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+L+ + ++ EYM SL + + L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 132
Query: 271 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
+HRDL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-43
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+ +G+G FG V G G +VAVK + N + F E ++ +L+H +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 211 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+L G +E+ + ++ EYM SL +L + + +LG ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 270 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+HRDL A N+L+ D K+SDFG+ + +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-41
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 149 ATENFS-TQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTE-FKNEMMLIAK 203
+N +LG G FG V +G +VA+K L + + TE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
L + ++VRL G C + +L+ E L FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGM 122
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR-IVGT 318
YL + +HRDL A N+LL + KISDFG+++ G D+ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-41
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 16/169 (9%)
Query: 158 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFG 214
++G G F VYKG EVA L ++ + FK E ++ LQH ++VR +
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 215 CCIEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
+ +L+ E M + +L +L K+ +++ + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 271 RLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTKRIVGT 318
IIHRDLK NI + + KI D G+A + K ++GT
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 9e-41
Identities = 47/196 (23%), Positives = 77/196 (39%), Gaps = 31/196 (15%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-TEFKNEMMLIAK 203
N +GEG FG V++ R VAVK L ++ + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF---------------------YPK 242
+ ++V+L G C L++EYM L+ FL
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 243 KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
L ++ I +A G+ YL + + +HRDL N L+ +M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 303 FGGDELQGNTKRIVGT 318
+
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-40
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQH 206
E+F LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
+++RL+G + LI EY P ++ L +K Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
H R+IHRD+K N+LL S KI+DFG + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 10/178 (5%)
Query: 142 SLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMML 200
S+ SV + ++ K+G+G G VY + GQEVA+++++ Q NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 201 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 260
+ + ++ ++V + E ++ EY+ SL + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECL 126
Query: 261 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-40
Identities = 48/191 (25%), Positives = 68/191 (35%), Gaps = 26/191 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LTEFKNEMMLIAK 203
S LG G FG V + VAVK L + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 204 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL---------------L 247
L H ++V L G C G ++I EY L FL + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 248 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ + +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 308 LQGNTKRIVGT 318
Sbjct: 200 NYVVKGNARLP 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-40
Identities = 47/196 (23%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LTEFKNEMMLIAK 203
EN LG G FG V +VAVK L ++ +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 204 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKK------------------ 244
L H ++V L G C G LI+EY L +L ++K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 245 --RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302
+L ++ + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 303 FGGDELQGNTKRIVGT 318
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (351), Expect = 3e-39
Identities = 36/170 (21%), Positives = 67/170 (39%), Gaps = 8/170 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
+++ +LG G FG V++ G A K + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
V L + E ++IYE+M L + + + V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 270 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVG 317
+H DLK NI+ + + K+ DFG+ + T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-39
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 158 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LTEFKNEMMLIAKLQHRHLVRL 212
+LG G FG V KG + VAVK L N++ E E ++ +L + ++VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 213 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
G C E +L+ E L+ +L + R + + + ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 273 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK-RIVGT 318
+HRDL A N+LL + KISDFG+++ DE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-39
Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 10/171 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 206
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
V+L+ + + Y N L + K R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR----FYTAEIVSAL 121
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 317
IIHRDLK NILL+ DM+ +I+DFG A++ + Q VG
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-39
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLTEFKNEMMLIAKL 204
F LG G FG VYKG + E VA+K L S + E +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 205 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
+ H+ RL G C+ LI + MP L + + K +G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
YL R++HRDL A N+L+ + + KI+DFG+A++ G +E + + +
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 2e-38
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 8/161 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
+ + +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ L ++ E +LI E++ L F + + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 270 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDEL 308
I+H D+K NI+ ++ KI DFG+A DE+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 11/163 (6%)
Query: 158 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRL 212
+G G FG VY G LL+ AVK L+ + G +++F E +++ H +++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 213 FGCCIE-QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
G C+ +G +++ YM + L F + + + +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 314
+ +HRDL A N +LD K++DFG+AR E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (343), Expect = 4e-38
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 13/166 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNE---MMLIAK 203
+FS +G GGFG VY R G+ A+K L + QG T NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
+V + + I + M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-38
Identities = 48/175 (27%), Positives = 73/175 (41%), Gaps = 13/175 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAK 203
++ KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
L HR+L+RL+G + ++ E P SL K + R +A+G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
YL R IHRDL A N+LL + KI DFG+ R ++ +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-37
Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 24/186 (12%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLTEFKNEMMLIAKL-Q 205
+ Q +GEG FG V K R+ + A+KR+ S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQAR 252
H +++ L G C +G L EY P+ +L FL L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 253 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
+ +A+G+ YL Q + IHRDL A NIL+ + KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 313 KRIVGT 318
Sbjct: 184 TMGRLP 189
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 17/182 (9%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLTEFKNEMMLIAK 203
E + +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 204 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------LGWQARVRII 256
H+VRL G + ++I E M L +L + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 257 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 316
IA G+ YL+ + +HRDL A N ++ D KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 317 GT 318
Sbjct: 197 LP 198
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-36
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 11/168 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LTEFKNEMMLIAKL 204
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 205 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
H +++RL G + ++I EYM N + + F +K V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 265 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
YL + +HRDL A NIL++S++ K+SDFG++R+ D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 4e-36
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 206
++F LG G FG V+ R NG+ A+K L + + + +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++R++G + + +I +Y+ L F K +R A+ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
II+RDLK NILLD + + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 15/169 (8%)
Query: 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+++ +G G FG VY+ +L +G+ VA+K++ E+ ++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 211 RLFGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 264
RL GE L+ +Y+P V Y + K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 YLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNT 312
Y+H I HRD+K N+LLD D K+ DFG A+ E +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 207
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
+++ + + Y+ + L+ K + L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
++HRDLK SN+LL++ + KI DFG+AR+ D
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-36
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 12/173 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQ 205
E +GEG FG V++G ++ VA+K N + + E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H H+V+L G E +I E L F +K L + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
L R +HRD+ A N+L+ S+ K+ DFG++R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 45/190 (23%), Positives = 68/190 (35%), Gaps = 25/190 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTE--FKNEMMLIA 202
+ LG G FG V + + VAVK L + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 203 KLQHRHLVRLFGCCIEQGENILI-YEYMPNKSLDVFLFYPKK-------------KRLLG 248
H ++V L G C + G +++ E+ +L +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 249 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308
+ + +A+G+ +L + IHRDL A NILL KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 309 QGNTKRIVGT 318
Sbjct: 190 YVRKGDARLP 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (319), Expect = 3e-35
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE---------FKNEMML 200
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 201 IAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 259
+ K+ H ++++L L+++ M L +L +K L + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ + LH +L I+HRDLK NILLD DMN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-34
Identities = 33/160 (20%), Positives = 66/160 (41%), Gaps = 9/160 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 209
E + LG G FG V++ + + K + + G K E+ ++ +HR++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 210 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 269
+ L E ++I+E++ + + L + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 270 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDE 307
I H D++ NI+ + + KI +FG AR +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (309), Expect = 7e-34
Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH 208
E + K+GEG +G VYK + G+ A+K RL + + E+ ++ +L+H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+V+L+ + +L++E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 312
R++HRDLK N+L++ + KI+DFG+AR FG +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-33
Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLTEFKNEMMLI 201
+ LGEG FG V + +VAVK L S+ + + L++ +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 202 AKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------L 247
+ +H++++ L G C + G +I EY +L +L + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 248 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ V +A+G+ YL + IHRDL A N+L+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 308 LQGNTKRIVGT 318
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-33
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 158 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE-----FKNEMMLIAKLQHRHLVR 211
LGEG F VYK R N Q VA+K++ + E+ L+ +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 212 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 271
L + L++++M +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 272 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
I+HRDLK +N+LLD + K++DFG+A+ FG
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-33
Identities = 45/173 (26%), Positives = 68/173 (39%), Gaps = 13/173 (7%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN----EMMLIAKLQ 205
E+F LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 206 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 265
H L +F + + EY+ L + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 266 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
LH I++RDLK NILLD D + KI+DFGM + + + NT GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 1e-32
Identities = 35/171 (20%), Positives = 68/171 (39%), Gaps = 8/171 (4%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 207
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++V L G LI + + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ + LD D ISDFG++++ + GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-32
Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
ENF K+GEG +G VYK R L G+ VA+K RL ++ + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++V+L + + L++E++ + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
+ R++HRDLK N+L++++ K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHR 207
+ K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 208 HLVRLFGCCIEQ--------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 259
++V L C + G L++++ + + K R+++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 260 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR--IVG 317
GL Y+H+ +I+HRD+KA+N+L+ D K++DFG+AR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 318 T 318
T
Sbjct: 184 T 184
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (290), Expect = 4e-31
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 15/178 (8%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQ 205
++ + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 206 HRHLVRLFGCCIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
H +V ++ + ++ EY+ +L + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG-GDELQGNTKRIVGT 318
L + H + IIHRD+K +NI++ + K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 40/172 (23%), Positives = 66/172 (38%), Gaps = 12/172 (6%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 206
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
L L + EY L L + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 267 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+++RD+K N++LD D + KI+DFG+ + D K GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-30
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 207
+ + K+GEG +G V+K + + VA+K RL + + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 208 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 267
++VRL + L++E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 268 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307
++HRDLK N+L++ + K+++FG+AR FG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-30
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 16/180 (8%)
Query: 149 ATENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQGLTEFK-----NEMMLI 201
A + + ++GEG +G V+K R L G+ VA+KR+ Q+G+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 202 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD---VFLFYPKKKRLLGWQARVRIIEG 258
+H ++VRLF C + + + +D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 259 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
+ +GL +LH R++HRDLK NIL+ S K++DFG+ARI+ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (276), Expect = 6e-29
Identities = 33/180 (18%), Positives = 72/180 (40%), Gaps = 20/180 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR-H 208
++ ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
+ ++ E N+L+ + + + R + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 269 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIFGGDELQGN-----TKRIVGT 318
+++RD+K N L+ + + DFGM + + + + K + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (277), Expect = 1e-28
Identities = 42/199 (21%), Positives = 73/199 (36%), Gaps = 10/199 (5%)
Query: 112 NMSITTRTNELCEADGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGR 171
N + + +E +D + + +A + F LG G FG V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 172 -LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227
+G A+K L Q + + NE ++ + LV+L + ++ E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 287
Y+ + L + I YLH L +I+RDLK N+L+D
Sbjct: 122 YVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 288 SDMNPKISDFGMARIFGGD 306
+++DFG A+ G
Sbjct: 176 QQGYIQVTDFGFAKRVKGR 194
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 20/172 (11%)
Query: 158 KLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHRHLV 210
+LG G F V K R G + A K + S++ G + + E+ ++ ++QH +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 211 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 270
L + + ILI E + L + +K L + ++ I G ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG---VYYLH 130
Query: 271 RLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 318
L+I H DLK NI+L P KI DFG+A K I GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-28
Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 19/171 (11%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------LTEFKNEMMLIAKLQHRH-- 208
LG GGFG VY G + + VA+K + T E++L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 268
++RL +LI E + ++ L + + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDL--FDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 269 YSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNTKRIVGT 318
++HRD+K NIL+D + K+ DFG + GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 1e-27
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 17/165 (10%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHR 207
+ +G G +G V G +VA+K+L QS E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 208 HLVRLFGCCIEQG------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
+++ L + L+ +M + K LG ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306
GL Y+H IIHRDLK N+ ++ D KI DFG+AR +
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (266), Expect = 1e-27
Identities = 36/170 (21%), Positives = 67/170 (39%), Gaps = 16/170 (9%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 216
K+G G FG +Y G + G+EVA+K ++ + E + +Q + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 217 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276
+G+ ++ + SL+ + R + + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 277 RDLKASNIL---LDSDMNPKISDFGMARIFGGDELQGN-----TKRIVGT 318
RD+K N L I DFG+A+ + + K + GT
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-27
Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 18/158 (11%)
Query: 159 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCC 216
LG G G V + ++ A+K L + + + E+ L + Q H+VR+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74
Query: 217 IEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 272
+++ E + L + + + + I++ I + + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 273 RIIHRDLKASNILLDSDMNP---KISDFGMARIFGGDE 307
I HRD+K N+L S K++DFG A+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-27
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 151 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLTEFKNEMMLIA 202
ENF LG G +G V+ R + G+ A+K L Q + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 203 KLQHR-HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
++ LV L + + LI +Y+ L L +++R + ++ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYV----GE 137
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 309
+L L +L II+RD+K NILLDS+ + ++DFG+++ F DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (260), Expect = 2e-26
Identities = 34/173 (19%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRH 208
+++ KLG G + V++ + N ++V VK L + + K E+ ++ L+ +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 209 LVRLFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 266
++ L + L++E++ N + L + R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 267 HQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNTKRIVGT 318
H + I+HRD+K N+++D + ++ D+G+A + + V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.7 bits (245), Expect = 1e-25
Identities = 28/158 (17%), Positives = 56/158 (35%), Gaps = 28/158 (17%)
Query: 158 KLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQ--------GLTEFKNEMMLIAKLQHR 207
+GEG V+ E VK ++ + S + G F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 208 HLVRLFGCCI----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 263
L +L G + N ++ E + K+ + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELI----------DAKELYRVRVENPDEVLDMILEEV 116
Query: 264 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301
+ I+H DL N+L+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 1e-24
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 21/177 (11%)
Query: 151 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 207
+ + +G G G V + + VA+K+LS Q+ E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 208 HLVRLFGCCIEQG------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
+++ L Q + L+ E M V + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318
G+ +LH IIHRDLK SNI++ SD KI DFG+AR G + V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 6e-24
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 150 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQH 206
E + +G G +G V G VAVK+LS QS E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 207 RHLVRLFGCC-----IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 261
+++ L +E+ ++ + ++ L+ K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132
Query: 262 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304
GL Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.5 bits (210), Expect = 2e-19
Identities = 35/175 (20%), Positives = 68/175 (38%), Gaps = 18/175 (10%)
Query: 158 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH---------- 206
KLG G F V+ + ++N VA+K + ++E+ L+ ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 207 -RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQGL 263
H+++L +G N + + + L KK G +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 264 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTKRIVG 317
Y+H+ R IIH D+K N+L++ D + +A + + +
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 318 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.98 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.65 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=276.01 Aligned_cols=163 Identities=29% Similarity=0.412 Sum_probs=141.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999987 468999999987543 2344678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
|+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999883 3457999999999999999999999988 9999999999999999999999999999886554
Q ss_pred cccccceeecC
Q 021046 308 LQGNTKRIVGT 318 (318)
Q Consensus 308 ~~~~~~~~~Gt 318 (318)
........+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred ccccccceeeC
Confidence 44444556776
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-38 Score=270.89 Aligned_cols=160 Identities=26% Similarity=0.409 Sum_probs=141.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999986 56899999999866666678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCcc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 308 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 308 (318)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+..
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999987732 45899999999999999999999988 99999999999999999999999999998865432
Q ss_pred ccccceeecC
Q 021046 309 QGNTKRIVGT 318 (318)
Q Consensus 309 ~~~~~~~~Gt 318 (318)
. ....+||
T Consensus 172 ~--~~~~~gt 179 (293)
T d1yhwa1 172 K--RSTMVGT 179 (293)
T ss_dssp C--BCCCCSC
T ss_pred c--ccccccC
Confidence 2 2334555
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-38 Score=275.06 Aligned_cols=156 Identities=29% Similarity=0.486 Sum_probs=140.1
Q ss_pred HHhcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
...++|+..+.||+|+||.||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44578999999999999999999875 5889999999753 455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|..++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....+
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999988543 3467899999999999999999999987 999999999999999999999999999987665
Q ss_pred cc
Q 021046 307 EL 308 (318)
Q Consensus 307 ~~ 308 (318)
..
T Consensus 169 ~~ 170 (287)
T d1opja_ 169 TY 170 (287)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=268.86 Aligned_cols=151 Identities=32% Similarity=0.559 Sum_probs=131.6
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
++|+..+.||+|+||.||+|.+.+++.||||+++. .....++|.+|+.++++++|||||+++|+|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57888999999999999999998889999999976 34556789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
+|+|.+++.. ....+++..+..++.|+|.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999998853 3456899999999999999999999987 9999999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=269.89 Aligned_cols=153 Identities=36% Similarity=0.541 Sum_probs=136.1
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
..++|++.+.||+|+||.||+|.+++++.||||+++.. ....++|.+|+.++.+++|||||+++|++. ++..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 35689999999999999999999988889999999753 455678999999999999999999999875 4667999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999877432 2345899999999999999999999987 9999999999999999999999999999886554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-38 Score=268.51 Aligned_cols=162 Identities=31% Similarity=0.479 Sum_probs=132.1
Q ss_pred HhcCCccccccccCCcccEEEEEecCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
..++|.+.+.||+|+||.||+|++. ..||||+++.. .....+.|.+|+.++.+++|||||+++|++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3568899999999999999999874 36999998754 34456789999999999999999999998754 5689999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999998532 346899999999999999999999987 999999999999999999999999999988654
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
........+.||
T Consensus 158 ~~~~~~~~~~gt 169 (276)
T d1uwha_ 158 SGSHQFEQLSGS 169 (276)
T ss_dssp --------CCCC
T ss_pred CCcccccccccC
Confidence 433344455555
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-38 Score=271.33 Aligned_cols=151 Identities=27% Similarity=0.419 Sum_probs=137.9
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.+.|++.+.||+|+||.||+|+. .+++.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 45789999999999999999987 46889999999876666778899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 91 ~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 91 CAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999998743 2356999999999999999999999988 99999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=268.52 Aligned_cols=162 Identities=30% Similarity=0.427 Sum_probs=138.1
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||+|.. .+++.||||++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999987 46899999998642 3445678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998874 3456899999999999999999999988 999999999999999999999999999998765
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 444444455676
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-37 Score=268.23 Aligned_cols=153 Identities=32% Similarity=0.515 Sum_probs=126.3
Q ss_pred hcCCccccccccCCcccEEEEEecC-C---cEEEEEEccCCC-CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|+..+.||+|+||+||+|++.. + ..||||++.... ....++|.+|+.+|++++|||||+++|++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3567788999999999999998743 2 268999987543 3345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ....++|.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998753 3456899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
.+.
T Consensus 180 ~~~ 182 (299)
T d1jpaa_ 180 DDT 182 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-37 Score=262.25 Aligned_cols=151 Identities=30% Similarity=0.400 Sum_probs=135.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 367999999999999999999874 6889999998642 234567889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999998843 356899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
+
T Consensus 159 ~ 159 (263)
T d2j4za1 159 S 159 (263)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=258.82 Aligned_cols=151 Identities=30% Similarity=0.487 Sum_probs=137.9
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEecc
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 230 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (318)
++|+..++||+|+||.||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 688999999999999999999988889999999864 4456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 231 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
+|+|..++.. ....+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+|+.+....
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999988743 3456889999999999999999999987 9999999999999999999999999998776543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=273.31 Aligned_cols=159 Identities=27% Similarity=0.360 Sum_probs=137.7
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|++.++||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|+.+|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999987 4689999999875433 334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+++|+|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+|||+++++.+||+|||+|+.+.++
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999853 34689999999999999999999974 6 999999999999999999999999999977543
Q ss_pred ccccccceeecC
Q 021046 307 ELQGNTKRIVGT 318 (318)
Q Consensus 307 ~~~~~~~~~~Gt 318 (318)
. ....+||
T Consensus 159 ~----~~~~~GT 166 (322)
T d1s9ja_ 159 M----ANSFVGT 166 (322)
T ss_dssp T----C---CCS
T ss_pred c----cccccCC
Confidence 2 2344665
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=263.02 Aligned_cols=158 Identities=27% Similarity=0.449 Sum_probs=127.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEe--cCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 224 (318)
.++|++.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|+.++++++|||||++++++.+ ++..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999986 468999999987543 2334578999999999999999999999975 456799
Q ss_pred EEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 225 IYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
||||+++|+|.+++... +....+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988532 23567999999999999999999999864 2359999999999999999999999999999
Q ss_pred eecCCc
Q 021046 302 IFGGDE 307 (318)
Q Consensus 302 ~~~~~~ 307 (318)
.+..+.
T Consensus 163 ~~~~~~ 168 (269)
T d2java1 163 ILNHDT 168 (269)
T ss_dssp HC----
T ss_pred ecccCC
Confidence 876543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-37 Score=263.51 Aligned_cols=152 Identities=32% Similarity=0.526 Sum_probs=132.4
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEec
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 229 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (318)
.++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. +++.++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 4689999999999999999999988889999999753 455678999999999999999999999985 56789999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
++|+|..++... ....++|..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999887543 2346899999999999999999999987 9999999999999999999999999999876544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.2e-36 Score=265.19 Aligned_cols=153 Identities=23% Similarity=0.391 Sum_probs=137.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999987 46899999999876555567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999988843 3456999999999999999999999988 999999999999964 678999999999988654
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-36 Score=265.26 Aligned_cols=167 Identities=28% Similarity=0.402 Sum_probs=136.7
Q ss_pred HhcCCccccccccCCcccEEEEEecC-C-----cEEEEEEccCC-CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecC
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG 220 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 220 (318)
..++|++.+.||+|+||+||+|++.. + ..||||.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 45789999999999999999998643 2 36999988654 334456799999999998 8999999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKK--------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 280 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 280 (318)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999865421 245899999999999999999999987 9999999
Q ss_pred CCCEEEcCCCCceEeecccceeecCCccccccceeecC
Q 021046 281 ASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 281 ~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
|+|||++.++.+||+|||+|+...............||
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 99999999999999999999987655433223334444
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.8e-36 Score=264.75 Aligned_cols=153 Identities=25% Similarity=0.368 Sum_probs=137.0
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.........+.+|+.++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36799999999999999999986 56999999999765545556788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++. .....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999987763 23456999999999999999999999987 99999999999998 5789999999999988765
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 183 ~ 183 (352)
T d1koba_ 183 E 183 (352)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-36 Score=264.15 Aligned_cols=161 Identities=26% Similarity=0.330 Sum_probs=141.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.++|++.+.||+|+||.||+|+. .+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999986 56899999998753 334567889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999998884 3456889999999999999999999988 99999999999999999999999999997654
Q ss_pred CccccccceeecC
Q 021046 306 DELQGNTKRIVGT 318 (318)
Q Consensus 306 ~~~~~~~~~~~Gt 318 (318)
... ....++||
T Consensus 158 ~~~--~~~~~~GT 168 (337)
T d1o6la_ 158 DGA--TMKTFCGT 168 (337)
T ss_dssp TTC--CBCCCEEC
T ss_pred CCc--ccccceeC
Confidence 432 23345676
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-36 Score=262.79 Aligned_cols=150 Identities=33% Similarity=0.514 Sum_probs=133.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC---cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (318)
.+.|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 34689999999999999999986 5688999999875432 2345689999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999977663 3456899999999999999999999988 99999999999999999999999999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-36 Score=258.05 Aligned_cols=152 Identities=30% Similarity=0.502 Sum_probs=131.1
Q ss_pred hcCCcccc-ccccCCcccEEEEEec---CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
.++|...+ +||+|+||.||+|.+. ++..||||+++.... ...++|.+|+.+|.+++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35666666 4999999999999763 355799999976433 345689999999999999999999999864 56899
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 3456899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
...
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-36 Score=255.75 Aligned_cols=149 Identities=29% Similarity=0.430 Sum_probs=127.7
Q ss_pred ccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEe----cCeeEEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIY 226 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 226 (318)
+..++||+|+||.||+|... +++.||+|++.... ....+.|.+|+.++++++|||||++++++.. ++..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999874 58899999987542 2345678999999999999999999999875 34579999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~ki~DfGla~~~~~ 305 (318)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999843 356899999999999999999999874 4599999999999996 578999999999987554
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-36 Score=260.19 Aligned_cols=152 Identities=25% Similarity=0.353 Sum_probs=123.2
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
.+.|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999874 688999999875432 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCCceEeecccceeec
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARIFG 304 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~ki~DfGla~~~~ 304 (318)
|+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999984 3457999999999999999999999987 99999999999994 57899999999999876
Q ss_pred CCc
Q 021046 305 GDE 307 (318)
Q Consensus 305 ~~~ 307 (318)
.+.
T Consensus 162 ~~~ 164 (307)
T d1a06a_ 162 PGS 164 (307)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-35 Score=254.76 Aligned_cols=151 Identities=28% Similarity=0.372 Sum_probs=135.1
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc---------CHHHHHHHHHHHhccC-CCccceEEEEEEec
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ---------GLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ 219 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 219 (318)
++|++.+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 56889999998754321 1235889999999997 99999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 220 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999843 456899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCc
Q 021046 300 ARIFGGDE 307 (318)
Q Consensus 300 a~~~~~~~ 307 (318)
|+.+..+.
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-36 Score=262.25 Aligned_cols=170 Identities=28% Similarity=0.436 Sum_probs=141.3
Q ss_pred HHHHHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCCc-CHHHHHHHHHHHhccCCCccceEEEEEE
Q 021046 145 SVSAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCI 217 (318)
Q Consensus 145 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~ 217 (318)
+++.+.++|++.+.||+|+||.||+|++. +++.||||+++..... ..++|.+|+.++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34456789999999999999999999864 3568999999764333 3567999999999999999999999999
Q ss_pred ecCeeEEEEEeccCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021046 218 EQGENILIYEYMPNKSLDVFLFYPK---------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 276 (318)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 276 (318)
..+..+++|||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999885321 1235899999999999999999999987 999
Q ss_pred cCCCCCCEEEcCCCCceEeecccceeecCCccccccceeec
Q 021046 277 RDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 317 (318)
Q Consensus 277 ~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~G 317 (318)
|||||+|||++.++.+||+|||+|+.+..+..........|
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~ 204 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 204 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence 99999999999999999999999998765543333333344
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-36 Score=257.74 Aligned_cols=153 Identities=35% Similarity=0.548 Sum_probs=128.1
Q ss_pred hcCCccccccccCCcccEEEEEecCC-----cEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
.+.|+..++||+|+||.||+|.+.+. ..||||+++.... ....+|.+|+.++.+++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999987542 3699999875432 33457999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|++.+++.. ....++|..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999887643 3457999999999999999999999987 999999999999999999999999999987
Q ss_pred cCCc
Q 021046 304 GGDE 307 (318)
Q Consensus 304 ~~~~ 307 (318)
..+.
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 6543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-35 Score=259.14 Aligned_cols=150 Identities=29% Similarity=0.423 Sum_probs=135.4
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6799999999999999999987 56899999998643 3445678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988874 3456788899999999999999999987 999999999999999999999999999987543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=255.51 Aligned_cols=143 Identities=31% Similarity=0.492 Sum_probs=124.4
Q ss_pred cccccCCcccEEEEEecC---CcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEeccC
Q 021046 157 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 231 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (318)
++||+|+||.||+|.+.+ ++.||||+++... ....++|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999997643 4689999997542 2235679999999999999999999999864 567899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 232 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 99999884 3456899999999999999999999987 999999999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-35 Score=253.94 Aligned_cols=152 Identities=29% Similarity=0.408 Sum_probs=135.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC------CcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|++.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999987 568999999986432 22457899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----CceEeecc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 298 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~ki~DfG 298 (318)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999843 346999999999999999999999988 99999999999998877 49999999
Q ss_pred cceeecCCc
Q 021046 299 MARIFGGDE 307 (318)
Q Consensus 299 la~~~~~~~ 307 (318)
+|+.+....
T Consensus 163 ~a~~~~~~~ 171 (293)
T d1jksa_ 163 LAHKIDFGN 171 (293)
T ss_dssp TCEECTTSC
T ss_pred hhhhcCCCc
Confidence 999886543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=252.32 Aligned_cols=152 Identities=21% Similarity=0.304 Sum_probs=133.9
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.++|.+.+.||+|+||.||+|... +++.||||.++... .....+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999874 68899999997643 3345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC--CCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+|+.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998842 2346899999999999999999999987 9999999999999854 47999999999987654
Q ss_pred c
Q 021046 307 E 307 (318)
Q Consensus 307 ~ 307 (318)
.
T Consensus 158 ~ 158 (321)
T d1tkia_ 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-34 Score=256.92 Aligned_cols=149 Identities=25% Similarity=0.329 Sum_probs=135.5
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (318)
++|++.+.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999987 46899999998642 2345678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999988843 346899999999999999999999987 99999999999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-35 Score=255.40 Aligned_cols=171 Identities=26% Similarity=0.370 Sum_probs=131.0
Q ss_pred HHHHHhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCC-CcCHHHHHHHHHHHhcc-CCCccceEEEEE
Q 021046 145 SVSAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCC 216 (318)
Q Consensus 145 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 216 (318)
.++...++|++.++||+|+||.||+|.+. +++.||||+++... ....+.+..|...+.++ +||||+++++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33445678999999999999999999863 34689999997543 23355788888888877 689999999998
Q ss_pred EecC-eeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 021046 217 IEQG-ENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKAS 282 (318)
Q Consensus 217 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~ 282 (318)
..++ ..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ ||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 7654 68999999999999999864321 345899999999999999999999987 999999999
Q ss_pred CEEEcCCCCceEeecccceeecCCccccccceeecC
Q 021046 283 NILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 283 Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
|||+++++.+||+|||+|+..........+....||
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 999999999999999999987655443344445555
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-35 Score=255.27 Aligned_cols=162 Identities=32% Similarity=0.519 Sum_probs=131.6
Q ss_pred cCCccccccccCCcccEEEEEec-CCc----EEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 224 (318)
++|+..+.||+|+||.||+|.+. +|+ +||+|+++.. +....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 5899988753 445677899999999999999999999999864 5678
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeec
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 304 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~ 304 (318)
++||+.+|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887753 3567899999999999999999999987 9999999999999999999999999999887
Q ss_pred CCccccccceeecC
Q 021046 305 GDELQGNTKRIVGT 318 (318)
Q Consensus 305 ~~~~~~~~~~~~Gt 318 (318)
.+.....+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65544334444454
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-34 Score=258.01 Aligned_cols=152 Identities=28% Similarity=0.342 Sum_probs=131.4
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHH---HHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKN---EMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+. .......+.+ |+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999874 6899999998642 1223333444 46777888999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999843 456789999999999999999999988 99999999999999999999999999998
Q ss_pred ecCCc
Q 021046 303 FGGDE 307 (318)
Q Consensus 303 ~~~~~ 307 (318)
+....
T Consensus 157 ~~~~~ 161 (364)
T d1omwa3 157 FSKKK 161 (364)
T ss_dssp CSSSC
T ss_pred cCCCc
Confidence 86543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=253.49 Aligned_cols=167 Identities=28% Similarity=0.427 Sum_probs=140.0
Q ss_pred HhcCCccccccccCCcccEEEEEec------CCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 221 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 221 (318)
..++|.+.+.||+|+||.||+|.+. ++..||||+++.... .....|.+|+.++++++||||++++|+|..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 4578999999999999999999763 256899999975432 334568999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceE
Q 021046 222 NILIYEYMPNKSLDVFLFYP-------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 294 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki 294 (318)
.++||||+++|+|.+++... .....+++..+..++.|+|+||.|||+++ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 99999999999999987532 12345789999999999999999999987 999999999999999999999
Q ss_pred eecccceeecCCccccccceeecC
Q 021046 295 SDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 295 ~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
+|||+|+.+.............||
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEEC
T ss_pred eecccceeccCCcceeeccceecc
Confidence 999999988655433333333443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=249.54 Aligned_cols=151 Identities=29% Similarity=0.481 Sum_probs=130.5
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|+..+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 568999999996532 2345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+.++.+.... . .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 99866444332 2 23556999999999999999999999988 999999999999999999999999999877544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-34 Score=250.88 Aligned_cols=150 Identities=27% Similarity=0.373 Sum_probs=132.7
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCC---CCcCHHHHHHHHHHHh-ccCCCccceEEEEEEecCeeEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIA-KLQHRHLVRLFGCCIEQGENILI 225 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 225 (318)
++|.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999874 6899999999743 2345566777777665 68999999999999999999999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecC
Q 021046 226 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 305 (318)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~ 305 (318)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3456889999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 156 ~ 156 (320)
T d1xjda_ 156 G 156 (320)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=247.78 Aligned_cols=152 Identities=32% Similarity=0.454 Sum_probs=124.5
Q ss_pred hcCCccccccccCCcccEEEEEecC--C--cEEEEEEccCC---CCcCHHHHHHHHHHHhccCCCccceEEEEEEecCee
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN 222 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 222 (318)
.++|+..+.||+|+||.||+|++.. + ..||||+++.. .....++|.+|+.++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999997632 2 37899988754 23335689999999999999999999999965 567
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
++||||+++|++.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999887753 2456899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCc
Q 021046 303 FGGDE 307 (318)
Q Consensus 303 ~~~~~ 307 (318)
+....
T Consensus 161 ~~~~~ 165 (273)
T d1u46a_ 161 LPQND 165 (273)
T ss_dssp CCC-C
T ss_pred cccCC
Confidence 86553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=247.29 Aligned_cols=152 Identities=27% Similarity=0.425 Sum_probs=124.3
Q ss_pred HhcCCccccccccCCcccEEEEEecC----CcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecCeeE
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 223 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 223 (318)
..++|++.+.||+|+||.||+|.+.. +..||||.++.... ...+.|.+|+.++++++||||++++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 34689999999999999999998643 34689999875433 33467999999999999999999999985 56789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
+||||+++|+|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||+|+.+
T Consensus 84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999988743 3456899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 159 ~~~ 161 (273)
T d1mp8a_ 159 EDS 161 (273)
T ss_dssp ---
T ss_pred cCC
Confidence 654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-34 Score=248.87 Aligned_cols=153 Identities=34% Similarity=0.538 Sum_probs=132.3
Q ss_pred hcCCccccccccCCcccEEEEEecC-Cc--EEEEEEccCC-CCcCHHHHHHHHHHHhcc-CCCccceEEEEEEecCeeEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (318)
-++|+..++||+|+||.||+|++.+ +. .||||+++.. .....++|.+|+.+|.++ +|||||+++|+|.+++..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3688999999999999999998754 43 5788888643 334566899999999999 79999999999999999999
Q ss_pred EEEeccCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCC
Q 021046 225 IYEYMPNKSLDVFLFYP-------------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 291 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 291 (318)
||||+++|+|.++++.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999998643 23467999999999999999999999987 999999999999999999
Q ss_pred ceEeecccceeecC
Q 021046 292 PKISDFGMARIFGG 305 (318)
Q Consensus 292 ~ki~DfGla~~~~~ 305 (318)
+||+|||+|+....
T Consensus 166 ~kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 166 AKIADFGLSRGQEV 179 (309)
T ss_dssp EEECCTTCEESSCE
T ss_pred eEEccccccccccc
Confidence 99999999986643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-34 Score=248.32 Aligned_cols=148 Identities=27% Similarity=0.399 Sum_probs=125.8
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHH--HHHHHHhccCCCccceEEEEEEecC----eeEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK--NEMMLIAKLQHRHLVRLFGCCIEQG----ENIL 224 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 224 (318)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. ...++. .|+..+..++||||++++|+|.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4677889999999999999997 6789999998653 223443 4555666789999999999998765 5799
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCEEEcCCCCceEeeccc
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGM 299 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlk~~Nill~~~~~~ki~DfGl 299 (318)
||||+++|+|.+++.. ..++|..+..++.|+|.||+|||+. ...+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999953 3589999999999999999999974 124599999999999999999999999999
Q ss_pred ceeecCC
Q 021046 300 ARIFGGD 306 (318)
Q Consensus 300 a~~~~~~ 306 (318)
++.+...
T Consensus 155 ~~~~~~~ 161 (303)
T d1vjya_ 155 AVRHDSA 161 (303)
T ss_dssp CEEEETT
T ss_pred cccccCC
Confidence 9988654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-34 Score=246.80 Aligned_cols=150 Identities=26% Similarity=0.447 Sum_probs=135.2
Q ss_pred cCCccccccccCCcccEEEEEecCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
++|+..++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999996542 33457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988777665 34567999999999999999999999987 999999999999999999999999999887644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-34 Score=250.55 Aligned_cols=168 Identities=29% Similarity=0.364 Sum_probs=141.0
Q ss_pred HHhcCCccccccccCCcccEEEEEe------cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEec
Q 021046 148 AATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ 219 (318)
Q Consensus 148 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 219 (318)
...++|++.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.++..+ +|||||+++|+|.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3457899999999999999999975 2456899999976433 3445789999999999 699999999999999
Q ss_pred CeeEEEEEeccCCChhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 021046 220 GENILIYEYMPNKSLDVFLFYPK---------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 284 (318)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 284 (318)
+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999986432 2336899999999999999999999988 99999999999
Q ss_pred EEcCCCCceEeecccceeecCCccccccceeecC
Q 021046 285 LLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 318 (318)
Q Consensus 285 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 318 (318)
+++.++.+||+|||+|+...............||
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccccCcccccccchheeccCCCcceEeeecccC
Confidence 9999999999999999987654433333334444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-34 Score=248.38 Aligned_cols=147 Identities=31% Similarity=0.417 Sum_probs=125.7
Q ss_pred cccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc-----CHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEEe
Q 021046 155 TQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY 228 (318)
Q Consensus 155 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (318)
.+++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999987 46899999998753221 134688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCCc
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 307 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~~ 307 (318)
++++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998776655 34566888999999999999999999988 9999999999999999999999999998776543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-34 Score=243.79 Aligned_cols=150 Identities=30% Similarity=0.518 Sum_probs=126.7
Q ss_pred hcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEec-CeeEEEEEe
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYEY 228 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 228 (318)
.++|+..+.||+|+||.||+|.+ .|..||||+++.. ...++|.+|+.++++++||||++++|+|.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46788899999999999999998 4788999999753 3457899999999999999999999999754 568999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
+++|+|.+++... ....++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999998532 2345899999999999999999999987 999999999999999999999999999987544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-33 Score=241.94 Aligned_cols=163 Identities=26% Similarity=0.375 Sum_probs=132.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCc---CHHHHHHHHHHHhccCCCccceEEEEEEecCe----
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE---- 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 221 (318)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... ....|.+|+.++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 56899999999764332 34578999999999999999999999987653
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++||||+++|+|..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998874 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCCcc-ccccceeecC
Q 021046 302 IFGGDEL-QGNTKRIVGT 318 (318)
Q Consensus 302 ~~~~~~~-~~~~~~~~Gt 318 (318)
....... .......+||
T Consensus 160 ~~~~~~~~~~~~~~~~Gt 177 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGT 177 (277)
T ss_dssp ECC---------------
T ss_pred hhccccccccccccccCc
Confidence 7654322 2223344554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-33 Score=244.71 Aligned_cols=146 Identities=28% Similarity=0.507 Sum_probs=127.2
Q ss_pred ccccccCCcccEEEEEecCC----cEEEEEEccCC-CCcCHHHHHHHHHHHhccCCCccceEEEEEEec-CeeEEEEEec
Q 021046 156 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYEYM 229 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 229 (318)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+.++++++||||++++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987442 26899999753 334457899999999999999999999998864 5889999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 230 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999998853 3456778899999999999999999987 999999999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=245.18 Aligned_cols=166 Identities=29% Similarity=0.441 Sum_probs=135.1
Q ss_pred HhcCCccccccccCCcccEEEEEecC--------CcEEEEEEccCCCC-cCHHHHHHHHHHHhcc-CCCccceEEEEEEe
Q 021046 149 ATENFSTQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE 218 (318)
Q Consensus 149 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 218 (318)
..++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 45789999999999999999997532 24799999976433 3456788999999888 79999999999999
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 285 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 285 (318)
++..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+++ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999964431 346899999999999999999999988 999999999999
Q ss_pred EcCCCCceEeecccceeecCCccccccceeec
Q 021046 286 LDSDMNPKISDFGMARIFGGDELQGNTKRIVG 317 (318)
Q Consensus 286 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~G 317 (318)
++.++.+||+|||+++..........+....|
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred ecCCCCeEeccchhhccccccccccccccCCC
Confidence 99999999999999998876544333333333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-33 Score=243.52 Aligned_cols=149 Identities=23% Similarity=0.314 Sum_probs=127.7
Q ss_pred hcCCcccc-ccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhcc-CCCccceEEEEEEe----cCee
Q 021046 150 TENFSTQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE----QGEN 222 (318)
Q Consensus 150 ~~~~~~~~-~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 222 (318)
.++|.+.. .||+|+||.||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ++..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888765 599999999999986 56899999998642 4678899887655 89999999999876 4568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeeccc
Q 021046 223 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM 299 (318)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfGl 299 (318)
++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998532 2356999999999999999999999988 999999999999986 55799999999
Q ss_pred ceeecCCc
Q 021046 300 ARIFGGDE 307 (318)
Q Consensus 300 a~~~~~~~ 307 (318)
|+......
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.5e-33 Score=239.66 Aligned_cols=150 Identities=25% Similarity=0.364 Sum_probs=128.7
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC------cCHHHHHHHHHHHhccC--CCccceEEEEEEecCe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQGE 221 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 221 (318)
++|++.+.||+|+||.||+|+. .+++.||||++..... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999986 5689999999875321 12234678999999986 8999999999999999
Q ss_pred eEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCCceEeeccc
Q 021046 222 NILIYEYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGM 299 (318)
Q Consensus 222 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~ki~DfGl 299 (318)
.++||||+.+ +++.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 56766663 3456899999999999999999999988 999999999999985 47899999999
Q ss_pred ceeecCC
Q 021046 300 ARIFGGD 306 (318)
Q Consensus 300 a~~~~~~ 306 (318)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9976543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=243.25 Aligned_cols=149 Identities=30% Similarity=0.495 Sum_probs=125.6
Q ss_pred CCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccceEEEEEEecC------eeEE
Q 021046 152 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ENIL 224 (318)
Q Consensus 152 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 224 (318)
+|...++||+|+||+||+|+.. +|+.||||++...... ..+|+.+|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999874 6899999999764322 347999999999999999999996532 4689
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceee
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIF 303 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~ 303 (318)
||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765554443345667999999999999999999999987 99999999999999775 8999999999987
Q ss_pred cCCc
Q 021046 304 GGDE 307 (318)
Q Consensus 304 ~~~~ 307 (318)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=7e-32 Score=237.66 Aligned_cols=145 Identities=22% Similarity=0.394 Sum_probs=127.9
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEec--CeeEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ--GENILIY 226 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 226 (318)
++|++.++||+|+||+||+|+. .+++.||||+++. ...+++.+|+.+|..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999987 5689999999875 33567899999999995 99999999999854 4689999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-CceEeecccceeecC
Q 021046 227 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGG 305 (318)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~ki~DfGla~~~~~ 305 (318)
||+++++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 35899999999999999999999988 99999999999998765 599999999998765
Q ss_pred Cc
Q 021046 306 DE 307 (318)
Q Consensus 306 ~~ 307 (318)
+.
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.2e-32 Score=234.15 Aligned_cols=150 Identities=26% Similarity=0.425 Sum_probs=134.6
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEecCeeEEEEE
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (318)
++|++.++||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999987 568899999986543 2335688999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceeecCC
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 306 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~~~~ 306 (318)
|+.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999887763 3457889999999999999999999987 999999999999999999999999999987643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-32 Score=241.98 Aligned_cols=150 Identities=25% Similarity=0.401 Sum_probs=127.4
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC-cCHHHHHHHHHHHhccCCCccceEEEEEEecC----eeE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----ENI 223 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 223 (318)
+++|++.++||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999976 5799999999975432 33457899999999999999999999997653 345
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccceee
Q 021046 224 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 303 (318)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~~ 303 (318)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677889999999842 36899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 021046 304 GGD 306 (318)
Q Consensus 304 ~~~ 306 (318)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-31 Score=233.47 Aligned_cols=151 Identities=28% Similarity=0.508 Sum_probs=128.7
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCC--CCcCHHHHHHHHHHHhccCCCccceEEEEEEe--------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-------- 218 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 218 (318)
.++|++.++||+|+||+||+|+. .+|+.||||++... .......+.+|+.+|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57899999999999999999987 57899999998643 33445678999999999999999999999865
Q ss_pred cCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecc
Q 021046 219 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 298 (318)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfG 298 (318)
++..++||||++++.+..+. .....+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999988776554 34556888999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCC
Q 021046 299 MARIFGGD 306 (318)
Q Consensus 299 la~~~~~~ 306 (318)
+|+.+...
T Consensus 163 ~~~~~~~~ 170 (318)
T d3blha1 163 LARAFSLA 170 (318)
T ss_dssp TCEECCC-
T ss_pred eeeecccc
Confidence 99887643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.1e-32 Score=237.52 Aligned_cols=153 Identities=28% Similarity=0.366 Sum_probs=134.0
Q ss_pred hcCCccccccccCCcccEEEEEe----cCCcEEEEEEccCC----CCcCHHHHHHHHHHHhccCC-CccceEEEEEEecC
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQ----SGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQG 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~ 220 (318)
.++|++.+.||+|+||+||+|.. .+|+.||||.++.. .....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37799999999999999999975 24789999998643 22345678899999999977 89999999999999
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..+++|||+.+|+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998843 345678889999999999999999987 999999999999999999999999999
Q ss_pred eeecCCcc
Q 021046 301 RIFGGDEL 308 (318)
Q Consensus 301 ~~~~~~~~ 308 (318)
+.+.....
T Consensus 177 ~~~~~~~~ 184 (322)
T d1vzoa_ 177 KEFVADET 184 (322)
T ss_dssp EECCGGGG
T ss_pred hhhccccc
Confidence 98765443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=236.69 Aligned_cols=149 Identities=26% Similarity=0.413 Sum_probs=123.3
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEecC------
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ 220 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 220 (318)
.++|+..++||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999986 4689999999975322 23457889999999999999999999998664
Q ss_pred eeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccc
Q 021046 221 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 300 (318)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla 300 (318)
..++||||+ +.+|..+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 556766652 346899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCC
Q 021046 301 RIFGGD 306 (318)
Q Consensus 301 ~~~~~~ 306 (318)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.5e-31 Score=230.14 Aligned_cols=152 Identities=29% Similarity=0.459 Sum_probs=125.9
Q ss_pred hcCCccccccccCCcccEEEEEe-cC-CcEEEEEEccCCC--CcCHHHHHHHHHHHhcc---CCCccceEEEEEEec---
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LN-GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQ--- 219 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~--- 219 (318)
.++|++.++||+|+||.||+|+. .+ ++.||||+++... ......+.+|+.+++.| +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999987 34 5679999986432 22334566787777665 799999999998642
Q ss_pred --CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeec
Q 021046 220 --GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 297 (318)
Q Consensus 220 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~Df 297 (318)
...+++|||++++++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 46799999999987765442 34567899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCC
Q 021046 298 GMARIFGGD 306 (318)
Q Consensus 298 Gla~~~~~~ 306 (318)
|+++....+
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=1.7e-30 Score=225.04 Aligned_cols=149 Identities=22% Similarity=0.357 Sum_probs=129.1
Q ss_pred hcCCccccccccCCcccEEEEEec-CCcEEEEEEccCCCCcCHHHHHHHHHHHhccCC-CccceEEEEEEecCeeEEEEE
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGENILIYE 227 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 227 (318)
.++|++.+.||+|+||.||+|+.. +|+.||||.++... ....+.+|+..+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999864 68899999886532 22457889999999976 899999999999999999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----CCCceEeeccccee
Q 021046 228 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARI 302 (318)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-----~~~~ki~DfGla~~ 302 (318)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6888888743 3456899999999999999999999988 999999999999975 57799999999998
Q ss_pred ecCC
Q 021046 303 FGGD 306 (318)
Q Consensus 303 ~~~~ 306 (318)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 8654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.5e-31 Score=232.23 Aligned_cols=149 Identities=28% Similarity=0.390 Sum_probs=126.5
Q ss_pred hcCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCC--cCHHHHHHHHHHHhccCCCccceEEEEEEec-----Ce
Q 021046 150 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE 221 (318)
Q Consensus 150 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 221 (318)
.++|++.++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999986 5699999999975432 2345788999999999999999999998643 34
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.++++||+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577888899999999883 346899999999999999999999988 9999999999999999999999999998
Q ss_pred eecC
Q 021046 302 IFGG 305 (318)
Q Consensus 302 ~~~~ 305 (318)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 7643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=6.9e-30 Score=221.93 Aligned_cols=148 Identities=24% Similarity=0.393 Sum_probs=122.2
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccce-EEEEEEecCeeEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR-LFGCCIEQGENILIYEY 228 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~ 228 (318)
++|++.+.||+|+||.||+|++ .+++.||||.+..... ..++..|+.+++.++|+|++. +.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999986 5688999998875432 346889999999998776554 55666777889999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCCceEeecccceeecC
Q 021046 229 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGG 305 (318)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~ki~DfGla~~~~~ 305 (318)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 455554432 3456899999999999999999999988 999999999999864 55799999999998865
Q ss_pred C
Q 021046 306 D 306 (318)
Q Consensus 306 ~ 306 (318)
.
T Consensus 159 ~ 159 (299)
T d1ckia_ 159 A 159 (299)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5e-30 Score=228.00 Aligned_cols=147 Identities=29% Similarity=0.392 Sum_probs=120.8
Q ss_pred cCCccccccccCCcccEEEEEec-CCcEEEEEEccCCC--CcCHHHHHHHHHHHhccCCCccceEEEEEEec------Ce
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------GE 221 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 221 (318)
++|++.++||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++... +.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999875 68999999997542 23345688999999999999999999999643 67
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 222 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.|+||||+.++.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876554432 35789999999999999999999988 9999999999999999999999999998
Q ss_pred eecCC
Q 021046 302 IFGGD 306 (318)
Q Consensus 302 ~~~~~ 306 (318)
.....
T Consensus 168 ~~~~~ 172 (355)
T d2b1pa1 168 TAGTS 172 (355)
T ss_dssp -----
T ss_pred ccccc
Confidence 77543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=9.6e-26 Score=182.75 Aligned_cols=135 Identities=20% Similarity=0.222 Sum_probs=106.1
Q ss_pred ccccccccCCcccEEEEEecCCcEEEEEEccCCCCc------------------CHHHHHHHHHHHhccCCCccceEEEE
Q 021046 154 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ------------------GLTEFKNEMMLIAKLQHRHLVRLFGC 215 (318)
Q Consensus 154 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~ 215 (318)
.+.++||+|+||.||+|...+|+.||||.++..... .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999889999999987532100 01234567888999999999988765
Q ss_pred EEecCeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCCceEe
Q 021046 216 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 295 (318)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ki~ 295 (318)
. ..+++|||++++.+.. ++......++.|++.+|.|||+++ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 3479999998875533 223345678999999999999987 99999999999998654 8999
Q ss_pred ecccceeecCC
Q 021046 296 DFGMARIFGGD 306 (318)
Q Consensus 296 DfGla~~~~~~ 306 (318)
|||+|+.....
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999887543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.91 E-value=7.3e-25 Score=194.91 Aligned_cols=151 Identities=22% Similarity=0.300 Sum_probs=121.9
Q ss_pred cCCccccccccCCcccEEEEEe-cCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-----------CCccceEEEEEEe
Q 021046 151 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----------HRHLVRLFGCCIE 218 (318)
Q Consensus 151 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 218 (318)
.+|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999987 568999999997532 23456788998888775 5789999998875
Q ss_pred c--CeeEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCC----
Q 021046 219 Q--GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMN---- 291 (318)
Q Consensus 219 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~---- 291 (318)
. ...++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 5667778777666544443334456678899999999999999999998 55 999999999999987654
Q ss_pred --ceEeecccceeecC
Q 021046 292 --PKISDFGMARIFGG 305 (318)
Q Consensus 292 --~ki~DfGla~~~~~ 305 (318)
+|++|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 89999999987653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.87 E-value=1e-08 Score=85.08 Aligned_cols=148 Identities=16% Similarity=0.104 Sum_probs=101.2
Q ss_pred HHHHhcCCccccccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC-CCccceEEEEEEecCeeEE
Q 021046 146 VSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 146 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 224 (318)
+....+.|...+..+-++-+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+...++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 444556776655544444568999875 45667888887654444556788888877764 4446788888888899999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 021046 225 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS---------------------------------- 270 (318)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------- 270 (318)
||+++++.++....... .....++.+++..+..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998875543110 112234455555555565321
Q ss_pred ----------------------CCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 271 ----------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 271 ----------------------~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
...++|+|+.|.||++++++.+-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999877778999998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.47 E-value=5.7e-07 Score=73.83 Aligned_cols=131 Identities=18% Similarity=0.190 Sum_probs=87.0
Q ss_pred ccccCCc-ccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccC--CCccceEEEEEEecCeeEEEEEeccCCCh
Q 021046 158 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQGENILIYEYMPNKSL 234 (318)
Q Consensus 158 ~lg~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L 234 (318)
.+..|.. +.||+....++..+.+|...... ...+..|...+..+. .-.+.+++.+..+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 57899988888888888765433 235677887777664 33467788888888889999999988766
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 021046 235 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH----------------------------------------------- 267 (318)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH----------------------------------------------- 267 (318)
.... ... ...+.+++..|.-||
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3311 000 011122222333333
Q ss_pred ----hc----CCCCeeecCCCCCCEEEcCCCCceEeeccccee
Q 021046 268 ----QY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 268 ----~~----~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
.. ....++|+|+.|.||+++.+..+-|.||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112389999999999999877788999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.85 E-value=3.8e-05 Score=66.95 Aligned_cols=76 Identities=12% Similarity=0.156 Sum_probs=49.0
Q ss_pred ccccccCCcccEEEEEecC-CcEEEEEEccCC-------CCcCHHHHHHHHHHHhccC-C--CccceEEEEEEecCeeEE
Q 021046 156 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLTEFKNEMMLIAKLQ-H--RHLVRLFGCCIEQGENIL 224 (318)
Q Consensus 156 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 224 (318)
.+.||.|....||+....+ ++.+.||.-... -+...++...|...|..+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3578999999999998654 678888864321 1123345566887776652 2 345566644 5566789
Q ss_pred EEEeccCCC
Q 021046 225 IYEYMPNKS 233 (318)
Q Consensus 225 v~e~~~~g~ 233 (318)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.42 E-value=0.00058 Score=57.57 Aligned_cols=135 Identities=15% Similarity=0.158 Sum_probs=78.4
Q ss_pred ccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCccc--eEE-----EEEEecCeeEEEEEeccCCChhh-
Q 021046 165 GPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV--RLF-----GCCIEQGENILIYEYMPNKSLDV- 236 (318)
Q Consensus 165 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~g~L~~- 236 (318)
-.||+.+..+|..+++|..+.. ....+++..|...+..|...++. ..+ .....++..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998653 23456788888888777432221 111 12244567789999998755421
Q ss_pred ----h------h---hc------CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCe
Q 021046 237 ----F------L---FY------PKKKRLLGWQ-------------------ARVRIIEGIAQGLLYLHQ----YSRLRI 274 (318)
Q Consensus 237 ----~------l---~~------~~~~~~l~~~-------------------~~~~i~~~i~~~l~yLH~----~~~~~i 274 (318)
+ + +. .......++. ....+...+...++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0 00 0011112211 111122222233333322 223468
Q ss_pred eecCCCCCCEEEcCCCCceEeeccccee
Q 021046 275 IHRDLKASNILLDSDMNPKISDFGMARI 302 (318)
Q Consensus 275 vH~Dlk~~Nill~~~~~~ki~DfGla~~ 302 (318)
||+|+.|.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.05 E-value=0.00098 Score=57.69 Aligned_cols=72 Identities=21% Similarity=0.335 Sum_probs=48.6
Q ss_pred cccccCCcccEEEEEecCC--------cEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc-ceEEEEEEecCeeEEEEE
Q 021046 157 CKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYE 227 (318)
Q Consensus 157 ~~lg~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 227 (318)
+.|+.|-.=.+|+...+++ +.|.+++.- . .....+..+|..+++.+.-.++ +++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5777788888999987543 456665554 2 3344556788888888753344 467777642 68999
Q ss_pred eccCCCh
Q 021046 228 YMPNKSL 234 (318)
Q Consensus 228 ~~~~g~L 234 (318)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.65 E-value=0.0099 Score=49.23 Aligned_cols=157 Identities=12% Similarity=0.030 Sum_probs=80.9
Q ss_pred cHHHHHHHhcCCcccc-----ccccCCcccEEEEEecCCcEEEEEEccCCCCcCHHHHHHHHHHHhccCCCcc--ceEEE
Q 021046 142 SLASVSAATENFSTQC-----KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL--VRLFG 214 (318)
Q Consensus 142 ~~~~~~~~~~~~~~~~-----~lg~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~ 214 (318)
+.+++.....+|.+++ .|..|---+.|+.+..+|+ +++|+..... ..+++..|+.++..|...++ +..+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 4455666667776543 3445555778999876664 7888876532 22345556666666643222 11110
Q ss_pred ------EEEecCeeEEEEEeccCCChhhhh--------------h------c-CCCCCCCCH-----------------H
Q 021046 215 ------CCIEQGENILIYEYMPNKSLDVFL--------------F------Y-PKKKRLLGW-----------------Q 250 (318)
Q Consensus 215 ------~~~~~~~~~lv~e~~~~g~L~~~l--------------~------~-~~~~~~l~~-----------------~ 250 (318)
+....+....++.+..+....... + . ........+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 122345566777777665442110 0 0 000000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCCceEeecccce
Q 021046 251 ARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 301 (318)
Q Consensus 251 ~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~ki~DfGla~ 301 (318)
.....+......+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111122222222221 123469999999999999988888999999875
|